comparison	O
of	O
24	O
-	O
h	O
volume	O
and	O
creatinine	O
-	O
corrected	O
total	O
urinary	O
polyphenol	O
as	O
a	O
biomarker	O
of	O
total	O
dietary	O
polyphenols	B
in	O
the	O
invecchiare	O
inchianti	O
study	O
..	O

polyphenols	B
have	O
beneficial	O
effects	O
on	O
several	O
chronic	O
diseases	O
but	O
assessing	O
polyphenols	B
intake	O
from	O
self	O
-	O
reported	O
dietary	O
questionnaires	O
tends	O
to	O
be	O
inaccurate	O
and	O
not	O
very	O
reliable	O
.	O

a	O
promising	O
alternative	O
is	O
to	O
use	O
urinary	O
excretion	O
of	O
polyphenols	B
as	O
a	O
proxy	O
measure	O
of	O
intake	O
.	O

the	O
purpose	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
correlation	O
between	O
polyphenols	B
dietary	O
intake	O
and	O
total	O
urinary	O
polyphenol	O
excretion	O
(	O
tpe	O
)	O
,	O
expressed	O
by	O
both	O
24	O
-	O
h	O
volume	O
and	O
urinary	O
creatinine	O
normalization	O
in	O
928	O
participants	O
from	O
the	O
inchianti	O
study	O
.	O

however	O
,	O
urinary	O
tpe	O
expressed	O
by	O
creatinine	O
correction	O
was	O
significantly	O
correlated	O
with	O
dietary	O
polyphenols	B
after	O
adjusting	O
for	O
covariates	O
(	O
pr=0.113	O
;	O
p=0.002	O
)	O
.	O

overnight	O
urinary	O
isoflavone	O
excretion	O
in	O
a	O
population	O
of	O
women	O
living	O
in	O
the	O
united	O
states	O
,	O
and	O
its	O
relationship	O
to	O
isoflavone	O
intake	O
..	O
dietary	O
isoflavones	B
are	O
biologically	O
active	O
in	O
humans	O
,	O
but	O
few	O
observational	O
data	O
exist	O
on	O
the	O
relationship	O
between	O
isoflavone	O
intake	O
and	O
excretion	O
in	O
western	O
populations	O
.	O

isoflavones	B
(	O
genistein	O
,	O
daidzein	O
,	O
o	O
-	O
desmethylangolensin	O
,	O
and	O
equol	B
)	O
were	O
measured	O
in	O
two	O
overnight	O
urine	O
collections	O
from	O
363	O
women	O
recruited	O
from	O
a	O
health	O
maintenance	O
organization	O
.	O

women	O
who	O
consumed	O
soy	O
at	O
either	O
of	O
the	O
two	O
diet	O
recalls	O
or	O
at	O
the	O
ffq	O
(	O
at	O
least	O
once	O
a	O
week	O
or	O
at	O
least	O
once	O
a	O
month	O
)	O
had	O
a	O
significantly	O
higher	O
urinary	O
excretion	O
of	O
isoflavones	B
than	O
women	O
who	O
did	O
not	O
consume	O
soy	O
(	O
p	O
<	O
0.01	O
)	O
.	O

excretion	O
of	O
the	O
individual	O
isoflavones	B
correlated	O
significantly	O
between	O
the	O
two	O
urine	O
samples	O
collected	O
48	O
h	O
apart	O
(	O
genistein	O
,	O
r	O
=	O
0.41	O
and	O
p	O
<	O
0.001	O
;	O
daidzein	O
,	O
r	O
=	O
0.30	O
and	O
p	O
<	O
0.001	O
;	O
o	O
-	O
desmethylangolensin	O
,	O
r	O
=	O
0.46	O
and	O
p	O
<	O
0.001	O
;	O
equol	B
,	O
r	O
=	O
0.60	O
and	O
p	O
<	O
0.001	O
)	O
.	O

phyto	O
-	O
oestrogen	O
intake	O
in	O
scottish	O
men	O
:	O
use	O
of	O
serum	O
to	O
validate	O
a	O
self	O
-	O
administered	O
food	O
-	O
frequency	O
questionnaire	O
in	O
older	O
men	O
..	O
objective	O
:	O
to	O
study	O
dietary	O
intake	O
and	O
serum	O
concentrations	O
of	O
isoflavones	B
in	O
order	O
to	O
provide	O
relative	O
validation	O
of	O
isoflavone	O
intake	O
estimates	O
from	O
the	O
scottish	O
collaborative	O
group	O
-	O
food	O
-	O
frequency	O
questionnaire	O
(	O
scg	O
-	O
ffq	O
)	O
.	O

method	O
:	O
dietary	O
intake	O
of	O
isoflavones	B
was	O
estimated	O
using	O
the	O
semiquantitative	O
scg	O
-	O
ffq	O
and	O
rank	O
correlation	O
and	O
kappa	O
statistics	O
were	O
used	O
for	O
the	O
relative	O
validation	O
of	O
intakes	O
against	O
serum	O
isoflavone	O
concentrations	O
in	O
203	O
male	O
participants	O
who	O
were	O
population	O
controls	O
in	O
a	O
case	O
-	O
control	O
study	O
of	O
diet	O
and	O
prostate	O
cancer	O
.	O

results	O
:	O
the	O
median	O
intake	O
of	O
isoflavones	B
(	O
daidzein	B
and	O
genistein	B
)	O
was	O
1.0mg	O
/	O
day	O
(	O
l	O
-	O
qr	O
0.6	O
-	O
1.8	O
)	O
.	O

the	O
median	O
serum	O
concentration	O
of	O
genistein	B
was	O
33.79	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
14.12	O
-	O
64.93	O
)	O
,	O
nearly	O
twice	O
that	O
of	O
daidzein	B
(	O
18.00	O
nmol	O
/	O
l	O
,	O
i	O
-	O
qr	O
8.26	O
-	O
29.45	O
)	O
.	O

equol	B
was	O
detected	O
in	O
49	O
%	O
of	O
subjects	O
;	O
in	O
these	O
subjects	O
the	O
median	O
was	O
0.67	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
0.34	O
-	O
1.51	O
)	O
.	O

isoflavone	O
intake	O
was	O
significantly	O
correlated	O
with	O
serum	O
concentrations	O
of	O
daidzein	B
(	O
p	O
=	O
0.24	O
,	O
p	O
=	O
0.001	O
)	O
,	O
genistein	B
(	O
p	O
=	O
0.26	O
,	O
p	O
<	O
0.001	O
)	O
and	O
total	O
isoflavonoids	O
(	O
sum	O
of	O
daidzein	B
,	O
genistein	B
and	O
equol	B
)	O
(	O
p	O
=	O
0.27	O
,	O
p	O
<	O
0.001	O
)	O
.	O

whereas	O
values	O
for	O
weighted	O
kappa	O
ranged	O
from	O
0.16	O
(	O
p	O
=	O
0.002	O
)	O
for	O
daidzein	B
and	O
equol	B
combined	O
to	O
0.22	O
(	O
p	O
<	O
0.001	O
)	O
for	O
genistein	B
.	O

objective	O
:	O
to	O
study	O
dietary	O
intake	O
and	O
serum	O
concentrations	O
of	O
isoflavones	B
in	O
order	O
to	O
provide	O
relative	O
validation	O
of	O
isoflavone	O
intake	O
estimates	O
from	O
the	O
scottish	O
collaborative	O
group	O
-	O
food	O
-	O
frequency	O
questionnaire	O
(	O
scg	O
-	O
ffq	O
)	O
.	O

method	O
:	O
dietary	O
intake	O
of	O
isoflavones	B
was	O
estimated	O
using	O
the	O
semiquantitative	O
scg	O
-	O
ffq	O
and	O
rank	O
correlation	O
and	O
kappa	O
statistics	O
were	O
used	O
for	O
the	O
relative	O
validation	O
of	O
intakes	O
against	O
serum	O
isoflavone	O
concentrations	O
in	O
203	O
male	O
participants	O
who	O
were	O
population	O
controls	O
in	O
a	O
case	O
-	O
control	O
study	O
of	O
diet	O
and	O
prostate	O
cancer	O
.	O

results	O
:	O
the	O
median	O
intake	O
of	O
isoflavones	B
(	O
daidzein	B
and	O
genistein	B
)	O
was	O
1.0mg	O
/	O
day	O
(	O
l	O
-	O
qr	O
0.6	O
-	O
1.8	O
)	O
.	O

the	O
median	O
serum	O
concentration	O
of	O
genistein	B
was	O
33.79	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
14.12	O
-	O
64.93	O
)	O
,	O
nearly	O
twice	O
that	O
of	O
daidzein	B
(	O
18.00	O
nmol	O
/	O
l	O
,	O
i	O
-	O
qr	O
8.26	O
-	O
29.45	O
)	O
.	O

equol	B
was	O
detected	O
in	O
49	O
%	O
of	O
subjects	O
;	O
in	O
these	O
subjects	O
the	O
median	O
was	O
0.67	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
0.34	O
-	O
1.51	O
)	O
.	O

isoflavone	O
intake	O
was	O
significantly	O
correlated	O
with	O
serum	O
concentrations	O
of	O
daidzein	B
(	O
p	O
=	O
0.24	O
,	O
p	O
=	O
0.001	O
)	O
,	O
genistein	B
(	O
p	O
=	O
0.26	O
,	O
p	O
<	O
0.001	O
)	O
and	O
total	O
isoflavonoids	O
(	O
sum	O
of	O
daidzein	B
,	O
genistein	B
and	O
equol	B
)	O
(	O
p	O
=	O
0.27	O
,	O
p	O
<	O
0.001	O
)	O
.	O

whereas	O
values	O
for	O
weighted	O
kappa	O
ranged	O
from	O
0.16	O
(	O
p	O
=	O
0.002	O
)	O
for	O
daidzein	B
and	O
equol	B
combined	O
to	O
0.22	O
(	O
p	O
<	O
0.001	O
)	O
for	O
genistein	B
.	O

objective	O
:	O
to	O
study	O
dietary	O
intake	O
and	O
serum	O
concentrations	O
of	O
isoflavones	B
in	O
order	O
to	O
provide	O
relative	O
validation	O
of	O
isoflavone	O
intake	O
estimates	O
from	O
the	O
scottish	O
collaborative	O
group	O
-	O
food	O
-	O
frequency	O
questionnaire	O
(	O
scg	O
-	O
ffq	O
)	O
.	O

method	O
:	O
dietary	O
intake	O
of	O
isoflavones	B
was	O
estimated	O
using	O
the	O
semiquantitative	O
scg	O
-	O
ffq	O
and	O
rank	O
correlation	O
and	O
kappa	O
statistics	O
were	O
used	O
for	O
the	O
relative	O
validation	O
of	O
intakes	O
against	O
serum	O
isoflavone	O
concentrations	O
in	O
203	O
male	O
participants	O
who	O
were	O
population	O
controls	O
in	O
a	O
case	O
-	O
control	O
study	O
of	O
diet	O
and	O
prostate	O
cancer	O
.	O

results	O
:	O
the	O
median	O
intake	O
of	O
isoflavones	B
(	O
daidzein	B
and	O
genistein	B
)	O
was	O
1.0mg	O
/	O
day	O
(	O
l	O
-	O
qr	O
0.6	O
-	O
1.8	O
)	O
.	O

the	O
median	O
serum	O
concentration	O
of	O
genistein	B
was	O
33.79	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
14.12	O
-	O
64.93	O
)	O
,	O
nearly	O
twice	O
that	O
of	O
daidzein	B
(	O
18.00	O
nmol	O
/	O
l	O
,	O
i	O
-	O
qr	O
8.26	O
-	O
29.45	O
)	O
.	O

equol	B
was	O
detected	O
in	O
49	O
%	O
of	O
subjects	O
;	O
in	O
these	O
subjects	O
the	O
median	O
was	O
0.67	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
0.34	O
-	O
1.51	O
)	O
.	O

isoflavone	O
intake	O
was	O
significantly	O
correlated	O
with	O
serum	O
concentrations	O
of	O
daidzein	B
(	O
p	O
=	O
0.24	O
,	O
p	O
=	O
0.001	O
)	O
,	O
genistein	B
(	O
p	O
=	O
0.26	O
,	O
p	O
<	O
0.001	O
)	O
and	O
total	O
isoflavonoids	O
(	O
sum	O
of	O
daidzein	B
,	O
genistein	B
and	O
equol	B
)	O
(	O
p	O
=	O
0.27	O
,	O
p	O
<	O
0.001	O
)	O
.	O

whereas	O
values	O
for	O
weighted	O
kappa	O
ranged	O
from	O
0.16	O
(	O
p	O
=	O
0.002	O
)	O
for	O
daidzein	B
and	O
equol	B
combined	O
to	O
0.22	O
(	O
p	O
<	O
0.001	O
)	O
for	O
genistein	B
.	O

objective	O
:	O
to	O
study	O
dietary	O
intake	O
and	O
serum	O
concentrations	O
of	O
isoflavones	B
in	O
order	O
to	O
provide	O
relative	O
validation	O
of	O
isoflavone	O
intake	O
estimates	O
from	O
the	O
scottish	O
collaborative	O
group	O
-	O
food	O
-	O
frequency	O
questionnaire	O
(	O
scg	O
-	O
ffq	O
)	O
.	O

method	O
:	O
dietary	O
intake	O
of	O
isoflavones	B
was	O
estimated	O
using	O
the	O
semiquantitative	O
scg	O
-	O
ffq	O
and	O
rank	O
correlation	O
and	O
kappa	O
statistics	O
were	O
used	O
for	O
the	O
relative	O
validation	O
of	O
intakes	O
against	O
serum	O
isoflavone	O
concentrations	O
in	O
203	O
male	O
participants	O
who	O
were	O
population	O
controls	O
in	O
a	O
case	O
-	O
control	O
study	O
of	O
diet	O
and	O
prostate	O
cancer	O
.	O

results	O
:	O
the	O
median	O
intake	O
of	O
isoflavones	B
(	O
daidzein	B
and	O
genistein	B
)	O
was	O
1.0mg	O
/	O
day	O
(	O
l	O
-	O
qr	O
0.6	O
-	O
1.8	O
)	O
.	O

the	O
median	O
serum	O
concentration	O
of	O
genistein	B
was	O
33.79	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
14.12	O
-	O
64.93	O
)	O
,	O
nearly	O
twice	O
that	O
of	O
daidzein	B
(	O
18.00	O
nmol	O
/	O
l	O
,	O
i	O
-	O
qr	O
8.26	O
-	O
29.45	O
)	O
.	O

equol	B
was	O
detected	O
in	O
49	O
%	O
of	O
subjects	O
;	O
in	O
these	O
subjects	O
the	O
median	O
was	O
0.67	O
nmol	O
/	O
l	O
(	O
i	O
-	O
qr	O
0.34	O
-	O
1.51	O
)	O
.	O

isoflavone	O
intake	O
was	O
significantly	O
correlated	O
with	O
serum	O
concentrations	O
of	O
daidzein	B
(	O
p	O
=	O
0.24	O
,	O
p	O
=	O
0.001	O
)	O
,	O
genistein	B
(	O
p	O
=	O
0.26	O
,	O
p	O
<	O
0.001	O
)	O
and	O
total	O
isoflavonoids	O
(	O
sum	O
of	O
daidzein	B
,	O
genistein	B
and	O
equol	B
)	O
(	O
p	O
=	O
0.27	O
,	O
p	O
<	O
0.001	O
)	O
.	O

whereas	O
values	O
for	O
weighted	O
kappa	O
ranged	O
from	O
0.16	O
(	O
p	O
=	O
0.002	O
)	O
for	O
daidzein	B
and	O
equol	B
combined	O
to	O
0.22	O
(	O
p	O
<	O
0.001	O
)	O
for	O
genistein	B
.	O

overnight	O
urinary	O
excretion	O
of	O
isoflavones	B
as	O
an	O
indicator	O
for	O
dietary	O
isoflavone	O
intake	O
in	O
korean	O
girls	O
of	O
pubertal	O
age	O
..	O
little	O
is	O
known	O
about	O
the	O
bioavailability	O
of	O
isoflavones	B
in	O
children	O
.	O

total	O
and	O
individual	O
isoflavone	O
(	O
daidzein	O
,	O
genistein	B
and	O
glycitein	B
)	O
intakes	O
were	O
calculated	O
from	O
diet	O
records	O
.	O

the	O
parent	O
isoflavone	O
compounds	O
(	O
daidzein	O
,	O
genistein	B
and	O
glycitein	B
)	O
and	O
their	O
metabolites	O
(	O
equol	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydrodaidzein	B
and	O
dihydrogenistein	B
)	O
present	O
in	O
the	O
urine	O
samples	O
were	O
analysed	O
using	O
liquid	O
chromatography	O
-	O
ms	O
.	O

results	O
:	O
the	O
mean	O
intake	O
estimates	O
(	O
7	O
-	O
d	O
period	O
)	O
of	O
quercetin	O
,	O
kaempferol	O
,	O
naringenin	O
,	O
and	O
hesperetin	B
amounted	O
to	O
17.9	O
,	O
4.7	O
,	O
12.1	O
,	O
and	O
17.4	O
mg	O
/	O
d	O
,	O
respectively	O
;	O
the	O
corresponding	O
mean	O
plasma	O
concentrations	O
were	O
22.9	O
,	O
10.7	O
,	O
8.2	O
,	O
and	O
22.2	O
nmol	O
/	O

food	O
frequency	O
questionnaires	O
and	O
overnight	O
urines	O
are	O
valid	O
indicators	O
of	O
daidzein	B
and	O
genistein	B
intake	O
in	O
u.s	O
.	O

in	O
these	O
women	O
,	O
24	O
-	O
h	O
sample	O
measures	O
were	O
correlated	O
with	O
sfq	O
estimates	O
of	O
daidzein	B
(	O
spearman	O
r	O
=	O
.48	O
)	O
and	O
genistein	B
(	O
r	O
=	O
.54	O
)	O
intake	O
,	O
moderately	O
correlated	O
with	O
the	O
willett	O
ffq	O
(	O
daidzein	B
r	O
=	O
.38	O
,	O
genistein	B
r	O
=	O
.33	O
)	O
,	O
and	O
strongly	O
correlated	O
with	O
overnight	O
urine	O
excretion	O
(	O
daidzein	B
r	O
=	O
.84	O
,	O
genistein	B
r	O
=	O
0.93	O
)	O
.	O

among	O
all	O
451	O
sfq	O
respondents	O
,	O
mean	O
(	O
median	O
)	O
daidzein	B
and	O
genistein	B
intakes	O
were	O
2.8	O
(	O
0.24	O
)	O
and	O
3.9	O
(	O
0.30	O
)	O

urine	O
flavonoids	B
and	O
plasma	O
carotenoids	B
in	O
the	O
validation	O
of	O
fruit	O
,	O
vegetable	O
and	O
tea	O
intake	O
during	O
pregnancy	O
in	O
the	O
norwegian	O
mother	O
and	O
child	O
cohort	O
study	O
(	O
moba	O
)	O
..	O
objective	O
:	O
to	O
validate	O
a	O
new	O
food	O
-	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
for	O
measuring	O
the	O
intake	O
of	O
fruit	O
,	O
vegetables	O
and	O
tea	O
reported	O
by	O
women	O
participating	O
in	O
the	O
norwegian	O
mother	O
and	O
child	O
cohort	O
study	O
(	O
moba	O
)	O
.	O

results	O
:	O
the	O
ffq	O
estimate	O
of	O
fruit	O
intake	O
was	O
significantly	O
correlated	O
with	O
urine	O
phloretin	B
(	O
r	O
=	O
0.33	O
)	O
,	O
citrus	O
fruit	O
/	O
juice	O
with	O
urine	O
hesperetin	B
(	O
r	O
=	O
0.44	O
)	O
,	O
cooked	O
vegetables	O
with	O
plasma	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.37	O
)	O
,	O
and	O
tea	O
with	O
urine	O
kaempferol	B
(	O
r	O
=	O
0.41	O
)	O
(	O
p	O
<	O
0.01	O
for	O
all	O
)	O
.	O

comparison	O
of	O
standard	O
methods	O
for	O
assessing	O
dietary	O
intake	O
of	O
benzo[a]pyrene	B
..	O
background	O
:	O
inconsistent	O
presence	O
and	O
strength	O
of	O
associations	O
between	O
dietary	O
benzo[a]pyrene	B
(	O
bap	O
)	O
exposure	O
and	O
cancers	O
may	O
be	O
due	O
to	O
differences	O
in	O
exposure	O
assessment	O
methods	O
.	O

meat	O
and	O
bap	O
intake	O
estimated	O
from	O
baseline	O
and	O
follow	O
-	O
up	O
ffqs	O
combined	O
with	O
a	O
bap	O
residue	O
database	O
(	O
ffq	O
-	O
rd	O
)	O
,	O
mean	O
meat	O
and	O
bap	O
intake	O
estimated	O
from	O
three	O
diet	O
diaries	O
coupled	O
with	O
the	O
residue	O
database	O
(	O
diary	O
-	O
rd	O
)	O
,	O
and	O
mean	O
of	O
three	O
urinary	O
1	B
-	I
hydroxypyrene	I
glucuronide	I
(	O
1	O
-	O
ohpg	O
)	O
measurements	O
were	O
compared	O
using	O
spearman	O
correlations	O
.	O

background	O
:	O
inconsistent	O
presence	O
and	O
strength	O
of	O
associations	O
between	O
dietary	O
benzo[a]pyrene	B
(	O
bap	O
)	O
exposure	O
and	O
cancers	O
may	O
be	O
due	O
to	O
differences	O
in	O
exposure	O
assessment	O
methods	O
.	O

meat	O
and	O
bap	O
intake	O
estimated	O
from	O
baseline	O
and	O
follow	O
-	O
up	O
ffqs	O
combined	O
with	O
a	O
bap	O
residue	O
database	O
(	O
ffq	O
-	O
rd	O
)	O
,	O
mean	O
meat	O
and	O
bap	O
intake	O
estimated	O
from	O
three	O
diet	O
diaries	O
coupled	O
with	O
the	O
residue	O
database	O
(	O
diary	O
-	O
rd	O
)	O
,	O
and	O
mean	O
of	O
three	O
urinary	O
1	B
-	I
hydroxypyrene	I
glucuronide	I
(	O
1	O
-	O
ohpg	O
)	O
measurements	O
were	O
compared	O
using	O
spearman	O
correlations	O
.	O

plasma	O
alkylresorcinol	B
metabolites	I
as	O
potential	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
cereal	O
fibre	O
intakes	O
in	O
women	O
..	O

duplicate	O
diets	O
,	O
complete	O
urine	O
collections	O
and	O
plasma	O
samples	O
were	O
analysed	O
for	O
total	O
genistein	B
and	O
daidzein	B
using	O
liquid	O
chromatography	O
-	O
ms	O
to	O
determine	O
po	O
intake	O
.	O

rapid	O
folin	O
-	O
ciocalteu	O
method	O
using	O
microtiter	O
96	O
-	O
well	O
plate	O
cartridges	O
for	O
solid	O
phase	O
extraction	O
to	O
assess	O
urinary	O
total	O
phenolic	O
compounds	O
,	O
as	O
a	O
biomarker	O
of	O
total	O
polyphenols	B
intake	O
..	O
nutritional	O
markers	O
have	O
several	O
advantages	O
for	O
epidemiologic	O
and	O
clinical	O
assays	O
,	O
when	O
compared	O
to	O
dietary	O
data	O
obtained	O
by	O
food	O
frequency	O
questionnaires	O
.	O

the	O
assay	O
was	O
optimized	O
;	O
the	O
sensitivity	O
and	O
the	O
polarity	O
range	O
of	O
urine	O
polyphenols	B
were	O
increased	O
and	O
the	O
detection	O
and	O
quantification	O
limits	O
were	O
significantly	O
reduced	O
.	O

relation	O
between	O
plasma	O
enterodiol	B
and	O
enterolactone	B
and	O
dietary	O
intake	O
of	O
lignans	B
in	O
a	O
dutch	O
endoscopy	O
-	O
based	O
population	O
..	O
enterolignans	O
are	O
phytoestrogenic	O
compounds	O
derived	O
from	O
the	O
conversion	O
of	O
dietary	O
lignans	B
by	O
the	O
intestinal	O
microflora	O
that	O
may	O
be	O
protective	O
against	O
cardiovascular	O
diseases	O
and	O
cancer	O
.	O

to	O
evaluate	O
the	O
use	O
of	O
enterolignans	O
as	O
biomarkers	O
of	O
dietary	O
lignan	O
intake	O
,	O
we	O
studied	O
the	O
relation	O
between	O
plasma	O
and	O
dietary	O
lignans	B
.	O

we	O
determined	O
the	O
dietary	O
intake	O
of	O
4	O
lignans	B
(	O
secoisolariciresinol	B
(	O
seco	O
)	O
,	O
matairesinol	B
(	O
mat	O
)	O
,	O
pinoresinol	O
,	O
and	O
lariciresinol	B
)	O
using	O
the	O
european	O
prospective	O
investigation	O
into	O
cancer	O
and	O
nutrition	O
ffq	O
,	O
and	O
plasma	O
enterodiol	B
(	O
end	O
)	O
and	O
enterolactone	B
(	O
enl	O
)	O
concentrations	O
were	O
determined	O
by	O
liquid	O
chromatography	O
-	O
tandem	O
mass	O
spectrometry	O
.	O

validity	O
correlations	O
(	O
ffq	O
compared	O
to	O
dietary	O
recalls	O
)	O
ranged	O
from	O
0.67	O
to	O
0.79	O
for	O
the	O
major	O
phytoestrogenic	O
compounds	O
(	O
i.e.	O
,	O
daidzein	O
,	O
genistein	O
,	O
and	O
secoisolariciresinol	B
)	O
and	O
0.43	O
to	O
0.54	O
for	O
the	O
less	O
common	O
compounds	O
.	O

compared	O
to	O
urinary	O
levels	O
,	O
validity	O
correlations	O
ranged	O
from	O
0.41	O
to	O
0.55	O
for	O
the	O
isoflavones	B
and	O
0.16	O
to	O
0.21	O
for	O
total	O
lignans	O
.	O

pearson	O
correlation	O
coefficients	O
between	O
2	O
ffqs	O
were	O
0.62	O
for	O
flavonol	O
and	O
0.65	O
for	O
flavone	O
and	O
ranged	O
from	O
0.48	O
(	O
quercetin	B
)	O
to	O
0.63	O
(	O
luteolin	B
)	O
(	O
all	O
p	O
<	O
.05	O
)	O
.	O

pearson	O
correlation	O
coefficients	O
between	O
ffq	O
and	O
24	O
-	O
hdr	O
were	O
0.62	O
for	O
flavonol	O
and	O
0.68	O
for	O
flavone	O
and	O
ranged	O
from	O
0.36	O
(	O
quercetin	B
)	O
to	O
0.63	O
(	O
luteolin	B
)	O
(	O
all	O
p	O
<	O
.05	O
)	O
.	O

between	O
the	O
ffq	O
and	O
plasma	O
samples	O
,	O
pearson	O
correlation	O
coefficients	O
were	O
0.52	O
for	O
flavonol	O
and	O
0.41	O
for	O
flavone	O
and	O
ranged	O
from	O
0.32	O
(	O
quercetin	B
)	O
to	O
0.44	O
(	O
kaempferol	B
)	O
(	O
all	O
p	O
<	O
.05	O
)	O
.	O

resveratrol	B
metabolites	I
in	O
urine	O
as	O
a	O
biomarker	O
of	O
wine	O
intake	O
in	O
free	O
-	O
living	O
subjects	O
:	O
the	O
predimed	O
study	O
..	O
several	O
clinical	O
and	O
epidemiological	O
studies	O
have	O
shown	O
that	O
moderate	O
wine	O
consumption	O
may	O
exert	O
a	O
protective	O
effect	O
against	O
oxidative	O
stress	O
involved	O
in	O
several	O
diseases	O
,	O
such	O
as	O
cardiovascular	O
and	O
neurodegenerative	O
disorders	O
.	O

a	O
reliable	O
biomarker	O
for	O
wine	O
consumption	O
is	O
,	O
therefore	O
,	O
needed	O
.	O
to	O
validate	O
urinary	O
resveratrol	B
metabolites	I
(	O
rms	O
)	O
as	O
a	O
biomarker	O
of	O
wine	O
consumption	O
in	O
a	O
large	O
cohort	O
of	O
free	O
-	O
living	O
subjects	O
,	O
1000	O
consecutive	O
subjects	O
entering	O
a	O
substudy	O
of	O
the	O
predimed	O
trial	O
(	O
prevención	O
con	O
dieta	O
mediterránea	O
)	O
were	O
evaluated	O
.	O

soya	O
intake	O
and	O
plasma	O
concentrations	O
of	O
daidzein	B
and	O
genistein	B
:	O
validity	O
of	O
dietary	O
assessment	O
among	O
eighty	O
british	O
women	O
(	O
oxford	O
arm	O
of	O
the	O
european	O
prospective	O
investigation	O
into	O
cancer	O
and	O
nutrition	O
)	O
..	O

soya	O
products	O
contain	O
high	O
levels	O
of	O
the	O
isoflavones	B
genistein	B
and	O
daidzein	B
,	O
and	O
their	O
glucosides	O
,	O
and	O
may	O
lower	O
the	O
risk	O
of	O
cardiovascular	O
disease	O
,	O
osteoporosis	O
and	O
cancer	O
.	O

the	O
present	O
cross	O
-	O
sectional	O
study	O
investigated	O
plasma	O
concentrations	O
of	O
daidzein	B
and	O
genistein	B
and	O
their	O
correlations	O
with	O
dietary	O
soya	O
consumption	O
in	O
four	O
groups	O
of	O
twenty	O
premenopausal	O
british	O
women	O
.	O

dietary	O
intakes	O
of	O
isoflavones	B
were	O
additionally	O
assessed	O
by	O
7	O
d	O
food	O
diaries	O
.	O

plasma	O
concentrations	O
of	O
daidzein	B
and	O
genistein	B
were	O
measured	O
by	O
time	O
-	O
resolved	O
fluoroimmunoassay	O
.	O

geometric	O
mean	O
plasma	O
concentrations	O
(	O
nmol	O
/	O
l	O
)	O
were	O
for	O
the	O
four	O
groups	O
,	O
which	O
were	O
based	O
on	O
increasing	O
soya	O
intake	O
,	O
4.9	O
,	O
8.4	O
,	O
39.2	O
and	O
132	O
for	O
daidzein	B
and	O
14.3	O
,	O
16.5	O
,	O
119	O
and	O
378	O
for	O
genistein	B
.	O

we	O
conclude	O
that	O
both	O
the	O
food	O
diary	O
and	O
the	O
ffq	O
estimate	O
dietary	O
soya	O
isoflavone	O
intakes	O
sufficiently	O
well	O
to	O
use	O
them	O
in	O
epidemiological	O
studies	O
,	O
and	O
that	O
plasma	O
concentrations	O
of	O
daidzein	B
and	O
genistein	B
in	O
western	O
women	O
who	O
consumed	O
soya	O
products	O
as	O
a	O
part	O
of	O
their	O
regular	O
diet	O
were	O
close	O
to	O
those	O
in	O
asian	O
populations	O
.	O

the	O
relationship	O
between	O
fasting	O
plasma	O
concentrations	O
of	O
selected	O
flavonoids	B
and	O
their	O
ordinary	O
dietary	O
intake	O
..	O
epidemiological	O
studies	O
suggest	O
that	O
a	O
diet	O
high	O
in	O
flavonoids	B
protects	O
against	O
chronic	O
diseases	O
such	O
as	O
cvd	O
and	O
cancer	O
.	O

the	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
relationship	O
between	O
the	O
intake	O
of	O
quercetin	O
,	O
kaempferol	O
,	O
isorhamnetin	O
,	O
apigenin	B
and	O
luteolin	B
and	O
their	O
corresponding	O
plasma	O
concentrations	O
,	O
and	O
further	O
to	O
explore	O
whether	O
these	O
flavonoids	B
can	O
serve	O
as	O
biomarkers	O
of	O
their	O
intake	O
.	O

in	O
addition	O
,	O
we	O
undertook	O
a	O
dietary	O
intervention	O
study	O
to	O
investigate	O
plasma	O
apigenin	B
concentration	O
after	O
the	O
consumption	O
of	O
celery	O
leaf	O
.	O

the	O
mean	O
intake	O
estimates	O
of	O
quercetin	O
,	O
kaempferol	O
,	O
isorhamnetin	O
,	O
apigenin	B
and	O
luteolin	B
amounted	O
to	O
13.58	O
,	O
14.97	O
,	O
12.31	O
,	O
4.23	O
and	O
8.08	O
mg	O
/	O
d	O
,	O
respectively	O
.	O

l.	O
the	O
mean	O
7	O
d	O
intake	O
of	O
five	O
flavonoids	B
was	O
positively	O
correlated	O
to	O
their	O
corresponding	O
plasma	O
concentrations	O
,	O
with	O
correlation	O
coefficients	O
ranging	O
from	O
0.33	O
to	O
0.51	O
(	O
p	O
<	O
0.05	O
)	O
.	O

in	O
the	O
dietary	O
intervention	O
study	O
,	O
the	O
plasma	O
apigenin	B
concentration	O
rose	O
after	O
celery	O
leaf	O
ingestion	O
,	O
and	O
fell	O
within	O
28	O
h	O
to	O
below	O
the	O
limit	O
of	O
detection	O
(	O
2.32	O
nmol	O
/	O
l	O
)	O
.	O

the	O
present	O
results	O
suggest	O
that	O
quercetin	O
,	O
kaempferol	O
,	O
isorhamnetin	O
,	O
apigenin	B
and	O
luteolin	B
are	O
bioavailable	O
from	O
the	O
diet	O
.	O

the	O
levels	O
of	O
fasting	O
plasma	O
flavonoids	B
seem	O
to	O
be	O
suitable	O
biomarkers	O
of	O
short	O
-	O
term	O
intake	O
.	O

the	O
combination	O
of	O
plasma	O
flavonoids	B
with	O
their	O
intake	O
may	O
prove	O
useful	O
when	O
the	O
possible	O
health	O
-	O
protective	O
effects	O
of	O
flavonoids	B
are	O
studied	O
.	O

hippuric	B
acid	I
in	O
24	O
-	O
hour	O
urine	O
collections	O
is	O
a	O
potential	O
biomarker	O
for	O
fruit	O
and	O
vegetable	O
consumption	O
in	O
healthy	O
children	O
and	O
adolescents	O
..	O
an	O
objective	O
noninvasive	O
biomarker	O
for	O
fruit	O
and	O
vegetable	O
(	O
fv	O
)	O
consumption	O
would	O
help	O
to	O
more	O
reliably	O
characterize	O
the	O
relationship	O
between	O
fv	O
intake	O
and	O
health	O
status	O
in	O
observational	O
studies	O
.	O

because	O
increases	O
in	O
urinary	O
hippuric	B
acid	I
(	O
ha	O
)	O
were	O
observed	O
after	O
consumption	O
of	O
several	O
fv	O
varieties	O
,	O
we	O
aimed	O
to	O
investigate	O
whether	O
24	O
-	O
h	O
urinary	O
ha	O
may	O
represent	O
a	O
potential	O
biomarker	O
for	O
fv	O
consumption	O
in	O
children	O
and	O
adolescents	O
.	O

the	O
association	O
of	O
fv	O
and	O
juice	O
(	O
fvj	O
)	O
intake	O
calculated	O
from	O
3	O
-	O
d	O
weighed	O
dietary	O
records	O
with	O
24	O
-	O
h	O
urinary	O
ha	O
excretion	O
was	O
analyzed	O
in	O
240	O
healthy	O
children	O
and	O
adolescents	O
and	O
compared	O
with	O
associations	O
of	O
the	O
established	O
biomarkers	O
urinary	O
nitrogen	B
(	O
un	O
)	O
and	O
urinary	O
potassium	B
(	O
uk	O
)	O
with	O
protein	O
and	O
potassium	B
intake	O
,	O
respectively	O
.	O

potential	O
confounders	O
for	O
the	O
ha	O
-	O
fvj	O
association	O
were	O
examined	O
in	O
linear	O
regression	O
models	O
.	O
in	O
children	O
,	O
correlations	O
of	O
ha	O
with	O
fvj	O
(	O
r	O
=	O
0.62	O
)	O
,	O
un	O
with	O
protein	O
(	O
r	O
=	O
0.64	O
)	O
,	O
and	O
potassium	B
intake	O
with	O
uk	O
(	O
r	O
=	O
0.65	O
)	O
were	O
comparable	O
.	O
in	O
adolescents	O
,	O
the	O
ha	O
-	O
fvj	O
association	O
was	O
weaker	O
(	O
r	O
=	O
0.41	O
)	O
compared	O
with	O
the	O
biomarkers	O
un	O
(	O
r	O
=	O
0.60	O
)	O
and	O
uk	O
(	O
r	O
=	O
0.58	O
)	O
(	O
all	O
p	O
<	O
0.0001	O
)	O
.	O

urinary	O
isoflavones	B
and	O
their	O
metabolites	O
validate	O
the	O
dietary	O
isoflavone	O
intakes	O
in	O
us	O
adults	O
..	O
background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

background	O
:	O
isoflavones	B
are	O
derived	O
from	O
dietary	O
sources	O
and	O
considered	O
to	O
promote	O
health	O
by	O
preventing	O
the	O
onset	O
of	O
such	O
chronic	O
diseases	O
as	O
cardiovascular	O
disease	O
,	O
cancer	O
,	O
and	O
osteoporosis	O
.	O

valid	O
and	O
reliable	O
estimation	O
of	O
isoflavone	O
intake	O
is	O
a	O
prerequisite	O
to	O
establishing	O
biological	O
functions	O
of	O
isoflavones	B
on	O
health	O
risks	O
.	O

the	O
isoflavone	O
intakes	O
were	O
from	O
genistein	B
(	O
55	O
%	O
)	O
,	O
diadzein	O
(	O
35	O
%	O
)	O
,	O
glycitein	B
(	O
7	O
%	O
)	O
,	O
biochanin	B
a	I
(	O
2	O
%	O
)	O
,	O
and	O
formononetin	B
(	O
2	O
%	O
)	O
.	O

geometric	O
mean	O
urinary	O
isoflavone	O
concentration	O
was	O
5.0	O
ng	O
/	O
ml	O
among	O
isoflavone	O
consumers	O
and	O
the	O
urinary	O
genistein	B
and	O
daidzein	B
excretion	O
correlated	O
with	O
their	O
isoflavone	O
intake	O
levels	O
(	O
p<0.01	O
)	O
.	O

conclusions	O
:	O
in	O
large	O
population	O
-	O
based	O
studies	O
,	O
estimated	O
dietary	O
isoflavone	O
intake	O
can	O
be	O
validated	O
by	O
urinary	O
isoflavones	B
.	O

validation	O
of	O
a	O
phytoestrogen	O
food	O
frequency	O
questionnaire	O
with	O
urinary	O
concentrations	O
of	O
isoflavones	B
and	O
lignan	O
metabolites	O
in	O
premenopausal	O
women	O
..	O
objective	O
:	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
dietary	O
intake	O
of	O
phytoestrogens	B
estimated	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
with	O
urinary	O
metabolites	O
.	O

dietary	O
intake	O
of	O
isoflavones	B
(	O
genistein	B
and	O
daidzein	B
)	O
and	O
lignans	B
(	O
secoisolariciresinol	B
and	O
matairesinol	O
)	O
were	O
estimated	O
by	O
a	O
53	O
-	O
item	O
interviewer	O
-	O
administered	O
ffq	O
on	O
two	O
occasions	O
,	O
reflecting	O
'	O
habitual	O
'	O
(	O
previous	O
2	O
months	O
)	O
and	O
'	O
recent	O
'	O
(	O
previous	O
2	O
days	O
)	O
dietary	O
intake	O
.	O

isoflavone	O
(	O
genistein	B
,	O
daidzein	B
)	O
and	O
lignan	O
(	O
enterolactone	O
,	O
enterodiol	B
and	O
secoisolariciresinol	B
)	O
concentrations	O
were	O
measured	O
in	O
24	O
-	O
hour	O
urine	O
samples	O
by	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
.	O

mean	O
urinary	O
concentrations	O
of	O
isoflavones	B
and	O
lignans	B
were	O
17.4	O
micromol	O
/	O
day	O
and	O
20.6	O
micromol	O
/	O
day	O
,	O
respectively	O
.	O

urinary	O
excretion	O
of	O
lignans	B
was	O
also	O
modestly	O
correlated	O
with	O
recent	O
and	O
habitual	O
lignan	O
intakes	O
(	O
r	O
=	O
0.46	O
,	O
p	O
=	O
0.02	O
and	O
r	O
=	O
0.40	O
,	O
p	O
=	O
0.05	O
,	O
respectively	O
)	O
.	O

fasting	O
plasma	O
daidzein	B
and	O
genistein	B
concentrations	O
were	O
determined	O
with	O
liquid	O
chromatography	O
-	O
mass	O
spectrometry	O
.	O

we	O
investigated	O
the	O
validity	O
and	O
reproducibility	O
of	O
isoflavone	O
(	O
daidzein	B
and	O
genistein	B
)	O
intakes	O
from	O
self	O
-	O
administered	O
semiquantitative	O
ffq	O
used	O
in	O
the	O
jphc	O
study	O
(	O
japan	O
public	O
health	O
center	O
-	O
based	O
prospective	O
study	O
on	O
cancer	O
and	O
cardiovascular	O
diseases	O
)	O
.	O

for	O
daidzein	B
,	O
mean	O
intakes	O
estimated	O
from	O
ffq	O
and	O
dr	O
,	O
serum	O
concentration	O
and	O
urine	O
excretion	O
were	O
18.3	O
mg	O
/	O
d	O
,	O
14.5	O
mg	O
/	O
d	O
,	O
119.9	O
nmol	O
/	O
l	O
and	O
17.0	O
micromol	O
/	O
d	O
and	O
for	O
genistein	B
,	O
31.4	O
mg	O
/	O
d	O
,	O
23.4	O
mg	O
/	O
d	O
,	O
475.3	O
nmol	O
/	O
l	O
and	O
14.2	O
micromol	O
/	O
d	O
,	O
respectively	O
.	O

spearman	O
correlation	O
coefficients	O
for	O
daidzein	B
of	O
energy	O
-	O
adjusted	O
intakes	O
from	O
ffq	O
with	O
those	O
from	O
dr	O
,	O
serum	O
concentration	O
and	O
creatinine	O
-	O
adjusted	O
urinary	O
excretion	O
were	O
0.64	O
,	O
0.31	O
and	O
0.43	O
,	O
respectively	O
.	O

results	O
were	O
similar	O
for	O
genistein	B
.	O

we	O
investigated	O
the	O
validity	O
and	O
reproducibility	O
of	O
isoflavone	O
(	O
daidzein	B
and	O
genistein	B
)	O
intakes	O
from	O
self	O
-	O
administered	O
semiquantitative	O
ffq	O
used	O
in	O
the	O
jphc	O
study	O
(	O
japan	O
public	O
health	O
center	O
-	O
based	O
prospective	O
study	O
on	O
cancer	O
and	O
cardiovascular	O
diseases	O
)	O
.	O

for	O
daidzein	B
,	O
mean	O
intakes	O
estimated	O
from	O
ffq	O
and	O
dr	O
,	O
serum	O
concentration	O
and	O
urine	O
excretion	O
were	O
18.3	O
mg	O
/	O
d	O
,	O
14.5	O
mg	O
/	O
d	O
,	O
119.9	O
nmol	O
/	O
l	O
and	O
17.0	O
micromol	O
/	O
d	O
and	O
for	O
genistein	B
,	O
31.4	O
mg	O
/	O
d	O
,	O
23.4	O
mg	O
/	O
d	O
,	O
475.3	O
nmol	O
/	O
l	O
and	O
14.2	O
micromol	O
/	O
d	O
,	O
respectively	O
.	O

spearman	O
correlation	O
coefficients	O
for	O
daidzein	B
of	O
energy	O
-	O
adjusted	O
intakes	O
from	O
ffq	O
with	O
those	O
from	O
dr	O
,	O
serum	O
concentration	O
and	O
creatinine	O
-	O
adjusted	O
urinary	O
excretion	O
were	O
0.64	O
,	O
0.31	O
and	O
0.43	O
,	O
respectively	O
.	O

results	O
were	O
similar	O
for	O
genistein	B
.	O

free	O
fruit	O
at	O
workplace	O
intervention	O
increases	O
total	O
fruit	O
intake	O
:	O
a	O
validation	O
study	O
using	O
24	O
 	O
h	O
dietary	O
recall	O
and	O
urinary	O
flavonoid	O
excretion	O
..	O
background	O
/	O
objectives	O
:	O
to	O
validate	O
24	O
 	O
h	O
dietary	O
recall	O
of	O
fruit	O
intake	O
by	O
measuring	O
the	O
total	O
24	O
 	O
h	O
excretion	O
of	O
10	O
different	O
flavonoids	B
in	O
24	O
 	O
h	O
urine	O
during	O
an	O
intervention	O
with	O
free	O
fruit	O
at	O
workplaces	O
.	O

ten	O
flavonoids	B
,	O
quercetin	O
,	O
isorhamnetin	O
,	O
tamarixetin	O
,	O
kaempferol	O
,	O
hesperetin	B
,	O
naringenin	B
,	O
eriodictyol	O
,	O
daidzein	O
,	O
genistein	O
,	O
and	O
phloretin	B
,	O
were	O
measured	O
using	O
hplc	O
-	O
electrospray	O
ionization	O
-	O
ms	O
.	O

results	O
:	O
the	O
24	O
 	O
h	O
urinary	O
excretion	O
of	O
total	O
flavonoids	B
and	O
the	O
estimated	O
intake	O
of	O
fruits	O
were	O
significantly	O
correlated	O
(	O
r	O
(	O
s)=0.31	O
,	O
p<0.01	O
)	O
.	O

the	O
dietary	O
intake	O
of	O
citrus	O
fruits	O
and	O
citrus	O
juices	O
was	O
significantly	O
correlated	O
with	O
total	O
excretion	O
of	O
citrus	O
specific	O
flavonoids	B
(	O
r	O
(	O
s)=0.28	O
,	O
p<0.01	O
)	O
,	O
and	O
orange	O
was	O
positively	O
correlated	O
with	O
naringenin	B
(	O
r	O
(	O
s)=0.24	O
,	O
p<0.01	O
)	O
and	O
hesperetin	B
(	O
r	O
(	O
s)=0.24	O
,	O
p<0.01	O
)	O
.	O

phloretin	B
in	O
urine	O
was	O
correlated	O
with	O
apple	O
intake	O
(	O
r	O
(	O
s)=0.22	O
,	O
p<0.01	O
)	O
and	O
also	O
with	O
overall	O
estimated	O
intake	O
of	O
fruit	O
(	O
r	O
(	O
s)=0.22	O
,	O
p<0.01	O
)	O
.	O

validation	O
of	O
a	O
soy	O
food	O
frequency	O
questionnaire	O
with	O
plasma	O
concentrations	O
of	O
isoflavones	O
in	O
us	O
adults	O
..	O
objective	O
:	O
to	O
validate	O
assessment	O
of	O
soy	O
intake	O
using	O
food	O
frequency	O
questionnaires	O
(	O
ffqs	O
)	O
compared	O
with	O
plasma	O
isoflavone	O
(	O
genistein	B
and	O
daidzein	B
)	O
concentrations	O
.	O

genistein	B
and	O
daidzein	B
intakes	O
determined	O
by	O
the	O
soy	O
ffq	O
were	O
significantly	O
correlated	O
with	O
plasma	O
concentrations	O
(	O
r	O
=	O
0.53	O
and	O
0.45	O
,	O
respectively	O
)	O
.	O

validity	O
and	O
reproducibility	O
of	O
a	O
food	O
frequency	O
questionnaire	O
for	O
assessment	O
of	O
fruit	O
and	O
vegetable	O
intake	O
in	O
iranian	O
adults	O
(	O
*	O
)	O
..	O
background	O
:	O
this	O
study	O
's	O
aim	O
was	O
to	O
design	O
and	O
validate	O
a	O
semi	O
-	O
quantitative	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
for	O
assessment	O
of	O
fruits	O
and	O
vegetables	O
(	O
fv	O
)	O
consumption	O
in	O
adults	O
of	O
isfahan	O
by	O
comparing	O
the	O
ffq	O
with	O
dietary	O
reference	O
method	O
and	O
blood	O
plasma	O
levels	O
of	O
beta	B
-	I
carotene	I
,	O
vitamin	O
c	O
,	O
and	O
retinol	B
.	O

in	O
each	O
phase	O
a	O
ffq	O
and	O
1	O
day	O
recall	O
,	O
and	O
2	O
days	O
of	O
food	O
records	O
as	O
the	O
dietary	O
reference	O
method	O
were	O
completed	O
and	O
plasma	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
retinol	B
were	O
measured	O
.	O

results	O
:	O
serum	O
lipids	O
,	O
sex	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
and	O
educational	O
level	O
adjusted	O
pearson	O
correlation	O
coefficient	O
of	O
fv	O
with	O
plasma	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
retinol	B
were	O
0.55	O
,	O
0.47	O
and	O
0.28	O
in	O
the	O
cold	O
season	O
(	O
p	O
<	O
0.05	O
)	O
and	O
0.52	O
,	O
0.45	O
and	O
0.35	O
in	O
the	O
warm	O
season	O
(	O
p	O
<	O
0.001	O
)	O
,	O
respectively	O
.	O

plasma	O
alkylresorcinol	O
concentrations	O
correlate	O
with	O
whole	O
grain	O
wheat	O
and	O
rye	O
intake	O
and	O
show	O
moderate	O
reproducibility	O
over	O
a	O
2-	O
to	O
3	O
-	O
month	O
period	O
in	O
free	O
-	O
living	O
swedish	O
adults	O
..	O
plasma	O
alkylresorcinols	B
(	O
ar	O
)	O
are	O
useful	O
as	O
dietary	O
biomarkers	O
of	O
wheat	O
and	O
rye	O
whole	O
grain	O
(	O
wg	O
)	O
during	O
interventions	O
but	O
need	O
to	O
be	O
validated	O
in	O
free	O
-	O
living	O
populations	O
.	O

mean	O
intakes	O
from	O
4	O
-	O
d	O
dietary	O
recalls	O
were	O
correlated	O
with	O
plasma	O
xanthophyll	O
concentrations	O
(	O
lutein	O
+	O
zeaxanthin	O
and	O
β	O
-	O
cryptoxanthin	O
)	O
and	O
hydrocarbon	O
carotenoids	O
(	O
lycopene	B
,	O
α	O
-	O
carotene	O
,	O
and	O
β	O
-	O
carotene	O
)	O
.	O

results	O
:	O
adjusted	O
correlations	O
of	O
plasma	O
carotenoids	O
with	O
reported	O
dietary	O
intakes	O
for	O
african	O
americans	O
in	O
the	O
24	O
-	O
h	O
dietary	O
recall	O
ranged	O
from	O
0.03	O
for	O
β	O
-	O
carotene	O
to	O
0.40	O
for	O
β	O
-	O
cryptoxanthin	O
.	O
for	O
whites	O
,	O
the	O
correlations	O
ranged	O
from	O
0.13	O
for	O
lycopene	B
to	O
0.51	O
for	O
β	O
-	O
cryptoxanthin	O
.	O

conclusions	O
:	O
despite	O
stronger	O
validity	O
in	O
reported	O
energy	B
intakes	O
for	O
african	O
americans	O
than	O
for	O
whites	O
in	O
the	O
24	O
-	O
h	O
dietary	O
recall	O
in	O
the	O
energetics	O
study	O
,	O
both	O
recalls	O
and	O
food	O
-	O
frequency	O
dietary	O
assessment	O
methods	O
yielded	O
lower	O
correlations	O
in	O
african	O
americans	O
than	O
in	O
whites	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O
.	O

results	O
:	O
the	O
urinary	O
level	O
of	O
each	O
water	O
-	O
soluble	O
vitamin	O
was	O
correlated	O
positively	O
to	O
its	O
mean	O
intake	O
in	O
the	O
past	O
2	O
-	O
4	O
d	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0·42	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0·43	O
,	O
p	O
<	O
0·001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0·49	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0·32	O
,	O
p	O
<	O
0·001	O
;	O
folic	O
acid	O
:	O
r	O
=	O
0·27	O
,	O
p	O
<	O
0·01	O
;	O
vitamin	O
c	O
:	O
r	O
=	O
0·39	O
,	O
p	O
<	O
0.001	O
)	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
r	O
=	O
0·10	O
,	O
p	O
=	O
ns	O
)	O
.	O

estimated	O
mean	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
levels	O
and	O
recovery	O
rates	O
were	O
97	O
-	O
102	O
%	O
of	O
their	O
3	O
d	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
79	O
%	O
)	O
.	O

conclusions	O
:	O
the	O
results	O
show	O
that	O
urinary	O
levels	O
of	O
water	O
-	O
soluble	O
vitamins	O
,	O
except	O
for	O
vitamin	B
b12	I
,	O
reflected	O
their	O
recent	O
intakes	O
in	O
free	O
-	O
living	O
japanese	O
schoolchildren	O
and	O
could	O
be	O
used	O
as	O
a	O
potential	O
biomarker	O
to	O
estimate	O
mean	O
vitamin	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

results	O
:	O
water	O
-	O
soluble	O
vitamin	O
intake	O
using	O
a	O
food	O
database	O
including	O
cooked	O
food	O
was	O
lower	O
than	O
intakes	O
estimated	O
using	O
a	O
database	O
composed	O
of	O
raw	O
food	O
only	O
,	O
except	O
for	O
pantothenic	B
acid	I
and	O
vitamin	O
b(12	O
)	O
intake	O
.	O

determinants	O
of	O
plasma	O
alkylresorcinol	O
concentration	O
in	O
danish	O
post	O
-	O
menopausal	O
women	O
..	O
background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

background	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
,	O
a	O
group	O
of	O
phenolic	O
lipids	O
present	O
in	O
the	O
outer	O
parts	O
of	O
wheat	O
and	O
rye	O
grain	O
kernels	O
,	O
have	O
been	O
suggested	O
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
.	O

validation	O
of	O
an	O
ffq	O
to	O
estimate	O
the	O
intake	O
of	O
fatty	B
acids	I
using	O
erythrocyte	O
membrane	O
fatty	B
acids	I
and	O
multiple	O
3d	O
dietary	O
records	O
..	O
objective	O
:	O
the	O
estimation	O
of	O
dietary	O
intake	O
in	O
population	O
-	O
based	O
studies	O
is	O
often	O
assessed	O
by	O
the	O
ffq	O
.	O

design	O
:	O
the	O
method	O
of	O
triads	O
was	O
applied	O
to	O
obtain	O
the	O
validity	O
coefficients	O
(	O
vc	O
)	O
of	O
the	O
ffq	O
for	O
specific	O
fatty	B
acids	I
.	O

the	O
vc	O
of	O
the	O
ffq	O
estimated	O
by	O
the	O
method	O
of	O
triads	O
were	O
0.72	O
,	O
0.61	O
,	O
0.65	O
,	O
0.75	O
and	O
0.67	O
for	O
mufa	O
,	O
total	O
n-6	O
fatty	B
acids	I
,	O
alpha	O
-	O
linolenic	O
acid	O
,	O
epa	O
and	O
dha	O
,	O
respectively	O
.	O

the	O
vc	O
could	O
not	O
be	O
calculated	O
for	O
sfa	O
,	O
pufa	O
and	O
total	O
n-3	O
fatty	B
acids	I
because	O
of	O
negative	O
correlations	O
among	O
the	O
three	O
measurements	O
.	O

but	O
,	O
the	O
correlations	O
between	O
the	O
ffq	O
and	O
the	O
dietary	O
records	O
were	O
moderate	O
for	O
these	O
fatty	B
acids	I
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

results	O
:	O
each	O
urinary	O
water	O
-	O
soluble	O
vitamin	O
level	O
,	O
except	O
for	O
vitamin	O
b(12	O
)	O
,	O
was	O
correlated	O
positively	O
with	O
its	O
mean	O
intake	O
in	O
the	O
recent	O
2	O
-	O
4	O
days	O
(	O
vitamin	O
b(1	O
):	O
r=0.42	O
,	O
p<0.001	O
;	O
vitamin	O
b(2	O
):	O
r=0.43	O
,	O
p<0.001	O
;	O
vitamin	O
b(6	O
):	O
r=0.40	O
,	O
p<0.001	O
;	O
vitamin	O
b(12	O
):	O
r=0.06	O
,	O
p=0.493	O
;	O
niacin	B
:	O
r=0.35	O
,	O
p<0.001	O
;	O
niacin	B
equivalents	O
:	O
r=0.33	O
,	O
p<0.001	O
;	O
pantothenic	O
acid	O
:	O
r=0.47	O
,	O
p<0.001	O
;	O
folate	O
:	O
r=0.27	O
,	O
p=0.001	O
;	O
vitamin	O
c	O
:	O
r=0.44	O
,	O
p<0.001	O
)	O
.	O

alcohol	O
consumption	O
is	O
associated	O
with	O
high	O
concentrations	O
of	O
urinary	O
hydroxytyrosol	B
..	O
background	O
:	O
previously	O
,	O
we	O
reported	O
the	O
presence	O
of	O
hydroxytyrosol	B
in	O
red	O
wine	O
and	O
higher	O
human	O
urinary	O
recovery	O
of	O
total	O
hydroxytyrosol	B
than	O
that	O
expected	O
after	O
a	O
single	O
red	O
wine	O
intake	O
.	O

we	O
hypothesized	O
that	O
the	O
alcohol	O
present	O
in	O
wine	O
could	O
promote	O
endogenous	O
hydroxytyrosol	B
generation	O
.	O

objective	O
:	O
the	O
objective	O
was	O
to	O
assess	O
the	O
relation	O
between	O
alcohol	O
consumption	O
and	O
urinary	O
hydroxytyrosol	B
concentrations	O
.	O

urinary	O
hydroxytyrosol	B
and	O
ethyl	B
glucuronide	I
,	O
a	O
biomarker	O
of	O
alcohol	O
consumption	O
,	O
were	O
measured	O
.	O

results	O
:	O
urinary	O
ethyl	B
glucuronide	I
concentrations	O
were	O
directly	O
related	O
to	O
alcohol	O
and	O
wine	O
consumption	O
(	O
p	O
<	O
0.001	O
)	O
as	O
well	O
as	O
to	O
urinary	O
hydroxytyrosol	B
in	O
both	O
sexes	O
(	O
p	O
<	O
0.001	O
)	O
.	O

the	O
degree	O
of	O
alcohol	O
consumption	O
was	O
directly	O
associated	O
with	O
urinary	O
hydroxytyrosol	B
in	O
male	O
alcohol	O
consumers	O
(	O
p	O
<	O
0.001	O
)	O
.	O

multivariate	O
logistic	O
regression	O
analyses	O
showed	O
a	O
significant	O
linear	O
trend	O
(	O
p	O
<	O
0.05	O
)	O
for	O
elevated	O
hydroxytyrosol	B
concentrations	O
with	O
an	O
increase	O
in	O
alcohol	O
consumption	O
.	O

intakes	O
of	O
>	O
20	O
g	O
(	O
2	O
drinks)/d	O
and	O
>	O
10	O
g	O
(	O
1	O
drink)/d	O
alcohol	O
in	O
men	O
and	O
women	O
,	O
respectively	O
,	O
were	O
associated	O
(	O
p	O
<	O
0.05	O
)	O
with	O
elevated	O
concentrations	O
of	O
hydroxytyrosol	B
.	O

conclusions	O
:	O
we	O
report	O
for	O
the	O
first	O
time	O
a	O
direct	O
association	O
between	O
urinary	O
hydroxytyrosol	B
and	O
alcohol	O
consumption	O
at	O
a	O
population	O
level	O
.	O

these	O
findings	O
reinforce	O
previous	O
work	O
in	O
human	O
and	O
animal	O
models	O
that	O
examines	O
wine	O
as	O
a	O
source	O
of	O
hydroxytyrosol	B
and	O
alcohol	O
as	O
an	O
indirect	O
promoter	O
of	O
endogenous	O
hydroxytyrosol	B
generation	O
.	O

this	O
study	O
evaluated	O
the	O
accuracy	O
of	O
dietary	O
intakes	O
of	O
folate	O
,	O
vitamin	B
b12	I
,	O
riboflavin	B
and	O
vitamin	B
b6	I
as	O
measured	O
by	O
the	O
northern	O
sweden	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
against	O
repeated	O
24	O
-	O
h	O
recalls	O
(	O
24hr	O
)	O
and	O
plasma	O
levels	O
,	O
taking	O
into	O
consideration	O
the	O
mthfr	O
677c	O
>	O
t	O
polymorphism	O
.	O

subjects	O
/	O
methods	O
:	O
b	O
vitamin	O
intakes	O
assessed	O
by	O
a	O
semi	O
-	O
quantitative	O
ffq	O
designed	O
to	O
measure	O
the	O
intake	O
over	O
the	O
previous	O
year	O
were	O
compared	O
with	O
those	O
from	O
10	O
24hr	O
,	O
as	O
well	O
as	O
to	O
plasma	O
levels	O
of	O
folate	O
and	O
vitamin	B
b12	I
,	O
in	O
randomly	O
selected	O
men	O
(	O
n=96	O
)	O
and	O
women	O
(	O
n=99	O
)	O
aged	O
30	O
-	O
60	O
years	O
.	O

results	O
:	O
intakes	O
of	O
vitamins	O
b12	O
and	O
riboflavin	B
were	O
similar	O
,	O
whereas	O
folate	O
and	O
b6	O
intakes	O
were	O
16	O
-	O
27	O
%	O
higher	O
,	O
as	O
estimated	O
by	O
ffq	O
versus	O
24hr	O
.	O

spearman	O
correlation	O
coefficients	O
between	O
the	O
two	O
methods	O
ranged	O
from	O
0.31	O
to	O
0.63	O
(	O
all	O
p	O
<	O
or=0.002	O
)	O
,	O
and	O
were	O
lowest	O
for	O
vitamin	B
b12	I
.	O

intakes	O
estimated	O
by	O
ffq	O
were	O
correlated	O
with	O
plasma	O
levels	O
,	O
but	O
coefficients	O
were	O
lower	O
(	O
range	O
:	O
0.13	O
-	O
0.33	O
)	O
,	O
particularly	O
for	O
vitamin	B
b12	I
in	O
men	O
(	O
0.15	O
-	O
0.18	O
)	O
.	O

the	O
ffq	O
is	O
suitable	O
for	O
ranking	O
individuals	O
by	O
intake	O
of	O
folate	O
,	O
riboflavin	B
,	O
vitamin	B
b6	I
and	O
to	O
a	O
lesser	O
extent	O
vitamin	B
b12	I
.	O

biomarkers	O
of	O
low	O
-	O
level	O
mercury	B
exposure	O
through	O
fish	O
consumption	O
in	O
pregnant	O
and	O
lactating	O
slovenian	O
women	O
..	O
in	O
order	O
to	O
assess	O
the	O
mercury	B
exposure	O
of	O
pregnant	O
and	O
lactating	O
women	O
in	O
slovenia	O
,	O
levels	O
of	O
total	O
mercury	B
(	O
thg	O
)	O
and	O
methylmercury	B
(	O
mehg	O
)	O
were	O
determined	O
in	O
hair	O
,	O
cord	O
blood	O
and	O
breast	O
milk	O
.	O

this	O
could	O
be	O
due	O
to	O
the	O
approximate	O
information	O
on	O
fish	O
consumption	O
obtained	O
from	O
the	O
questionnaires	O
,	O
the	O
high	O
variability	O
of	O
mehg	O
concentrations	O
in	O
fish	O
and	O
a	O
relatively	O
high	O
proportion	O
of	O
inorganic	O
mercury	B
in	O
the	O
biomarkers	O
which	O
originates	O
from	O
sources	O
other	O
than	O
fish	O
.	O

dioxins	O
,	O
polychlorinated	O
biphenyls	O
,	O
methyl	O
mercury	O
and	O
omega-3	O
polyunsaturated	O
fatty	B
acids	I
as	O
biomarkers	O
of	O
fish	O
consumption	O
..	O
background	O
/	O
objectives	O
:	O
to	O
assess	O
biomarkers	O
and	O
frequency	O
questions	O
as	O
measures	O
of	O
fish	O
consumption	O
.	O

dioxins	O
,	O
polychlorinated	O
biphenyls	O
(	O
pcbs	O
)	O
and	O
methyl	O
mercury	O
(	O
mehg	O
)	O
(	O
in	O
the	O
fishermen	O
substudy	O
alone	O
)	O
,	O
and	O
omega-3	O
polyunsaturated	O
fatty	B
acids	I
(	O
omega-3	O
pufas	O
)	O
(	O
in	O
both	O
studies	O
)	O
were	O
analyzed	O
from	O
fasting	O
serum	O
/	O
blood	O
samples	O
.	O

dioxins	O
,	O
polychlorinated	O
biphenyls	O
(	O
pcbs	O
)	O
and	O
methyl	O
mercury	O
(	O
mehg	O
)	O
(	O
in	O
the	O
fishermen	O
substudy	O
alone	O
)	O
,	O
and	O
omega-3	O
polyunsaturated	O
fatty	B
acids	I
(	O
omega-3	O
pufas	O
)	O
(	O
in	O
both	O
studies	O
)	O
were	O
analyzed	O
from	O
fasting	O
serum	O
/	O
blood	O
samples	O
.	O

here	O
we	O
determined	O
the	O
relationship	O
between	O
red	O
blood	O
cell	O
(	O
rbc	O
)	O
omega-3	O
(	O
n-3	O
)	O
long	O
-	O
chain	O
polyunsaturated	O
fatty	B
acids	I
(	O
lc	O
-	O
pufas	O
)	O
and	O
usual	O
dietary	O
marine	O
food	O
product	O
intake	O
among	O
630	O
nunavik	O
inuit	O
adults	O
.	O

marine	O
food	O
product	O
intake	O
was	O
determined	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
and	O
fatty	B
acids	I
were	O
quantified	O
in	O
rbc	O
membranes	O
.	O

urinary	O
excretion	O
of	O
vitamin	O
b1	O
,	O
b2	O
,	O
b6	O
,	O
niacin	B
,	O
pantothenic	O
acid	O
,	O
folate	O
,	O
and	O
vitamin	B
c	I
correlates	O
with	O
dietary	O
intakes	O
of	O
free	O
-	O
living	O
elderly	O
,	O
female	O
japanese	O
..	O
we	O
hypothesized	O
that	O
24	O
-	O
hour	O
urinary	O
excretion	O
of	O
water	O
-	O
soluble	O
vitamins	O
might	O
correlate	O
with	O
their	O
intake	O
in	O
free	O
-	O
living	O
japanese	O
elderly	O
females	O
aged	O
70	O
to	O
84	O
years	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

the	O
urinary	O
levels	O
of	O
all	O
vitamins	O
,	O
except	O
for	O
b(12	O
)	O
(	O
r	O
=	O
0.01	O
;	O
p	O
=	O
.936	O
)	O
,	O
were	O
correlated	O
positively	O
with	O
the	O
mean	O
intake	O
over	O
the	O
recent	O
4	O
days	O
(	O
vitamin	O
b1	O
:	O
r	O
=	O
0.62	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b2	O
:	O
r	O
=	O
0.57	O
;	O
p	O
<	O
.001	O
;	O
vitamin	O
b6	O
:	O
r	O
=	O
0.37	O
;	O
p	O
<	O
.005	O
;	O
niacin	B
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
niacin	B
equivalents	O
:	O
r	O
=	O
0.54	O
;	O
p	O
<	O
.001	O
;	O
pantothenic	O
acid	O
:	O
r	O
=	O
0.59	O
;	O
p	O
<	O
.001	O
;	O
folate	O
:	O
r	O
=	O
0.55	O
;	O
p	O
=	O
.001	O
;	O
and	O
vitamin	B
c	I
:	O
r	O
=	O
0.53	O
;	O
p	O
<	O
.001	O
)	O
.	O

mean	O
estimated	O
intakes	O
of	O
water	O
-	O
soluble	O
vitamins	O
calculated	O
using	O
urinary	O
concentrations	O
and	O
recovery	O
rates	O
showed	O
96	O
%	O
to	O
107	O
%	O
of	O
their	O
3	O
-	O
day	O
mean	O
intake	O
,	O
except	O
for	O
vitamin	B
b12	I
(	O
65	O
%	O
)	O
.	O

biochemical	O
validation	O
of	O
food	O
frequency	O
questionnaire	O
-	O
estimated	O
carotenoid	O
,	O
alpha	B
-	I
tocopherol	I
,	O
and	O
folate	O
intakes	O
among	O
african	O
americans	O
and	O
non	O
-	O
hispanic	O
whites	O
in	O
the	O
southern	O
community	O
cohort	O
study	O
..	O
few	O
food	O
frequency	O
questionnaires	O
(	O
ffqs	O
)	O
have	O
been	O
developed	O
specifically	O
for	O
use	O
among	O
african	O
americans	O
,	O
and	O
reports	O
of	O
ffq	O
performance	O
among	O
african	O
americans	O
or	O
low	O
-	O
income	O
groups	O
assessed	O
using	O
biochemical	O
indicators	O
are	O
scarce	O
.	O

the	O
authors	O
conducted	O
a	O
validation	O
study	O
within	O
the	O
southern	O
community	O
cohort	O
study	O
to	O
evaluate	O
ffq	O
-	O
estimated	O
intakes	O
of	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
beta	B
-	I
cryptoxanthin	I
,	O
lutein	O
/	O
zeaxanthin	O
,	O
lycopene	B
,	O
folate	O
,	O
and	O
alpha	B
-	I
tocopherol	I
in	O
relation	O
to	O
blood	O
levels	O
of	O
these	O
nutrients	O
.	O

levels	O
of	O
biochemical	O
indicators	O
of	O
each	O
micronutrient	O
(	O
alpha	B
-	I
tocopherol	I
among	O
women	O
only	O
)	O
significantly	O
increased	O
with	O
increasing	O
ffq	O
-	O
estimated	O
intake	O
(	O
adjusted	O
correlation	O
coefficients	O
:	O
alpha	O
-	O
carotene	O
,	O
0.35	O
;	O
beta	O
-	O
carotene	O
,	O
0.28	O
;	O
beta	B
-	I
cryptoxanthin	I
,	O
0.35	O
;	O
lutein	O
/	O
zeaxanthin	O
,	O
0.28	O
;	O
lycopene	B
,	O
0.15	O
;	O
folate	O
,	O
0.26	O
;	O
alpha	B
-	I
tocopherol	I
,	O
0.26	O
among	O
women	O
;	O
all	O
p	O
's	O
<	O
0.05	O
)	O
.	O

subjects	O
in	O
the	O
top	O
decile	O
of	O
ffq	O
intake	O
had	O
blood	O
levels	O
that	O
were	O
27	O
%	O
(	O
lycopene	B
)	O
to	O
178	O
%	O
(	O
beta	B
-	I
cryptoxanthin	I
)	O
higher	O
than	O
those	O
of	O
subjects	O
in	O
the	O
lowest	O
decile	O
.	O

linoleic	O
acid	O
is	O
associated	O
with	O
lower	O
long	O
-	O
chain	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
red	O
blood	O
cell	O
lipids	O
of	O
canadian	O
pregnant	O
women	O
..	O
background	O
:	O
arachidonic	O
(	O
ara	O
)	O
,	O
eicosapentaenoic	O
(	O
epa	O
)	O
,	O
and	O
docosahexaenoic	O
(	O
dha	O
)	O
acids	O
are	O
important	O
in	O
membrane	O
glycerophospholipids	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

objective	O
:	O
we	O
determined	O
the	O
relation	O
between	O
dietary	O
n-6	O
(	O
omega-6	O
)	O
and	O
n-3	O
(	O
omega-3	O
)	O
fatty	O
acid	O
intakes	O
and	O
n-6	O
and	O
n-3	O
fatty	B
acids	I
in	O
rbc	O
epgs	O
and	O
phosphatidylcholine	O
in	O
near	O
-	O
term	O
pregnant	O
women	O
.	O

conclusions	O
:	O
membrane	O
fatty	B
acids	I
are	O
influenced	O
by	O
the	O
amount	O
and	O
balance	O
of	O
fatty	O
acid	O
substrates	O
.	O

design	O
:	O
dietary	O
(	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
beta	O
-	O
cryptoxanthin	O
,	O
lutein	O
/	O
zeaxanthin	O
,	O
lycopene	B
,	O
retinol	B
,	O
and	O
vitamin	O
e	O
)	O
intakes	O
over	O
12	O
months	O
were	O
estimated	O
from	O
a	O
121	O
-	O
item	O
ffq	O
.	O

results	O
:	O
correlation	O
coefficients	O
for	O
the	O
carotenoids	O
ranged	O
from	O
0.28	O
for	O
lycopene	B
to	O
0.46	O
for	O
beta	O
-	O
cryptoxanthin	O
.	O

there	O
was	O
no	O
association	O
between	O
dietary	O
and	O
plasma	O
retinol	B
or	O
dietary	O
vitamin	O
e	O
with	O
plasma	O
alpha-	O
and	O
gamma	O
-	O
tocopherol	O
.	O

conclusions	O
:	O
our	O
data	O
suggest	O
that	O
the	O
ffq	O
provides	O
useful	O
information	O
on	O
intakes	O
of	O
each	O
of	O
the	O
carotenoids	O
:	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
beta	O
-	O
cryptoxanthin	O
,	O
lycopene	B
and	O
lutein	O
/	O
zeaxanthin	O
.	O

there	O
was	O
no	O
association	O
between	O
diet	O
and	O
plasma	O
markers	O
of	O
retinol	B
or	O
vitamin	O
e	O
;	O
this	O
may	O
reflect	O
the	O
importance	O
of	O
factors	O
other	O
than	O
intake	O
in	O
modifying	O
circulating	O
levels	O
of	O
these	O
nutrients	O
.	O

correlations	O
between	O
protein	O
intake	O
from	O
the	O
wfr	O
and	O
urinary	O
urea	B
were	O
significant	O
.	O

spearman	O
correlations	O
were	O
calculated	O
between	O
dietary	O
intake	O
and	O
the	O
corresponding	O
biomarkers	O
(	O
serum	O
carotenoids	B
,	O
tocopherols	O
,	O
and	O
erythrocyte	O
fatty	B
acids	I
)	O
.	O

correlations	O
with	O
beta	B
-	I
carotene	I
and	O
beta	B
-	I
cryptoxanthin	I
were	O
significant	O
in	O
the	O
13-	O
and	O
14	O
-	O
y	O
age	O
group	O
(	O
r=0.220	O
-	O
0.333	O
,	O
p<0.030	O
)	O
and	O
the	O
10-	O
and	O
11	O
-	O
y	O
age	O
subgroup	O
who	O
answered	O
the	O
questionnaire	O
with	O
assistance	O
(	O
r=0.295	O
-	O
0.299	O
,	O
respectively	O
,	O
p=0.006	O
)	O
.	O

consumption	O
of	O
green	O
-	O
yellow	O
vegetables	O
and	O
fruits	O
was	O
significantly	O
correlated	O
with	O
beta	B
-	I
carotene	I
and	O
beta	B
-	I
cryptoxanthin	I
levels	O
(	O
r=0.205	O
-	O
0.341	O
,	O
p<0.047	O
)	O
.	O

total	O
seafood	O
intake	O
was	O
significantly	O
correlated	O
with	O
marine	O
n-3	O
polyunsaturated	O
fatty	B
acids	I
(	O
pufas	O
;	O
r=0.239	O
-	O
0.420	O
,	O
p<0.023	O
)	O
.	O

pearson	O
correlation	O
coefficients	O
between	O
reported	O
dietary	O
intake	O
of	O
carotenoids	O
and	O
plasma	O
carotenoid	O
concentrations	O
were	O
strongest	O
after	O
adjustment	O
for	O
bmi	O
(	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.56	O
,	O
p	O
<	O
0.05	O
)	O
,	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.51	O
,	O
p	O
<	O
0.001	O
)	O
,	O
cryptoxanthin	O
(	O
r	O
=	O
0.32	O
,	O
p	O
<	O
0.001	O
)	O
)	O
.	O

relative	O
validity	O
of	O
fruit	O
and	O
vegetable	O
intake	O
estimated	O
from	O
an	O
ffq	O
,	O
using	O
carotenoid	O
and	O
flavonoid	O
biomarkers	O
and	O
the	O
method	O
of	O
triads	O
..	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
validate	O
the	O
intakes	O
of	O
fruit	O
,	O
juice	O
and	O
vegetables	O
from	O
an	O
ffq	O
.	O
in	O
sub	O
-	O
study	O
i	O
(	O
n	O
147	O
)	O
,	O
intakes	O
from	O
the	O
ffq	O
were	O
evaluated	O
against	O
7	O
d	O
weighed	O
food	O
records	O
(	O
wr	O
)	O
and	O
plasma	O
carotenoid	O
concentrations	O
,	O
whereas	O
in	O
sub	O
-	O
study	O
ii	O
(	O
n	O
85	O
)	O
,	O
the	O
intakes	O
were	O
evaluated	O
against	O
plasma	O
carotenoid	O
concentrations	O
and	O
amounts	O
of	O
flavonoids	B
in	O
24	O
h	O
urine	O
samples	O
.	O

in	O
sub	O
-	O
study	O
ii	O
,	O
the	O
intakes	O
of	O
fruit	O
and	O
vegetables	O
correlated	O
significantly	O
with	O
plasma	O
carotenoid	O
concentrations	O
and	O
urinary	O
flavonoids	B
.	O

evaluation	O
of	O
relative	O
intake	O
of	O
fatty	B
acids	I
according	O
to	O
the	O
northern	O
sweden	O
ffq	O
with	O
fatty	O
acid	O
levels	O
in	O
erythrocyte	O
membranes	O
as	O
biomarkers	O
..	O
objective	O
:	O
to	O
evaluate	O
the	O
validity	O
of	O
the	O
northern	O
sweden	O
eighty	O
-	O
four	O
-	O
item	O
ffq	O
to	O
estimate	O
intake	O
of	O
fatty	B
acids	I
relative	O
to	O
24	O
h	O
diet	O
recalls	O
(	O
24	O
-	O
hdr	O
)	O
and	O
fatty	B
acids	I
in	O
erythrocyte	O
membranes	O
.	O

intake	O
of	O
fatty	B
acids	I
measured	O
by	O
the	O
ffq	O
was	O
compared	O
with	O
intake	O
by	O
the	O
24	O
-	O
hdr	O
and	O
fatty	O
acid	O
levels	O
in	O
erythrocytes	O
.	O

results	O
:	O
spearman	O
correlation	O
coefficients	O
(	O
rs	O
)	O
between	O
intakes	O
of	O
the	O
fatty	B
acids	I
14	O
:	O
0	O
,	O
15	O
:	O
0	O
,	O
16	O
:	O
0	O
,	O
17	O
:	O
0	O
,	O
18	O
:	O
2n-6	O
,	O
18	O
:	O
3n-3	O
,	O
20	O
:	O
5n-3	O
and	O
22	O
:	O
6n-3	O
estimated	O
by	O
the	O
ffq	O
and	O
the	O
24	O
-	O
hdr	O
were	O
all	O
significant	O
and	O
ranged	O
from	O
0.29	O
(	O
22	O
:	O
6n-3	O
in	O
men	O
and	O
women	O
)	O
to	O
0.60	O
(	O
16	O
:	O
0	O
in	O
men	O
)	O
,	O
whereas	O
significant	O
correlations	O
between	O
ffq	O
-	O
estimated	O
intake	O
and	O
erythrocyte	O
membrane	O
content	O
were	O
only	O
seen	O
for	O
milk	O
fatty	B
acids	I
14	O
:	O
0	O
,	O
15	O
:	O
0	O
and	O
17	O
:	O
0	O

(	O
rs	O
=	O
0.23	O
-	O
0.34	O
)	O
and	O
fish	O
fatty	B
acids	I
20	O
:	O
5n-3	O
and	O
22	O
:	O

conclusion	O
:	O
the	O
northern	O
sweden	O
eighty	O
-	O
four	O
-	O
item	O
ffq	O
gives	O
a	O
satisfactory	O
estimate	O
of	O
the	O
intake	O
of	O
fish	O
fatty	B
acids	I
(	O
20	O
:	O
5n-3	O
and	O
22	O
:	O
6n-3	O
)	O
and	O
milk	O
fatty	B
acids	I
(	O
15	O
:	O
0	O
and	O
17	O
:	O
0	O
)	O
,	O
whereas	O
its	O
validity	O
for	O
fatty	B
acids	I
18	O
:	O
2n-6	O
and	O
18	O
:	O
3n-3	O
,	O
derived	O
mainly	O
from	O
vegetable	O
oils	O
,	O
can	O
not	O
be	O
shown	O
.	O

correlations	O
of	O
urinary	O
phytoestrogen	O
excretion	O
with	O
lifestyle	O
factors	O
and	O
dietary	O
intakes	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

our	O
study	O
adds	O
important	O
information	O
to	O
the	O
rapidly	O
growing	O
body	O
of	O
research	O
on	O
the	O
potential	O
health	O
benefits	O
of	O
phytoestrogens	O
..	O
isoflavones	B
and	O
lignans	O
,	O
two	O
major	O
groups	O
of	O
phytoestrogens	O
,	O
have	O
been	O
postulated	O
to	O
have	O
multiple	O
health	O
benefits	O
,	O
including	O
anti	O
-	O
estrogenic	O
,	O
anti	O
-	O
cancer	O
,	O
pro	O
-	O
cardiovascular	O
health	O
,	O
and	O
ameliorating	O
menopausal	O
symptoms	O
.	O

urinary	O
excretion	O
of	O
isoflavonoids	O
,	O
including	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
,	O
dihydro	O
-	O
daidzein	O
,	O
dihydrogenistein	O
,	O
and	O
equol	O
,	O
and	O
lignans	O
,	O
including	O
enterodiol	B
and	O
enterolactone	B
,	O
have	O
been	O
used	O
as	O
biomarkers	O
of	O
phytoestrogen	O
exposure	O
in	O
epidemiologic	O
studies	O
.	O

the	O
medians	O
(	O
in	O
nmol	O
/	O
mg	O
creatinine	O
)	O
were	O
:	O
isoflavonoids	O
,	O
17.13	O
;	O
daidzein	O
,	O
5.57	O
;	O
genistein	O
,	O
2.41	O
;	O
glycitein	O
,	O
0.94	O
;	O
o	O
-	O
dma	O
,	O
1.52	O
;	O
dihydrodaidzein	O
,	O
0.81	O
;	O
dihydrogenistein	O
,	O
0.19	O
;	O
equol	O
,	O
0.11	O
;	O
enterodiol	B
,	O
0.30	O
;	O
and	O
enterolactone	B
,	O
1.18	O
.	O

these	O
levels	O
are	O
2-	O
(	O
enterodiol	B
)	O
to	O
126-	O
(	O
o	O
-	O
dma	O
)	O
fold	O
higher	O
than	O
levels	O
among	O
us	O
women	O
similar	O
in	O
age	O
range	O
with	O
the	O
exception	O
of	O
enterolactone	B
,	O
for	O
which	O
a	O
similar	O
level	O
was	O
observed	O
for	O
both	O
populations	O
.	O

urinary	O
excretions	O
of	O
dihydrodaidzein	O
,	O
dihydrogenistein	O
,	O
equol	O
,	O
enterodiol	B
,	O
and	O
enterolactone	B
were	O
inversely	O
associated	O
with	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

urinary	O
excretion	O
of	O
isoflavones	B
correlated	O
with	O
soy	O
food	O
intake	O
and	O
healthy	O
lifestyle	O
but	O
was	O
inversely	O
associated	O
with	O
fruit	O
intake	O
among	O
middle	O
-	O
aged	O
and	O
elderly	O
chinese	O
women	O
.	O

site	O
-	O
specific	O
concentrations	O
of	O
carotenoids	B
in	O
adipose	O
tissue	O
:	O
relations	O
with	O
dietary	O
and	O
serum	O
carotenoid	O
concentrations	O
in	O
healthy	O
adults	O
..	O
background	O
:	O
dietary	O
carotenoids	B
are	O
related	O
to	O
a	O
decreased	O
risk	O
of	O
certain	O
diseases	O
.	O

objectives	O
:	O
the	O
objectives	O
of	O
this	O
study	O
were	O
to	O
evaluate	O
site	O
-	O
specific	O
concentrations	O
of	O
carotenoids	B
in	O
adipose	O
tissue	O
and	O
to	O
examine	O
relations	O
between	O
carotenoid	O
concentrations	O
in	O
the	O
diet	O
,	O
serum	O
,	O
and	O
adipose	O
tissue	O
.	O

dietary	O
carotenoids	B
over	O
the	O
past	O
year	O
were	O
assessed	O
with	O
a	O
food	O
-	O
frequency	O
questionnaire	O
.	O

serum	O
and	O
adipose	O
tissue	O
biopsy	O
samples	O
were	O
collected	O
from	O
the	O
abdomen	O
,	O
buttock	O
,	O
and	O
inner	O
thigh	O
for	O
the	O
measurement	O
of	O
carotenoids	B
by	O
hplc	O
.	O

results	O
:	O
many	O
adipose	O
carotenoids	B
were	O
inversely	O
related	O
to	O
percentage	O
body	O
fat	O
,	O
although	O
lycopene	B
was	O
the	O
only	O
carotenoid	O
inversely	O
correlated	O
with	O
all	O
3	O
sites	O
.	O

most	O
of	O
the	O
carotenoids	B
were	O
significantly	O
higher	O
in	O
the	O
abdominal	O
adipose	O
tissue	O
than	O
in	O
the	O
thigh	O
(	O
p	O
<	O
0.05	O
)	O
.	O

concentrations	O
of	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
5	O
-	O
cis	O
-	O
lycopene	O
,	O
and	O
total	O
carotenoids	B
were	O
significantly	O
higher	O
in	O
the	O
buttocks	O
than	O
in	O
the	O
thigh	O
(	O
p	O
<	O
0.05	O
)	O
.	O

concentrations	O
of	O
alpha	O
-	O
carotene	O
,	O
cis	O
-	O
lycopene	O
,	O
and	O
lutein	B
(	O
with	O
or	O
without	O
zeaxanthin	B
)	O
were	O
significantly	O
higher	O
in	O
the	O
abdomen	O
than	O
in	O
the	O
buttocks	O
(	O
p	O
<	O
0.05	O
)	O
.	O

dietary	O
intake	O
was	O
significantly	O
correlated	O
with	O
serum	O
concentrations	O
of	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
beta	O
-	O
cryptoxanthin	O
,	O
and	O
total	O
carotenoids	B
.	O

carotenoid	O
intake	O
was	O
significantly	O
correlated	O
with	O
adipose	O
tissue	O
concentrations	O
of	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
beta	O
-	O
cryptoxanthin	O
,	O
cis	O
-	O
lycopene	O
,	O
and	O
total	O
carotenoids	B
(	O
p	O
<	O
0.05	O
)	O
but	O
varied	O
by	O
site	O
.	O
of	O
all	O
the	O
adipose	O
tissue	O
sites	O
evaluated	O
,	O
the	O
abdomen	O
showed	O
the	O
strongest	O
correlation	O
with	O
long	O
-	O
term	O
dietary	O
carotenoid	O
intakes	O
and	O
with	O
serum	O
(	O
indicator	O
of	O
short	O
-	O
term	O
intake	O
)	O
for	O
most	O
carotenoids	B
.	O

conclusions	O
:	O
body	O
fat	O
may	O
influence	O
the	O
tissue	O
distribution	O
of	O
carotenoids	B
.	O

the	O
objective	O
of	O
this	O
paper	O
is	O
to	O
evaluate	O
the	O
relationship	O
between	O
different	O
seafood	O
meals	O
and	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
[	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
]	O
biomarkers	O
in	O
the	O
multi	O
-	O
ethnic	O
study	O
of	O
atherosclerosis	O
(	O
mesa	O
)	O
with	O
white	O
,	O
chinese	O
-	O
american	O
,	O
black	O
,	O
and	O
hispanic	O
participants	O
.	O

dietary	O
intake	O
from	O
a	O
ffq	O
and	O
plasma	O
phospholipid	O
fatty	B
acids	I
were	O
assessed	O
in	O
900	O
mesa	O
participants	O
who	O
were	O
not	O
taking	O
fish	O
oil	O
supplements	O
.	O

this	O
study	O
highlights	O
the	O
importance	O
of	O
cooking	O
methods	O
(	O
nonfried	O
vs.	O
fried	O
fish	O
)	O
,	O
types	O
of	O
seafood	O
(	O
fish	O
vs.	O
shellfish	O
)	O
,	O
and	O
the	O
overall	O
seafood	O
consumption	O
when	O
assessing	O
health	O
effects	O
of	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
of	O
seafood	O
consumption	O
..	O
few	O
studies	O
have	O
adequately	O
considered	O
the	O
type	O
of	O
seafood	O
and	O
background	O
dietary	O
factors	O
when	O
evaluating	O
diet	O
-	O
biomarker	O
and	O
diet	O
-	O
disease	O
associations	O
.	O

the	O
objective	O
of	O
this	O
paper	O
is	O
to	O
evaluate	O
the	O
relationship	O
between	O
different	O
seafood	O
meals	O
and	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
[	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
]	O
biomarkers	O
in	O
the	O
multi	O
-	O
ethnic	O
study	O
of	O
atherosclerosis	O
(	O
mesa	O
)	O
with	O
white	O
,	O
chinese	O
-	O
american	O
,	O
black	O
,	O
and	O
hispanic	O
participants	O
.	O

dietary	O
intake	O
from	O
a	O
ffq	O
and	O
plasma	O
phospholipid	O
fatty	B
acids	I
were	O
assessed	O
in	O
900	O
mesa	O
participants	O
who	O
were	O
not	O
taking	O
fish	O
oil	O
supplements	O
.	O

this	O
study	O
highlights	O
the	O
importance	O
of	O
cooking	O
methods	O
(	O
nonfried	O
vs.	O
fried	O
fish	O
)	O
,	O
types	O
of	O
seafood	O
(	O
fish	O
vs.	O
shellfish	O
)	O
,	O
and	O
the	O
overall	O
seafood	O
consumption	O
when	O
assessing	O
health	O
effects	O
of	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
of	O
seafood	O
consumption	O
..	O
few	O
studies	O
have	O
adequately	O
considered	O
the	O
type	O
of	O
seafood	O
and	O
background	O
dietary	O
factors	O
when	O
evaluating	O
diet	O
-	O
biomarker	O
and	O
diet	O
-	O
disease	O
associations	O
.	O

the	O
objective	O
of	O
this	O
paper	O
is	O
to	O
evaluate	O
the	O
relationship	O
between	O
different	O
seafood	O
meals	O
and	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
[	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
]	O
biomarkers	O
in	O
the	O
multi	O
-	O
ethnic	O
study	O
of	O
atherosclerosis	O
(	O
mesa	O
)	O
with	O
white	O
,	O
chinese	O
-	O
american	O
,	O
black	O
,	O
and	O
hispanic	O
participants	O
.	O

dietary	O
intake	O
from	O
a	O
ffq	O
and	O
plasma	O
phospholipid	O
fatty	B
acids	I
were	O
assessed	O
in	O
900	O
mesa	O
participants	O
who	O
were	O
not	O
taking	O
fish	O
oil	O
supplements	O
.	O

this	O
study	O
highlights	O
the	O
importance	O
of	O
cooking	O
methods	O
(	O
nonfried	O
vs.	O
fried	O
fish	O
)	O
,	O
types	O
of	O
seafood	O
(	O
fish	O
vs.	O
shellfish	O
)	O
,	O
and	O
the	O
overall	O
seafood	O
consumption	O
when	O
assessing	O
health	O
effects	O
of	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
of	O
seafood	O
consumption	O
..	O
few	O
studies	O
have	O
adequately	O
considered	O
the	O
type	O
of	O
seafood	O
and	O
background	O
dietary	O
factors	O
when	O
evaluating	O
diet	O
-	O
biomarker	O
and	O
diet	O
-	O
disease	O
associations	O
.	O

the	O
objective	O
of	O
this	O
paper	O
is	O
to	O
evaluate	O
the	O
relationship	O
between	O
different	O
seafood	O
meals	O
and	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
[	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
]	O
biomarkers	O
in	O
the	O
multi	O
-	O
ethnic	O
study	O
of	O
atherosclerosis	O
(	O
mesa	O
)	O
with	O
white	O
,	O
chinese	O
-	O
american	O
,	O
black	O
,	O
and	O
hispanic	O
participants	O
.	O

dietary	O
intake	O
from	O
a	O
ffq	O
and	O
plasma	O
phospholipid	O
fatty	B
acids	I
were	O
assessed	O
in	O
900	O
mesa	O
participants	O
who	O
were	O
not	O
taking	O
fish	O
oil	O
supplements	O
.	O

this	O
study	O
highlights	O
the	O
importance	O
of	O
cooking	O
methods	O
(	O
nonfried	O
vs.	O
fried	O
fish	O
)	O
,	O
types	O
of	O
seafood	O
(	O
fish	O
vs.	O
shellfish	O
)	O
,	O
and	O
the	O
overall	O
seafood	O
consumption	O
when	O
assessing	O
health	O
effects	O
of	O
long	O
-	O
chain	O
(	O
n-3	O
)	O
fatty	B
acids	I
of	O
seafood	O
consumption	O
.	O

validation	O
of	O
a	O
food	O
frequency	O
questionnaire	O
measurement	O
of	O
dietary	O
acrylamide	B
intake	O
using	O
hemoglobin	O
adducts	O
of	O
acrylamide	B
and	O
glycidamide	O
..	O
objective	O
:	O
acrylamide	B
,	O
a	O
probable	O
human	O
carcinogen	O
,	O
is	O
formed	O
during	O
high	O
-	O
heat	O
cooking	O
of	O
many	O
common	O
foods	O
.	O

the	O
validity	O
of	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
measures	O
of	O
acrylamide	B
intake	O
has	O
not	O
been	O
established	O
.	O

we	O
assessed	O
the	O
validity	O
of	O
acrylamide	B
intake	O
calculated	O
from	O
an	O
ffq	O
using	O
a	O
biomarker	O
of	O
acrylamide	B
exposure	O
.	O

methods	O
:	O
we	O
calculated	O
acrylamide	B
intake	O
from	O
an	O
ffq	O
in	O
the	O
nurses	O
'	O
health	O
study	O
ii	O
.	O

we	O
measured	O
hemoglobin	O
adducts	O
of	O
acrylamide	B
and	O
its	O
metabolite	O
,	O
glycidamide	O
,	O
in	O
a	O
random	O
sample	O
of	O
342	O
women	O
.	O

correlation	O
and	O
regression	O
analyses	O
were	O
used	O
to	O
assess	O
the	O
relationship	O
between	O
acrylamide	B
intakes	O
and	O
adducts	O
.	O

results	O
:	O
the	O
correlation	O
between	O
acrylamide	B
intake	O
and	O
the	O
sum	O
of	O
acrylamide	B
and	O
glycidamide	O
adducts	O
was	O
0.31	O
(	O
95	O
%	O
ci	O
:	O
0.20	O
-	O
0.41	O
)	O
,	O
adjusted	O
for	O
laboratory	O
batch	O
,	O
energy	B
intake	O
,	O
and	O
age	O
.	O

conclusions	O
:	O
acrylamide	B
intake	O
and	O
hemoglobin	O
adducts	O
of	O
acrylamide	B
and	O
glycidamide	O
were	O
moderately	O
correlated	O
.	O

soy	O
protein	O
estimates	O
from	O
ffqs	O
were	O
compared	O
against	O
repeated	O
24	O
-	O
h	O
recalls	O
and	O
urinary	O
excretion	O
of	O
daidzein	O
,	O
genistein	O
,	O
total	O
isoflavonoids	O
(	O
tifls	O
)	O
,	O
and	O
equol	B
(	O
measured	O
by	O
hplc	O
/	O
photodiode	O
array	O
/	O
mass	O
spectrometry	O
)	O
as	O
reference	O
criteria	O
.	O

comparison	O
between	O
plasma	O
and	O
erythrocyte	O
fatty	O
acid	O
content	O
as	O
biomarkers	O
of	O
fatty	O
acid	O
intake	O
in	O
us	O
women	O
..	O
background	O
:	O
erythrocyte	O
fatty	B
acids	I
may	O
be	O
superior	O
to	O
plasma	O
fatty	B
acids	I
for	O
reflecting	O
long	O
-	O
term	O
fatty	O
acid	O
intake	O
because	O
of	O
less	O
sensitivity	O
to	O
recent	O
intake	O
and	O
a	O
slower	O
turnover	O
rate	O
.	O

design	O
:	O
fatty	B
acids	I
in	O
plasma	O
and	O
erythrocytes	O
were	O
measured	O
by	O
capillary	O
gas	O
-	O
liquid	O
chromatography	O
in	O
306	O
us	O
women	O
aged	O
43	O
-	O
69	O
y.	O
fatty	O
acid	O
intake	O
was	O
assessed	O
with	O
a	O
food	O
-	O
frequency	O
questionnaire	O
,	O
which	O
was	O
validated	O
for	O
measuring	O
intakes	O
of	O
various	O
fatty	B
acids	I
.	O

total	O
trans	O
fatty	B
acids	I
(	O
r(s)=0.43	O
)	O
and	O
total	O
18:1	O
trans	O
isomers	O
(	O
r(s)=0.42	O
)	O
in	O
erythrocytes	O
were	O
also	O
more	O
strongly	O
correlated	O
with	O
intake	O
than	O
were	O
those	O
in	O
plasma	O
(	O
r(s)=0.30	O
and	O
r(s)=0.29	O
,	O
respectively	O
)	O
.	O

for	O
polyunsaturated	O
and	O
trans	O
fatty	B
acids	I
,	O
correlations	O
between	O
intakes	O
and	O
biomarkers	O
improved	O
moderately	O
when	O
average	O
intakes	O
over	O
previous	O
years	O
were	O
used	O
.	O

conclusion	O
:	O
erythrocyte	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
and	O
trans	O
fatty	O
acid	O
content	O
are	O
suitable	O
biomarkers	O
for	O
long	O
-	O
term	O
intake	O
.	O

plasma	O
concentrations	O
of	O
carotenoids	O
and	O
vitamin	B
c	I
are	O
better	O
correlated	O
with	O
dietary	O
intake	O
in	O
normal	O
weight	O
than	O
overweight	O
and	O
obese	O
elderly	O
subjects	O
..	O
carotenoid	O
and	O
vitamin	B
c	I
intakes	O
,	O
assessed	O
by	O
ffq	O
,	O
have	O
been	O
positively	O
associated	O
with	O
plasma	O
concentrations	O
in	O
different	O
populations	O
.	O

we	O
explored	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
the	O
relation	O
between	O
dietary	O
carotenoid	O
and	O
vitamin	B
c	I
intakes	O
,	O
using	O
a	O
135	O
-	O
item	O
ffq	O
,	O
with	O
their	O
plasma	O
concentrations	O
by	O
bmi	O
categories	O
in	O
252	O
men	O
and	O
293	O
women	O
,	O
65	O
years	O
and	O
older	O
.	O

for	O
men	O
and	O
women	O
combined	O
,	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
pearson	O
correlations	O
were	O
observed	O
between	O
energy	O
-	O
adjusted	O
dietary	O
intakes	O
and	O
plasma	O
concentrations	O
(	O
carotenoids	O
adjusted	O
for	O
cholesterol	B
)	O
for	O
:	O
alpha	B
-	I
carotene	I
0.21	O
,	O
beta	B
-	I
carotene	I
0.19	O
,	O
lycopene	B
0.18	O
,	O
beta	B
-	I
cryptoxanthin	I
0.20	O
and	O
vitamin	B
c	I
0.36	O
.	O

multiple	O
linear	O
regression	O
analyses	O
showed	O
that	O
the	O
intake	O
of	O
carotenoids	O
and	O
vitamin	B
c	I
were	O
significant	O
predictors	O
of	O
their	O
respective	O
plasma	O
concentration	O
(	O
p<0.01	O
)	O
,	O
and	O
that	O
bmi	O
was	O
inversely	O
associated	O
with	O
plasma	O
concentration	O
of	O
carotenoids	O
(	O
p	O
<	O
or	O
=	O
0.01	O
)	O
but	O
not	O
with	O
plasma	O
vitamin	O
c.	O
in	O
addition	O
,	O
we	O
observed	O
significant	O
interactions	O
between	O
bmi	O
and	O
the	O
intakes	O
of	O
alpha	B
-	I
carotene	I
and	O
lutein	O
+	O
zeaxanthin	O
,	O
and	O
to	O
a	O
lower	O
extent	O
beta	B
-	I
carotene	I
,	O
suggesting	O
that	O
these	O
intakes	O
in	O
subjects	O
with	O
high	O
bmi	O
were	O
not	O
good	O
predictors	O
of	O
their	O
plasma	O
concentration	O
.	O

the	O
present	O
data	O
suggest	O
that	O
plasma	O
carotenoids	O
and	O
vitamin	B
c	I
may	O
be	O
good	O
markers	O
of	O
dietary	O
intake	O
in	O
elderly	O
subjects	O
,	O
but	O
not	O
so	O
for	O
alpha	B
-	I
carotene	I
,	O
beta	B
-	I
carotene	I
and	O
lutein	O
+	O
zeaxanthin	O
in	O
obese	O
subjects	O
.	O

plasma	O
n-6	O
and	O
n-3	O
polyunsaturated	O
fatty	B
acids	I
as	O
biomarkers	O
of	O
their	O
dietary	O
intakes	O
:	O
a	O
cross	O
-	O
sectional	O
study	O
within	O
a	O
cohort	O
of	O
middle	O
-	O
aged	O
french	O
men	O
and	O
women	O
..	O
objective	O
:	O
to	O
measure	O
the	O
correlations	O
between	O
habitual	O
intakes	O
of	O
individual	O
n-6	O
and	O
n-3	O
polyunsaturated	O
fatty	B
acids	I
(	O
pufa	O
)	O
and	O
their	O
percentages	O
in	O
total	O
plasma	O
fatty	B
acids	I
in	O
a	O
population	O
of	O
adult	O
men	O
and	O
women	O
.	O

total	O
fatty	B
acids	I
in	O
both	O
men	O
and	O
women	O
.	O

conclusions	O
:	O
the	O
percentages	O
of	O
linoleic	O
acid	O
,	O
arachidonic	O
acid	O
,	O
epa	O
and	O
dha	O
in	O
plasma	O
total	O
fatty	B
acids	I
,	O
but	O
not	O
that	O
of	O
alpha	O
-	O
linolenic	O
acid	O
,	O
are	O
acceptable	O
markers	O
of	O
their	O
habitual	O
levels	O
of	O
intake	O
.	O

phytanic	B
acid	I
:	O
measurement	O
of	O
plasma	O
concentrations	O
by	O
gas	O
-	O
liquid	O
chromatography	O
-	O
mass	O
spectrometry	O
analysis	O
and	O
associations	O
with	O
diet	O
and	O
other	O
plasma	O
fatty	O
acids	O
..	O
epidemiological	O
data	O
suggest	O
that	O
a	O
diet	O
rich	O
in	O
animal	O
foods	O
may	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
several	O
cancers	O
,	O
including	O
cancers	O
of	O
the	O
prostate	O
,	O
colorectum	O
and	O
breast	O
,	O
but	O
the	O
possible	O
mechanism	O
is	O
unclear	O
.	O

it	O
is	O
hypothesised	O
that	O
phytanic	B
acid	I
,	O
a	O
c20	O
branched	O
-	O
chain	O
fatty	O
acid	O
found	O
predominantly	O
in	O
foods	O
from	O
ruminant	O
animals	O
,	O
may	O
be	O
involved	O
in	O
early	O
cancer	O
development	O
because	O
it	O
has	O
been	O
shown	O
to	O
up	O
regulate	O
activity	O
of	O
alpha	O
-	O
methylacyl	O
-	O
coenzyme	O
a	O
racemase	O
,	O
an	O
enzyme	O
commonly	O
found	O
to	O
be	O
over	O
-	O
expressed	O
in	O
tumour	O
cells	O
compared	O
with	O
normal	O
tissue	O
.	O

however	O
,	O
little	O
is	O
known	O
about	O
the	O
distribution	O
of	O
plasma	O
phytanic	B
acid	I
concentrations	O
or	O
its	O
dietary	O
determinants	O
in	O
the	O
general	O
population	O
.	O

the	O
primary	O
aim	O
of	O
the	O
present	O
cross	O
-	O
sectional	O
study	O
was	O
to	O
determine	O
circulating	O
phytanic	B
acid	I
concentrations	O
among	O
ninety	O
-	O
six	O
meat	O
-	O
eating	O
,	O
lacto	O
-	O
ovo	O
-	O
vegetarian	O
and	O
vegan	O
women	O
,	O
aged	O
20	O
-	O
69	O
years	O
,	O
recruited	O
into	O
the	O
oxford	O
component	O
of	O
the	O
european	O
prospective	O
investigation	O
into	O
cancer	O
and	O
nutrition	O
(	O
epic	O
-	O
oxford	O
)	O
.	O

meat	O
-	O
eaters	O
had	O
,	O
on	O
average	O
,	O
a	O
6.7	O
-	O
fold	O
higher	O
geometric	O
mean	O
plasma	O
phytanic	B
acid	I
concentration	O
than	O
the	O
vegans	O
(	O
5.77	O
v.	O
0.86	O
micromol	O
/	O
l	O
;	O
p	O
<	O
0.0001	O
)	O
and	O
a	O
47	O
%	O
higher	O
mean	O
concentration	O
than	O
the	O
vegetarians	O
(	O
5.77	O
v.	O
3.93	O
micromol	O
/	O
l	O
;	O
p	O
=	O
0.016	O
)	O
.	O

the	O
strongest	O
determinant	O
of	O
plasma	O
phytanic	B
acid	I
concentration	O
appeared	O
to	O
be	O
dairy	O
fat	O
intake	O
(	O
r	O
0.68	O
;	O
p	O
<	O
0.0001	O
)	O
;	O
phytanic	B
acid	I
levels	O
were	O
not	O
associated	O
with	O
age	O
or	O
other	O
lifestyle	O
factors	O
.	O

these	O
data	O
show	O
that	O
a	O
diet	O
high	O
in	O
fat	O
from	O
dairy	O
products	O
is	O
associated	O
with	O
increased	O
plasma	O
phytanic	B
acid	I
concentration	O
,	O
which	O
may	O
play	O
a	O
role	O
in	O
cancer	O
development	O
.	O

validation	O
of	O
the	O
assessment	O
of	O
folate	O
and	O
vitamin	B
b12	I
intake	O
in	O
women	O
of	O
reproductive	O
age	O
:	O
the	O
method	O
of	O
triads	O
..	O
objective	O
:	O
to	O
validate	O
the	O
folate	O
and	O
vitamin	B
b12	I
intakes	O
estimated	O
by	O
a	O
food	O
-	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
designed	O
to	O
be	O
used	O
in	O
a	O
case	O
-	O
control	O
study	O
on	O
the	O
association	O
between	O
maternal	O
dietary	O
intake	O
and	O
the	O
risk	O
of	O
having	O
a	O
child	O
with	O
a	O
congenital	O
heart	O
defect	O
.	O

immediately	O
thereafter	O
,	O
blood	O
samples	O
were	O
taken	O
to	O
determine	O
serum	O
folate	O
,	O
red	O
blood	O
cell	O
(	O
rbc	O
)	O
folate	O
and	O
serum	O
vitamin	B
b12	I
concentrations	O
.	O

results	O
:	O
the	O
comparison	O
of	O
b	O
-	O
vitamin	O
intakes	O
reported	O
by	O
the	O
ffq	O
and	O
the	O
mean	O
of	O
the	O
24hr	O
revealed	O
deattenuated	O
correlation	O
coefficients	O
of	O
0.98	O
for	O
folate	O
and	O
0.66	O
for	O
vitamin	B
b12	I
.	O

the	O
correlation	O
coefficients	O
between	O
the	O
b	O
-	O
vitamin	O
intakes	O
estimated	O
by	O
the	O
ffq	O
and	O
concentrations	O
of	O
serum	O
folate	O
,	O
rbc	O
folate	O
and	O
serum	O
vitamin	B
b12	I
were	O
0.20	O
,	O
0.28	O
and	O
0.21	O
,	O
respectively	O
.	O

the	O
validity	O
coefficients	O
for	O
serum	O
folate	O
,	O
rbc	O
folate	O
and	O
serum	O
vitamin	B
b12	I
were	O
0.94	O
,	O
0.75	O
and	O
1.00	O
,	O
respectively	O
.	O

the	O
estimated	O
folate	O
and	O
vitamin	B
b12	I
intakes	O
were	O
comparable	O
with	O
the	O
results	O
of	O
the	O
most	O
recent	O
dutch	O
food	O
consumption	O
survey	O
.	O

conclusions	O
:	O
the	O
adapted	O
ffq	O
is	O
a	O
reliable	O
tool	O
to	O
estimate	O
the	O
dietary	O
intake	O
of	O
energy	O
,	O
macronutrients	O
,	O
folate	O
and	O
vitamin	B
b12	I
in	O
women	O
of	O
reproductive	O
age	O
.	O

validation	O
of	O
a	O
ffq	O
to	O
estimate	O
the	O
intake	O
of	O
pufa	O
using	O
plasma	O
phospholipid	O
fatty	B
acids	I
and	O
weighed	O
foods	O
records	O
..	O
due	O
to	O
the	O
growing	O
knowledge	O
about	O
the	O
role	O
of	O
specific	O
fatty	B
acids	I
in	O
health	O
and	O
disease	O
,	O
dietary	O
intake	O
measurements	O
of	O
individual	O
fatty	B
acids	I
or	O
classes	O
of	O
fatty	B
acids	I
are	O
becoming	O
increasingly	O
important	O
.	O

the	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
ability	O
of	O
the	O
nambour	O
ffq	O
to	O
estimate	O
intakes	O
of	O
specific	O
fatty	B
acids	I
,	O
particularly	O
pufa	O
.	O

non	O
-	O
fasting	O
blood	O
samples	O
were	O
collected	O
and	O
analysed	O
for	O
plasma	O
phospholipid	O
fatty	B
acids	I
.	O

correlations	O
between	O
the	O
ffq	O
and	O
wfr	O
were	O
moderate	O
(	O
r	O
0	O
x	O
32	O
-	O
0	O
x	O
59	O
)	O
except	O
for	O
trans	O
fatty	B
acids	I
(	O
r	O
0	O
x	O
03	O
)	O
.	O

correlations	O
between	O
each	O
of	O
the	O
dietary	O
assessment	O
methods	O
and	O
the	O
plasma	O
phospholipids	O
were	O
poor	O
for	O
all	O
fatty	B
acids	I
other	O
than	O
the	O
pufa	O
.	O
using	O
the	O
methods	O
of	O
triads	O
approach	O
,	O
the	O
ffq	O
validity	O
coefficients	O
for	O
total	O
n-3	O
fatty	B
acids	I
,	O
total	O
long	O
chain	O
n-3	O
fatty	B
acids	I
,	O
epa	O
,	O
arachidonic	O
acid	O
,	O
docosapentaenoic	O
acid	O
and	O
dha	O
were	O
0	O
x	O
50	O
,	O
0	O
x	O
63	O
,	O
0	O
x	O
45	O
and	O
0	O
x	O
62	O
and	O
0	O
x	O
62	O
,	O
respectively	O
.	O

for	O
most	O
fatty	B
acids	I
,	O
the	O
ffq	O
adequately	O
estimates	O
group	O
mean	O
fatty	O
acid	O
intakes	O
and	O
can	O
adequately	O
rank	O
individuals	O
;	O
however	O
,	O
the	O
ability	O
of	O
this	O
ffq	O
to	O
estimate	O
trans	O
fatty	B
acids	I
was	O
poor	O
.	O

vitamin	B
b6	I
status	O
assessment	O
in	O
relation	O
to	O
dietary	O
intake	O
in	O
high	O
school	O
students	O
aged	O
16	O
-	O
18	O
years	O
..	O
the	O
vitamin	B
b6	I
status	O
of	O
high	O
school	O
students	O
and	O
its	O
relationship	O
with	O
dietary	O
intake	O
were	O
investigated	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
by	O
face	O
-	O
to	O
-	O
face	O
interview	O
.	O

vitamin	B
b6	I
intakes	O
were	O
calculated	O
from	O
three	O
24	O
-	O
h	O
dietary	O
records	O
.	O

direct	O
and	O
indirect	O
vitamin	B
b6	I
status	O
indicators	O
were	O
measured	O
in	O
plasma	O
,	O
erythrocytes	O
and	O
urine	O
.	O

all	O
students	O
except	O
one	O
girl	O
(	O
28.7	O
nmol	O
/	O
l	O
)	O
had	O
plasma	O
pyridoxal-5'-phosphate	O
(	O
plp	O
)	O
levels	O
>	O
35	O
nmol	O
/	O
l	O
,	O
indicating	O
an	O
adequate	O
vitamin	B
b6	I
status	O
.	O

the	O
mean	O
dietary	O
vitamin	B
b6	I
intakes	O
of	O
boys	O
and	O
girls	O
were	O
1.04	O
(	O
sd	O
0.29	O
)	O
and	O
0.96	O
(	O
sd	O
0.27	O
)	O

vitamin	B
b6	I
status	O
indicators	O
,	O
including	O
plasma	O
plp	O
,	O
erythrocyte	O
alanine	O
aminotransferase	O
activity	O
coefficient	O
(	O
ealt	O
-	O
ac	O
)	O
,	O
aspartate	O
aminotransferase	O
activity	O
coefficient	O
(	O
east	O
-	O
ac	O
)	O
and	O
urinary	O
4	B
-	I
pyridoxic	I
acid	I
(	O
4	O
-	O
pa	O
)	O
,	O
were	O
correlated	O
with	O
vitamin	B
b6	I
intake	O
.	O

this	O
study	O
suggests	O
that	O
vitamin	B
b6	I
requirements	O
for	O
boys	O
and	O
girls	O
aged	O
16	O
-	O
18	O
years	O
were	O
approximately	O
1.1	O
and	O
1.0	O
mg	O
/	O
d	O
,	O
respectively	O
..	O

the	O
vitamin	B
b6	I
status	O
of	O
high	O
school	O
students	O
and	O
its	O
relationship	O
with	O
dietary	O
intake	O
were	O
investigated	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
by	O
face	O
-	O
to	O
-	O
face	O
interview	O
.	O

vitamin	B
b6	I
intakes	O
were	O
calculated	O
from	O
three	O
24	O
-	O
h	O
dietary	O
records	O
.	O

direct	O
and	O
indirect	O
vitamin	B
b6	I
status	O
indicators	O
were	O
measured	O
in	O
plasma	O
,	O
erythrocytes	O
and	O
urine	O
.	O

all	O
students	O
except	O
one	O
girl	O
(	O
28.7	O
nmol	O
/	O
l	O
)	O
had	O
plasma	O
pyridoxal-5'-phosphate	O
(	O
plp	O
)	O
levels	O
>	O
35	O
nmol	O
/	O
l	O
,	O
indicating	O
an	O
adequate	O
vitamin	B
b6	I
status	O
.	O

the	O
mean	O
dietary	O
vitamin	B
b6	I
intakes	O
of	O
boys	O
and	O
girls	O
were	O
1.04	O
(	O
sd	O
0.29	O
)	O
and	O
0.96	O
(	O
sd	O
0.27	O
)	O

vitamin	B
b6	I
status	O
indicators	O
,	O
including	O
plasma	O
plp	O
,	O
erythrocyte	O
alanine	O
aminotransferase	O
activity	O
coefficient	O
(	O
ealt	O
-	O
ac	O
)	O
,	O
aspartate	O
aminotransferase	O
activity	O
coefficient	O
(	O
east	O
-	O
ac	O
)	O
and	O
urinary	O
4	B
-	I
pyridoxic	I
acid	I
(	O
4	O
-	O
pa	O
)	O
,	O
were	O
correlated	O
with	O
vitamin	B
b6	I
intake	O
.	O

this	O
study	O
suggests	O
that	O
vitamin	B
b6	I
requirements	O
for	O
boys	O
and	O
girls	O
aged	O
16	O
-	O
18	O
years	O
were	O
approximately	O
1.1	O
and	O
1.0	O
mg	O
/	O
d	O
,	O
respectively	O
..	O

the	O
vitamin	B
b6	I
status	O
of	O
high	O
school	O
students	O
and	O
its	O
relationship	O
with	O
dietary	O
intake	O
were	O
investigated	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
by	O
face	O
-	O
to	O
-	O
face	O
interview	O
.	O

vitamin	B
b6	I
intakes	O
were	O
calculated	O
from	O
three	O
24	O
-	O
h	O
dietary	O
records	O
.	O

direct	O
and	O
indirect	O
vitamin	B
b6	I
status	O
indicators	O
were	O
measured	O
in	O
plasma	O
,	O
erythrocytes	O
and	O
urine	O
.	O

all	O
students	O
except	O
one	O
girl	O
(	O
28.7	O
nmol	O
/	O
l	O
)	O
had	O
plasma	O
pyridoxal-5'-phosphate	O
(	O
plp	O
)	O
levels	O
>	O
35	O
nmol	O
/	O
l	O
,	O
indicating	O
an	O
adequate	O
vitamin	B
b6	I
status	O
.	O

the	O
mean	O
dietary	O
vitamin	B
b6	I
intakes	O
of	O
boys	O
and	O
girls	O
were	O
1.04	O
(	O
sd	O
0.29	O
)	O
and	O
0.96	O
(	O
sd	O
0.27	O
)	O

vitamin	B
b6	I
status	O
indicators	O
,	O
including	O
plasma	O
plp	O
,	O
erythrocyte	O
alanine	O
aminotransferase	O
activity	O
coefficient	O
(	O
ealt	O
-	O
ac	O
)	O
,	O
aspartate	O
aminotransferase	O
activity	O
coefficient	O
(	O
east	O
-	O
ac	O
)	O
and	O
urinary	O
4	B
-	I
pyridoxic	I
acid	I
(	O
4	O
-	O
pa	O
)	O
,	O
were	O
correlated	O
with	O
vitamin	B
b6	I
intake	O
.	O

this	O
study	O
suggests	O
that	O
vitamin	B
b6	I
requirements	O
for	O
boys	O
and	O
girls	O
aged	O
16	O
-	O
18	O
years	O
were	O
approximately	O
1.1	O
and	O
1.0	O
mg	O
/	O
d	O
,	O
respectively	O
..	O

the	O
vitamin	B
b6	I
status	O
of	O
high	O
school	O
students	O
and	O
its	O
relationship	O
with	O
dietary	O
intake	O
were	O
investigated	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
by	O
face	O
-	O
to	O
-	O
face	O
interview	O
.	O

vitamin	B
b6	I
intakes	O
were	O
calculated	O
from	O
three	O
24	O
-	O
h	O
dietary	O
records	O
.	O

direct	O
and	O
indirect	O
vitamin	B
b6	I
status	O
indicators	O
were	O
measured	O
in	O
plasma	O
,	O
erythrocytes	O
and	O
urine	O
.	O

all	O
students	O
except	O
one	O
girl	O
(	O
28.7	O
nmol	O
/	O
l	O
)	O
had	O
plasma	O
pyridoxal-5'-phosphate	O
(	O
plp	O
)	O
levels	O
>	O
35	O
nmol	O
/	O
l	O
,	O
indicating	O
an	O
adequate	O
vitamin	B
b6	I
status	O
.	O

the	O
mean	O
dietary	O
vitamin	B
b6	I
intakes	O
of	O
boys	O
and	O
girls	O
were	O
1.04	O
(	O
sd	O
0.29	O
)	O
and	O
0.96	O
(	O
sd	O
0.27	O
)	O

vitamin	B
b6	I
status	O
indicators	O
,	O
including	O
plasma	O
plp	O
,	O
erythrocyte	O
alanine	O
aminotransferase	O
activity	O
coefficient	O
(	O
ealt	O
-	O
ac	O
)	O
,	O
aspartate	O
aminotransferase	O
activity	O
coefficient	O
(	O
east	O
-	O
ac	O
)	O
and	O
urinary	O
4	B
-	I
pyridoxic	I
acid	I
(	O
4	O
-	O
pa	O
)	O
,	O
were	O
correlated	O
with	O
vitamin	B
b6	I
intake	O
.	O

this	O
study	O
suggests	O
that	O
vitamin	B
b6	I
requirements	O
for	O
boys	O
and	O
girls	O
aged	O
16	O
-	O
18	O
years	O
were	O
approximately	O
1.1	O
and	O
1.0	O
mg	O
/	O
d	O
,	O
respectively	O
.	O

adjustment	O
for	O
age	O
,	O
sex	O
,	O
bmi	O
and	O
total	O
energy	B
intake	O
did	O
not	O
affect	O
the	O
results	O
.	O

the	O
strongest	O
association	O
was	O
observed	O
between	O
oily	O
fish	O
and	O
epa	O
,	O
whereas	O
no	O
significant	O
association	O
was	O
observed	O
between	O
lean	O
fish	O
and	O
omega-3	O
fatty	B
acids	I
.	O

variation	O
in	O
omega-3	O
fatty	B
acids	I
was	O
best	O
accounted	O
for	O
by	O
a	O
model	O
containing	O
variables	O
representing	O
different	O
categories	O
of	O
fish	O
and	O
seafood	O
consumption	O
(	O
r	O
(	O
2	O
)	O
0.484	O
)	O
,	O
rather	O
than	O
a	O
single	O
variable	O
representing	O
overall	O
fish	O
and	O
seafood	O
consumption	O
(	O
r	O
(	O
2	O
)	O
0.313	O
)	O
.	O

conclusions	O
:	O
this	O
study	O
confirms	O
that	O
the	O
varying	O
content	O
of	O
omega-3	O
fatty	B
acids	I
in	O
foods	O
are	O
reflected	O
in	O
omega-3	O
biomarkers	O
,	O
and	O
that	O
the	O
questionnaire	O
is	O
a	O
valid	O
measure	O
of	O
fish	O
consumption	O
that	O
enables	O
differentiation	O
between	O
cooking	O
and	O
processing	O
methods	O
and	O
oily	O
versus	O
lean	O
fish	O
intake	O
.	O

plasma	O
phospholipid	O
fatty	O
acid	O
composition	O
as	O
a	O
biomarker	O
of	O
habitual	O
dietary	O
fat	O
intake	O
in	O
an	O
ethnically	O
diverse	O
cohort	O
..	O
background	O
and	O
aim	O
:	O
as	O
an	O
evaluation	O
of	O
fatty	O
acid	O
intake	O
measurement	O
,	O
our	O
aim	O
was	O
to	O
examine	O
associations	O
between	O
diet	O
and	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
fatty	B
acids	I
,	O
and	O
whether	O
these	O
were	O
modified	O
by	O
age	O
,	O
sex	O
,	O
country	O
of	O
birth	O
,	O
fasting	O
status	O
,	O
use	O
of	O
cholesterol	O
-	O
lowering	O
medication	O
,	O
body	O
size	O
,	O
chronic	O
disease	O
and	O
other	O
lifestyle	O
factors	O
.	O

crude	O
correlation	O
coefficients	O
ranged	O
from	O
0.18	O
to	O
0.40	O
;	O
and	O
corrected	O
correlation	O
coefficients	O
from	O
0.38	O
to	O
0.78	O
for	O
total	O
monounsaturated	O
,	O
polyunsaturated	O
,	O
n-6	O
,	O
n-3	O
fatty	B
acids	I
,	O
oleic	O
acid	O
,	O
linoleic	O
acid	O
,	O
epa	O
and	O
dha	O
.	O

weaker	O
associations	O
were	O
observed	O
for	O
other	O
fatty	B
acids	I
.	O

the	O
associations	O
did	O
not	O
vary	O
significantly	O
by	O
fasting	O
status	O
,	O
use	O
of	O
lipid	O
lowering	O
medication	O
or	O
alcohol	O
intake	O
,	O
but	O
for	O
some	O
fatty	B
acids	I
did	O
vary	O
by	O
sex	O
,	O
age	O
,	O
body	O
mass	O
index	O
,	O
country	O
of	O
birth	O
,	O
smoking	O
and	O
previous	O
heart	O
attack	O
or	O
diabetes	O
.	O

conclusions	O
:	O
the	O
ffq	O
provides	O
useful	O
information	O
on	O
intakes	O
of	O
mono-	O
and	O
polyunsaturated	O
fatty	B
acids	I
.	O

plasma	O
alkylresorcinols	B
and	O
urinary	O
alkylresorcinol	O
metabolites	O
as	O
biomarkers	O
of	O
cereal	O
fiber	O
intake	O
in	O
finnish	O
women	O
..	O
alkylresorcinols	B
(	O
ar	O
)	O
could	O
be	O
good	O
biomarkers	O
of	O
consumption	O
of	O
fiber	O
-	O
rich	O
cereal	O
products	O
.	O

blood	O
samples	O
of	O
participants	O
were	O
analysed	O
for	O
beta	B
-	I
carotene	I
,	O
vitamin	B
c	I
and	O
alpha	B
-	I
tocopherol	I
.	O

it	O
was	O
found	O
that	O
women	O
had	O
higher	O
mean	O
beta	B
-	I
carotene	I
and	O
vitamin	B
c	I
serum	O
concentrations	O
than	O
men	O
,	O
but	O
lower	O
alpha	B
-	I
tocopherol	I
serum	O
concentrations	O
.	O

serum	O
beta	B
-	I
carotene	I
and	O
vitamin	B
c	I
concentrations	O
were	O
positively	O
correlated	O
with	O
consumption	O
of	O
both	O
fruit	O
and	O
vegetables	O
,	O
as	O
well	O
as	O
with	O
most	O
of	O
the	O
fruit	O
and	O
vegetable	O
groups	O
tested	O
.	O

root	O
vegetables	O
and	O
citrus	O
fruits	O
were	O
particularly	O
associated	O
with	O
beta	B
-	I
carotene	I
serum	O
status	O
as	O
were	O
citrus	O
fruits	O
for	O
vitamin	O
c.	O
fruit	O
and	O
vegetable	O
consumption	O
was	O
either	O
not	O
or	O
weakly	O
associated	O
with	O
alpha	B
-	I
tocopherol	I
serum	O
concentrations	O
.	O

correlation	O
coefficients	O
between	O
fruit	O
and	O
vegetable	O
intake	O
and	O
carotenoids	B
ranged	O
from	O
-0.08	O
(	O
lycopene	B
)	O
to	O
0.44	O
(	O
alpha	B
-	I
carotene	I
)	O
.	O

for	O
the	O
residuals	O
the	O
correlation	O
coefficients	O
ranged	O
from	O
-0.004	O
(	O
lycopene	B
)	O
to	O
0.47	O
(	O
alpha	B
-	I
carotene	I
)	O
.	O

red	O
blood	O
cell	O
delta15n	O
:	O
a	O
novel	O
biomarker	O
of	O
dietary	O
eicosapentaenoic	O
acid	O
and	O
docosahexaenoic	O
acid	O
intake	O
..	O
background	O
:	O
the	O
long	O
-	O
chain	O
omega-3	O
(	O
n-3	O
)	O
fatty	B
acids	I
derived	O
from	O
fish	O
,	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
,	O
are	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
cardiovascular	O
disease	O
and	O
other	O
chronic	O
diseases	O
.	O

design	O
:	O
we	O
examined	O
the	O
relation	O
between	O
red	O
blood	O
cell	O
(	O
rbc	O
)	O
delta(15)n	O
and	O
rbc	O
epa	O
and	O
dha	O
in	O
a	O
community	O
-	O
based	O
sample	O
of	O
496	O
yup'ik	O
eskimos	O
with	O
widely	O
varying	O
intake	O
of	O
n-3	O
fatty	B
acids	I
.	O

evaluation	O
of	O
urinary	O
iodine	B
excretion	O
as	O
a	O
biomarker	O
for	O
intake	O
of	O
milk	O
and	O
dairy	O
products	O
in	O
pregnant	O
women	O
in	O
the	O
norwegian	O
mother	O
and	O
child	O
cohort	O
study	O
(	O
moba	O
)	O
..	O
background	O
/	O
objectives	O
:	O
milk	O
and	O
dairy	O
products	O
are	O
the	O
main	O
sources	O
of	O
iodine	B
in	O
the	O
norwegian	O
diet	O
.	O

this	O
is	O
due	O
to	O
a	O
high	O
consumption	O
of	O
milk	O
and	O
dairy	O
products	O
combined	O
with	O
a	O
relatively	O
high	O
concentration	O
of	O
iodine	B
in	O
milk	O
because	O
of	O
mandatory	O
iodine	B
fortification	O
of	O
cow	O
fodder	O
.	O

the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
relation	O
between	O
24	O
-	O
h	O
urinary	O
iodine	B
excretion	O
and	O
estimated	O
dietary	O
intake	O
,	O
and	O
to	O
explore	O
the	O
use	O
of	O
24	O
-	O
h	O
urinary	O
iodine	B
excretion	O
as	O
a	O
possible	O
biomarker	O
for	O
the	O
intake	O
of	O
milk	O
and	O
dairy	O
products	O
when	O
assessing	O
the	O
validity	O
of	O
a	O
new	O
food	O
frequency	O
questionnaire	O
for	O
pregnant	O
women	O
participating	O
the	O
norwegian	O
mother	O
and	O
child	O
cohort	O
study	O
(	O
moba	O
)	O
.	O

iodine	B
was	O
analyzed	O
in	O
24	O
-	O
h	O
urine	O
.	O

dietary	O
intakes	O
were	O
estimated	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
and	O
a	O
4	O
-	O
day	O
weighed	O
food	O
diary	O
(	O
fd	O
)	O
.	O
using	O
linear	O
regression	O
,	O
predictors	O
of	O
urinary	O
iodine	B
excretion	O
were	O
identified	O
.	O

results	O
:	O
significant	O
predictors	O
of	O
24	O
-	O
h	O
urinary	O
iodine	B
excretion	O
were	O
:	O
intake	O
of	O
dairy	O
products	O
,	O
iodine	O
-	O
containing	O
supplements	O
and	O
intake	O
of	O
fruit	O
/	O
vegetables	O
.	O

fish	O
/	O
seafood	O
intake	O
and	O
time	O
of	O
the	O
year	O
influenced	O
24	O
-	O
h	O
urinary	O
iodine	B
excretion	O
,	O
although	O
not	O
significantly	O
.	O

the	O
validity	O
coefficients	O
observed	O
for	O
total	O
intake	O
of	O
dairy	O
products	O
were	O
0.65	O
,	O
0.94	O
and	O
0.52	O
for	O
the	O
ffq	O
,	O
the	O
fd	O
and	O
the	O
24	O
-	O
h	O
urinary	O
iodine	B
excretion	O
,	O
respectively	O
.	O

conclusions	O
:	O
the	O
present	O
study	O
showed	O
that	O
24	O
-	O
h	O
urinary	O
iodine	B
excretion	O
may	O
be	O
a	O
useful	O
biomarker	O
for	O
validating	O
the	O
intake	O
of	O
milk	O
and	O
dairy	O
products	O
in	O
pregnant	O
norwegian	O
women	O
.	O

biomarkers	O
studied	O
were	O
plasma	O
levels	O
of	O
beta	O
-	O
carotene	O
,	O
alpha	B
-	I
tocopherol	I
,	O
retinol	O
,	O
vitamins	O
b12	O
,	O
c	O
and	O
folates	B
as	O
well	O
as	O
serum	O
total	O
cholesterol	O
,	O
hdl	O
cholesterol	O
,	O
ldl	O
cholesterol	O
and	O
triglycerides	O
.	O

results	O
and	O
conclusions	O
:	O
subjects	O
with	O
higher	O
md	O
adherence	O
,	O
as	O
measured	O
by	O
the	O
two	O
dietary	O
indexes	O
,	O
had	O
significantly	O
higher	O
plasma	O
concentrations	O
of	O
beta	O
-	O
carotene	O
,	O
folates	B
,	O
vitamin	O
c	O
,	O
alpha	B
-	I
tocopherol	I
and	O
hdl	O
cholesterol	O
.	O

the	O
most	O
highly	O
significant	O
relationship	O
was	O
that	O
between	O
folates	B
and	O
the	O
adherence	O
to	O
the	O
md	O
pattern	O
,	O
as	O
determined	O
by	O
both	O
indexes	O
.	O

plasma	O
phylloquinone	B
(	O
vitamin	O
k1	O
)	O
concentration	O
and	O
its	O
relationship	O
to	O
intake	O
in	O
british	O
adults	O
aged	O
19	O
-	O
64	O
years	O
..	O
plasma	O
phylloquinone	B
(	O
vitamin	O
k1	O
)	O
concentration	O
from	O
non	O
-	O
fasted	O
blood	O
samples	O
was	O
examined	O
by	O
season	O
,	O
smoking	O
status	O
,	O
socio	O
-	O
demographic	O
factors	O
and	O
phylloquinone	B
intake	O
in	O
a	O
nationally	O
representative	O
sample	O
of	O
1154	O
british	O
individuals	O
aged	O
19	O
-	O
64	O
years	O
from	O
the	O
2000	O
-	O
1	O
national	O
diet	O
and	O
nutrition	O
survey	O
.	O

geometric	O
mean	O
plasma	O
phylloquinone	B
concentration	O
was	O
0.94	O
(	O
95	O
%	O
ci	O
0.88	O
,	O
1.00	O
)	O
nmol	O
/	O
l	O
,	O
with	O
95	O
%	O
of	O
values	O
in	O
the	O
range	O
0.10	O
-	O
8.72	O
nmol	O
/	O
l.	O
plasma	O
phylloquinone	B
concentrations	O
of	O
530	O
men	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
624	O
women	O
(	O
1.13	O
(	O
95	O
%	O
ci	O
1.04	O
,	O
1.22	O
)	O
v.	O
0.81	O
(	O
95	O
%	O
ci	O
0.74	O
,	O
0.88	O
)	O
nmol	O
/	O
l	O
;	O
p<0.001	O
)	O
,	O
independent	O
of	O
other	O
factors	O
.	O

women	O
aged	O
19	O
-	O
34	O
years	O
had	O
significantly	O
lower	O
plasma	O
phylloquinone	B
concentration	O
than	O
their	O
older	O
counterparts	O
.	O

women	O
were	O
also	O
found	O
to	O
have	O
lower	O
plasma	O
phylloquinone	B
concentrations	O
during	O
summer	O
compared	O
with	O
winter	O
and	O
spring	O
(	O
each	O
p<0.01	O
)	O
.	O

in	O
contrast	O
,	O
plasma	O
phylloquinone	B
concentration	O
in	O
men	O
did	O
not	O
vary	O
significantly	O
by	O
season	O
or	O
any	O
of	O
the	O
socio	O
-	O
demographic	O
or	O
lifestyle	O
factors	O
.	O

plasma	O
phylloquinone	B
concentrations	O
were	O
positively	O
correlated	O
with	O
phylloquinone	B
intake	O
in	O
men	O
and	O
women	O
(	O
r	O
0.26	O
and	O
0.32	O
respectively	O
;	O
each	O
p<0.001	O
)	O
.	O

overall	O
,	O
forward	O
stepwise	O
multiple	O
regression	O
analysis	O
revealed	O
that	O
8	O
%	O
of	O
the	O
variation	O
in	O
plasma	O
phylloquinone	B
concentration	O
was	O
explained	O
by	O
phylloquinone	B
intake	O
,	O
with	O
a	O
further	O
10	O
%	O
of	O
its	O
variation	O
explained	O
by	O
plasma	O
concentrations	O
of	O
gamma	O
-	O
tocopherol	O
(	O
6	O
%	O
)	O
and	O
retinyl	O
palmitate	O
(	O
4	O
%	O
)	O
.	O

after	O
adjustment	O
for	O
age	O
and	O
corresponding	O
nutrient	O
intakes	O
,	O
plasma	O
phylloquinone	B
concentration	O
was	O
significantly	O
associated	O
(	O
each	O
p<0.01	O
)	O
with	O
plasma	O
concentrations	O
of	O
total	O
and	O
ldl	O
-	O
cholesterol	O
,	O
alpha-	O
and	O
gamma	O
-	O
tocopherols	O
,	O
retinyl	O
palmitate	O
,	O
beta	O
-	O
carotene	O
,	O
lycopene	O
and	O
lutein	O
plus	O
zeaxanthin	O
in	O
men	O
and	O
women	O
.	O

development	O
of	O
a	O
food	O
frequency	O
questionnaire	O
for	O
the	O
assessment	O
of	O
quercetin	B
and	O
naringenin	B
intake	O
..	O
objectives	O
:	O
to	O
measure	O
the	O
relationship	O
between	O
quercetin	B
and	O
naringenin	B
intakes	O
as	O
estimated	O
by	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
,	O
and	O
the	O
urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
aglycones	O
after	O
their	O
enzymatic	O
hydrolysis	O
in	O
human	O
volunteers	O
.	O

a	O
modified	O
ffq	O
was	O
developed	O
and	O
used	O
to	O
estimate	O
daily	O
intake	O
of	O
quercetin	B
and	O
naringenin	B
in	O
49	O
healthy	O
volunteers	O
who	O
also	O
provided	O
five	O
24	O
-	O
h	O
urine	O
samples	O
over	O
a	O
2	O
-	O
week	O
period	O
.	O

urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
metabolites	O
was	O
determined	O
by	O
solid	O
-	O
phase	O
extraction	O
and	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

results	O
:	O
the	O
estimated	O
mean	O
intakes	O
of	O
quercetin	B
and	O
naringenin	B
were	O
29.4	O
mg	O

mean	O
urinary	O
excretion	O
of	O
quercetin	B
was	O
60.1	O
microg	O
(	O
s.d	O
.	O

33.1	O
)	O
and	O
that	O
of	O
naringenin	B
was	O
0.56	O
mg	O

the	O
correlation	O
between	O
ffq	O
estimated	O
intake	O
of	O
quercetin	B
and	O
naringenin	B
and	O
levels	O
excreted	O
in	O
the	O
urine	O
were	O
r=0.82	O
(	O
p<0.0001	O
)	O
and	O
r=0.25	O
(	O
p=0.05	O
)	O
,	O
respectively	O
.	O

conclusions	O
:	O
we	O
observed	O
a	O
statistically	O
significant	O
correlation	O
between	O
the	O
urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
metabolites	O
and	O
their	O
dietary	O
intake	O
as	O
estimated	O
by	O
ffq	O
.	O
use	O
of	O
ffqs	O
in	O
epidemiological	O
studies	O
requiring	O
an	O
estimate	O
of	O
flavonoid	O
intake	O
seems	O
justified	O
.	O
.	O

objectives	O
:	O
to	O
measure	O
the	O
relationship	O
between	O
quercetin	B
and	O
naringenin	B
intakes	O
as	O
estimated	O
by	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
,	O
and	O
the	O
urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
aglycones	O
after	O
their	O
enzymatic	O
hydrolysis	O
in	O
human	O
volunteers	O
.	O

a	O
modified	O
ffq	O
was	O
developed	O
and	O
used	O
to	O
estimate	O
daily	O
intake	O
of	O
quercetin	B
and	O
naringenin	B
in	O
49	O
healthy	O
volunteers	O
who	O
also	O
provided	O
five	O
24	O
-	O
h	O
urine	O
samples	O
over	O
a	O
2	O
-	O
week	O
period	O
.	O

urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
metabolites	O
was	O
determined	O
by	O
solid	O
-	O
phase	O
extraction	O
and	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

results	O
:	O
the	O
estimated	O
mean	O
intakes	O
of	O
quercetin	B
and	O
naringenin	B
were	O
29.4	O
mg	O

mean	O
urinary	O
excretion	O
of	O
quercetin	B
was	O
60.1	O
microg	O
(	O
s.d	O
.	O

33.1	O
)	O
and	O
that	O
of	O
naringenin	B
was	O
0.56	O
mg	O

the	O
correlation	O
between	O
ffq	O
estimated	O
intake	O
of	O
quercetin	B
and	O
naringenin	B
and	O
levels	O
excreted	O
in	O
the	O
urine	O
were	O
r=0.82	O
(	O
p<0.0001	O
)	O
and	O
r=0.25	O
(	O
p=0.05	O
)	O
,	O
respectively	O
.	O

conclusions	O
:	O
we	O
observed	O
a	O
statistically	O
significant	O
correlation	O
between	O
the	O
urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
metabolites	O
and	O
their	O
dietary	O
intake	O
as	O
estimated	O
by	O
ffq	O
.	O
use	O
of	O
ffqs	O
in	O
epidemiological	O
studies	O
requiring	O
an	O
estimate	O
of	O
flavonoid	O
intake	O
seems	O
justified	O
.	O
.	O

objectives	O
:	O
to	O
measure	O
the	O
relationship	O
between	O
quercetin	B
and	O
naringenin	B
intakes	O
as	O
estimated	O
by	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
,	O
and	O
the	O
urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
aglycones	O
after	O
their	O
enzymatic	O
hydrolysis	O
in	O
human	O
volunteers	O
.	O

a	O
modified	O
ffq	O
was	O
developed	O
and	O
used	O
to	O
estimate	O
daily	O
intake	O
of	O
quercetin	B
and	O
naringenin	B
in	O
49	O
healthy	O
volunteers	O
who	O
also	O
provided	O
five	O
24	O
-	O
h	O
urine	O
samples	O
over	O
a	O
2	O
-	O
week	O
period	O
.	O

urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
metabolites	O
was	O
determined	O
by	O
solid	O
-	O
phase	O
extraction	O
and	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

results	O
:	O
the	O
estimated	O
mean	O
intakes	O
of	O
quercetin	B
and	O
naringenin	B
were	O
29.4	O
mg	O

mean	O
urinary	O
excretion	O
of	O
quercetin	B
was	O
60.1	O
microg	O
(	O
s.d	O
.	O

33.1	O
)	O
and	O
that	O
of	O
naringenin	B
was	O
0.56	O
mg	O

the	O
correlation	O
between	O
ffq	O
estimated	O
intake	O
of	O
quercetin	B
and	O
naringenin	B
and	O
levels	O
excreted	O
in	O
the	O
urine	O
were	O
r=0.82	O
(	O
p<0.0001	O
)	O
and	O
r=0.25	O
(	O
p=0.05	O
)	O
,	O
respectively	O
.	O

conclusions	O
:	O
we	O
observed	O
a	O
statistically	O
significant	O
correlation	O
between	O
the	O
urinary	O
excretion	O
of	O
quercetin	B
and	O
naringenin	B
metabolites	O
and	O
their	O
dietary	O
intake	O
as	O
estimated	O
by	O
ffq	O
.	O
use	O
of	O
ffqs	O
in	O
epidemiological	O
studies	O
requiring	O
an	O
estimate	O
of	O
flavonoid	O
intake	O
seems	O
justified	O
.	O

for	O
both	O
the	O
dhq	O
and	O
the	O
4	O
24	O
-	O
hr	O
,	O
crude	O
correlations	O
between	O
serum	O
and	O
diet	O
were	O
modest	O
to	O
strong	O
for	O
the	O
provitamin	O
a	O
carotenoids	O
(	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
beta	B
-	I
cryptoxanthin	I
)	O
,	O
low	O
to	O
modest	O
for	O
lycopene	O
,	O
and	O
very	O
low	O
for	O
lutein	B
.	O

the	O
individual	O
dietary	O
tocopherols	O
were	O
weakly	O
correlated	O
with	O
the	O
serum	O
tocopherols	O
,	O
but	O
vitamin	O
e	O
from	O
food	O
and	O
dietary	O
supplements	O
was	O
strongly	O
and	O
positively	O
correlated	O
with	O
serum	O
alpha	B
-	I
tocopherol	I
and	O
strongly	O
and	O
inversely	O
correlated	O
with	O
serum	O
gamma	B
-	I
tocopherol	I
for	O
both	O
instruments	O
.	O

adjustment	O
for	O
energy	O
,	O
bmi	O
,	O
smoking	O
status	O
,	O
serum	O
total	O
cholesterol	O
,	O
and	O
serum	O
triacylglycerol	O
did	O
not	O
appreciably	O
change	O
the	O
correlations	O
.	O
using	O
the	O
method	O
of	O
triads	O
,	O
validity	O
coefficients	O
for	O
the	O
dhq	O
were	O
comparable	O
to	O
the	O
4	O
24	O
-	O
hr	O
and	O
were	O
especially	O
strong	O
for	O
alpha	O
-	O
carotene	O
,	O
beta	B
-	I
cryptoxanthin	I
,	O
lutein	B
+	O
zeaxanthin	O
,	O
and	O
total	O
vitamin	O
e	O
in	O
men	O
and	O
gamma	B
-	I
tocopherol	I
and	O
total	O
vitamin	O
e	O
in	O
women	O
.	O

validity	O
of	O
protein	O
,	O
retinol	B
,	O
folic	O
acid	O
and	O
n-3	O
fatty	O
acid	O
intakes	O
estimated	O
from	O
the	O
food	O
-	O
frequency	O
questionnaire	O
used	O
in	O
the	O
danish	O
national	O
birth	O
cohort	O
..	O
objective	O
:	O
to	O
validate	O
intakes	O
of	O
protein	O
,	O
folic	O
acid	O
,	O
retinol	B
and	O
n-3	O
fatty	B
acids	I
estimated	O
from	O
a	O
food	O
-	O
frequency	O
questionnaire	O
in	O
week	O
25	O
of	O
pregnancy	O
(	O
ffq-25	O
)	O
.	O

results	O
:	O
estimated	O
intakes	O
of	O
protein	O
,	O
retinol	B
and	O
folic	O
acid	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
two	O
dietary	O
methods	O
,	O
but	O
intake	O
of	O
n-3	O
fatty	B
acids	I
was	O
one	O
third	O
larger	O
when	O
estimated	O
from	O
the	O
ffq-25	O
.	O

the	O
intakes	O
estimated	O
from	O
the	O
two	O
dietary	O
methods	O
were	O
all	O
significantly	O
correlated	O
,	O
ranging	O
from	O
0.20	O
for	O
retinol	B
intake	O
to	O
0.57	O
for	O
folic	O
acid	O
intake	O
.	O

no	O
correlations	O
with	O
plasma	O
retinol	B
were	O
found	O
.	O

erythrocyte	O
eicosapentaenoic	O
acid	O
(	O
c20:5n-3	O
)	O
correlated	O
significantly	O
with	O
n-3	O
fatty	B
acids	I
intake	O
estimated	O
from	O
both	O
the	O
ffq-25	O
(	O
r	O
=	O
0.37	O
,	O
p	O
<	O
0.001	O
)	O
and	O
the	O
fd	O
(	O
r	O
=	O
0.62	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

conclusion	O
:	O
the	O
ffq-25	O
gives	O
reasonable	O
valid	O
estimates	O
of	O
protein	O
,	O
retinol	B
and	O
folic	O
acid	O
intakes	O
,	O
but	O
seems	O
to	O
overestimate	O
intake	O
of	O
n-3	O
fatty	B
acids	I
.	O

urinary	O
flavonoids	B
and	O
phenolic	O
acids	O
as	O
biomarkers	O
of	O
intake	O
for	O
polyphenol	O
-	O
rich	O
foods	O
..	O
estimation	O
of	O
dietary	O
intake	O
of	O
polyphenols	B
is	O
difficult	O
,	O
due	O
to	O
limited	O
availability	O
of	O
food	O
composition	O
data	O
and	O
bias	O
inherent	O
to	O
dietary	O
assessment	O
methods	O
.	O

fifty	O
-	O
three	O
participants	O
of	O
the	O
su.vi.max	O
study	O
(	O
a	O
randomised	O
primary	O
-	O
prevention	O
trial	O
evaluating	O
the	O
effect	O
of	O
daily	O
antioxidant	O
supplementation	O
on	O
chronic	O
diseases	O
)	O
collected	O
a	O
24	O
h	O
urine	O
and	O
a	O
spot	O
urine	O
sample	O
and	O
filled	O
a	O
dietary	O
record	O
during	O
a	O
2	O
d	O
period	O
.	O
thirteen	O
polyphenols	B
and	O
metabolites	O
,	O
chlorogenic	O
acid	O
,	O
caffeic	O
acid	O
,	O
m	O
-	O
coumaric	O
acid	O
,	O
gallic	B
acid	I
,	O
4	O
-	O
o	O
-	O
methylgallic	O
acid	O
,	O
quercetin	O
,	O
isorhamnetin	O
,	O
kaempferol	O
,	O
hesperetin	O
,	O
naringenin	B
,	O
phloretin	B
,	O
enterolactone	B
and	O
enterodiol	O
,	O
were	O
measured	O
using	O
hplc	O
-	O
electrospray	O
ionisation	O
-	O
ms	O
-	O
ms	O
.	O

in	O
spot	O
samples	O
apple	O
consumption	O
was	O
positively	O
correlated	O
to	O
phloretin	B
,	O
grapefruit	O
consumption	O
to	O
naringenin	B
,	O
orange	O
to	O
hesperetin	O
,	O
citrus	O
fruit	O
consumption	O
to	O
both	O
naringenin	B
and	O
hesperetin	O
,	O
with	O
r	O
coefficients	O
ranging	O
from	O
0.31	O
to	O
0.57	O
(	O
p	O
<	O
0.05	O
)	O
.	O

the	O
combination	O
of	O
fruits	O
and/or	O
fruit	O
juices	O
was	O
positively	O
correlated	O
to	O
gallic	B
acid	I
and	O
4	O
-	O
o	O
-	O
methylgallic	O
acid	O
,	O
isorhamnetin	O
,	O
kaempferol	O
,	O
hesperetin	O
,	O
naringenin	B
and	O
phloretin	B
(	O
r	O
0.24	O
-	O
0.44	O
,	O
p	O
<	O
0.05	O
)	O
.	O

the	O
present	O
results	O
suggest	O
that	O
several	O
polyphenols	B
measured	O
in	O
a	O
spot	O
urine	O
sample	O
can	O
be	O
used	O
as	O
biomarkers	O
of	O
polyphenol	O
-	O
rich	O
food	O
intake	O
.	O

exploration	O
of	O
different	O
methods	O
to	O
assess	O
dietary	O
acrylamide	O
exposure	O
in	O
pregnant	O
women	O
participating	O
in	O
the	O
norwegian	O
mother	O
and	O
child	O
cohort	O
study	O
(	O
moba	O
)	O
..	O
we	O
assessed	O
dietary	O
exposure	O
to	O
acrylamide	O
in	O
119	B
pregnant	O
norwegian	O
women	O
.	O

the	O
aim	O
of	O
the	O
study	O
was	O
to	O
explore	O
three	B
different	O
methods	O
for	O
estimation	O
of	O
long	O
-	O
term	O
intake	O
of	O
acrylamide	O
and	O
whether	O
it	O
is	O
possible	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
identify	O
pregnant	O
women	O
with	O
high	O
exposure	O
to	O
acrylamide	O
.	O

acrylamide	O
excreted	O
as	O
mercapturic	O
acid	O
metabolites	O
in	O
24	B
-	O
h	O
urine	O
was	O
used	O
as	O
an	O
evaluation	O
tool	O
.	O

food	O
consumption	O
was	O
assessed	O
by	O
an	O
ffq	O
and	O
by	O
a	O
4	B
-	I
day	I
weighed	O
food	O
diary	O
(	O
fd	O
)	O
.	O

acrylamide	O
intake	O
was	O
also	O
estimated	O
by	O
a	O
probabilistic	O
approach	O
based	O
on	O
2	B
days	I
from	O
the	O
fd	O
.	O

the	O
dietary	O
exposure	O
to	O
acrylamide	O
estimated	O
as	O
mug	O
/	O
kg	O
bw	O
/	O
day	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.48	B
(	O
0.92	B
)	O
by	O
the	O
ffq	O
,	O
0.41	B
(	O
0.82	B
)	O
by	O
the	O
fd	O
and	O
0.42	B
(	O
0.70	B
)	O
by	O
the	O
probabilistic	O
approach	O
.	O

the	O
amount	O
of	O
acrylamide	O
excreted	O
as	O
urinary	O
metabolites	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.16	B
microg	O
/	O
kg	O

bw/24	O
-	O
h	O
(	O
0.50	O
)	O
in	O
non	O
-	O
smokers	O
,	O
corresponding	O
to	O
a	O
dietary	O
exposure	O
of	O
approximately	O
0.30	B
microg	O
/	O
kg	O
bw	O
/	O
day	O
(	O
0.91	B
)	O
.	O

we	O
assessed	O
dietary	O
exposure	O
to	O
acrylamide	O
in	O
119	B
pregnant	O
norwegian	O
women	O
.	O

the	O
aim	O
of	O
the	O
study	O
was	O
to	O
explore	O
three	B
different	O
methods	O
for	O
estimation	O
of	O
long	O
-	O
term	O
intake	O
of	O
acrylamide	O
and	O
whether	O
it	O
is	O
possible	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
identify	O
pregnant	O
women	O
with	O
high	O
exposure	O
to	O
acrylamide	O
.	O

acrylamide	O
excreted	O
as	O
mercapturic	O
acid	O
metabolites	O
in	O
24	B
-	O
h	O
urine	O
was	O
used	O
as	O
an	O
evaluation	O
tool	O
.	O

food	O
consumption	O
was	O
assessed	O
by	O
an	O
ffq	O
and	O
by	O
a	O
4	B
-	I
day	I
weighed	O
food	O
diary	O
(	O
fd	O
)	O
.	O

acrylamide	O
intake	O
was	O
also	O
estimated	O
by	O
a	O
probabilistic	O
approach	O
based	O
on	O
2	B
days	I
from	O
the	O
fd	O
.	O

the	O
dietary	O
exposure	O
to	O
acrylamide	O
estimated	O
as	O
mug	O
/	O
kg	O
bw	O
/	O
day	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.48	B
(	O
0.92	B
)	O
by	O
the	O
ffq	O
,	O
0.41	B
(	O
0.82	B
)	O
by	O
the	O
fd	O
and	O
0.42	B
(	O
0.70	B
)	O
by	O
the	O
probabilistic	O
approach	O
.	O

the	O
amount	O
of	O
acrylamide	O
excreted	O
as	O
urinary	O
metabolites	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.16	B
microg	O
/	O
kg	O

bw/24	O
-	O
h	O
(	O
0.50	O
)	O
in	O
non	O
-	O
smokers	O
,	O
corresponding	O
to	O
a	O
dietary	O
exposure	O
of	O
approximately	O
0.30	B
microg	O
/	O
kg	O
bw	O
/	O
day	O
(	O
0.91	B
)	O
.	O

we	O
assessed	O
dietary	O
exposure	O
to	O
acrylamide	O
in	O
119	B
pregnant	O
norwegian	O
women	O
.	O

the	O
aim	O
of	O
the	O
study	O
was	O
to	O
explore	O
three	B
different	O
methods	O
for	O
estimation	O
of	O
long	O
-	O
term	O
intake	O
of	O
acrylamide	O
and	O
whether	O
it	O
is	O
possible	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
identify	O
pregnant	O
women	O
with	O
high	O
exposure	O
to	O
acrylamide	O
.	O

acrylamide	O
excreted	O
as	O
mercapturic	O
acid	O
metabolites	O
in	O
24	B
-	O
h	O
urine	O
was	O
used	O
as	O
an	O
evaluation	O
tool	O
.	O

food	O
consumption	O
was	O
assessed	O
by	O
an	O
ffq	O
and	O
by	O
a	O
4	B
-	I
day	I
weighed	O
food	O
diary	O
(	O
fd	O
)	O
.	O

acrylamide	O
intake	O
was	O
also	O
estimated	O
by	O
a	O
probabilistic	O
approach	O
based	O
on	O
2	B
days	I
from	O
the	O
fd	O
.	O

the	O
dietary	O
exposure	O
to	O
acrylamide	O
estimated	O
as	O
mug	O
/	O
kg	O
bw	O
/	O
day	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.48	B
(	O
0.92	B
)	O
by	O
the	O
ffq	O
,	O
0.41	B
(	O
0.82	B
)	O
by	O
the	O
fd	O
and	O
0.42	B
(	O
0.70	B
)	O
by	O
the	O
probabilistic	O
approach	O
.	O

the	O
amount	O
of	O
acrylamide	O
excreted	O
as	O
urinary	O
metabolites	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.16	B
microg	O
/	O
kg	O

bw/24	O
-	O
h	O
(	O
0.50	O
)	O
in	O
non	O
-	O
smokers	O
,	O
corresponding	O
to	O
a	O
dietary	O
exposure	O
of	O
approximately	O
0.30	B
microg	O
/	O
kg	O
bw	O
/	O
day	O
(	O
0.91	B
)	O
.	O

we	O
assessed	O
dietary	O
exposure	O
to	O
acrylamide	O
in	O
119	B
pregnant	O
norwegian	O
women	O
.	O

the	O
aim	O
of	O
the	O
study	O
was	O
to	O
explore	O
three	B
different	O
methods	O
for	O
estimation	O
of	O
long	O
-	O
term	O
intake	O
of	O
acrylamide	O
and	O
whether	O
it	O
is	O
possible	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
identify	O
pregnant	O
women	O
with	O
high	O
exposure	O
to	O
acrylamide	O
.	O

acrylamide	O
excreted	O
as	O
mercapturic	O
acid	O
metabolites	O
in	O
24	B
-	O
h	O
urine	O
was	O
used	O
as	O
an	O
evaluation	O
tool	O
.	O

food	O
consumption	O
was	O
assessed	O
by	O
an	O
ffq	O
and	O
by	O
a	O
4	B
-	I
day	I
weighed	O
food	O
diary	O
(	O
fd	O
)	O
.	O

acrylamide	O
intake	O
was	O
also	O
estimated	O
by	O
a	O
probabilistic	O
approach	O
based	O
on	O
2	B
days	I
from	O
the	O
fd	O
.	O

the	O
dietary	O
exposure	O
to	O
acrylamide	O
estimated	O
as	O
mug	O
/	O
kg	O
bw	O
/	O
day	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.48	B
(	O
0.92	B
)	O
by	O
the	O
ffq	O
,	O
0.41	B
(	O
0.82	B
)	O
by	O
the	O
fd	O
and	O
0.42	B
(	O
0.70	B
)	O
by	O
the	O
probabilistic	O
approach	O
.	O

the	O
amount	O
of	O
acrylamide	O
excreted	O
as	O
urinary	O
metabolites	O
(	O
median	O
and	O
95	B
percentile	O
)	O
was	O
0.16	B
microg	O
/	O
kg	O

bw/24	O
-	O
h	O
(	O
0.50	O
)	O
in	O
non	O
-	O
smokers	O
,	O
corresponding	O
to	O
a	O
dietary	O
exposure	O
of	O
approximately	O
0.30	B
microg	O
/	O
kg	O
bw	O
/	O
day	O
(	O
0.91	B
)	O
.	O

plasma	O
carotenoids	B
as	O
biomarkers	O
of	O
intake	O
of	O
fruits	O
and	O
vegetables	O
:	O
individual	O
-	O
level	O
correlations	O
in	O
the	O
european	O
prospective	O
investigation	O
into	O
cancer	O
and	O
nutrition	O
(	O
epic	O
)	O
..	O
objective	O
:	O
the	O
aim	O
in	O
this	O
study	O
was	O
to	O
assess	O
the	O
association	O
between	O
individual	O
plasma	O
carotenoid	O
levels	O
(	O
alpha	B
-	I
carotene	I
,	O
beta	O
-	O
carotene	O
,	O
lycopene	B
,	O
beta	B
-	I
cryptoxanthin	I
,	O
lutein	O
,	O
zeaxanthin	B
)	O
and	O
fruit	O
and	O
vegetable	O
intakes	O
recorded	O
by	O
a	O
calibrated	O
food	O
questionnaire	O
(	O
fq	O
)	O
and	O
24	O
-	O
h	O
dietary	O
recall	O
records	O
(	O
24hdr	O
)	O
in	O
nine	O
different	O
european	O
countries	O
with	O
diverse	O
populations	O
and	O
widely	O
varying	O
intakes	O
of	O
plant	O
foods	O
.	O

results	O
:	O
beta	B
-	I
cryptoxanthin	I
was	O
most	O
strongly	O
correlated	O
with	O
total	O
fruits	O
(	O
fq	O
r	O
=	O
0.52	O
,	O
24hdr	O
r	O
=	O
0.39	O
)	O
,	O
lycopene	B
with	O
tomato	O
and	O
tomato	O
products	O
(	O
fq	O
r	O
=	O
0.38	O
,	O
24hdr	O
r	O
=	O
0.25	O
)	O
,	O
and	O
alpha	B
-	I
carotene	I
with	O
intake	O
of	O
root	O
vegetables	O
(	O
r	O
=	O
0.39	O
)	O
and	O
of	O
total	O
carrots	O
(	O
r	O
=	O
0.38	O
)	O
for	O
fq	O
only	O
.	O

based	O
on	O
diet	O
measured	O
by	O
fq	O
and	O
adjusting	O
for	O
possible	O
confounding	O
by	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
,	O
age	O
,	O
gender	O
,	O
smoking	O
status	O
,	O
alcohol	O
intake	O
,	O
and	O
energy	O
intake	O
,	O
the	O
strongest	O
predictors	O
of	O
individual	O
plasma	O
carotenoid	O
levels	O
were	O
fruits	O
(	O
r(partial)(2	O
)	O
=	O
17.2	O
%	O
)	O
for	O
beta	B
-	I
cryptoxanthin	I
,	O
total	O
carrots	O
(	O
(	O
partial)(2	O
)	O
=	O
13.4	O
%	O
)	O
and	O
root	O
vegetables	O
(	O
r(partial)(2	O
)	O
=	O
13.3	O
%	O
)	O
for	O
alpha	B
-	I
carotene	I
,	O
and	O
tomato	O
products	O
(	O
r(partial)(2	O
)	O
=	O
13.8	O
%	O
)	O
for	O
lycopene	B
.	O

for	O
24hdr	O
,	O
the	O
highest	O
r(partial)(2	O
)	O
was	O
for	O
fruits	O
in	O
relation	O
to	O
beta	B
-	I
cryptoxanthin	I
(	O
7.9	O
%	O
)	O
.	O

at	O
individual	O
subject	O
levels	O
,	O
fq	O
measurements	O
of	O
fruits	O
,	O
root	O
vegetables	O
and	O
carrots	O
,	O
and	O
tomato	O
products	O
are	O
,	O
respectively	O
,	O
good	O
predictors	O
of	O
beta	B
-	I
cryptoxanthin	I
,	O
alpha	B
-	I
carotene	I
,	O
and	O
lycopene	B
in	O
plasma	O
.	O

the	O
excretion	O
of	O
nitrogen	B
was	O
measured	O
on	O
four	O
24	O
-	O
h	O
urine	O
samples	O
,	O
and	O
plasma	O
levels	O
of	O
beta	O
-	O
carotene	O
,	O
retinol	O
,	O
vitamin	B
c	I
and	O
alpha	B
-	I
tocopherol	I
was	O
measured	O
from	O
two	O
time	O
points	O
.	O

relative	O
validity	O
of	O
ffq	O
and	O
24	O
-	O
h	O
diet	O
recall	O
was	O
assessed	O
by	O
comparing	O
nutrient	O
intake	O
derived	O
from	O
both	O
methods	O
with	O
the	O
urinary	O
nitrogen	B
and	O
plasma	O
levels	O
of	O
beta	O
-	O
carotene	O
,	O
retinol	O
,	O
vitamin	B
c	I
and	O
alpha	B
-	I
tocopherol	I
.	O

results	O
:	O
correlation	O
coefficients	O
comparing	O
energy	B
and	O
nutrients	O
intake	O
based	O
on	O
the	O
mean	O
of	O
the	O
four	O
ffq	O
and	O
the	O
mean	O
of	O
twelve	O
24	O
-	O
h	O
diet	O
recalls	O
were	O
0.75	O
for	O
total	O
energy	B
,	O
0.75	O
for	O
carbohydrates	O
,	O
0.76	O
for	O
proteins	B
and	O
0.65	O
for	O
fat	O
.	O

correlation	O
coefficients	O
between	O
the	O
ffq	O
-	O
based	O
intake	O
and	O
serum	O
levels	O
of	O
beta	O
-	O
carotene	O
,	O
retinol	O
,	O
vitamin	B
c	I
and	O
vitamin	O
e	O
/	O
alpha	B
-	I
tocopherol	I
were	O
0.37	O
,	O
0.32	O
,	O
0.35	O
and	O
0.06	O
,	O
respectively	O
.	O

correlation	O
coefficients	O
between	O
urinary	O
nitrogen	B
and	O
ffq	O
-	O
based	O
protein	O
intake	O
ranged	O
from	O
0.23	O
to	O
0.35	O
.	O

conclusion	O
:	O
we	O
found	O
that	O
the	O
ffq	O
provides	O
valid	O
and	O
reliable	O
measurements	O
of	O
habitual	O
intake	O
for	O
energy	B
and	O
most	O
of	O
the	O
nutrients	O
studied	O
.	O

home	O
use	O
of	O
margarine	O
is	O
an	O
important	O
determinant	O
of	O
plasma	O
trans	O
fatty	O
acid	O
status	O
:	O
a	O
biomarker	O
study	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

the	O
home	O
use	O
of	O
margarine	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetable	O
oils	O
,	O
is	O
an	O
important	O
determinant	O
of	O
trans	O
fatty	O
acid	O
exposure	O
in	O
new	O
zealand	O
..	O
the	O
contribution	O
of	O
the	O
home	O
use	O
of	O
margarines	O
,	O
made	O
with	O
partially	O
hydrogenated	O
vegetables	O
oils	O
,	O
to	O
total	O
trans	O
fatty	O
acid	O
intake	O
is	O
difficult	O
to	O
determine	O
using	O
dietary	O
assessment	O
because	O
food	O
composition	O
databases	O
are	O
incomplete	O
for	O
trans	O
fatty	O
acids	O
;	O
moreover	O
,	O
hidden	O
fats	B
in	O
manufactured	O
foods	O
may	O
be	O
the	O
predominant	O
sources	O
of	O
trans	O
fatty	O
acids	O
.	O

between	O
-	O
subjects	O
seasonal	O
variations	O
were	O
observed	O
for	O
beta	B
-	I
cryptoxanthin	I
intake	O
and	O
serum	O
levels	O
(	O
higher	O
in	O
winter	O
)	O
and	O
serum	O
lycopene	B
(	O
higher	O
in	O
summer	O
)	O
.	O

significant	O
within	O
-	O
subjects	O
seasonal	O
changes	O
were	O
shown	O
for	O
dietary	O
and	O
serum	O
beta	B
-	I
cryptoxanthin	I
and	O
serum	O
beta	O
-	O
carotene	O
.	O

subjects	O
with	O
clinically	O
acceptable	O
glycaemic	O
control	O
showed	O
lower	O
lycopene	B
intake	O
than	O
those	O
with	O
unacceptable	O
control	O
.	O

with	O
the	O
exception	O
of	O
lycopene	B
,	O
serum	O
carotenoids	O
were	O
predicted	O
by	O
dietary	O
intake	O
,	O
but	O
in	O
no	O
case	O
by	O
fasting	O
glycaemia	O
,	O
hba1c	O
or	O
fructosamine	O
.	O

between	O
-	O
subjects	O
seasonal	O
variations	O
were	O
observed	O
for	O
beta	B
-	I
cryptoxanthin	I
intake	O
and	O
serum	O
levels	O
(	O
higher	O
in	O
winter	O
)	O
and	O
serum	O
lycopene	B
(	O
higher	O
in	O
summer	O
)	O
.	O

significant	O
within	O
-	O
subjects	O
seasonal	O
changes	O
were	O
shown	O
for	O
dietary	O
and	O
serum	O
beta	B
-	I
cryptoxanthin	I
and	O
serum	O
beta	O
-	O
carotene	O
.	O

subjects	O
with	O
clinically	O
acceptable	O
glycaemic	O
control	O
showed	O
lower	O
lycopene	B
intake	O
than	O
those	O
with	O
unacceptable	O
control	O
.	O

with	O
the	O
exception	O
of	O
lycopene	B
,	O
serum	O
carotenoids	O
were	O
predicted	O
by	O
dietary	O
intake	O
,	O
but	O
in	O
no	O
case	O
by	O
fasting	O
glycaemia	O
,	O
hba1c	O
or	O
fructosamine	O
.	O

between	O
-	O
subjects	O
seasonal	O
variations	O
were	O
observed	O
for	O
beta	B
-	I
cryptoxanthin	I
intake	O
and	O
serum	O
levels	O
(	O
higher	O
in	O
winter	O
)	O
and	O
serum	O
lycopene	B
(	O
higher	O
in	O
summer	O
)	O
.	O

significant	O
within	O
-	O
subjects	O
seasonal	O
changes	O
were	O
shown	O
for	O
dietary	O
and	O
serum	O
beta	B
-	I
cryptoxanthin	I
and	O
serum	O
beta	O
-	O
carotene	O
.	O

subjects	O
with	O
clinically	O
acceptable	O
glycaemic	O
control	O
showed	O
lower	O
lycopene	B
intake	O
than	O
those	O
with	O
unacceptable	O
control	O
.	O

with	O
the	O
exception	O
of	O
lycopene	B
,	O
serum	O
carotenoids	O
were	O
predicted	O
by	O
dietary	O
intake	O
,	O
but	O
in	O
no	O
case	O
by	O
fasting	O
glycaemia	O
,	O
hba1c	O
or	O
fructosamine	O
.	O

between	O
-	O
subjects	O
seasonal	O
variations	O
were	O
observed	O
for	O
beta	B
-	I
cryptoxanthin	I
intake	O
and	O
serum	O
levels	O
(	O
higher	O
in	O
winter	O
)	O
and	O
serum	O
lycopene	B
(	O
higher	O
in	O
summer	O
)	O
.	O

significant	O
within	O
-	O
subjects	O
seasonal	O
changes	O
were	O
shown	O
for	O
dietary	O
and	O
serum	O
beta	B
-	I
cryptoxanthin	I
and	O
serum	O
beta	O
-	O
carotene	O
.	O

subjects	O
with	O
clinically	O
acceptable	O
glycaemic	O
control	O
showed	O
lower	O
lycopene	B
intake	O
than	O
those	O
with	O
unacceptable	O
control	O
.	O

with	O
the	O
exception	O
of	O
lycopene	B
,	O
serum	O
carotenoids	O
were	O
predicted	O
by	O
dietary	O
intake	O
,	O
but	O
in	O
no	O
case	O
by	O
fasting	O
glycaemia	O
,	O
hba1c	O
or	O
fructosamine	O
.	O

between	O
-	O
subjects	O
seasonal	O
variations	O
were	O
observed	O
for	O
beta	B
-	I
cryptoxanthin	I
intake	O
and	O
serum	O
levels	O
(	O
higher	O
in	O
winter	O
)	O
and	O
serum	O
lycopene	B
(	O
higher	O
in	O
summer	O
)	O
.	O

significant	O
within	O
-	O
subjects	O
seasonal	O
changes	O
were	O
shown	O
for	O
dietary	O
and	O
serum	O
beta	B
-	I
cryptoxanthin	I
and	O
serum	O
beta	O
-	O
carotene	O
.	O

subjects	O
with	O
clinically	O
acceptable	O
glycaemic	O
control	O
showed	O
lower	O
lycopene	B
intake	O
than	O
those	O
with	O
unacceptable	O
control	O
.	O

with	O
the	O
exception	O
of	O
lycopene	B
,	O
serum	O
carotenoids	O
were	O
predicted	O
by	O
dietary	O
intake	O
,	O
but	O
in	O
no	O
case	O
by	O
fasting	O
glycaemia	O
,	O
hba1c	O
or	O
fructosamine	O
.	O

between	O
-	O
subjects	O
seasonal	O
variations	O
were	O
observed	O
for	O
beta	B
-	I
cryptoxanthin	I
intake	O
and	O
serum	O
levels	O
(	O
higher	O
in	O
winter	O
)	O
and	O
serum	O
lycopene	B
(	O
higher	O
in	O
summer	O
)	O
.	O

significant	O
within	O
-	O
subjects	O
seasonal	O
changes	O
were	O
shown	O
for	O
dietary	O
and	O
serum	O
beta	B
-	I
cryptoxanthin	I
and	O
serum	O
beta	O
-	O
carotene	O
.	O

subjects	O
with	O
clinically	O
acceptable	O
glycaemic	O
control	O
showed	O
lower	O
lycopene	B
intake	O
than	O
those	O
with	O
unacceptable	O
control	O
.	O

with	O
the	O
exception	O
of	O
lycopene	B
,	O
serum	O
carotenoids	O
were	O
predicted	O
by	O
dietary	O
intake	O
,	O
but	O
in	O
no	O
case	O
by	O
fasting	O
glycaemia	O
,	O
hba1c	O
or	O
fructosamine	O
.	O

intake	O
frequency	O
of	O
fish	O
and	O
serum	O
levels	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
:	O
a	O
cross	O
-	O
sectional	O
study	O
within	O
the	O
japan	O
collaborative	O
cohort	O
study	O
..	O
background	O
:	O
several	O
investigations	O
have	O
adopted	O
self	O
-	O
reported	O
intake	O
frequency	O
of	O
fish	O
as	O
a	O
surrogate	O
for	O
intake	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
,	O
for	O
which	O
protective	O
effects	O
against	O
cancer	O
have	O
been	O
suggested	O
.	O

methods	O
:	O
we	O
examined	O
the	O
association	O
between	O
intake	O
frequency	O
of	O
fish	O
and	O
serum	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
(	O
weight	O
percentage	O
of	O
total	O
fatty	B
acids	I
)	O
among	O
1,257	O
control	O
subjects	O
(	O
631	O
men	O
and	O
626	O
women	O
)	O
,	O
aged	O
40	O
-	O
79	O
years	O
,	O
in	O
case	O
-	O
control	O
studies	O
nested	O
in	O
the	O
japan	O
collaborative	O
cohort	O
study	O
.	O

serum	O
fatty	B
acids	I
were	O
determined	O
by	O
gas	O
chromatography	O
.	O

conclusions	O
:	O
a	O
population	O
with	O
high	O
self	O
-	O
reported	O
frequency	O
of	O
fish	O
intake	O
,	O
as	O
a	O
group	O
,	O
may	O
have	O
higher	O
bioavailability	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
than	O
one	O
with	O
low	O
frequency	O
.	O
.	O

background	O
:	O
several	O
investigations	O
have	O
adopted	O
self	O
-	O
reported	O
intake	O
frequency	O
of	O
fish	O
as	O
a	O
surrogate	O
for	O
intake	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
,	O
for	O
which	O
protective	O
effects	O
against	O
cancer	O
have	O
been	O
suggested	O
.	O

methods	O
:	O
we	O
examined	O
the	O
association	O
between	O
intake	O
frequency	O
of	O
fish	O
and	O
serum	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
(	O
weight	O
percentage	O
of	O
total	O
fatty	B
acids	I
)	O
among	O
1,257	O
control	O
subjects	O
(	O
631	O
men	O
and	O
626	O
women	O
)	O
,	O
aged	O
40	O
-	O
79	O
years	O
,	O
in	O
case	O
-	O
control	O
studies	O
nested	O
in	O
the	O
japan	O
collaborative	O
cohort	O
study	O
.	O

serum	O
fatty	B
acids	I
were	O
determined	O
by	O
gas	O
chromatography	O
.	O

conclusions	O
:	O
a	O
population	O
with	O
high	O
self	O
-	O
reported	O
frequency	O
of	O
fish	O
intake	O
,	O
as	O
a	O
group	O
,	O
may	O
have	O
higher	O
bioavailability	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
than	O
one	O
with	O
low	O
frequency	O
.	O
.	O

background	O
:	O
several	O
investigations	O
have	O
adopted	O
self	O
-	O
reported	O
intake	O
frequency	O
of	O
fish	O
as	O
a	O
surrogate	O
for	O
intake	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
,	O
for	O
which	O
protective	O
effects	O
against	O
cancer	O
have	O
been	O
suggested	O
.	O

methods	O
:	O
we	O
examined	O
the	O
association	O
between	O
intake	O
frequency	O
of	O
fish	O
and	O
serum	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
(	O
weight	O
percentage	O
of	O
total	O
fatty	B
acids	I
)	O
among	O
1,257	O
control	O
subjects	O
(	O
631	O
men	O
and	O
626	O
women	O
)	O
,	O
aged	O
40	O
-	O
79	O
years	O
,	O
in	O
case	O
-	O
control	O
studies	O
nested	O
in	O
the	O
japan	O
collaborative	O
cohort	O
study	O
.	O

serum	O
fatty	B
acids	I
were	O
determined	O
by	O
gas	O
chromatography	O
.	O

conclusions	O
:	O
a	O
population	O
with	O
high	O
self	O
-	O
reported	O
frequency	O
of	O
fish	O
intake	O
,	O
as	O
a	O
group	O
,	O
may	O
have	O
higher	O
bioavailability	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
than	O
one	O
with	O
low	O
frequency	O
.	O
.	O

background	O
:	O
several	O
investigations	O
have	O
adopted	O
self	O
-	O
reported	O
intake	O
frequency	O
of	O
fish	O
as	O
a	O
surrogate	O
for	O
intake	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
,	O
for	O
which	O
protective	O
effects	O
against	O
cancer	O
have	O
been	O
suggested	O
.	O

methods	O
:	O
we	O
examined	O
the	O
association	O
between	O
intake	O
frequency	O
of	O
fish	O
and	O
serum	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
(	O
weight	O
percentage	O
of	O
total	O
fatty	B
acids	I
)	O
among	O
1,257	O
control	O
subjects	O
(	O
631	O
men	O
and	O
626	O
women	O
)	O
,	O
aged	O
40	O
-	O
79	O
years	O
,	O
in	O
case	O
-	O
control	O
studies	O
nested	O
in	O
the	O
japan	O
collaborative	O
cohort	O
study	O
.	O

serum	O
fatty	B
acids	I
were	O
determined	O
by	O
gas	O
chromatography	O
.	O

conclusions	O
:	O
a	O
population	O
with	O
high	O
self	O
-	O
reported	O
frequency	O
of	O
fish	O
intake	O
,	O
as	O
a	O
group	O
,	O
may	O
have	O
higher	O
bioavailability	O
of	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
than	O
one	O
with	O
low	O
frequency	O
.	O

fatty	B
acids	I
were	O
identified	O
by	O
using	O
capillary	O
gas	O
chromatography	O
.	O

the	O
strongest	O
correlations	O
were	O
observed	O
between	O
vegetable	O
intake	O
and	O
serum	O
alpha	B
-	I
carotene	I
.	O

the	O
highest	O
validity	O
coefficients	O
(	O
vc	O
)	O
were	O
observed	O
for	O
vegetable	O
intake	O
estimated	O
from	O
weighed	O
records	O
,	O
the	O
180	O
-	O
item	O
ffq	O
,	O
the	O
twenty	O
-	O
seven	O
item	O
ffq	O
and	O
by	O
the	O
biomarker	O
serum	O
alpha	B
-	I
carotene	I
,	O
with	O
vc	O
of	O
0.77	O
,	O
0.58	O
,	O
0.51	O
and	O
0.67	O
,	O
respectively	O
.	O

both	O
the	O
estimated	O
partial	O
correlation	O
coefficients	O
and	O
vc	O
suggest	O
that	O
serum	O
alpha	B
-	I
carotene	I
is	O
the	O
best	O
biomarker	O
for	O
intake	O
of	O
vegetable	O
alone	O
and	O
total	O
intake	O
of	O
fruit	O
and	O
vegetables	O
in	O
this	O
population	O
of	O
norwegian	O
men	O
,	O
but	O
the	O
biomarkers	O
did	O
not	O
perform	O
any	O
better	O
than	O
the	O
ffq	O
.	O

evaluation	O
of	O
the	O
odd	O
fatty	B
acids	I
15:0	O
and	O
17:0	O
in	O
serum	O
and	O
adipose	O
tissue	O
as	O
markers	O
of	O
intake	O
of	O
milk	O
and	O
dairy	O
fat	O
..	O
background	O
:	O
there	O
is	O
a	O
need	O
for	O
biomarkers	O
of	O
dietary	O
saturated	O
fatty	B
acids	I
,	O
because	O
several	O
diseases	O
have	O
been	O
related	O
to	O
intake	O
of	O
these	O
fatty	B
acids	I
.	O

design	O
:	O
the	O
study	O
population	O
was	O
a	O
sub	O
-	O
sample	O
of	O
adult	O
participants	O
in	O
a	O
randomised	O
controlled	O
trial	O
of	O
beta	B
-	I
carotene	I
and	O
sunscreen	O
in	O
the	O
prevention	O
of	O
skin	O
cancer	O
.	O

nonfasting	O
blood	O
samples	O
were	O
collected	O
and	O
plasma	O
analysed	O
for	O
five	O
carotenoids	B
(	O
alpha	B
-	I
carotene	I
,	O
beta	B
-	I
carotene	I
,	O
beta	B
-	I
cryptoxanthin	I
,	O
lutein	O
,	O
lycopene	B
)	O
and	O
vitamin	O
e.	O
correlation	O
coefficients	O
were	O
calculated	O
between	O
each	O
of	O
the	O
dietary	O
methods	O
and	O
the	O
validity	O
coefficient	O
was	O
calculated	O
using	O
the	O
method	O
of	O
triads	O
.	O

results	O
:	O
the	O
validity	O
coefficients	O
of	O
the	O
ffq	O
were	O
highest	O
for	O
alpha	B
-	I
carotene	I
(	O
0.85	O
)	O
and	O
lycopene	B
(	O
0.62	O
)	O
,	O
followed	O
by	O
beta	B
-	I
carotene	I
(	O
0.55	O
)	O
and	O
total	O
carotenoids	B
(	O
0.55	O
)	O
,	O
while	O
the	O
lowest	O
validity	O
coefficient	O
was	O
for	O
lutein	O
(	O
0.19	O
)	O
.	O

the	O
method	O
of	O
triads	O
could	O
not	O
be	O
used	O
for	O
beta	B
-	I
cryptoxanthin	I
and	O
vitamin	O
e	O
,	O
as	O
one	O
of	O
the	O
three	O
underlying	O
correlations	O
was	O
negative	O
.	O

therefore	O
,	O
we	O
investigated	O
the	O
relation	O
between	O
plasma	O
carotenoids	B
and	O
usual	O
vegetable	O
and	O
fruit	O
intake	O
.	O

results	O
:	O
in	O
this	O
sample	O
of	O
the	O
general	O
dutch	O
population	O
,	O
in	O
both	O
genders	O
,	O
relative	O
to	O
the	O
other	O
carotenoids	B
,	O
plasma	O
beta	B
-	I
cryptoxanthin	I
was	O
the	O
best	O
indicator	O
for	O
fruit	O
intake	O
,	O
and	O
for	O
the	O
sum	O
of	O
vegetable	O
,	O
fruit	O
and	O
juice	O
intake	O
,	O
while	O
lutein	B
concentrations	O
best	O
reflected	O
intake	O
of	O
vegetables	O
,	O
although	O
quartiles	O
of	O
intake	O
were	O
not	O
consistently	O
separated	O
.	O

since	O
levels	O
of	O
lycopene	B
were	O
not	O
associated	O
with	O
any	O
of	O
the	O
main	O
food	O
groups	O
examined	O
,	O
associations	O
with	O
total	O
carotenoids	B
improved	O
when	O
excluding	O
lycopene	B
,	O
and	O
monotonously	O
increasing	O
plasma	O
levels	O
were	O
seen	O
for	O
intakes	O
of	O
vegetables	O
,	O
of	O
fruits	O
,	O
and	O
of	O
the	O
sum	O
of	O
vegetables	O
,	O
fruits	O
and	O
juices	O
.	O

several	O
vegetable	O
types	O
and	O
orange	O
/	O
grapefruit	O
juice	O
were	O
associated	O
with	O
plasma	O
levels	O
of	O
one	O
of	O
the	O
carotenoids	B
.	O

conclusion	O
:	O
plasma	O
carotenoids	B
were	O
only	O
crude	O
indicators	O
of	O
vegetable	O
and	O
fruit	O
intake	O
as	O
assessed	O
by	O
a	O
ffq	O
;	O
beta	B
-	I
cryptoxanthin	I
for	O
fruit	O
intake	O
and	O
lutein	B
for	O
vegetable	O
intake	O
.	O

none	O
of	O
the	O
plasma	O
carotenoids	B
could	O
distinguish	O
all	O
four	O
quartiles	O
of	O
vegetables	O
,	O
fruit	O
and/or	O
juice	O
intake	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

results	O
:	O
the	O
pearson	O
correlation	O
coefficients	O
for	O
various	O
carotenoids	O
as	O
measured	O
by	O
the	O
questionnaire	O
,	O
with	O
the	O
corresponding	O
measurements	O
in	O
plasma	O
specimens	O
,	O
ranged	O
from	O
0.33	O
to	O
0.44	O
(	O
all	O
p	O
<	O
.001	O
)	O
,	O
adjusted	O
for	O
total	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
,	O
age	O
,	O
sex	O
,	O
smoking	O
status	O
,	O
and	O
total	O
plasma	O
cholesterol	O
.	O

similarly	O
,	O
the	O
adjusted	O
correlation	O
between	O
self	O
-	O
reported	O
total	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.34	O
(	O
p	O
<	O
.001	O
)	O
.	O

energy	O
-	O
adjusted	O
spearman	O
correlations	O
coefficients	O
between	O
the	O
estimates	O
obtained	O
by	O
the	O
ffq	O
and	O
the	O
24	O
-	O
h	O
recalls	O
were	O
0.55	O
for	O
genistein	B
,	O
0.60	O
for	O
daidzein	B
,	O
0.70	O
for	O
secoisolariciresinol	O
,	O
and	O
0.63	O
for	O
matairesinol	B
(	O
all	O
p	O
<	O
0.001	O
)	O
.	O

spearman	O
correlation	O
coefficients	O
between	O
the	O
ffq	O
estimates	O
and	O
plasma	O
levels	O
were	O
0.21	O
(	O
p	O
=	O
0.12	O
)	O
for	O
genistein	B
,	O
0.32	O
(	O
p	O
=	O
0.02	O
)	O
for	O
daidzein	B
and	O
0.10	O
(	O
p	O
=	O
0.43	O
)	O
for	O
enterolactone	O
;	O
the	O
corresponding	O
values	O
for	O
the	O
24	O
-	O
h	O
recalls	O
compared	O
with	O
plasma	O
levels	O
were	O
0.43	O
(	O
p	O
<	O
0.001	O
)	O
,	O
0.40	O
(	O
p	O
=	O
0.002	O
)	O
,	O
and	O
0.08	O
(	O
p	O
=	O
0.50	O
)	O
,	O
respectively	O
.	O

the	O
ffq	O
had	O
the	O
highest	O
vc	O
for	O
lignans	B
(	O
0.91	O
vs.	O
0.73	O
for	O
24	O
-	O
h	O
recalls	O
and	O
0.11	O
for	O
plasma	O
samples	O
)	O
and	O
satisfactory	O
vcs	O
for	O
both	O
genistein	B
(	O
0.46	O
vs.	O
0.95	O
and	O
0.45	O
,	O
respectively	O
)	O
and	O
daidzein	B
(	O
0.67	O
vs.	O
0.83	O
and	O
0.45	O
,	O
respectively	O
)	O
.	O

dietary	O
evaluation	O
and	O
attenuation	O
of	O
relative	O
risk	O
:	O
multiple	O
comparisons	O
between	O
blood	O
and	O
urinary	O
biomarkers	O
,	O
food	O
frequency	O
,	O
and	O
24	O
-	O
hour	O
recall	O
questionnaires	O
:	O
the	O
dearr	O
study	O
..	O
estimates	O
of	O
diet	O
-	O
disease	O
relative	O
risks	O
(	O
rrs	O
)	O
suffer	O
from	O
inaccuracies	O
introduced	O
by	O
dietary	O
measurement	O
errors	O
.	O
using	O
the	O
"	O
method	O
of	O
triads	O
,	O
"	O
by	O
which	O
the	O
validity	O
coefficient	O
(	O
vc	O
)	O
of	O
the	O
dietary	O
assessment	O
method	O
and	O
"	O
true	O
"	O
long	O
-	O
term	O
intake	O
could	O
be	O
estimated	O
from	O
3	O
pairwise	O
correlations	O
between	O
the	O
ffq	O
,	O
the	O
reference	O
method	O
,	O
and	O
the	O
biomarker	O
,	O
the	O
authors	O
evaluated	O
the	O
performance	O
of	O
a	O
newly	O
developed	O
ffq	O
.	O
over	O
a	O
period	O
of	O
13	O
mo	O
(	O
september	O
2000	O
to	O
september	O
2001	O
)	O
,	O
161	O
participants	O
completed	O
3	O
ffqs	O
and	O
six	O
24	O
-	O
h	O
recalls	O
(	O
24hrs	O
)	O
,	O
and	O
supplied	O
2	O
blood	O
samples	O
and	O
three	O
24	O
-	O
h	O
urine	O
collections	O
.	O
for	O
protein	O
,	O
beta	B
-	I
carotene	I
,	O
and	O
folic	O
acid	O
,	O
the	O
vcs	O
of	O
the	O
ffq	O
with	O
the	O
"	O
true	O
intake	O
"	O
(	O
0.77	O
,	O
0.65	O
,	O
and	O
0.72	O
,	O
respectively	O
)	O
were	O
relatively	O
higher	O
than	O
the	O
vcs	O
of	O
24hrs	O
(	O
0.68	O
,	O
0.60	O
and	O
0.39	O
,	O
respectively	O
)	O
.	O

among	O
the	O
biomarkers	O
,	O
the	O
vcs	O
of	O
serum	O
beta	B
-	I
carotene	I
and	O
folic	O
acid	O
with	O
the	O
"	O
true	O
intake	O
"	O
(	O
0.65	O
and	O
0.65	O
)	O
were	O
higher	O
than	O
the	O
vcs	O
of	O
urinary	O
nitrogen	B
and	O
alpha	B
-	I
tocopherol	I
(	O
0.44	O
and	O
0.34	O
,	O
respectively	O
)	O
.	O

phytoestrogen	O
concentrations	O
in	O
serum	O
and	O
spot	O
urine	O
as	O
biomarkers	O
for	O
dietary	O
phytoestrogen	O
intake	O
and	O
their	O
relation	O
to	O
breast	O
cancer	O
risk	O
in	O
european	O
prospective	O
investigation	O
of	O
cancer	O
and	O
nutrition	O
-	O
norfolk	O
..	O
subjects	O
of	O
this	O
study	O
consisted	O
of	O
333	O
women	O
(	O
aged	O
45	O
-	O
75	O
years	O
)	O
drawn	O
from	O
a	O
large	O
united	O
kingdom	O
prospective	O
study	O
of	O
diet	O
and	O
cancer	O
,	O
the	O
european	O
prospective	O
investigation	O
of	O
cancer	O
and	O
nutrition	O
-	O
norfolk	O
study	O
.	O
using	O
newly	O
developed	O
gas	O
chromatography	O
/	O
mass	O
spectrometry	O
and	O
liquid	O
chromatography	O
/	O
mass	O
spectrometry	O
methods	O
incorporating	O
triply	O
(	O
13)c	O
-	O
labeled	O
standards	O
,	O
seven	O
phytoestrogens	O
(	O
daidzein	O
,	O
genistein	O
,	O
glycitein	O
,	O
o	O
-	O
desmethylangolensin	O
,	O
equol	B
,	O
enterodiol	B
,	O
and	O
enterolactone	B
)	O
were	O
measured	O
in	O
114	O
spot	O
urines	O
and	O
97	O
available	O
serum	O
samples	O
from	O
women	O
who	O
later	O
developed	O
breast	O
cancer	O
.	O

there	O
were	O
significant	O
relationships	O
(	O
p	O
<	O
0.02	O
)	O
between	O
both	O
urinary	O
and	O
serum	O
concentrations	O
of	O
isoflavones	B
across	O
increasing	O
tertiles	O
of	O
dietary	O
intakes	O
.	O

urinary	O
enterodiol	B
and	O
enterolactone	B
and	O
serum	O
enterolactone	B
were	O
significantly	O
correlated	O
with	O
dietary	O
fiber	O
intake	O
(	O
r	O
=	O
0.13	O
-	O
0.29	O
)	O
.	O

exposure	O
to	O
all	O
isoflavones	B
was	O
associated	O
with	O
increased	O
breast	O
cancer	O
risk	O
,	O
significantly	O
so	O
for	O
equol	B
and	O
daidzein	O
.	O
for	O
a	O
doubling	O
of	O
levels	O
,	O
odds	O
ratios	O
increased	O
by	O
20	O
-	O
45	O
%	O
[	O
log(2	O
)	O
odds	O
ratio	O
=	O
1.34	O
(	O
1.06	O
-	O
1.70	O
;	O
p	O
=	O
0.013	O
)	O
for	O
urine	O
equol	B
,	O
1.46	O
(	O
1.05	O
-	O
2.02	O
;	O
p	O
=	O
0.024	O
)	O
for	O
serum	O
equol	B
,	O
and	O
1.22	O
(	O
1.01	O
-	O
1.48	O
;	O
p	O
=	O
0.044	O
)	O
for	O
serum	O
daidzein	O
]	O
.	O

plasma	O
concentrations	O
of	O
vitamin	B
c	I
and	O
total	O
and	O
specific	O
carotenoids	B
served	O
as	O
biomarkers	O
against	O
which	O
validity	O
was	O
assessed	O
.	O

correlations	O
between	O
consumption	O
and	O
plasma	O
carotenoids	B
and	O
vitamin	B
c	I
at	O
baseline	O
were	O
0.39	O
and	O
0.37	O
,	O
respectively	O
,	O
for	O
fruits	O
and	O
0.24	O
and	O
0.26	O
,	O
respectively	O
,	O
for	O
vegetables	O
.	O

correlations	O
between	O
changes	O
in	O
consumption	O
and	O
plasma	O
carotenoids	B
and	O
vitamin	B
c	I
were	O
0.32	O
and	O
0.33	O
,	O
respectively	O
,	O
for	O
fruits	O
and	O
0.28	O
and	O
0.30	O
,	O
respectively	O
,	O
for	O
vegetables	O
.	O

plasma	O
concentrations	O
of	O
(	O
n-3	O
)	O
highly	O
unsaturated	O
fatty	B
acids	I
are	O
good	O
biomarkers	O
of	O
relative	O
dietary	O
fatty	O
acid	O
intakes	O
:	O
a	O
cross	O
-	O
sectional	O
study	O
..	O
a	O
cross	O
-	O
sectional	O
study	O
was	O
conducted	O
to	O
clarify	O
the	O
associations	O
of	O
lifestyle	O
factors	O
(	O
habitual	O
exercise	O
,	O
alcohol	O
intake	O
and	O
smoking	O
habit	O
)	O
and	O
plasma	O
fatty	O
acid	O
(	O
fa	O
)	O
concentrations	O
as	O
biomarkers	O
of	O
dietary	O
fa	O
intakes	O
.	O

multiple	O
linear	O
regression	O
analyses	O
adjusted	O
for	O
age	O
,	O
bmi	O
,	O
total	O
energy	B
intake	O
,	O
fat	O
(	O
or	O
respective	O
fa	O
)	O
consumption	O
and	O
lifestyle	O
factors	O
showed	O
that	O
dietary	O
intakes	O
of	O
epa	O
,	O
dha	O
and	O
(	O
n-3	O
)	O
hufa	O
were	O
positively	O
associated	O
with	O
age	O
in	O
men	O
(	O
p	O
<	O
0.05	O
)	O
and	O
negatively	O
associated	O
with	O
bmi	O
in	O
women	O
[	O
p	O
<	O
0.01	O
for	O
dha	O
and	O
(	O
n-3	O
)	O
hufa	O
]	O
.	O

the	O
plasma	O
concentrations	O
of	O
epa	O
,	O
dha	O
and	O
(	O
n-3	O
)	O
hufa	O
in	O
women	O
were	O
found	O
to	O
be	O
positively	O
associated	O
with	O
age	O
and	O
marine	O
oil	O
(	O
or	O
respective	O
fa	O
)	O
intake	O
(	O
p	O
<	O
0.01	O
)	O
,	O
and	O
negatively	O
associated	O
with	O
total	O
energy	B
intake	O
[	O
p	O
<	O
0.05	O
for	O
epa	O
and	O
(	O
n-3	O
)	O
hufa	O
]	O
.	O

4	B
-	I
o	I
-	I
methylgallic	I
acid	I
(	O
4omga	O
)	O
and	O
isoferulic	B
acid	I
are	O
potential	O
biomarkers	O
of	O
exposure	O
to	O
polyphenols	O
derived	O
from	O
tea	O
and	O
coffee	O
respectively	O
.	O

4omga	O
is	O
derived	O
from	O
gallic	O
acid	O
in	O
tea	O
,	O
and	O
isoferulic	B
acid	I
is	O
derived	O
from	O
chlorogenic	O
acid	O
in	O
coffee	O
.	O

our	O
major	O
objective	O
was	O
to	O
explore	O
the	O
relationships	O
of	O
tea	O
and	O
coffee	O
intake	O
with	O
24	O
h	O
urinary	O
excretion	O
of	O
4omga	O
and	O
isoferulic	B
acid	I
in	O
human	O
subjects	O
.	O

the	O
relationships	O
of	O
long	O
-	O
term	O
usual	O
(	O
111	O
participants	O
)	O
and	O
contemporaneously	O
recorded	O
current	O
(	O
344	O
participants	O
)	O
tea	O
and	O
coffee	O
intake	O
with	O
24	O
h	O
urinary	O
excretion	O
of	O
4omga	O
and	O
isoferulic	B
acid	I
were	O
assessed	O
in	O
two	O
populations	O
.	O

4omga	O
was	O
related	O
to	O
usual	O
(	O
r	O
0.50	O
,	O
p<0.001	O
)	O
and	O
current	O
(	O
r	O
0.57	O
,	O
p<0.001	O
)	O
tea	O
intake	O
,	O
and	O
isoferulic	B
acid	I
was	O
related	O
to	O
usual	O
(	O
r	O
0.26	O
,	O
p=0.008	O
)	O
and	O
current	O
(	O
r	O
0.18	O
,	O
p<0.001	O
)	O
coffee	O
intake	O
.	O

overall	O
,	O
our	O
present	O
results	O
are	O
consistent	O
with	O
the	O
proposal	O
that	O
4omga	O
is	O
a	O
good	O
biomarker	O
for	O
black	O
tea	O
-	O
derived	O
polyphenol	O
exposure	O
,	O
but	O
isoferulic	B
acid	I
may	O
be	O
of	O
limited	O
usefulness	O
as	O
a	O
biomarker	O
for	O
coffee	O
-	O
derived	O
polyphenol	O
exposure	O
..	O
tea	O
and	O
coffee	O
are	O
rich	O
in	O
polyphenols	O
with	O
a	O
variety	O
of	O
biological	O
activities	O
.	O

4	B
-	I
o	I
-	I
methylgallic	I
acid	I
(	O
4omga	O
)	O
and	O
isoferulic	B
acid	I
are	O
potential	O
biomarkers	O
of	O
exposure	O
to	O
polyphenols	O
derived	O
from	O
tea	O
and	O
coffee	O
respectively	O
.	O

4omga	O
is	O
derived	O
from	O
gallic	O
acid	O
in	O
tea	O
,	O
and	O
isoferulic	B
acid	I
is	O
derived	O
from	O
chlorogenic	O
acid	O
in	O
coffee	O
.	O

our	O
major	O
objective	O
was	O
to	O
explore	O
the	O
relationships	O
of	O
tea	O
and	O
coffee	O
intake	O
with	O
24	O
h	O
urinary	O
excretion	O
of	O
4omga	O
and	O
isoferulic	B
acid	I
in	O
human	O
subjects	O
.	O

the	O
relationships	O
of	O
long	O
-	O
term	O
usual	O
(	O
111	O
participants	O
)	O
and	O
contemporaneously	O
recorded	O
current	O
(	O
344	O
participants	O
)	O
tea	O
and	O
coffee	O
intake	O
with	O
24	O
h	O
urinary	O
excretion	O
of	O
4omga	O
and	O
isoferulic	B
acid	I
were	O
assessed	O
in	O
two	O
populations	O
.	O

4omga	O
was	O
related	O
to	O
usual	O
(	O
r	O
0.50	O
,	O
p<0.001	O
)	O
and	O
current	O
(	O
r	O
0.57	O
,	O
p<0.001	O
)	O
tea	O
intake	O
,	O
and	O
isoferulic	B
acid	I
was	O
related	O
to	O
usual	O
(	O
r	O
0.26	O
,	O
p=0.008	O
)	O
and	O
current	O
(	O
r	O
0.18	O
,	O
p<0.001	O
)	O
coffee	O
intake	O
.	O

overall	O
,	O
our	O
present	O
results	O
are	O
consistent	O
with	O
the	O
proposal	O
that	O
4omga	O
is	O
a	O
good	O
biomarker	O
for	O
black	O
tea	O
-	O
derived	O
polyphenol	O
exposure	O
,	O
but	O
isoferulic	B
acid	I
may	O
be	O
of	O
limited	O
usefulness	O
as	O
a	O
biomarker	O
for	O
coffee	O
-	O
derived	O
polyphenol	O
exposure	O
.	O

reasonable	O
estimates	O
of	O
serum	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
beta	B
-	I
cryptoxanthin	I
are	O
obtained	O
with	O
a	O
food	O
frequency	O
questionnaire	O
in	O
older	O
black	O
and	O
white	O
adults	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
..	O
few	O
studies	O
provide	O
correlations	O
between	O
different	O
indicators	O
of	O
the	O
dietary	O
intakes	O
of	O
older	O
(	O
>	O
or=	O
65	O
y	O
)	O
black	O
and	O
white	O
adults	O
.	O

this	O
study	O
compared	O
the	O
usual	O
intakes	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
,	O
and	O
selected	O
carotenoids	O
estimated	O
by	O
a	O
modified	O
harvard	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
to	O
those	O
estimated	O
by	O
multiple	O
24	O
-	O
h	O
recalls	O
,	O
and	O
to	O
blood	O
concentrations	O
of	O
components	O
in	O
a	O
randomly	O
selected	O
sample	O
of	O
participants	O
in	O
the	O
chicago	O
health	O
and	O
aging	O
project	O
(	O
chap	O
)	O
.	O

significant	O
(	O
p	O
<	O
0.05	O
)	O
correlations	O
between	O
total	O
(	O
diet	O
and	O
supplement	O
)	O
ffq	O
estimates	O
and	O
serum	O
measures	O
of	O
vitamin	B
e	I
and	O
vitamin	B
c	I
were	O
as	O
follows	O
:	O
0.49	O
and	O
0.39	O
for	O
blacks	O
,	O
and	O
0.42	O
and	O
0.29	O
for	O
whites	O
,	O
respectively	O
.	O

the	O
highest	O
correlations	O
between	O
serum	O
and	O
ffq	O
indicators	O
were	O
for	O
dietary	O
beta	B
-	I
cryptoxanthin	I
(	O
0.46	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.46	O
)	O
and	O
total	O
beta	B
-	I
carotene	I
(	O
0.44	O
)	O
among	O
whites	O
;	O
among	O
blacks	O
,	O
the	O
highest	O
correlations	O
were	O
for	O
dietary	O
alpha	B
-	I
carotene	I
(	O
0.81	O
)	O
,	O
total	O
alpha	B
-	I
tocopherol	I
(	O
0.53	O
)	O
and	O
total	O
beta	B
-	I
cryptoxanthin	I
(	O
0.50	O
)	O
;	O
all	O
were	O
significant	O
(	O
p	O
<	O
0.05	O
)	O
.	O

these	O
findings	O
indicate	O
that	O
the	O
modified	O
harvard	O
ffq	O
provides	O
reasonable	O
estimates	O
of	O
serum	O
levels	O
of	O
vitamin	B
e	I
,	O
vitamin	B
c	I
and	O
beta	B
-	I
cryptoxanthin	I
among	O
chap	O
participants	O
.	O

comparison	O
of	O
adipose	O
tissue	O
fatty	B
acids	I
with	O
dietary	O
fatty	B
acids	I
as	O
measured	O
by	O
24	O
-	O
hour	O
recall	O
and	O
food	O
frequency	O
questionnaire	O
in	O
black	O
and	O
white	O
adventists	O
:	O
the	O
adventist	O
health	O
study	O
..	O
purpose	O
:	O
to	O
calibrate	O
and	O
compare	O
intake	O
of	O
different	O
fats	B
and	O
individual	O
fatty	B
acids	I
as	O
assessed	O
with	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
against	O
that	O
estimated	O
with	O
(	O
i	O
)	O
a	O
series	O
of	O
dietary	O
recalls	O
and	O
;	O
(	O
ii	O
)	O
the	O
relative	O
fat	O
concentration	O
in	O
an	O
adipose	O
tissue	O
biopsy	O
.	O

methods	O
:	O
the	O
association	O
of	O
adipose	O
tissue	O
fatty	B
acids	I
and	O
dietary	O
fat	O
intake	O
was	O
assessed	O
in	O
49	O
black	O
and	O
72	O
white	O
seventh	O
-	O
day	O
adventists	O
subjects	O
using	O
8	O
different	O
24	O
-	O
hour	O
recalls	O
,	O
a	O
200	O
-	O
item	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
and	O
adipose	O
tissue	O
biopsies	O
from	O
each	O
subject	O
.	O

results	O
:	O
pearson	O
correlation	O
between	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
and	O
dietary	O
intake	O
as	O
assessed	O
by	O
multiple	O
24	O
-	O
hour	O
recalls	O
were	O
as	O
follows	O
:	O
linoleic	O
acid	O
:	O
0.77	O
in	O
black	O
and	O
0.71	O
in	O
white	O
subjects	O
,	O
respectively	O
;	O
linolenic	O
acid	O
:	O
0.68	O
(	O
blacks	O
)	O
and	O
0.62	O
(	O
whites	O
)	O
;	O
total	O
polyunsaturated	O
fat	O
(	O
pufa	O
):	O
0.78	O
(	O
blacks	O
)	O
and	O
0.70	O
(	O
whites	O
)	O
;	O
total	O
monounsaturated	O
fat	O
(	O
mufa	O
):	O
0.35	O
(	O
blacks	O
)	O
and	O
0.03	O
(	O
whites	O
)	O
;	O
total	O
saturated	O
fat	O
(	O
sfa	O
):	O
0.46	O
(	O
blacks	O
)	O
and	O
0.56	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
and	O
dietary	O
intake	O
as	O
assessed	O
by	O
ffq	O
were	O
:	O
linoleic	O
acid	O
:	O
0.61	O
(	O
blacks	O
)	O
and	O
0.52	O
(	O
whites	O
)	O
,	O
respectively	O
;	O
linolenic	O
acid	O
:	O
0.29	O
(	O
blacks	O
)	O
and	O
0.49	O
(	O
whites	O
)	O
;	O
pufa	O
:	O
0.62	O
(	O
blacks	O
)	O
and	O
0.53	O
(	O
whites	O
)	O
;	O
mufa	O
:	O
0.07	O
(	O
blacks	O
)	O
and	O
0.31	O
(	O
whites	O
)	O
,	O
sfa	O
:	O
0.21	O
(	O
blacks	O
)	O
and	O
0.31	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
urine	O
and	O
7	O
-	O
day	O
wdr	O
dietary	O
nitrogen	B
and	O
potassium	B
were	O
found	O
to	O
be	O
statistically	O
significant	O
with	O
r	O
=	O
0.45	O
(	O
p	O
<	O
0.05	O
)	O
and	O
r	O
=	O
0.78	O
(	O
p	O
<	O
0.001	O
)	O
respectively	O
.	O

correlations	O
between	O
urine	O
and	O
7	O
-	O
day	O
wdr	O
dietary	O
nitrogen	B
and	O
potassium	B
were	O
found	O
to	O
be	O
statistically	O
significant	O
with	O
r	O
=	O
0.45	O
(	O
p	O
<	O
0.05	O
)	O
and	O
r	O
=	O
0.78	O
(	O
p	O
<	O
0.001	O
)	O
respectively	O
.	O

frequent	O
intake	O
of	O
tropical	O
fruits	O
that	O
are	O
rich	O
in	O
beta	B
-	I
cryptoxanthin	I
is	O
associated	O
with	O
higher	O
plasma	O
beta	B
-	I
cryptoxanthin	I
concentrations	O
in	O
costa	O
rican	O
adolescents	O
..	O
dietary	O
tocopherols	O
and	O
carotenoids	O
may	O
play	O
a	O
role	O
in	O
preventing	O
cancer	O
and	O
cardiovascular	O
diseases	O
.	O

carotenoid	O
and	O
tocopherol	O
intakes	O
were	O
adjusted	O
for	O
total	O
energy	B
and	O
plasma	O
concentrations	O
for	O
total	O
cholesterol	O
.	O

the	O
relative	O
abundance	O
of	O
carotenoids	O
in	O
the	O
diet	O
was	O
similar	O
to	O
their	O
distribution	O
in	O
plasma	O
;	O
lycopene	B
was	O
the	O
most	O
abundant	O
,	O
followed	O
by	O
beta	B
-	I
carotene	I
and	O
lutein	O
+	O
zeaxanthin	O
.	O

gamma	B
-	I
tocopherol	I
was	O
more	O
abundant	O
than	O
alpha	B
-	I
tocopherol	I
in	O
the	O
diet	O
,	O
but	O
alpha	B
-	I
tocopherol	I
was	O
approximately	O
sevenfold	O
higher	O
in	O
plasma	O
.	O

the	O
highest	O
diet	O
-	O
plasma	O
correlations	O
(	O
adjusted	O
for	O
age	O
,	O
sex	O
and	O
body	O
mass	O
index	O
)	O
were	O
0.38	O
for	O
beta	B
-	I
cryptoxanthin	I
,	O
0.33	O
for	O
gamma	B
-	I
tocopherol	I
and	O
0.17	O
for	O
lutein	O
+	O
zeaxanthin	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

papaya	O
intake	O
was	O
the	O
best	O
food	O
predictor	O
of	O
plasma	O
beta	B
-	I
cryptoxanthin	I
concentrations	O
(	O
r	O
=	O
0.41	O
)	O
.	O

subjects	O
that	O
frequently	O
(	O
>	O
or	O
=3	O
/	O
d	O
)	O
consumed	O
tropical	O
fruits	O
with	O
at	O
least	O
50	O
micro	O
g/100	O
g	O
beta	B
-	I
cryptoxanthin	I
(	O
papaya	O
,	O
tangerine	O
,	O
orange	O
and	O
watermelon	O
)	O
had	O
twofold	O
the	O
plasma	O
beta	B
-	I
cryptoxanthin	I
concentrations	O
of	O
those	O
with	O
intakes	O
of	O
<	O
4	O
/	O
wk	O
(	O
p	O
for	O
trend	O
=	O
0.0009	O
)	O
.	O

intakes	O
of	O
beta	B
-	I
cryptoxanthin	I
and	O
papaya	O
,	O
a	O
tropical	O
fruit	O
frequently	O
consumed	O
in	O
latin	O
america	O
,	O
were	O
the	O
best	O
predictors	O
of	O
beta	B
-	I
cryptoxanthin	I
concentrations	O
in	O
plasma	O
.	O

objective	O
:	O
the	O
objective	O
was	O
to	O
identify	O
which	O
adipose	O
tissue	O
fatty	B
acids	I
are	O
suitable	O
biomarkers	O
of	O
intake	O
as	O
assessed	O
with	O
a	O
validated	O
food	O
-	O
frequency	O
questionnaire	O
.	O

fifty	O
fatty	B
acids	I
were	O
identified	O
by	O
capillary	O
gas	O
chromatography	O
.	O

results	O
:	O
the	O
best	O
adipose	O
tissue	O
marker	O
for	O
total	O
intake	O
of	O
saturated	O
fatty	B
acids	I
was	O
15:0	O
+	O
17:0	O
(	O
r	O
=	O
0.18	O
)	O
.	O

the	O
diet	O
-	O
adipose	O
tissue	O
correlations	O
for	O
n-3	O
fatty	B
acids	I
were	O
r	O
=	O
0.34	O
for	O
18:3	O
,	O
r	O
=	O
0.15	O
for	O
20:5	O
,	O
and	O
r	O
=	O
0.18	O
for	O
22:6	O
.	O

fish	O
intake	O
correlated	O
significantly	O
with	O
these	O
adipose	O
tissue	O
n-3	O
fatty	B
acids	I
.	O

dietary	O
and	O
adipose	O
tissue	O
n-6	O
fatty	B
acids	I
were	O
highly	O
correlated	O
:	O
18:2	O
(	O
r	O
=	O
0.58	O
)	O
and	O
18:3	O
(	O
r	O
=	O
0.24	O
)	O
.	O

conclusions	O
:	O
adipose	O
tissue	O
is	O
a	O
suitable	O
biomarker	O
of	O
dietary	O
fatty	O
acid	O
intake	O
,	O
particularly	O
for	O
n-3	O
and	O
n-6	O
cis	O
polyunsaturated	O
fatty	B
acids	I
and	O
trans	O
fatty	B
acids	I
.	O

plasma	O
phylloquinone	B
(	O
vitamin	O
k1	O
)	O
concentration	O
and	O
its	O
relationship	O
to	O
intake	O
in	O
a	O
national	O
sample	O
of	O
british	O
elderly	O
people	O
..	O
plasma	O
phylloquinone	B
(	O
vitamin	O
k1	O
)	O
concentration	O
was	O
examined	O
according	O
to	O
season	O
,	O
socio	O
-	O
demographic	O
and	O
lifestyle	O
factors	O
and	O
phylloquinone	B
intake	O
in	O
a	O
nationally	O
representative	O
sample	O
of	O
british	O
people	O
aged	O
65	O
years	O
and	O
over	O
from	O
the	O
1994	O
-	O
5	O
national	O
diet	O
and	O
nutrition	O
survey	O
.	O

values	O
for	O
both	O
plasma	O
phylloquinone	B
concentration	O
and	O
phylloquinone	B
intake	O
were	O
available	O
from	O
1076	O
participants	O
(	O
561	O
men	O
,	O
515	O
women	O
)	O
.	O

weighted	O
geometric	O
mean	O
plasma	O
phylloquinone	B
concentrations	O
were	O
0.36	O
(	O
inner	O
95	O
%	O
range	O
[	O
corrected	O
]	O
0.06	O
,	O
2.01	O
)	O
and	O
0.24	O
(	O
inner	O
94	O
%	O
range	O
[	O
corrected	O
]	O
0.06	O
,	O
0.96	O
)	O
nmol	O
/	O
l	O
in	O
free	O
-	O
living	O
and	O
institution	O
samples	O
respectively	O
.	O

plasma	O
phylloquinone	B
concentrations	O
did	O
not	O
generally	O
differ	O
between	O
men	O
and	O
women	O
,	O
although	O
values	O
in	O
free	O
-	O
living	O
people	O
were	O
significantly	O
lower	O
during	O
autumn	O
and	O
winter	O
(	O
october	O
to	O
march	O
)	O
.	O

plasma	O
phylloquinone	B
concentration	O
was	O
not	O
significantly	O
associated	O
with	O
age	O
.	O

plasma	O
phylloquinone	B
concentrations	O
were	O
positively	O
correlated	O
with	O
phylloquinone	B
intake	O
in	O
free	O
-	O
living	O
men	O
and	O
women	O
(	O
r	O
0.18	O
and	O
0.30	O
respectively	O
,	O
both	O
p<0.001	O
)	O
.	O

stepwise	O
multiple	O
regression	O
analysis	O
found	O
that	O
11	O
%	O
of	O
the	O
variation	O
in	O
plasma	O
phylloquinone	B
concentration	O
was	O
explained	O
by	O
phylloquinone	B
intake	O
,	O
season	O
and	O
plasma	O
triacylglycerol	O
concentration	O
.	O

after	O
adjustment	O
for	O
age	O
and	O
corresponding	O
nutrient	O
intakes	O
,	O
plasma	O
phylloquinone	B
concentration	O
was	O
significantly	O
associated	O
(	O
each	O
p<0.01	O
)	O
with	O
plasma	O
concentrations	O
of	O
triacylglycerol	O
,	O
cholesterol	O
,	O
retinol	O
and	O
25	O
-	O
hydroxyvitamin	O
d	O
in	O
free	O
-	O
living	O
women	O
but	O
not	O
men	O
,	O
and	O
with	O
plasma	O
concentrations	O
of	O
carotenes	O
,	O
alpha-	O
and	O
gamma	O
-	O
tocopherols	O
and	O
lutein	O
in	O
free	O
-	O
living	O
men	O
and	O
women	O
.	O

intake	O
of	O
lignans	B
is	O
associated	O
with	O
serum	O
enterolactone	B
concentration	O
in	O
finnish	O
men	O
and	O
women	O
..	O

the	O
mammalian	O
lignans	B
(	O
a	O
form	O
of	O
phytoestrogens	O
)	O
,	O
metabolically	O
derived	O
by	O
the	O
intestinal	O
microflora	O
from	O
dietary	O
precursors	O
,	O
may	O
have	O
several	O
health	O
benefits	O
.	O

we	O
assessed	O
lignan	O
intake	O
via	O
a	O
24	O
-	O
h	O
dietary	O
recall	O
(	O
n	O
=	O
2852	O
)	O
and	O
determined	O
serum	O
enterolactone	B
(	O
el	O
)	O
concentration	O
(	O
n	O
=	O
1784	O
)	O
in	O
25-	O
to	O
64	O
-	O
y	O
-	O
old	O
finnish	O
men	O
and	O
women	O
participating	O
in	O
a	O
national	O
survey	O
in	O
1997	O
.	O

mean	O
intake	O
of	O
lignans	B
[	O
sum	O
of	O
matairesinol	B
(	O
mat	O
)	O
and	O
secoisolariciresinol	B
(	O
seco	O
)	O
]	O
in	O
men	O
and	O
women	O
was	O
173	O
microg	O
/	O
d	O
(	O
19	O
microg	O
/	O
mj	O
)	O
and	O
151	O
microg	O
/	O
d	O
(	O
23	O
microg	O
/	O
mj	O
)	O
,	O
respectively	O
.	O

we	O
conclude	O
that	O
lignans	B
are	O
common	O
components	O
of	O
the	O
finnish	O
diet	O
,	O
although	O
the	O
mean	O
daily	O
intake	O
is	O
low	O
(	O
<	O
0.2	O
mg	O
)	O
.	O

the	O
main	O
dietary	O
sources	O
of	O
lignans	B
,	O
i.e.	O
,	O
whole	O
grain	O
,	O
vegetables	O
and	O
fruits	O
,	O
are	O
foods	O
commonly	O
associated	O
with	O
lower	O
risk	O
of	O
cardiovascular	O
diseases	O
and	O
cancer	O
.	O

erythrocyte	O
cell	O
membrane	O
phospholipid	O
levels	O
compared	O
against	O
reported	O
dietary	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
in	O
pregnant	O
mexican	O
women	O
..	O
objective	O
:	O
to	O
evaluate	O
the	O
validity	O
of	O
a	O
food	O
-	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
for	O
assessment	O
of	O
the	O
dietary	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
(	O
pufas	O
)	O
against	O
a	O
biochemical	O
marker	O
of	O
fat	O
intake	O
,	O
erythrocyte	O
cell	O
membrane	O
phospholipid	O
levels	O
,	O
during	O
pregnancy	O
.	O

this	O
estimate	O
was	O
compared	O
to	O
an	O
estimate	O
of	O
the	O
average	O
daily	O
folate	O
intake	O
obtained	O
using	O
the	O
fred	O
hutchinson	O
cancer	O
research	O
center	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
and	O
to	O
plasma	O
folate	O
and	O
homocysteine	B
concentrations	O
.	O

intervention	O
:	O
after	O
an	O
initial	O
clinic	O
visit	O
,	O
during	O
which	O
a	O
baseline	O
blood	O
sample	O
was	O
collected	O
for	O
measurement	O
of	O
plasma	O
folate	O
and	O
total	O
homocysteine	B
concentrations	O
,	O
subjects	O
participated	O
in	O
focused	O
dietary	O
recall	O
interviews	O
by	O
telephone	O
and/or	O
internet	O
(	O
e	O
-	O
mail	O
)	O
.	O

main	O
outcome	O
measures	O
the	O
main	O
outcome	O
measures	O
were	O
to	O
describe	O
how	O
well	O
the	O
focused	O
recalls	O
were	O
able	O
to	O
describe	O
relative	O
dietary	O
folate	O
intake	O
as	O
compared	O
to	O
the	O
ffq	O
and	O
if	O
the	O
focused	O
recall	O
method	O
estimate	O
correlated	O
with	O
plasma	O
folate	O
and	O
homocysteine	B
concentrations	O
.	O

the	O
spearman	O
correlation	O
test	O
was	O
used	O
to	O
compare	O
the	O
focused	O
recall	O
and	O
the	O
ffq	O
dietary	O
data	O
to	O
plasma	O
folate	O
and	O
homocysteine	B
concentrations	O
.	O

estimated	O
folate	O
intake	O
based	O
on	O
focused	O
recalls	O
was	O
correlated	O
significantly	O
with	O
plasma	O
homocysteine	B
(	O
r=-0.443	O
,	O
p<.02	O
)	O
and	O
was	O
marginally	O
significantly	O
correlated	O
with	O
plasma	O
folate	O
(	O
r=0.354	O
;	O
p=.06	O
)	O
concentrations	O
.	O

estimated	O
folate	O
intake	O
based	O
on	O
the	O
focused	O
recall	O
approach	O
is	O
reasonably	O
correlated	O
with	O
plasma	O
folate	O
and	O
total	O
homocysteine	B
concentrations	O
even	O
in	O
this	O
small	O
sample	O
of	O
women	O
.	O
accurate	O
data	O
on	O
folate	O
intake	O
can	O
form	O
the	O
basis	O
of	O
dietary	O
counseling	O
to	O
increase	O
intake	O
of	O
this	O
important	O
micronutrient	O
in	O
the	O
target	O
population	O
of	O
young	O
women	O
.	O

after	O
carotenoid	O
intake	O
was	O
adjusted	O
for	O
total	O
energy	B
intake	O
and	O
plasma	O
concentrations	O
were	O
adjusted	O
for	O
hdl-	O
,	O
ldl-	O
,	O
and	O
vldl	O
-	O
cholesterol	O
concentrations	O
,	O
we	O
calculated	O
partial	O
spearman	O
correlation	O
coefficients	O
that	O
were	O
adjusted	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
,	O
and	O
body	O
mass	O
index	O
.	O

results	O
:	O
in	O
women	O
,	O
the	O
correlations	O
(	O
r	O
)	O
between	O
intakes	O
and	O
concentrations	O
of	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
beta	O
-	O
cryptoxanthin	O
,	O
and	O
lutein+zeaxanthin	B
were	O
0.25	O
,	O
0.29	O
,	O
0.44	O
,	O
and	O
0.17	O
,	O
respectively	O
(	O
p	O
<	O
0.05	O
for	O
r	O
>	O
or	O
=	O
0.19	O
)	O
,	O
in	O
adipose	O
tissue	O
and	O
0.26	O
,	O
0.13	O
,	O
0.55	O
,	O
and	O
0.22	O
in	O
plasma	O
.	O

in	O
women	O
and	O
men	O
,	O
correlations	O
for	O
lycopene	B
were	O
higher	O
in	O
plasma	O
(	O
r	O
=	O
0.19	O
and	O
0.35	O
,	O
respectively	O
)	O
than	O
in	O
adipose	O
tissue	O
(	O
r	O
=	O
0.14	O
and	O
0.26	O
)	O
.	O

adipose	O
tissue	O
was	O
a	O
poor	O
biomarker	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
but	O
performed	O
well	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
validity	O
coefficients	O
,	O
0.45	O
-	O
1.01	O
)	O
and	O
lycopene	B
(	O
validity	O
coefficient	O
,	O
0.51	O
)	O
.	O

a	O
blood	O
sample	O
to	O
measure	O
serum	O
aspartate	B
aminotransferase	I
(	I
asat	I
)	I
,	O
alanine	B
aminotransferase	I
(	I
alat	I
)	I
,	O
gamma	O
-	O
glutamyltransferase	O
(	O
ggt	O
)	O
and	O
%	O
carbohydrate	B
-	I
deficient	I
transferrin	I
(	I
cdt	I
)	I
was	O
obtained	O
at	O
the	O
outset	O
.	O

consumption	O
of	O
fruit	O
was	O
predictive	O
for	O
serum	O
levels	O
of	O
beta	B
-	I
carotene	I
,	O
alpha	B
-	I
carotene	I
and	O
beta	O
-	O
cryptoxanthin	O
,	O
while	O
vegetable	O
consumption	O
was	O
predictive	O
for	O
serum	O
beta	B
-	I
carotene	I
,	O
lutein	B
,	O
zeaxanthin	B
and	O
lycopene	O
.	O

conclusions	O
:	O
one	O
single	O
serum	O
measurement	O
of	O
alpha	B
-	I
carotene	I
,	O
beta	B
-	I
carotene	I
and	O
lutein	B
can	O
accurately	O
rank	O
subjects	O
according	O
to	O
their	O
usual	O
serum	O
level	O
.	O

very	O
-	O
long	O
-	O
chain	O
omega-3	O
fatty	B
acids	I
as	O
markers	O
for	O
habitual	O
fish	O
intake	O
in	O
a	O
population	O
consuming	O
mainly	O
lean	O
fish	O
:	O
the	O
epic	O
cohort	O
of	O
gipuzkoa	O
.	O

fasting	O
venous	O
blood	O
samples	O
were	O
drawn	O
and	O
fatty	B
acids	I
were	O
measured	O
by	O
gas	O
-	O
liquid	O
chromatography	O
.	O

the	O
mean	O
concentrations	O
of	O
omega-3	O
polyunsaturated	O
fatty	B
acids	I
(	O
pufa	O
)	O
,	O
eicosapentaenoic	O
acid	O
(	O
epa	O
,	O
c20:5	O
,	O
omega-3	O
)	O
,	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
,	O
c22:6	O
,	O
omega-3	O
)	O
in	O
serum	O
and	O
in	O
the	O
ldl	O
fractions	O
of	O
serum	O
phospholipids	O
and	O
cholesteryl	O
esters	O
increased	O
significantly	O
from	O
the	O
lowest	O
to	O
the	O
highest	O
fish	O
consumption	O
categories	O
.	O

the	O
concentrations	O
of	O
very	O
-	O
long	O
-	O
chain	O
omega-3	O
fatty	B
acids	I
are	O
useful	O
biomarkers	O
for	O
dietary	O
fish	O
intake	O
,	O
mainly	O
lean	O
fish	O
.	O

comparing	O
biological	O
measurements	O
of	O
vitamin	B
c	I
,	O
folate	O
,	O
alpha	B
-	I
tocopherol	I
and	O
carotene	O
with	O
24	O
-	O
hour	O
dietary	O
recall	O
information	O
in	O
nonhispanic	O
blacks	O
and	O
whites	O
..	O
purpose	O
:	O
to	O
assess	O
intake	O
of	O
several	O
vitamins	O
in	O
preparation	O
for	O
a	O
large	O
cohort	O
study	O
investigating	O
the	O
effect	O
of	O
diet	O
on	O
risk	O
of	O
colon	O
and	O
prostate	O
cancer	O
.	O

the	O
levels	O
of	O
alpha	B
-	I
tocopherol	I
,	O
carotene	O
,	O
folate	O
,	O
and	O
vitamin	B
c	I
in	O
the	O
blood	O
were	O
correlated	O
with	O
the	O
dietary	O
intakes	O
as	O
measured	O
by	O
both	O
24	O
-	O
hour	O
recalls	O
and	O
ffq	O
.	O

results	O
:	O
correlations	O
between	O
blood	O
levels	O
and	O
energy	O
-	O
adjusted	O
dietary	O
intake	O
assessed	O
by	O
24	O
-	O
hour	O
recalls	O
(	O
with	O
supplements	O
)	O
were	O
as	O
follows	O
:	O
carotene	O
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.47	O
and	O
0.55	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
;	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.61	O
(	O
blacks	O
)	O
and	O
0.50	O
(	O
whites	O
)	O
;	O
vitamin	B
c	I
:	O
0.22	O
(	O
blacks	O
)	O
and	O
0.17	O
(	O
whites	O
)	O
;	O
folate	O
:	O
0.54	O
(	O
blacks	O
)	O
and	O
0.55	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
blood	O
levels	O
and	O
ffq	O
indices	O
were	O
smaller	O
in	O
magnitude	O
:	O
0.34	O
and	O
0.28	O
for	O
carotene	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
,	O
0.37	O
and	O
0.56	O
for	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
)	O
,	O
0.20	O
and	O
0.03	O
for	O
vitamin	B
c	I
and	O
0.24	O
and	O
0.32	O
for	O
folate	O
.	O

the	O
levels	O
of	O
alpha	B
-	I
tocopherol	I
,	O
carotene	O
,	O
folate	O
,	O
and	O
vitamin	B
c	I
in	O
the	O
blood	O
were	O
correlated	O
with	O
the	O
dietary	O
intakes	O
as	O
measured	O
by	O
both	O
24	O
-	O
hour	O
recalls	O
and	O
ffq	O
.	O

results	O
:	O
correlations	O
between	O
blood	O
levels	O
and	O
energy	O
-	O
adjusted	O
dietary	O
intake	O
assessed	O
by	O
24	O
-	O
hour	O
recalls	O
(	O
with	O
supplements	O
)	O
were	O
as	O
follows	O
:	O
carotene	O
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.47	O
and	O
0.55	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
;	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.61	O
(	O
blacks	O
)	O
and	O
0.50	O
(	O
whites	O
)	O
;	O
vitamin	B
c	I
:	O
0.22	O
(	O
blacks	O
)	O
and	O
0.17	O
(	O
whites	O
)	O
;	O
folate	O
:	O
0.54	O
(	O
blacks	O
)	O
and	O
0.55	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
blood	O
levels	O
and	O
ffq	O
indices	O
were	O
smaller	O
in	O
magnitude	O
:	O
0.34	O
and	O
0.28	O
for	O
carotene	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
,	O
0.37	O
and	O
0.56	O
for	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
)	O
,	O
0.20	O
and	O
0.03	O
for	O
vitamin	B
c	I
and	O
0.24	O
and	O
0.32	O
for	O
folate	O
.	O

the	O
levels	O
of	O
alpha	B
-	I
tocopherol	I
,	O
carotene	O
,	O
folate	O
,	O
and	O
vitamin	B
c	I
in	O
the	O
blood	O
were	O
correlated	O
with	O
the	O
dietary	O
intakes	O
as	O
measured	O
by	O
both	O
24	O
-	O
hour	O
recalls	O
and	O
ffq	O
.	O

results	O
:	O
correlations	O
between	O
blood	O
levels	O
and	O
energy	O
-	O
adjusted	O
dietary	O
intake	O
assessed	O
by	O
24	O
-	O
hour	O
recalls	O
(	O
with	O
supplements	O
)	O
were	O
as	O
follows	O
:	O
carotene	O
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.47	O
and	O
0.55	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
;	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.61	O
(	O
blacks	O
)	O
and	O
0.50	O
(	O
whites	O
)	O
;	O
vitamin	B
c	I
:	O
0.22	O
(	O
blacks	O
)	O
and	O
0.17	O
(	O
whites	O
)	O
;	O
folate	O
:	O
0.54	O
(	O
blacks	O
)	O
and	O
0.55	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
blood	O
levels	O
and	O
ffq	O
indices	O
were	O
smaller	O
in	O
magnitude	O
:	O
0.34	O
and	O
0.28	O
for	O
carotene	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
,	O
0.37	O
and	O
0.56	O
for	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
)	O
,	O
0.20	O
and	O
0.03	O
for	O
vitamin	B
c	I
and	O
0.24	O
and	O
0.32	O
for	O
folate	O
.	O

the	O
levels	O
of	O
alpha	B
-	I
tocopherol	I
,	O
carotene	O
,	O
folate	O
,	O
and	O
vitamin	B
c	I
in	O
the	O
blood	O
were	O
correlated	O
with	O
the	O
dietary	O
intakes	O
as	O
measured	O
by	O
both	O
24	O
-	O
hour	O
recalls	O
and	O
ffq	O
.	O

results	O
:	O
correlations	O
between	O
blood	O
levels	O
and	O
energy	O
-	O
adjusted	O
dietary	O
intake	O
assessed	O
by	O
24	O
-	O
hour	O
recalls	O
(	O
with	O
supplements	O
)	O
were	O
as	O
follows	O
:	O
carotene	O
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.47	O
and	O
0.55	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
;	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.61	O
(	O
blacks	O
)	O
and	O
0.50	O
(	O
whites	O
)	O
;	O
vitamin	B
c	I
:	O
0.22	O
(	O
blacks	O
)	O
and	O
0.17	O
(	O
whites	O
)	O
;	O
folate	O
:	O
0.54	O
(	O
blacks	O
)	O
and	O
0.55	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
blood	O
levels	O
and	O
ffq	O
indices	O
were	O
smaller	O
in	O
magnitude	O
:	O
0.34	O
and	O
0.28	O
for	O
carotene	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
,	O
0.37	O
and	O
0.56	O
for	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
)	O
,	O
0.20	O
and	O
0.03	O
for	O
vitamin	B
c	I
and	O
0.24	O
and	O
0.32	O
for	O
folate	O
.	O

the	O
levels	O
of	O
alpha	B
-	I
tocopherol	I
,	O
carotene	O
,	O
folate	O
,	O
and	O
vitamin	B
c	I
in	O
the	O
blood	O
were	O
correlated	O
with	O
the	O
dietary	O
intakes	O
as	O
measured	O
by	O
both	O
24	O
-	O
hour	O
recalls	O
and	O
ffq	O
.	O

results	O
:	O
correlations	O
between	O
blood	O
levels	O
and	O
energy	O
-	O
adjusted	O
dietary	O
intake	O
assessed	O
by	O
24	O
-	O
hour	O
recalls	O
(	O
with	O
supplements	O
)	O
were	O
as	O
follows	O
:	O
carotene	O
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.47	O
and	O
0.55	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
;	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.61	O
(	O
blacks	O
)	O
and	O
0.50	O
(	O
whites	O
)	O
;	O
vitamin	B
c	I
:	O
0.22	O
(	O
blacks	O
)	O
and	O
0.17	O
(	O
whites	O
)	O
;	O
folate	O
:	O
0.54	O
(	O
blacks	O
)	O
and	O
0.55	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
blood	O
levels	O
and	O
ffq	O
indices	O
were	O
smaller	O
in	O
magnitude	O
:	O
0.34	O
and	O
0.28	O
for	O
carotene	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
,	O
0.37	O
and	O
0.56	O
for	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
)	O
,	O
0.20	O
and	O
0.03	O
for	O
vitamin	B
c	I
and	O
0.24	O
and	O
0.32	O
for	O
folate	O
.	O

the	O
levels	O
of	O
alpha	B
-	I
tocopherol	I
,	O
carotene	O
,	O
folate	O
,	O
and	O
vitamin	B
c	I
in	O
the	O
blood	O
were	O
correlated	O
with	O
the	O
dietary	O
intakes	O
as	O
measured	O
by	O
both	O
24	O
-	O
hour	O
recalls	O
and	O
ffq	O
.	O

results	O
:	O
correlations	O
between	O
blood	O
levels	O
and	O
energy	O
-	O
adjusted	O
dietary	O
intake	O
assessed	O
by	O
24	O
-	O
hour	O
recalls	O
(	O
with	O
supplements	O
)	O
were	O
as	O
follows	O
:	O
carotene	O
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.47	O
and	O
0.55	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
;	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
):	O
0.61	O
(	O
blacks	O
)	O
and	O
0.50	O
(	O
whites	O
)	O
;	O
vitamin	B
c	I
:	O
0.22	O
(	O
blacks	O
)	O
and	O
0.17	O
(	O
whites	O
)	O
;	O
folate	O
:	O
0.54	O
(	O
blacks	O
)	O
and	O
0.55	O
(	O
whites	O
)	O
.	O

correlations	O
between	O
blood	O
levels	O
and	O
ffq	O
indices	O
were	O
smaller	O
in	O
magnitude	O
:	O
0.34	O
and	O
0.28	O
for	O
carotene	O
in	O
black	O
and	O
white	O
subjects	O
,	O
respectively	O
,	O
0.37	O
and	O
0.56	O
for	O
alpha	B
-	I
tocopherol	I
(	O
adjusted	O
for	O
serum	O
cholesterol	O
)	O
,	O
0.20	O
and	O
0.03	O
for	O
vitamin	B
c	I
and	O
0.24	O
and	O
0.32	O
for	O
folate	O
.	O

mean	O
daily	O
intakes	O
of	O
dietary	O
energy	B
,	O
total	O
fat	O
,	O
saturated	O
,	O
monounsaturated	O
and	O
polyunsaturated	O
fatty	B
acids	I
,	O
linoleic	O
acid	O
,	O
total	O
carbohydrate	O
excluding	O
fibre	O
,	O
sugars	O
,	O
starch	O
,	O
dietary	O
fibre	O
,	O
protein	O
,	O
vitamin	O
c	O
,	O
vitamin	B
e	I
(	O
as	O
alpha	B
-	I
tocopherol	I
equivalents	O
)	O
,	O
folate	O
,	O
carotenes	O
(	O
as	O
total	O
beta	B
-	I
carotene	I
activity	O
)	O
,	O
fe	O
,	O
ca	O
,	O
mg	O
,	O
k	O
and	O
alcohol	O
were	O
measured	O
.	O

serum	O
cholesteryl	O
ester	O
fatty	B
acids	I
(	O
cefa	O
)	O
,	O
plasma	O
alpha	B
-	I
tocopherol	I
and	O
beta	B
-	I
carotene	I
were	O
also	O
measured	O
as	O
biomarkers	O
.	O

estimates	O
of	O
mean	O
energy	B
intake	O
from	O
the	O
two	O
methods	O
were	O
similar	O
in	O
men	O
,	O
and	O
some	O
10	O
%	O
higher	O
according	O
to	O
the	O
ffq	O
in	O
women	O
.	O
compared	O
with	O
the	O
7dd	O
,	O
the	O
ffq	O
tended	O
to	O
overestimate	O
plant	O
-	O
derived	O
micronutrient	O
intakes	O
(	O
carotenes	O
from	O
ffq	O
v.	O
7dd	O
men	O
2713	O
(	O
sd	O
1455	O
)	O
v.	O
2180	O
(	O
sd	O
1188	O
)	O
microg	O
/	O
d	O
,	O
women	O
3100	O
(	O
sd	O
1656	O
)	O
v.	O
2221	O
(	O
sd	O
1180	O
)	O
microg	O
/	O
d	O
,	O
both	O
differences	O
p<0.0001	O
)	O
and	O
to	O
underestimate	O
fat	O
intake	O
.	O
against	O
plasma	O
beta	B
-	I
carotene	I
/	O
cholesterol	O
,	O
carotene	O
intake	O
was	O
as	O
well	O
estimated	O
by	O
the	O
ffq	O
as	O
the	O
7dd	O
(	O
spearman	O
rank	O
correlations	O
,	O
men	O
0.32	O
v.	O
0.30	O
,	O
women	O
0.27	O
v.	O
0.22	O
,	O
all	O
p	O
<	O
or	O
=	O
0.0001	O
,	O
energy	O
-	O
adjusted	O
data	O
)	O
.	O

for	O
alpha	B
-	I
tocopherol	I
there	O
were	O
no	O
correlations	O
between	O
plasma	O
level	O
and	O
estimated	O
intakes	O
by	O
either	O
dietary	O
method	O
.	O

the	O
dietary	O
methods	O
yielded	O
similar	O
prevalences	O
(	O
about	O
34	O
%	O
)	O
of	O
low	O
energy	B
reporters	O
.	O

for	O
both	O
methods	O
,	O
regression	O
-	O
based	O
adjustment	O
of	O
nutrient	O
intake	O
to	O
mean	O
dietary	O
energy	B
intake	O
by	O
gender	O
appears	O
on	O
balance	O
to	O
be	O
the	O
optimal	O
approach	O
to	O
data	O
presentation	O
and	O
analysis	O
,	O
in	O
view	O
of	O
the	O
complex	O
problem	O
of	O
low	O
energy	B
reporting	O
.	O

site	O
-	O
specific	O
differences	O
in	O
the	O
fatty	O
acid	O
composition	O
of	O
abdominal	O
adipose	O
tissue	O
in	O
an	O
obese	O
population	O
from	O
a	O
mediterranean	O
area	O
:	O
relation	O
with	O
dietary	O
fatty	B
acids	I
,	O
plasma	O
lipid	O
profile	O
,	O
serum	O
insulin	O
,	O
and	O
central	O
obesity	O
..	O
background	O
:	O
abdominal	O
obesity	O
is	O
associated	O
with	O
coronary	O
risk	O
,	O
although	O
causality	O
is	O
not	O
well	O
established	O
.	O

objective	O
:	O
in	O
an	O
obese	O
mediterranean	O
population	O
,	O
we	O
measured	O
the	O
fatty	O
acid	O
composition	O
of	O
adipose	O
tissue	O
,	O
its	O
relation	O
with	O
dietary	O
fatty	B
acids	I
and	O
central	O
fat	O
deposition	O
,	O
and	O
its	O
influence	O
on	O
plasma	O
lipids	O
and	O
insulin	O
.	O

we	O
measured	O
concentrations	O
of	O
insulin	O
and	O
lipids	O
in	O
plasma	O
and	O
fatty	B
acids	I
in	O
subcutaneous	O
,	O
omental	O
,	O
and	O
perivisceral	O
fat	O
.	O

there	O
were	O
important	O
differences	O
in	O
fatty	O
acid	O
composition	O
between	O
tissue	O
sites	O
:	O
saturated	O
fatty	B
acids	I
were	O
higher	O
and	O
monounsaturated	O
fatty	B
acids	I
were	O
lower	O
in	O
perivisceral	O
than	O
in	O
subcutaneous	O
fat	O
(	O
p	O
<	O
0.05	O
)	O
.	O

significant	O
correlations	O
were	O
found	O
for	O
oleic	O
,	O
linoleic	O
,	O
alpha	O
-	O
linolenic	O
,	O
and	O
total	O
n-6	O
polyunsaturated	O
fatty	B
acids	I
between	O
the	O
subject	O
's	O
habitual	O
diet	O
and	O
adipose	O
tissue	O
composition	O
.	O

oleic	O
and	O
n-3	O
fatty	B
acids	I
from	O
adipose	O
regions	O
were	O
negatively	O
correlated	O
with	O
apolipoprotein	O
b	O
and	O
triacylglycerols	O
;	O
adipose	O
tissue	O
22:1n-9	O
,	O
20:2n-6	O
,	O
stearic	O
acid	O
,	O
and	O
eicosapentaenoic	O
acid	O
were	O
positively	O
correlated	O
with	O
hdl	O
and	O
apolipoprotein	O
a	O
;	O
and	O
adipose	O
tissue	O
myristic	O
acid	O
was	O
negatively	O
correlated	O
with	O
apolipoprotein	O
a	O
(	O
p	O
<	O
0.05	O
)	O
.	O

central	O
obesity	O
was	O
positively	O
associated	O
with	O
n-6	O
polyunsaturated	O
fatty	B
acids	I
and	O
inversely	O
associated	O
with	O
monounsaturated	O
fatty	B
acids	I
and	O
n-3	O
polyunsaturated	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
(	O
p	O
<	O
0.05	O
)	O
.	O

conclusion	O
:	O
the	O
differences	O
found	O
in	O
the	O
composition	O
and	O
metabolism	O
of	O
perivisceral	O
,	O
omental	O
,	O
and	O
subcutaneous	O
fats	B
may	O
indicate	O
that	O
their	O
atherogenic	O
capacities	O
also	O
differ	O
.	O

objective	O
:	O
our	O
objective	O
was	O
to	O
validate	O
a	O
7	O
-	O
d	O
food	O
diary	O
and	O
a	O
food	O
-	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
against	O
independent	O
biomarkers	O
of	O
intake	O
in	O
urine	O
(	O
nitrogen	B
,	O
potassium	B
,	O
and	O
sodium	B
)	O
and	O
blood	O
(	O
plasma	O
ascorbic	O
acid	O
)	O
.	O

over	O
a	O
9	O
-	O
mo	O
period	O
,	O
urinary	O
nitrogen	B
,	O
potassium	B
,	O
and	O
sodium	B
were	O
estimated	O
from	O
2	O
-	O
6	O
complete	O
24	O
-	O
h	O
urine	O
collections	O
in	O
134	O
subjects	O
and	O
plasma	O
ascorbic	O
acid	O
was	O
estimated	O
from	O
2	O
-	O
3	O
fasting	O
blood	O
samples	O
in	O
118	O
subjects	O
.	O

results	O
:	O
in	O
men	O
and	O
women	O
combined	O
,	O
correlations	O
between	O
24	O
-	O
h	O
urinary	O
nitrogen	B
excretion	O
and	O
dietary	O
intake	O
from	O
the	O
7	O
-	O
d	O
food	O
diary	O
were	O
high	O
(	O
r	O
=	O
0.57	O
-	O
0.67	O
)	O
compared	O
with	O
those	O
for	O
the	O
ffq	O
(	O
r	O
=	O
0.21	O
-	O
0.29	O
)	O
.	O

similarly	O
,	O
correlations	O
between	O
urinary	O
potassium	B
and	O
dietary	O
potassium	B
were	O
higher	O
for	O
the	O
7	O
-	O
d	O
food	O
diary	O
(	O
r	O
=	O
0.51	O
-	O
0.55	O
)	O
than	O
for	O
the	O
ffq	O
(	O
r	O
=	O
0.32	O
-	O
0.34	O
)	O
.	O

there	O
was	O
no	O
overall	O
difference	O
in	O
correlations	O
between	O
plasma	O
ascorbic	O
acid	O
and	O
dietary	O
vitamin	B
c	I
between	O
the	O
7	O
-	O
d	O
food	O
diary	O
(	O
r	O
=	O
0.40	O
-	O
0.52	O
)	O
and	O
the	O
ffq	O
(	O
r	O
=	O
0.44	O
-	O
0.45	O
)	O
.	O

conclusions	O
:	O
these	O
data	O
indicate	O
that	O
,	O
despite	O
increased	O
subject	O
burden	O
,	O
the	O
7	O
-	O
d	O
food	O
diary	O
provided	O
a	O
better	O
estimate	O
of	O
nitrogen	B
and	O
potassium	B
intakes	O
than	O
did	O
the	O
ffq	O
in	O
this	O
study	O
population	O
.	O

however	O
,	O
with	O
respect	O
to	O
plasma	O
ascorbic	O
acid	O
,	O
both	O
the	O
ffq	O
and	O
7	O
-	O
d	O
food	O
diary	O
provided	O
a	O
similar	O
ranking	O
of	O
subjects	O
according	O
to	O
vitamin	B
c	I
intake	O
.	O

carbohydrate	B
-	I
deficient	I
transferrin	I
(	I
cdt	I
)	I
,	O
gamma	O
-	O
glutamyltransferase	O
(	O
gamma	O
-	O
gt	O
)	O
and	O
mean	O
corpuscular	O
volume	O
(	O
mcv	O
)	O
were	O
determined	O
from	O
blood	O
samples	O
.	O

population	O
-	O
based	O
study	O
of	O
alpha-	O
and	O
gamma	B
-	I
tocopherol	I
in	O
plasma	O
and	O
adipose	O
tissue	O
as	O
biomarkers	O
of	O
intake	O
in	O
costa	O
rican	O
adults	O
..	O
background	O
:	O
gamma	B
-	I
tocopherol	I
is	O
the	O
most	O
abundant	O
form	O
of	O
vitamin	O
e	O
in	O
the	O
us	O
diet	O
,	O
but	O
alpha	B
-	I
tocopherol	I
concentrations	O
are	O
the	O
highest	O
in	O
plasma	O
and	O
tissues	O
.	O

although	O
plasma	O
and	O
adipose	O
tissue	O
concentrations	O
of	O
alpha	B
-	I
tocopherol	I
have	O
been	O
used	O
as	O
biomarkers	O
of	O
intake	O
,	O
the	O
relation	O
between	O
gamma	B
-	I
tocopherol	I
intake	O
and	O
concentrations	O
in	O
plasma	O
and	O
adipose	O
tissue	O
is	O
unknown	O
.	O

objective	O
:	O
our	O
goal	O
was	O
to	O
investigate	O
in	O
a	O
randomly	O
selected	O
population	O
from	O
costa	O
rica	O
whether	O
plasma	O
or	O
adipose	O
tissue	O
concentrations	O
of	O
alpha-	O
and	O
gamma	B
-	I
tocopherol	I
are	O
suitable	O
biomarkers	O
of	O
intake	O
.	O

results	O
:	O
dietary	O
gamma	B
-	I
tocopherol	I
correlated	O
with	O
adipose	O
tissue	O
(	O
r	O
=	O
0.37	O
,	O
p	O
<	O
0.001	O
)	O
and	O
plasma	O
(	O
r	O
=	O
0.42	O
,	O
p	O
<	O
0.001	O
)	O
concentrations	O
,	O
regardless	O
of	O
supplement	O
use	O
.	O

dietary	O
alpha	B
-	I
tocopherol	I
correlated	O
poorly	O
with	O
adipose	O
tissue	O
(	O
r	O
=	O
0.15	O
,	O
p	O
<	O
0.01	O
)	O
and	O
plasma	O
(	O
r	O
=	O
0.16	O
,	O
p	O
<	O
0.001	O
)	O
concentrations	O
,	O
and	O
these	O
correlations	O
were	O
even	O
lower	O
when	O
users	O
of	O
vitamin	O
supplements	O
(	O
n	O
=	O
24	O
)	O
were	O
excluded	O
(	O
adipose	O
tissue	O
:	O
r	O
=	O
0.10	O
,	O
p	O
<	O
0.05	O
;	O
plasma	O
:	O
r	O
=	O
0.09	O
,	O
p	O
<	O
0.05	O
)	O
.	O

compared	O
with	O
subjects	O
who	O
reported	O
palm	O
shortening	O
(	O
36	O
%	O
)	O
as	O
the	O
major	O
type	O
of	O
fat	O
used	O
for	O
cooking	O
,	O
subjects	O
using	O
soybean	O
oil	O
(	O
52	O
%	O
)	O
had	O
higher	O
amounts	O
of	O
both	O
alpha-	O
and	O
gamma	B
-	I
tocopherol	I
in	O
their	O
diets	O
.	O

however	O
,	O
only	O
gamma	B
-	I
tocopherol	I
concentrations	O
were	O
higher	O
in	O
the	O
plasma	O
and	O
adipose	O
tissue	O
of	O
soybean	O
oil	O
users	O
.	O

conclusions	O
:	O
plasma	O
and	O
adipose	O
tissue	O
concentrations	O
of	O
gamma	B
-	I
tocopherol	I
are	O
equally	O
good	O
biomarkers	O
of	O
intake	O
.	O

the	O
weak	O
associations	O
between	O
alpha	B
-	I
tocopherol	I
intake	O
and	O
plasma	O
or	O
adipose	O
tissue	O
concentrations	O
suggest	O
that	O
these	O
biomarkers	O
are	O
influenced	O
more	O
by	O
factors	O
other	O
than	O
alpha	B
-	I
tocopherol	I
intake	O
.	O

single	O
measurement	O
of	O
serum	O
phospholipid	O
fatty	O
acid	O
as	O
a	O
biomarker	O
of	O
specific	O
fatty	O
acid	O
intake	O
in	O
middle	O
-	O
aged	O
japanese	O
men	O
..	O
objective	O
:	O
to	O
assess	O
the	O
utility	O
of	O
serum	O
phospholipid	O
fatty	O
acid	O
(	O
fa	O
)	O
levels	O
as	O
a	O
biochemical	O
indicator	O
of	O
habitual	O
dietary	O
fatty	O
acid	O
intake	O
in	O
japanese	O
,	O
whose	O
diet	O
is	O
characterized	O
by	O
low	O
fat	O
intake	O
and	O
high	O
intake	O
of	O
n-3	O
polyunsaturated	O
fatty	B
acids	I
(	O
pufa	O
)	O
of	O
marine	O
origin	O
.	O

dietary	O
determinants	O
of	O
plasma	O
enterolactone	B
..	O
enterolactone	B
is	O
a	O
lignan	O
produced	O
by	O
fermentation	O
of	O
dietary	O
precursors	O
in	O
the	O
human	O
gut	O
.	O

because	O
lignan	O
precursors	O
are	O
uniquely	O
found	O
in	O
plant	O
foods	O
,	O
plasma	O
enterolactone	B
concentration	O
may	O
serve	O
as	O
a	O
biological	O
marker	O
of	O
plant	O
food	O
consumption	O
.	O

this	O
cross	O
-	O
sectional	O
study	O
examined	O
associations	O
of	O
dietary	O
intake	O
with	O
plasma	O
enterolactone	B
concentration	O
.	O

time	O
-	O
resolved	O
fluoroimmunoassay	O
was	O
used	O
to	O
measure	O
plasma	O
enterolactone	B
.	O
based	O
on	O
diet	O
records	O
,	O
plasma	O
enterolactone	B
was	O
positively	O
correlated	O
with	O
daily	O
vegetable	O
servings	O
(	O
r	O
=	O
0.17	O
;	O
p	O
<	O
0.05	O
)	O
,	O

fat	O
-	O
related	O
variables	O
were	O
not	O
correlated	O
with	O
plasma	O
enterolactone	B
.	O
based	O
on	O
linear	O
regression	O
models	O
,	O
plasma	O
enterolactone	B
increased	O
by	O
37.0	O
%	O
(	O
se	O
=	O
2.3	O
%	O
)	O
for	O
each	O
10	O
-	O
g	O
increase	O
in	O
fiber	O
and	O
by	O
6.6	O
%	O
(	O
se	O
=	O
0.2	O
%	O
)	O
for	O
each	O
50	O
-	O
mg	O
serving	O
of	O
caffeine	O
.	O

participants	O
consuming	O
0.5	O
-	O
1	O
alcoholic	O
drink	O
/	O
day	O
had	O
plasma	O
enterolactone	B
concentrations	O
that	O
were	O
131.4	O
%	O
(	O
se	O
=	O
37.6	O
%	O
)	O
higher	O
than	O
those	O
of	O
nondrinkers	O
.	O

although	O
plasma	O
enterolactone	B
may	O
be	O
useful	O
as	O
a	O
biological	O
measure	O
of	O
exposure	O
to	O
lignan	O
-	O
containing	O
foods	O
,	O
it	O
may	O
be	O
of	O
limited	O
use	O
as	O
a	O
specific	O
biomarker	O
of	O
fruit	O
and	O
vegetable	O
or	O
plant	O
food	O
intake	O
because	O
coffee	O
,	O
tea	O
,	O
and	O
alcoholic	O
beverages	O
also	O
significantly	O
increase	O
its	O
plasma	O
concentration	O
..	O
enterolactone	B
is	O
a	O
lignan	O
produced	O
by	O
fermentation	O
of	O
dietary	O
precursors	O
in	O
the	O
human	O
gut	O
.	O

because	O
lignan	O
precursors	O
are	O
uniquely	O
found	O
in	O
plant	O
foods	O
,	O
plasma	O
enterolactone	B
concentration	O
may	O
serve	O
as	O
a	O
biological	O
marker	O
of	O
plant	O
food	O
consumption	O
.	O

this	O
cross	O
-	O
sectional	O
study	O
examined	O
associations	O
of	O
dietary	O
intake	O
with	O
plasma	O
enterolactone	B
concentration	O
.	O

time	O
-	O
resolved	O
fluoroimmunoassay	O
was	O
used	O
to	O
measure	O
plasma	O
enterolactone	B
.	O
based	O
on	O
diet	O
records	O
,	O
plasma	O
enterolactone	B
was	O
positively	O
correlated	O
with	O
daily	O
vegetable	O
servings	O
(	O
r	O
=	O
0.17	O
;	O
p	O
<	O
0.05	O
)	O
,	O

fat	O
-	O
related	O
variables	O
were	O
not	O
correlated	O
with	O
plasma	O
enterolactone	B
.	O
based	O
on	O
linear	O
regression	O
models	O
,	O
plasma	O
enterolactone	B
increased	O
by	O
37.0	O
%	O
(	O
se	O
=	O
2.3	O
%	O
)	O
for	O
each	O
10	O
-	O
g	O
increase	O
in	O
fiber	O
and	O
by	O
6.6	O
%	O
(	O
se	O
=	O
0.2	O
%	O
)	O
for	O
each	O
50	O
-	O
mg	O
serving	O
of	O
caffeine	O
.	O

participants	O
consuming	O
0.5	O
-	O
1	O
alcoholic	O
drink	O
/	O
day	O
had	O
plasma	O
enterolactone	B
concentrations	O
that	O
were	O
131.4	O
%	O
(	O
se	O
=	O
37.6	O
%	O
)	O
higher	O
than	O
those	O
of	O
nondrinkers	O
.	O

although	O
plasma	O
enterolactone	B
may	O
be	O
useful	O
as	O
a	O
biological	O
measure	O
of	O
exposure	O
to	O
lignan	O
-	O
containing	O
foods	O
,	O
it	O
may	O
be	O
of	O
limited	O
use	O
as	O
a	O
specific	O
biomarker	O
of	O
fruit	O
and	O
vegetable	O
or	O
plant	O
food	O
intake	O
because	O
coffee	O
,	O
tea	O
,	O
and	O
alcoholic	O
beverages	O
also	O
significantly	O
increase	O
its	O
plasma	O
concentration	O
..	O
enterolactone	B
is	O
a	O
lignan	O
produced	O
by	O
fermentation	O
of	O
dietary	O
precursors	O
in	O
the	O
human	O
gut	O
.	O

because	O
lignan	O
precursors	O
are	O
uniquely	O
found	O
in	O
plant	O
foods	O
,	O
plasma	O
enterolactone	B
concentration	O
may	O
serve	O
as	O
a	O
biological	O
marker	O
of	O
plant	O
food	O
consumption	O
.	O

this	O
cross	O
-	O
sectional	O
study	O
examined	O
associations	O
of	O
dietary	O
intake	O
with	O
plasma	O
enterolactone	B
concentration	O
.	O

time	O
-	O
resolved	O
fluoroimmunoassay	O
was	O
used	O
to	O
measure	O
plasma	O
enterolactone	B
.	O
based	O
on	O
diet	O
records	O
,	O
plasma	O
enterolactone	B
was	O
positively	O
correlated	O
with	O
daily	O
vegetable	O
servings	O
(	O
r	O
=	O
0.17	O
;	O
p	O
<	O
0.05	O
)	O
,	O

fat	O
-	O
related	O
variables	O
were	O
not	O
correlated	O
with	O
plasma	O
enterolactone	B
.	O
based	O
on	O
linear	O
regression	O
models	O
,	O
plasma	O
enterolactone	B
increased	O
by	O
37.0	O
%	O
(	O
se	O
=	O
2.3	O
%	O
)	O
for	O
each	O
10	O
-	O
g	O
increase	O
in	O
fiber	O
and	O
by	O
6.6	O
%	O
(	O
se	O
=	O
0.2	O
%	O
)	O
for	O
each	O
50	O
-	O
mg	O
serving	O
of	O
caffeine	O
.	O

participants	O
consuming	O
0.5	O
-	O
1	O
alcoholic	O
drink	O
/	O
day	O
had	O
plasma	O
enterolactone	B
concentrations	O
that	O
were	O
131.4	O
%	O
(	O
se	O
=	O
37.6	O
%	O
)	O
higher	O
than	O
those	O
of	O
nondrinkers	O
.	O

although	O
plasma	O
enterolactone	B
may	O
be	O
useful	O
as	O
a	O
biological	O
measure	O
of	O
exposure	O
to	O
lignan	O
-	O
containing	O
foods	O
,	O
it	O
may	O
be	O
of	O
limited	O
use	O
as	O
a	O
specific	O
biomarker	O
of	O
fruit	O
and	O
vegetable	O
or	O
plant	O
food	O
intake	O
because	O
coffee	O
,	O
tea	O
,	O
and	O
alcoholic	O
beverages	O
also	O
significantly	O
increase	O
its	O
plasma	O
concentration	O
..	O
enterolactone	B
is	O
a	O
lignan	O
produced	O
by	O
fermentation	O
of	O
dietary	O
precursors	O
in	O
the	O
human	O
gut	O
.	O

because	O
lignan	O
precursors	O
are	O
uniquely	O
found	O
in	O
plant	O
foods	O
,	O
plasma	O
enterolactone	B
concentration	O
may	O
serve	O
as	O
a	O
biological	O
marker	O
of	O
plant	O
food	O
consumption	O
.	O

this	O
cross	O
-	O
sectional	O
study	O
examined	O
associations	O
of	O
dietary	O
intake	O
with	O
plasma	O
enterolactone	B
concentration	O
.	O

time	O
-	O
resolved	O
fluoroimmunoassay	O
was	O
used	O
to	O
measure	O
plasma	O
enterolactone	B
.	O
based	O
on	O
diet	O
records	O
,	O
plasma	O
enterolactone	B
was	O
positively	O
correlated	O
with	O
daily	O
vegetable	O
servings	O
(	O
r	O
=	O
0.17	O
;	O
p	O
<	O
0.05	O
)	O
,	O

fat	O
-	O
related	O
variables	O
were	O
not	O
correlated	O
with	O
plasma	O
enterolactone	B
.	O
based	O
on	O
linear	O
regression	O
models	O
,	O
plasma	O
enterolactone	B
increased	O
by	O
37.0	O
%	O
(	O
se	O
=	O
2.3	O
%	O
)	O
for	O
each	O
10	O
-	O
g	O
increase	O
in	O
fiber	O
and	O
by	O
6.6	O
%	O
(	O
se	O
=	O
0.2	O
%	O
)	O
for	O
each	O
50	O
-	O
mg	O
serving	O
of	O
caffeine	O
.	O

participants	O
consuming	O
0.5	O
-	O
1	O
alcoholic	O
drink	O
/	O
day	O
had	O
plasma	O
enterolactone	B
concentrations	O
that	O
were	O
131.4	O
%	O
(	O
se	O
=	O
37.6	O
%	O
)	O
higher	O
than	O
those	O
of	O
nondrinkers	O
.	O

although	O
plasma	O
enterolactone	B
may	O
be	O
useful	O
as	O
a	O
biological	O
measure	O
of	O
exposure	O
to	O
lignan	O
-	O
containing	O
foods	O
,	O
it	O
may	O
be	O
of	O
limited	O
use	O
as	O
a	O
specific	O
biomarker	O
of	O
fruit	O
and	O
vegetable	O
or	O
plant	O
food	O
intake	O
because	O
coffee	O
,	O
tea	O
,	O
and	O
alcoholic	O
beverages	O
also	O
significantly	O
increase	O
its	O
plasma	O
concentration	O
..	O
enterolactone	B
is	O
a	O
lignan	O
produced	O
by	O
fermentation	O
of	O
dietary	O
precursors	O
in	O
the	O
human	O
gut	O
.	O

because	O
lignan	O
precursors	O
are	O
uniquely	O
found	O
in	O
plant	O
foods	O
,	O
plasma	O
enterolactone	B
concentration	O
may	O
serve	O
as	O
a	O
biological	O
marker	O
of	O
plant	O
food	O
consumption	O
.	O

this	O
cross	O
-	O
sectional	O
study	O
examined	O
associations	O
of	O
dietary	O
intake	O
with	O
plasma	O
enterolactone	B
concentration	O
.	O

time	O
-	O
resolved	O
fluoroimmunoassay	O
was	O
used	O
to	O
measure	O
plasma	O
enterolactone	B
.	O
based	O
on	O
diet	O
records	O
,	O
plasma	O
enterolactone	B
was	O
positively	O
correlated	O
with	O
daily	O
vegetable	O
servings	O
(	O
r	O
=	O
0.17	O
;	O
p	O
<	O
0.05	O
)	O
,	O

fat	O
-	O
related	O
variables	O
were	O
not	O
correlated	O
with	O
plasma	O
enterolactone	B
.	O
based	O
on	O
linear	O
regression	O
models	O
,	O
plasma	O
enterolactone	B
increased	O
by	O
37.0	O
%	O
(	O
se	O
=	O
2.3	O
%	O
)	O
for	O
each	O
10	O
-	O
g	O
increase	O
in	O
fiber	O
and	O
by	O
6.6	O
%	O
(	O
se	O
=	O
0.2	O
%	O
)	O
for	O
each	O
50	O
-	O
mg	O
serving	O
of	O
caffeine	O
.	O

participants	O
consuming	O
0.5	O
-	O
1	O
alcoholic	O
drink	O
/	O
day	O
had	O
plasma	O
enterolactone	B
concentrations	O
that	O
were	O
131.4	O
%	O
(	O
se	O
=	O
37.6	O
%	O
)	O
higher	O
than	O
those	O
of	O
nondrinkers	O
.	O

although	O
plasma	O
enterolactone	B
may	O
be	O
useful	O
as	O
a	O
biological	O
measure	O
of	O
exposure	O
to	O
lignan	O
-	O
containing	O
foods	O
,	O
it	O
may	O
be	O
of	O
limited	O
use	O
as	O
a	O
specific	O
biomarker	O
of	O
fruit	O
and	O
vegetable	O
or	O
plant	O
food	O
intake	O
because	O
coffee	O
,	O
tea	O
,	O
and	O
alcoholic	O
beverages	O
also	O
significantly	O
increase	O
its	O
plasma	O
concentration	O
.	O

we	O
evaluated	O
whether	O
the	O
proportions	O
of	O
myristic	O
(	O
14:0	O
)	O
,	O
pentadecanoic	O
(	O
15:0	O
)	O
and	O
heptadecanoic	O
(	O
17:0	O
)	O
fatty	B
acids	I
in	O
the	O
adipose	O
tissue	O
triacylglycerols	O
and	O
serum	O
cholesterol	O
esters	O
and	O
phospholipids	O
reflect	O
long	O
-	O
term	O
dairy	O
fat	O
consumption	O
in	O
free	O
-	O
living	O
men	O
.	O

0.16	O
g/100	O
g	O
total	O
fat	O
,	O
and	O
the	O
content	O
in	O
adipose	O
tissue	O
was	O
3.6	O
,	O
0.36	O
and	O
0.25	O
g/100	O
g	O
fatty	B
acids	I
,	O
respectively	O
.	O

evaluation	O
of	O
a	O
semi	O
-	O
quantitative	O
food	O
frequency	O
questionnaire	O
to	O
estimate	O
iodine	B
intake	O
..	O
objective	O
:	O
to	O
evaluate	O
a	O
food	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
used	O
to	O
assess	O
the	O
dietary	O
intake	O
of	O
iodine	B
.	O

design	O
:	O
the	O
iodine	B
intake	O
determined	O
by	O
the	O
ffq	O
was	O
compared	O
with	O
4	O
-	O
day	O
dietary	O
records	O
and	O
with	O
iodine	B
excretion	O
in	O
24	O
h	O
urine	O
samples	O
in	O
a	O
subgroup	O
of	O
participants	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
iodine	B
intake	O
and	O
thyroid	O
diseases	O
in	O
denmark	O
.	O

y.	O
results	O
:	O
median	O
iodine	B
intake	O
was	O
similar	O
when	O
determined	O
from	O
the	O
ffq	O
and	O
from	O
dietary	O
records	O
and	O
the	O
correlation	O
between	O
these	O
measures	O
was	O
0.52	O
(	O
p	O
<	O
0.001	O
)	O
.	O

iodine	B
intake	O
was	O
higher	O
than	O
iodine	B
excretion	O
(	O
p	O
<	O
0.001	O
)	O
.	O

conclusion	O
:	O
the	O
ffq	O
can	O
be	O
used	O
to	O
classify	O
subjects	O
into	O
low	O
and	O
high	O
iodine	B
intake	O
groups	O
,	O
but	O
the	O
level	O
of	O
iodine	B
tends	O
to	O
be	O
overestimated	O
.	O

serum	O
levels	O
of	O
lycopene	O
,	O
lutein	O
,	O
cryptoxanthin	O
,	O
alpha	O
-	O
carotene	O
,	O
and	O
beta	B
-	I
carotene	I
were	O
assessed	O
in	O
813	O
participants	O
and	O
used	O
as	O
the	O
validity	O
criterion	O
.	O

urinary	O
isoflavonoid	O
and	O
lignan	O
excretion	O
on	O
a	O
western	O
diet	O
:	O
relation	O
to	O
soy	O
,	O
vegetable	O
,	O
and	O
fruit	O
intake	O
..	O
dietary	O
isoflavone	O
and	O
lignan	O
phytoestrogens	B
are	O
potential	O
chemopreventive	O
agents	O
.	O

typically	O
,	O
urinary	O
isoflavonoid	O
excretion	O
is	O
associated	O
with	O
soy	O
consumption	O
and	O
that	O
of	O
lignans	B
is	O
associated	O
with	O
whole	O
grains	O
.	O

isoflavonoids	O
(	O
genistein	B
,	O
daidzein	B
,	O
o	B
-	I
desmethylangolensin	I
,	O
and	O
equol	B
)	O
and	O
lignans	B
(	O
enterolactone	O
,	O
enterodiol	O
,	O
and	O
matairesinol	B
)	O
were	O
measured	O
in	O
urine	O
collected	O
for	O
3	O
days	O
from	O
49	O
male	O
and	O
49	O
female	O
volunteers	O
(	O
age	O
,	O
18	O
-	O
37	O
years	O
)	O
reporting	O
a	O
wide	O
range	O
of	O
habitual	O
v&f	O
intakes	O
.	O

intake	O
of	O
soyfoods	O
was	O
correlated	O
significantly	O
with	O
urinary	O
genistein	B
(	O
r	O
=	O
0.40	O
;	O
p	O
=	O
0.0001	O
)	O
,	O
o	B
-	I
desmethylangolensin	I
(	O
r	O
=	O
0.37	O
;	O
p	O
=	O
0.0002	O
)	O
,	O
daidzein	B
(	O
r	O
=	O
034	O
;	O
p	O
=	O
0.0007	O
)	O
,	O
and	O
the	O
sum	O
of	O
isoflavonoids	O
(	O
r	O
=	O
0.39	O
;	O
p	O
=	O
0.0001	O
)	O
.	O

there	O
was	O
no	O
association	O
between	O
equol	B
excretion	O
and	O
soy	O
intake	O
or	O
between	O
the	O
isoflavonoids	O
and	O
any	O
other	O
v&f	O
groupings	O
.	O

in	O
contrast	O
,	O
a	O
variety	O
of	O
fiber	O
-	O
containing	O
foods	O
contributed	O
to	O
lignan	O
excretion	O
;	O
the	O
sum	O
of	O
the	O
urinary	O
lignans	B
,	O
enterodiol	O
,	O
enterolactone	O
,	O
and	O
matairesinol	B
,	O
was	O
associated	O
with	O
intake	O
of	O
total	O
f	O
(	O
r	O
=	O
0.27	O
;	O
p	O
=	O
0.008	O
)	O
,	O
total	O
v&f	O
(	O
r	O
=	O
0.25	O
;	O
p	O
=	O
0.01	O
)	O
,	O
soyfoods	O
(	O
r	O
=	O
0.28	O
;	O
p	O
=	O
0.006	O
)	O
,	O
and	O
dietary	O
fiber	O
(	O
r	O
=	O
0.36	O
;	O
p	O
=	O
0.0003	O
)	O
.	O

overall	O
,	O
urinary	O
phytoestrogens	B
(	O
isoflavonoids	O
+	O
lignans	B
)	O
were	O
significantly	O
higher	O
in	O
"	O
high	O
"	O
compared	O
with	O
"	O
low	O
"	O
v&f	O
consumers	O
.	O
compared	O
with	O
the	O
"	O
low	O
"	O
v&f	O
group	O
,	O
the	O
"	O
high	O
"	O
group	O
consumed	O
diets	O
that	O
were	O
,	O
on	O
average	O
,	O
higher	O
in	O
fiber	O
and	O
carbohydrate	O
and	O
soyfoods	O
and	O
lower	O
in	O
fat	O
;	O
thus	O
,	O
the	O
urinary	O
phytoestrogens	B
may	O
also	O
be	O
a	O
useful	O
marker	O
of	O
healthier	O
dietary	O
patterns	O
.	O

urinary	O
1	B
-	I
methylhistidine	I
is	O
a	O
marker	O
of	O
meat	O
consumption	O
in	O
black	O
and	O
in	O
white	O
california	O
seventh	O
-	O
day	O
adventists	O
..	O
meat	O
consumption	O
predicts	O
risk	O
of	O
several	O
chronic	O
diseases	O
.	O

1	B
-	I
methylhistidine	I
excretion	O
predicts	O
vegetarian	O
status	O
in	O
black	O
(	O
p	O
=	O
0.02	O
)	O
and	O
in	O
white	O
(	O
p	O
=	O
0.005	O
)	O
subjects	O
.	O

spearman	O
's	O
correlation	O
coefficients	O
between	O
1	B
-	I
methylhistidine	I
and	O
estimated	O
meat	O
consumption	O
were	O
usually	O
between	O
0.4	O
and	O
0.6	O
for	O
both	O
food	O
frequency	O
questionnaires	O
and	O
24	O
-	O
hour	O
recall	O
data	O
.	O

basal	O
urinary	O
zinc	B
/	O
creatinine	O
ratio	O
as	O
an	O
indicator	O
of	O
dietary	O
zinc	B
intake	O
in	O
healthy	O
adult	O
women	O
..	O
objective	O
:	O
to	O
study	O
,	O
in	O
healthy	O
women	O
,	O
the	O
correlation	O
between	O
the	O
basal	O
urinary	O
zinc	B
/	O
creatinine	O
ratio	O
and	O
dietary	O
zinc	B
intake	O
.	O

mean	O
daily	O
dietary	O
intake	O
of	O
energy	B
(	O
de	O
)	O
and	O
zinc	B
(	O
dzn	O
)	O
were	O
calculated	O
according	O
to	O
the	O
incap	O
and	O
english	O
or	O
german	O
food	O
composition	O
tables	O
,	O
respectively	O
.	O

results	O
:	O
mean	O
dietary	O
daily	O
intake	O
were	O
as	O
follows	O
(	O
x	O
+	O
/-	O
sd	O
):	O
energy	B
(	O
kcal	O
):	O
1606+/-570	O
;	O
zinc	B
(	O
mg	O
):	O
9.1+/-3.8	O
;	O
basal	O
urine	O
zn	O
/	O
creat	O
ratio	O
:	O
0.41+/-0.24	O
.	O
individual	O
values	O
of	O
the	O
zn	O
/	O
creat	O
ratio	O
correlated	O
with	O
dietary	O
zn	O

comparison	O
of	O
isoflavones	O
among	O
dietary	O
intake	O
,	O
plasma	O
concentration	O
and	O
urinary	O
excretion	O
for	O
accurate	O
estimation	O
of	O
phytoestrogen	O
intake	O
..	O
biological	O
effects	O
of	O
dietary	O
isoflavones	O
,	O
such	O
as	O
daidzein	B
and	O
genistein	B
are	O
of	O
interest	O
in	O
preventive	O
medicine	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
was	O
64.6	O
and	O
111.6	O
mumol	O
/day	O
/	O
capita	O
(	O
16.4	O
and	O
30.1	O
mg	O
/	O
day	O
/	O
capita	O
)	O
,	O
respectively	O
.	O

the	O
median	O
of	O
plasma	O
daidzein	B
and	O
genistein	B
concentration	O
was	O
72.46	O
and	O
206.09	O
nmol	O
/	O
l	O
,	O
respectively	O
.	O

the	O
median	O
of	O
urinary	O
excretion	O
was	O
20.54	O
mumol	O
/day	O
for	O
daidzein	B
,	O
10.79	O
for	O
genistein	B
,	O
15.74	O
for	O
equol	B
and	O
1.64	O
for	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
.	O

equol	B
and	O
o	O
-	O
dma	O
were	O
excreted	O
by	O
50	O
%	O
and	O
84	O
%	O
of	O
all	O
participants	O
,	O
respectively	O
.	O

equol	B
metabolizers	O
were	O
significantly	O
lower	O
the	O
plasma	O
and	O
urinary	O
daidzein	B
and	O
urinary	O
o	O
-	O
dma	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
after	O
the	O
adjustment	O
for	O
total	O
energy	B
intake	O
was	O
significantly	O
correlated	O
with	O
the	O
urinary	O
excretion	O
(	O
r	O
=	O
0.365	O
for	O
daidzein	B
and	O
r	O
=	O
0.346	O
for	O
genistein	B
)	O
and	O
plasma	O
concentration	O
(	O
r	O
=	O
0.335	O
for	O
daidzein	B
and	O
r	O
=	O
0.429	O
for	O
genistein	B
)	O
.	O

we	O
conclude	O
that	O
in	O
epidemiological	O
studies	O
measurements	O
of	O
plasma	O
concentration	O
or	O
urinary	O
excretion	O
of	O
these	O
isoflavones	O
are	O
useful	O
biomarkers	O
of	O
dietary	O
intake	O
and	O
important	O
for	O
studies	O
on	O
their	O
relation	O
to	O
human	O
health	O
..	O
biological	O
effects	O
of	O
dietary	O
isoflavones	O
,	O
such	O
as	O
daidzein	B
and	O
genistein	B
are	O
of	O
interest	O
in	O
preventive	O
medicine	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
was	O
64.6	O
and	O
111.6	O
mumol	O
/day	O
/	O
capita	O
(	O
16.4	O
and	O
30.1	O
mg	O
/	O
day	O
/	O
capita	O
)	O
,	O
respectively	O
.	O

the	O
median	O
of	O
plasma	O
daidzein	B
and	O
genistein	B
concentration	O
was	O
72.46	O
and	O
206.09	O
nmol	O
/	O
l	O
,	O
respectively	O
.	O

the	O
median	O
of	O
urinary	O
excretion	O
was	O
20.54	O
mumol	O
/day	O
for	O
daidzein	B
,	O
10.79	O
for	O
genistein	B
,	O
15.74	O
for	O
equol	B
and	O
1.64	O
for	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
.	O

equol	B
and	O
o	O
-	O
dma	O
were	O
excreted	O
by	O
50	O
%	O
and	O
84	O
%	O
of	O
all	O
participants	O
,	O
respectively	O
.	O

equol	B
metabolizers	O
were	O
significantly	O
lower	O
the	O
plasma	O
and	O
urinary	O
daidzein	B
and	O
urinary	O
o	O
-	O
dma	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
after	O
the	O
adjustment	O
for	O
total	O
energy	B
intake	O
was	O
significantly	O
correlated	O
with	O
the	O
urinary	O
excretion	O
(	O
r	O
=	O
0.365	O
for	O
daidzein	B
and	O
r	O
=	O
0.346	O
for	O
genistein	B
)	O
and	O
plasma	O
concentration	O
(	O
r	O
=	O
0.335	O
for	O
daidzein	B
and	O
r	O
=	O
0.429	O
for	O
genistein	B
)	O
.	O

we	O
conclude	O
that	O
in	O
epidemiological	O
studies	O
measurements	O
of	O
plasma	O
concentration	O
or	O
urinary	O
excretion	O
of	O
these	O
isoflavones	O
are	O
useful	O
biomarkers	O
of	O
dietary	O
intake	O
and	O
important	O
for	O
studies	O
on	O
their	O
relation	O
to	O
human	O
health	O
..	O
biological	O
effects	O
of	O
dietary	O
isoflavones	O
,	O
such	O
as	O
daidzein	B
and	O
genistein	B
are	O
of	O
interest	O
in	O
preventive	O
medicine	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
was	O
64.6	O
and	O
111.6	O
mumol	O
/day	O
/	O
capita	O
(	O
16.4	O
and	O
30.1	O
mg	O
/	O
day	O
/	O
capita	O
)	O
,	O
respectively	O
.	O

the	O
median	O
of	O
plasma	O
daidzein	B
and	O
genistein	B
concentration	O
was	O
72.46	O
and	O
206.09	O
nmol	O
/	O
l	O
,	O
respectively	O
.	O

the	O
median	O
of	O
urinary	O
excretion	O
was	O
20.54	O
mumol	O
/day	O
for	O
daidzein	B
,	O
10.79	O
for	O
genistein	B
,	O
15.74	O
for	O
equol	B
and	O
1.64	O
for	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
.	O

equol	B
and	O
o	O
-	O
dma	O
were	O
excreted	O
by	O
50	O
%	O
and	O
84	O
%	O
of	O
all	O
participants	O
,	O
respectively	O
.	O

equol	B
metabolizers	O
were	O
significantly	O
lower	O
the	O
plasma	O
and	O
urinary	O
daidzein	B
and	O
urinary	O
o	O
-	O
dma	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
after	O
the	O
adjustment	O
for	O
total	O
energy	B
intake	O
was	O
significantly	O
correlated	O
with	O
the	O
urinary	O
excretion	O
(	O
r	O
=	O
0.365	O
for	O
daidzein	B
and	O
r	O
=	O
0.346	O
for	O
genistein	B
)	O
and	O
plasma	O
concentration	O
(	O
r	O
=	O
0.335	O
for	O
daidzein	B
and	O
r	O
=	O
0.429	O
for	O
genistein	B
)	O
.	O

we	O
conclude	O
that	O
in	O
epidemiological	O
studies	O
measurements	O
of	O
plasma	O
concentration	O
or	O
urinary	O
excretion	O
of	O
these	O
isoflavones	O
are	O
useful	O
biomarkers	O
of	O
dietary	O
intake	O
and	O
important	O
for	O
studies	O
on	O
their	O
relation	O
to	O
human	O
health	O
..	O
biological	O
effects	O
of	O
dietary	O
isoflavones	O
,	O
such	O
as	O
daidzein	B
and	O
genistein	B
are	O
of	O
interest	O
in	O
preventive	O
medicine	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
was	O
64.6	O
and	O
111.6	O
mumol	O
/day	O
/	O
capita	O
(	O
16.4	O
and	O
30.1	O
mg	O
/	O
day	O
/	O
capita	O
)	O
,	O
respectively	O
.	O

the	O
median	O
of	O
plasma	O
daidzein	B
and	O
genistein	B
concentration	O
was	O
72.46	O
and	O
206.09	O
nmol	O
/	O
l	O
,	O
respectively	O
.	O

the	O
median	O
of	O
urinary	O
excretion	O
was	O
20.54	O
mumol	O
/day	O
for	O
daidzein	B
,	O
10.79	O
for	O
genistein	B
,	O
15.74	O
for	O
equol	B
and	O
1.64	O
for	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
.	O

equol	B
and	O
o	O
-	O
dma	O
were	O
excreted	O
by	O
50	O
%	O
and	O
84	O
%	O
of	O
all	O
participants	O
,	O
respectively	O
.	O

equol	B
metabolizers	O
were	O
significantly	O
lower	O
the	O
plasma	O
and	O
urinary	O
daidzein	B
and	O
urinary	O
o	O
-	O
dma	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
after	O
the	O
adjustment	O
for	O
total	O
energy	B
intake	O
was	O
significantly	O
correlated	O
with	O
the	O
urinary	O
excretion	O
(	O
r	O
=	O
0.365	O
for	O
daidzein	B
and	O
r	O
=	O
0.346	O
for	O
genistein	B
)	O
and	O
plasma	O
concentration	O
(	O
r	O
=	O
0.335	O
for	O
daidzein	B
and	O
r	O
=	O
0.429	O
for	O
genistein	B
)	O
.	O

we	O
conclude	O
that	O
in	O
epidemiological	O
studies	O
measurements	O
of	O
plasma	O
concentration	O
or	O
urinary	O
excretion	O
of	O
these	O
isoflavones	O
are	O
useful	O
biomarkers	O
of	O
dietary	O
intake	O
and	O
important	O
for	O
studies	O
on	O
their	O
relation	O
to	O
human	O
health	O
..	O
biological	O
effects	O
of	O
dietary	O
isoflavones	O
,	O
such	O
as	O
daidzein	B
and	O
genistein	B
are	O
of	O
interest	O
in	O
preventive	O
medicine	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
was	O
64.6	O
and	O
111.6	O
mumol	O
/day	O
/	O
capita	O
(	O
16.4	O
and	O
30.1	O
mg	O
/	O
day	O
/	O
capita	O
)	O
,	O
respectively	O
.	O

the	O
median	O
of	O
plasma	O
daidzein	B
and	O
genistein	B
concentration	O
was	O
72.46	O
and	O
206.09	O
nmol	O
/	O
l	O
,	O
respectively	O
.	O

the	O
median	O
of	O
urinary	O
excretion	O
was	O
20.54	O
mumol	O
/day	O
for	O
daidzein	B
,	O
10.79	O
for	O
genistein	B
,	O
15.74	O
for	O
equol	B
and	O
1.64	O
for	O
o	B
-	I
desmethylangolensin	I
(	O
o	O
-	O
dma	O
)	O
.	O

equol	B
and	O
o	O
-	O
dma	O
were	O
excreted	O
by	O
50	O
%	O
and	O
84	O
%	O
of	O
all	O
participants	O
,	O
respectively	O
.	O

equol	B
metabolizers	O
were	O
significantly	O
lower	O
the	O
plasma	O
and	O
urinary	O
daidzein	B
and	O
urinary	O
o	O
-	O
dma	O
.	O

the	O
dietary	O
intake	O
of	O
daidzein	B
and	O
genistein	B
after	O
the	O
adjustment	O
for	O
total	O
energy	B
intake	O
was	O
significantly	O
correlated	O
with	O
the	O
urinary	O
excretion	O
(	O
r	O
=	O
0.365	O
for	O
daidzein	B
and	O
r	O
=	O
0.346	O
for	O
genistein	B
)	O
and	O
plasma	O
concentration	O
(	O
r	O
=	O
0.335	O
for	O
daidzein	B
and	O
r	O
=	O
0.429	O
for	O
genistein	B
)	O
.	O

the	O
intervention	O
group	O
had	O
significantly	O
higher	O
consumption	O
of	O
beta	B
-	I
carotene	I
,	O
alpha	B
-	I
carotene	I
,	O
lutein	O
and	O
beta	B
-	I
cryptoxanthin	I
at	O
12	O
mo	O
(	O
p	O
<	O
0.05	O
)	O
.	O

beta	B
-	I
carotene	I
,	O
alpha	B
-	I
carotene	I
and	O
lutein	O
intakes	O
also	O
were	O
significantly	O
higher	O
at	O
36	O
mo	O
(	O
p	O
<	O
0.05	O
)	O
.	O

at	O
36	O
mo	O
,	O
the	O
intervention	O
group	O
had	O
significantly	O
higher	O
plasma	O
concentrations	O
of	O
alpha	B
-	I
carotene	I
and	O
beta	B
-	I
carotene	I
compared	O
with	O
the	O
control	O
group	O
.	O

repeated	O
-	O
measures	O
anova	O
revealed	O
that	O
the	O
intervention	O
group	O
had	O
significantly	O
increased	O
(	O
p	O
<	O
0.05	O
with	O
bonferroni	O
correction	O
)	O
plasma	O
beta	B
-	I
carotene	I
,	O
alpha	B
-	I
carotene	I
,	O
lutein	O
and	O
lycopene	B
concentrations	O
at	O
12	O
and	O
36	O
mo	O
compared	O
with	O
baseline	O
.	O

unadjusted	O
correlations	O
were	O
higher	O
among	O
women	O
than	O
men	O
as	O
follows	O
:	O
alpha	B
-	I
carotene	I
0.33	O
and	O
0.18	O
,	O
beta	B
-	I
carotene	I
,	O
0.36	O
and	O
0.25	O
;	O
beta	B
-	I
cryptoxanthin	I
,	O
0.44	O
and	O
0.32	O
;	O
lycopene	B
,	O
0.35	O
and	O
0.21	O
;	O
and	O
lutein	O
+	O
zeaxanthin	O
,	O
0.27	O
and	O
0.10	O
,	O
respectively	O
.	O

adjustment	O
for	O
age	O
,	O
energy	B
intake	O
,	O
body	O
mass	O
index	O
(	O
bmi	O
,	O
kg	O
/	O
m2	O
)	O
,	O
plasma	O
cholesterol	O
concentrations	O
and	O
smoking	O
reduced	O
the	O
gender	O
differences	O
,	O
respectively	O
,	O
to	O
the	O
following	O
:	O
alpha	B
-	I
carotene	I
0.30	O
and	O
0.28	O
;	O
beta	B
-	I
carotene	I
,	O
0.34	O
and	O
0.31	O
;	O
beta	B
-	I
cryptoxanthin	I
,	O
0.45	O
and	O
0.36	O
;	O
lycopene	B
,	O
0.36	O
and	O
0.31	O
;	O
and	O
lutein	O
+	O
zeaxanthin	O
,	O
0.24	O
and	O
0.14	O
.	O

plots	O
of	O
adjusted	O
mean	O
plasma	O
carotenoid	O
concentration	O
by	O
quintile	O
of	O
respective	O
carotenoid	O
intake	O
show	O
apparent	O
greater	O
responsiveness	O
among	O
women	O
,	O
compared	O
with	O
men	O
,	O
to	O
dietary	O
intake	O
of	O
alpha-	O
and	O
beta	B
-	I
carotene	I
and	O
beta	B
-	I
cryptoxanthin	I
,	O
but	O
similar	O
blood	O
-	O
diet	O
relationships	O
for	O
lycopene	B
and	O
lutein	O
+	O
zeaxanthin	O
.	O
reported	O
daily	O
intake	O
of	O
fruits	O
and	O
vegetables	O
correlated	O
most	O
strongly	O
with	O
plasma	O
beta	B
-	I
cryptoxanthin	I
and	O
beta	B
-	I
carotene	I
among	O
women	O
and	O
with	O
plasma	O
alpha-	O
and	O
beta	B
-	I
carotene	I
among	O
men	O
.	O

with	O
the	O
exception	O
of	O
lutein	O
+	O
zeaxanthin	O
,	O
this	O
dietary	O
questionnaire	O
does	O
provide	O
reasonable	O
rankings	O
of	O
carotenoid	O
status	O
among	O
elderly	O
subjects	O
,	O
with	O
the	O
strongest	O
correlations	O
for	O
beta	B
-	I
cryptoxanthin	I
.	O

questionnaire	O
assessment	O
of	O
antioxidants	O
and	O
retinol	B
intakes	O
in	O
mexican	O
women	O
..	O
background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

background	O
:	O
in	O
order	O
to	O
assess	O
intake	O
of	O
antioxidants	O
and	O
retinol	B
,	O
we	O
evaluated	O
the	O
validity	O
and	O
reproducibility	O
of	O
a	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

in	O
addition	O
,	O
we	O
measured	O
serum	O
blood	O
levels	O
of	O
retinol	B
and	O
various	O
carotenoids	B
at	O
3	O
and	O
9	O
months	O
after	O
baseline	O
.	O

results	O
:	O
intraclass	O
correlation	O
coefficients	O
for	O
intake	O
of	O
energy	O
-	O
adjusted	O
daily	O
nutrients	O
,	O
assessed	O
by	O
the	O
questionnaires	O
1	O
year	O
apart	O
,	O
ranged	O
from	O
0.23	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.50	O
for	O
total	O
carotenes	O
.	O

correlation	O
coefficients	O
between	O
energy	O
-	O
adjusted	O
nutrient	O
intakes	O
were	O
measured	O
by	O
means	O
of	O
the	O
sixteen	O
24	O
-	O
h	O
dietary	O
recalls	O
,	O
and	O
the	O
second	O
questionnaire	O
ranged	O
from	O
0.09	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.45	O
for	O
total	O
carotenes	O
.	O

these	O
correlations	O
were	O
higher	O
after	O
adjusting	O
for	O
day	O
-	O
to	O
-	O
day	O
variations	O
in	O
diets	O
ranging	O
from	O
0.11	O
for	O
lutein	B
/	I
zeaxanthin	I
to	O
0.49	O
for	O
vitamin	O
c.	O
correlation	O
coefficients	O
between	O
intake	O
and	O
biochemical	O
measures	O
were	O
0.32	O
for	O
alpha	O
-	O
carotene	O
,	O
0.34	O
for	O
beta	O
-	O
carotene	O
,	O
and	O
0.40	O
for	O
total	O
carotene	O
after	O
adjusting	O
for	O
age	O
,	O
body	O
mass	O
index	O
,	O
cholesterol	O
and	O
triglyceride	O
plasma	O
levels	O
,	O
smoking	O
status	O
,	O
and	O
caloric	O
intake	O
.	O

day	O
-	O
to	O
-	O
day	O
and	O
within	O
-	O
day	O
variation	O
in	O
urinary	O
iodine	B
excretion	O
..	O
objective	O
:	O
to	O
examine	O
the	O
day	O
-	O
to	O
-	O
day	O
and	O
within	O
-	O
day	O
variation	O
in	O
urinary	O
iodine	B
excretion	O
and	O
the	O
day	O
-	O
to	O
-	O
day	O
variation	O
in	O
iodine	B
intake	O
.	O

main	O
outcome	O
measures	O
:	O
twenty	O
-	O
four	O
-	O
hour	O
urinary	O
iodine	B
excretion	O
,	O
24	O
-	O
h	O
urinary	O
iodine	B
excretion	O
estimated	O
as	O
i	O
/	O
cr*24	O
h	O
cr	O
and	O
as	O
a	O
concentration	O
in	O
casual	O
urine	O
samples	O
.	O

results	O
:	O
study	O
1	O
:	O
both	O
iodine	B
excreted	O
in	O
24	O
-	O
h	O
urine	O
and	O
iodine	B
intake	O
varied	O
from	O
day	O
-	O
to	O
-	O
day	O
.	O

iodine	B
excretion	O
correlated	O
with	O
iodine	B
intake	O

iodine	B
intake	O
(	O
mean	O
89	O
+	O
/-	O

6.5	O
microg	O
/	O
d	O
)	O
was	O
not	O
significantly	O
different	O
from	O
iodine	B
excretion	O
(	O
mean	O
95	O
+	O
/-	O

5.3	O
microg	O
/	O
d	O
)	O
.	O
study	O
2	O
:	O
twenty	O
-	O
four	O
hour	O
iodine	B
excretion	O
estimated	O
as	O
i	O
/	O
cr*24	O
h	O
cr	O
from	O
the	O
morning	O
urine	O
sample	O
was	O
significantly	O
lower	O
than	O
actual	O
24	O
-	O
h	O
iodine	B
excretion	O
,	O
whereas	O
24	O
-	O
h	O
iodine	B
excretion	O
estimated	O
as	O
i	O
/	O
cr*24	O
h	O
cr	O
from	O
the	O
first	O
sample	O
after	O
the	O
morning	O
sample	O
and	O
the	O
last	O
sample	O
before	O
the	O
subjects	O
went	O
to	O
bed	O
was	O
not	O
significantly	O
different	O
from	O
actual	O
24	O
-	O
h	O
iodine	B
excretion	O
.	O

twenty	O
-	O
four	O
-	O
hour	O
urine	O
excretion	O
estimated	O
as	O
a	O
concentration	O
was	O
lower	O
than	O
actual	O
24	O
-	O
h	O
iodine	B
excretion	O
in	O
casual	O
urine	O
taken	O
at	O
any	O
time	O
of	O
the	O
day	O
.	O

conclusions	O
:	O
for	O
determination	O
of	O
iodine	B
status	O
in	O
an	O
individual	O
,	O
more	O
than	O
one	O
24	O
-	O
h	O
urine	O
sample	O
must	O
be	O
used	O
.	O

the	O
use	O
of	O
the	O
i	O
/	O
cr	O
ratio	O
in	O
casual	O
urine	O
samples	O
is	O
a	O
usable	O
measure	O
of	O
iodine	B
status	O
if	O
corrected	O
for	O
the	O
age-	O
and	O
sex	O
-	O
adjusted	O
24	O
-	O
h	O
creatinine	O
excretion	O
.	O

further	O
,	O
the	O
study	O
suggests	O
that	O
fasting	O
morning	O
urine	O
samples	O
would	O
underestimate	O
iodine	B
status	O
in	O
this	O
population	O
.	O

validation	O
of	O
a	O
self	O
-	O
administered	O
food	O
-	O
frequency	O
questionnaire	O
administered	O
in	O
the	O
european	O
prospective	O
investigation	O
into	O
cancer	O
and	O
nutrition	O
(	O
epic	O
)	O
study	O
:	O
comparison	O
of	O
energy	B
,	O
protein	O
,	O
and	O
macronutrient	O
intakes	O
estimated	O
with	O
the	O
doubly	O
labeled	O
water	O
,	O
urinary	O
nitrogen	B
,	O
and	O
repeated	O
24	O
-	O
h	O
dietary	O
recall	O
methods	O
..	O
background	O
:	O
the	O
validation	O
of	O
dietary	O
assessment	O
instruments	O
is	O
critical	O
in	O
the	O
evaluation	O
of	O
diet	O
as	O
a	O
chronic	O
disease	O
risk	O
factor	O
.	O

objective	O
:	O
the	O
objective	O
was	O
to	O
assess	O
the	O
validity	O
of	O
a	O
self	O
-	O
administered	O
food	O
-	O
frequency	O
questionnaire	O
by	O
comparison	O
with	O
dietary	O
recall	O
,	O
urinary	O
nitrogen	B
excretion	O
,	O
and	O
total	O
energy	B
expenditure	O
data	O
.	O

in	O
a	O
substudy	O
of	O
28	O
participants	O
,	O
total	O
energy	B
expenditure	O
from	O
doubly	O
labeled	O
water	O
measurements	O
was	O
assessed	O
.	O

energy	B
intake	O
and	O
total	O
energy	B
expenditure	O
were	O
also	O
significantly	O
correlated	O
(	O
r	O
=	O
0.48	O
)	O
;	O
however	O
,	O
all	O
but	O
one	O
subject	O
underreported	O
their	O
energy	B
intake	O
.	O

the	O
magnitude	O
of	O
underreporting	O
varied	O
considerably	O
,	O
by	O
22	O
%	O
on	O
average	O
,	O
and	O
increased	O
slightly	O
with	O
increasing	O
energy	B
intake	O
.	O

a	O
similar	O
pattern	O
of	O
underreporting	O
was	O
observed	O
when	O
energy	B
intakes	O
from	O
the	O
24	O
-	O
h	O
dietary	O
recalls	O
were	O
compared	O
with	O
total	O
energy	B
expenditure	O
.	O

compared	O
with	O
measurements	O
of	O
total	O
energy	B
expenditure	O
and	O
protein	O
excretion	O
,	O
however	O
,	O
only	O
moderate	O
agreement	O
with	O
both	O
the	O
food	O
-	O
frequency	O
questionnaire	O
and	O
the	O
24	O
-	O
h	O
dietary	O
recalls	O
was	O
observed	O
.	O

after	O
adjustment	O
for	O
energy	B
intake	O
,	O
age	O
,	O
and	O
body	O
mass	O
index	O
,	O
the	O
correlation	O
coefficients	O
were	O
0.76	O
(	O
95	O
%	O
ci	O
0.51	O
-	O
0.89	O
)	O
among	O
men	O
and	O
0.52	O
(	O
95	O
%	O
ci	O
0.17	O
-	O
0.75	O
)	O
among	O
women	O
.	O

evaluation	O
of	O
a	O
biological	O
marker	O
of	O
dairy	O
fat	O
intake	O
..	O
we	O
evaluated	O
whether	O
the	O
adipose	O
tissue	O
content	O
of	O
2	O
fatty	B
acids	I
of	O
exogenous	O
origin	O
specific	O
for	O
ruminant	O
fat	O
,	O
15:0	O
and	O
17:0	O
,	O
reflect	O
average	O
long	O
-	O
term	O
dairy	O
fat	O
consumption	O
in	O
free	O
-	O
living	O
subjects	O
.	O

in	O
81	O
healthy	O
women	O
aged	O
30	O
-	O
77	O
y	O
,	O
we	O
compared	O
the	O
relative	O
content	O
of	O
these	O
2	O
fatty	B
acids	I
in	O
subcutaneous	O
adipose	O
tissue	O
with	O
relative	O
intake	O
(	O
%	O
of	O
total	O
fat	O
)	O
based	O
on	O
four	O
1	O
-	O
wk	O
weighed	O
diet	O
records	O
made	O
3	O
-	O
4	O
mo	O
apart	O
and	O
on	O
a	O
food	O
-	O
frequency	O
questionnaire	O
reflecting	O
average	O
past	O
year	O
consumption	O
.	O

carotenoid	O
intakes	O
were	O
estimated	O
from	O
values	O
for	O
the	O
five	O
major	O
carotenoids	O
found	O
in	O
human	O
plasma	O
,	O
specifically	O
,	O
alpha-	O
and	O
beta	B
-	I
carotene	I
,	O
beta	O
-	O
cryptoxanthin	O
,	O
lutein	O
,	O
and	O
lycopene	O
,	O
using	O
the	O
united	O
states	O
department	O
of	O
agriculture	O
-	O
national	O
cancer	O
institute	O
carotenoid	O
database	O
,	O
as	O
well	O
as	O
updated	O
values	O
for	O
tomato	O
products	O
.	O

among	O
nonsmoking	O
women	O
(	O
n	O
=	O
162	O
)	O
,	O
the	O
adjusted	O
diet	O
-	O
plasma	O
carotenoid	O
associations	O
were	O
0.48	O
for	O
alpha	B
-	I
carotene	I
,	O
0.27	O
for	O
beta	B
-	I
carotene	I
and	O
lutein	O
,	O
0.32	O
for	O
beta	O
-	O
cryptoxanthin	O
,	O
and	O
0.21	O
for	O
lycopene	O
.	O
among	O
nonsmoking	O
men	O
(	O
n	O
=	O
110	O
)	O
,	O
diet	O
-	O
plasma	O
correlations	O
were	O
0.47	O
for	O
alpha	B
-	I
carotene	I
and	O
lycopene	O
,	O
0.35	O
for	O
beta	B
-	I
carotene	I
,	O
0.43	O
for	O
beta	O
-	O
cryptoxanthin	O
,	O
and	O
0.40	O
for	O
lutein	O
.	O

evaluation	O
of	O
a	O
food	O
frequency	O
questionnaire	O
with	O
weighed	O
records	O
,	O
fatty	B
acids	I
,	O
and	O
alpha	B
-	I
tocopherol	I
in	O
adipose	O
tissue	O
and	O
serum	O
..	O

spearman	O
correlation	O
coefficients	O
between	O
the	O
two	O
measurements	O
ranged	O
from	O
0.42	O
for	O
percent	O
of	O
energy	B
from	O
fat	O
to	O
0.66	O
for	O
sugar	O
intake	O
(	O
median	O
r	O
=	O
0.51	O
)	O
.	O

correlation	O
coefficients	O
between	O
intake	O
of	O
fatty	B
acids	I
estimated	O
from	O
the	O
questionnaire	O
and	O
the	O
relative	O
amounts	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
:	O
linoleic	O
acid	O
(	O
18:2	O
,	O
n-6	O
)	O
,	O
r	O
=	O
0.38	O
;	O
alpha	O
-	O
linolenic	O
acid	O
(	O
18:3	O
,	O
n-3	O
)	O
,	O
r	O
=	O
0.42	O
;	O
eicosapentaenoic	O
acid	O
(	O
20:5	O
,	O
n-3	O
)	O
,	O
r	O
=	O
0.52	O
;	O
and	O
docosahexaenoic	O
acid	O
(	O
22:6	O
,	O
n-3	O
)	O
,	O
r	O
=	O
0.49	O
.	O

the	O
correlations	O
for	O
these	O
fatty	B
acids	I
between	O
the	O
total	O
serum	O
lipids	O
and	O
the	O
diet	O
were	O
0.16	O
,	O
0.28	O
,	O
0.51	O
and	O
0.52	O
,	O
respectively	O
.	O

the	O
data	O
suggest	O
that	O
very	O
-	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
and	O
total	O
serum	O
lipids	O
reflect	O
the	O
dietary	O
intake	O
of	O
very	O
-	O
long	O
-	O
chain	O
n-3	O
fatty	B
acids	I
to	O
the	O
same	O
degree	O
.	O

no	O
associations	O
were	O
observed	O
between	O
intake	O
of	O
alpha	B
-	I
tocopherol	I
and	O
concentration	O
in	O
adipose	O
tissue	O
and	O
serum	O
.	O

relation	O
between	O
the	O
intake	O
of	O
milk	O
fat	O
and	O
the	O
occurrence	O
of	O
conjugated	O
linoleic	O
acid	O
in	O
human	O
adipose	O
tissue	O
..	O
background	O
:	O
conjugated	O
linoleic	O
acid	O
(	O
cla	O
)	O
is	O
a	O
group	O
of	O
naturally	O
occurring	O
fatty	B
acids	I
mainly	O
present	O
in	O
fats	B
from	O
ruminants	O
.	O

results	O
:	O
the	O
average	O
amount	O
of	O
one	O
isomer	O
of	O
cla--9	O
-	O
cis,11	O
-	O
trans	O
-	O
octadecadienoic	O
acid	O
(	O
9c,11t-18:2)--as	O
a	O
percentage	O
of	O
total	O
fatty	B
acids	I
was	O
found	O
to	O
be	O
0.50	O
%	O
in	O
adipose	O
tissue	O
and	O
0.25	O
%	O
in	O
serum	O
.	O

dietary	O
iodine	B
intake	O
and	O
urinary	O
iodine	B
excretion	O
in	O
normal	O
korean	O
adults	O
..	O
korea	O
is	O
a	O
region	O
abundant	O
in	O
foods	O
containing	O
iodine	B
such	O
as	O
seaweed	O
and	O
fish	O
.	O

an	O
adequate	O
amount	O
of	O
iodine	B
consumption	O
is	O
extremely	O
important	O
as	O
both	O
a	O
deficiency	O
and	O
excess	O
of	O
iodine	B
can	O
result	O
in	O
health	O
problems	O
.	O

this	O
study	O
was	O
undertaken	O
to	O
assess	O
the	O
iodine	B
nutritional	O
status	O
of	O
normal	O
korean	O
adults	O
who	O
consume	O
seaweed	O
and	O
fish	O
,	O
and	O
to	O
determine	O
the	O
relationship	O
between	O
the	O
dietary	O
iodine	B
intake	O
and	O
the	O
urinary	O
excretion	O
of	O
iodine	B
.	O

the	O
dietary	O
assessment	O
of	O
iodine	B
using	O
a	O
food	O
frequency	O
questionnaire	O
and	O
a	O
urinary	O
iodine	B
excretion	O
examination	O
were	O
carried	O
out	O
in	O
278	O
healthy	O
adults	O
.	O

the	O
iodide	O
selective	O
electrode	O
(	O
ise	O
)	O
method	O
was	O
used	O
to	O
determine	O
urinary	O
iodine	B
excretion	O
.	O

the	O
average	O
usual	O
iodine	B
intake	O
of	O
korean	O
adults	O
was	O
479	O
micrograms	O
per	O
day	O
(	O
ranging	O
from	O
61	O
micrograms	O
to	O
4086	O
micrograms	O
)	O
.	O

the	O
major	O
food	O
sources	O
of	O
dietary	O
iodine	B
included	O
seaweed	O
(	O
66	O
%	O
)	O
,	O
milk	O
and	O
dairy	O
products	O
(	O
11	O
%	O
)	O
,	O
and	O
fish	O
(	O
9	O
%	O
)	O
.	O

the	O
contribution	O
of	O
seaweed	O
to	O
the	O
total	O
iodine	B
intake	O
tended	O
to	O
increase	O
with	O
age	O
while	O
the	O
contribution	O
of	O
milk	O
decreased	O
.	O

the	O
average	O
urinary	O
excretion	O
of	O
iodine	B
was	O
674	O
micrograms	O
/	O
g	O
creatinine	O
and	O
there	O
was	O
no	O
significant	O
difference	O
in	O
sex	O
or	O
age	O
.	O

the	O
dietary	O
iodine	B
intake	O
was	O
positively	O
correlated	O
with	O
the	O
urinary	O
excretion	O
of	O
iodine	B
(	O
gamma	O
=	O
0.60	O
,	O
p	O
<	O
0.01	O
)	O
.	O

the	O
study	O
data	O
indicated	O
that	O
the	O
iodine	B
intake	O
and	O
excretion	O
of	O
koreans	O
depends	O
mostly	O
on	O
the	O
amount	O
of	O
seaweed	O
consumption	O
like	O
sea	O
tangle	O
and	O
sea	O
mustard	O
.	O

as	O
well	O
,	O
the	O
current	O
iodine	B
intake	O
and	O
urinary	O
iodine	B
excretion	O
by	O
koreans	O
seems	O
to	O
be	O
higher	O
than	O
in	O
other	O
countries	O
.	O

dietary	O
soy	O
intake	O
and	O
urinary	O
isoflavone	O
excretion	O
among	O
women	O
from	O
a	O
multiethnic	O
population	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

the	O
strong	O
correlation	O
between	O
urinary	O
isoflavone	O
excretion	O
and	O
self	O
-	O
reported	O
soy	O
intake	O
validates	O
the	O
dietary	O
history	O
questionnaire	O
that	O
is	O
now	O
used	O
in	O
a	O
study	O
exploring	O
dietary	O
risk	O
factors	O
for	O
breast	O
cancer	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

the	O
strong	O
correlation	O
between	O
urinary	O
isoflavone	O
excretion	O
and	O
self	O
-	O
reported	O
soy	O
intake	O
validates	O
the	O
dietary	O
history	O
questionnaire	O
that	O
is	O
now	O
used	O
in	O
a	O
study	O
exploring	O
dietary	O
risk	O
factors	O
for	O
breast	O
cancer	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

the	O
strong	O
correlation	O
between	O
urinary	O
isoflavone	O
excretion	O
and	O
self	O
-	O
reported	O
soy	O
intake	O
validates	O
the	O
dietary	O
history	O
questionnaire	O
that	O
is	O
now	O
used	O
in	O
a	O
study	O
exploring	O
dietary	O
risk	O
factors	O
for	O
breast	O
cancer	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

the	O
strong	O
correlation	O
between	O
urinary	O
isoflavone	O
excretion	O
and	O
self	O
-	O
reported	O
soy	O
intake	O
validates	O
the	O
dietary	O
history	O
questionnaire	O
that	O
is	O
now	O
used	O
in	O
a	O
study	O
exploring	O
dietary	O
risk	O
factors	O
for	O
breast	O
cancer	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

the	O
strong	O
correlation	O
between	O
urinary	O
isoflavone	O
excretion	O
and	O
self	O
-	O
reported	O
soy	O
intake	O
validates	O
the	O
dietary	O
history	O
questionnaire	O
that	O
is	O
now	O
used	O
in	O
a	O
study	O
exploring	O
dietary	O
risk	O
factors	O
for	O
breast	O
cancer	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

the	O
strong	O
correlation	O
between	O
urinary	O
isoflavone	O
excretion	O
and	O
self	O
-	O
reported	O
soy	O
intake	O
validates	O
the	O
dietary	O
history	O
questionnaire	O
that	O
is	O
now	O
used	O
in	O
a	O
study	O
exploring	O
dietary	O
risk	O
factors	O
for	O
breast	O
cancer	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

the	O
strong	O
correlation	O
between	O
urinary	O
isoflavone	O
excretion	O
and	O
self	O
-	O
reported	O
soy	O
intake	O
validates	O
the	O
dietary	O
history	O
questionnaire	O
that	O
is	O
now	O
used	O
in	O
a	O
study	O
exploring	O
dietary	O
risk	O
factors	O
for	O
breast	O
cancer	O
..	O
isoflavones	B
are	O
present	O
in	O
soybeans	O
and	O
its	O
products	O
in	O
concentrations	O
up	O
to	O
300	O
mg/100	O
g	O
,	O
have	O
estrogenic	O
and	O
antiestrogenic	O
properties	O
,	O
and	O
may	O
be	O
protective	O
against	O
hormone	O
-	O
related	O
cancers	O
.	O

overnight	O
urine	O
samples	O
were	O
analyzed	O
for	O
coumestrol	B
and	O
the	O
soy	O
isoflavones	B
genistein	O
,	O
daidzein	O
,	O
and	O
glycitein	B
and	O
their	O
main	O
human	O
metabolites	O
by	O
reverse	O
-	O
phase	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

japanese	O
women	O
excreted	O
more	O
daidzein	O
,	O
genistein	O
,	O
and	O
glycitein	B
than	O
did	O
caucasian	O
women	O
,	O
whereas	O
caucasian	O
women	O
excreted	O
slightly	O
more	O
coumestrol	B
.	O

urinary	O
excretion	O
of	O
isoflavones	B
was	O
also	O
related	O
to	O
annual	O
dietary	O
soy	O
protein	O
and	O
isoflavone	O
intake	O
[	O
rs	O
=	O
0.32	O
(	O
p	O
<	O
0.0012	O
)	O
and	O
0.31	O
(	O
p	O
<	O
0.0016	O
)	O
,	O
respectively	O
]	O
.	O

validity	O
of	O
a	O
self	O
-	O
administered	O
diet	O
history	O
questionnaire	O
for	O
assessment	O
of	O
sodium	B
and	O
potassium	B
:	O
comparison	O
with	O
single	O
24	O
-	O
hour	O
urinary	O
excretion	O
..	O
we	O
developed	O
a	O
self	O
-	O
administered	O
diet	O
history	O
questionnaire	O
(	O
dhq	O
)	O
for	O
use	O
in	O
prevention	O
and	O
control	O
of	O
cardiovascular	O
diseases	O
and	O
cancer	O
,	O
and	O
validated	O
it	O
by	O
comparison	O
with	O
single	O
24	O
-	O
h	O
urinary	O
excretion	O
of	O
sodium	B
(	O
na	O
)	O
and	O
potassium	B
(	O
k	O
)	O
.	O

serum	O
caffeine	B
and	O
paraxanthine	B
as	O
markers	O
for	O
reported	O
caffeine	B
intake	O
in	O
pregnancy	O
..	O
purpose	O
:	O
previous	O
studies	O
of	O
maternal	O
caffeine	B
use	O
and	O
pregnancy	O
outcome	O
have	O
relied	O
on	O
self	O
-	O
reported	O
use	O
.	O

even	O
if	O
these	O
were	O
perfectly	O
accurate	O
,	O
inter	O
-	O
individual	O
differences	O
in	O
caffeine	B
metabolism	O
result	O
in	O
a	O
relatively	O
weak	O
correlation	O
between	O
caffeine	B
intake	O
and	O
serum	O
concentration	O
.	O

the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
the	O
serum	O
concentration	O
of	O
caffeine	B
or	O
its	O
primary	O
metabolite	O
,	O
paraxanthine	B
,	O
obtained	O
at	O
an	O
unknown	O
time	O
during	O
working	O
hours	O
,	O
is	O
useful	O
to	O
distinguish	O
between	O
pregnant	O
women	O
who	O
report	O
consuming	O
small	O
and	O
large	O
amounts	O
of	O
caffeine	B
.	O

methods	O
:	O
we	O
selected	O
from	O
the	O
birmingham	O
fetal	O
growth	O
study	O
60	O
women	O
with	O
normal	O
pregnancy	O
outcomes	O
who	O
reported	O
consuming	O
<	O
or	O
=	O
0.8	O
mg	O
/	O
kg	O
/	O
day	O
of	O
caffeine	B
in	O
a	O
24	O
-	O
hour	O
dietary	O
recall	O
,	O
60	O
who	O
consumed	O
0.81	O
-	O
2.5	O
mg	O
/	O
kg	O
/	O
day	O
,	O
60	O
who	O
consumed	O
2.51	O
-	O
5.0	O
mg	O
/	O
kg	O
/	O
day	O
and	O
59	O
who	O
consumed	O
>	O
or	O
=	O
5.01	O
mg	O
/	O
kg	O
/	O
day	O
.	O

caffeine	B
and	O
paraxanthine	B
were	O
measured	O
in	O
the	O
stored	O
serum	O
using	O
high	O
performance	O
liquid	O
chromatography	O
.	O

results	O
:	O
the	O
weighted	O
kappa	O
coefficient	O
between	O
strata	O
of	O
caffeine	B
intake	O
and	O
quartiles	O
of	O
serum	O
paraxanthine	B
was	O
0.58	O
among	O
smokers	O
and	O
0.53	O
among	O
nonsmokers	O
,	O
versus	O
0.44	O
and	O
0.51	O
,	O
respectively	O
,	O
for	O
quartiles	O
of	O
serum	O
caffeine	B
.	O

the	O
pearson	O
correlation	O
coefficient	O
between	O
intake	O
and	O
paraxanthine	B
was	O
0.50	O
for	O
smokers	O
and	O
0.53	O
for	O
nonsmokers	O
,	O
and	O
0.37	O
and	O
0.51	O
,	O
respectively	O
,	O
for	O
serum	O
caffeine	B
.	O

conclusions	O
:	O
the	O
serum	O
concentrations	O
of	O
paraxanthine	B
,	O
and	O
to	O
a	O
lesser	O
degree	O
,	O
caffeine	B
are	O
useful	O
to	O
distinguish	O
between	O
women	O
with	O
varying	O
levels	O
of	O
caffeine	B
intake	O
.	O

the	O
relation	O
between	O
dietary	O
intake	O
and	O
adipose	O
tissue	O
composition	O
of	O
selected	O
fatty	B
acids	I
in	O
us	O
women	O
..	O
we	O
compared	O
fatty	O
acid	O
amounts	O
in	O
adipose	O
tissue	O
with	O
fatty	O
acid	O
intake	O
calculated	O
from	O
2	O
separate	O
weeks	O
of	O
diet	O
recording	O
and	O
two	O
food	O
-	O
frequency	O
questionnaires	O
for	O
140	O
participants	O
in	O
the	O
nurses	O
'	O
health	O
study	O
.	O

our	O
results	O
showed	O
that	O
the	O
amounts	O
of	O
polyunsaturated	O
and	O
trans	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
reflect	O
dietary	O
intake	O
and	O
confirm	O
those	O
of	O
previous	O
studies	O
.	O

the	O
correlation	O
between	O
the	O
polyunsaturated	O
fatty	O
acid	O
content	O
of	O
adipose	O
tissue	O
and	O
polyunsaturated	O
fatty	O
acid	O
intake	O
from	O
the	O
average	O
of	O
the	O
two	O
food	O
-	O
frequency	O
questionnaires	O
was	O
0.40	O
;	O
this	O
correlation	O
for	O
trans	O
fatty	B
acids	I
was	O
also	O
0.40	O
.	O

an	O
estimate	O
of	O
trans	O
fatty	O
acid	O
intake	O
from	O
vegetable	O
sources	O
correlated	O
much	O
more	O
strongly	O
with	O
adipose	O
trans	O
fatty	B
acids	I
than	O
did	O
an	O
estimate	O
of	O
trans	O
fatty	B
acids	I
from	O
animal	O
sources	O
.	O

adipose	O
tissue	O
aspirates	O
can	O
be	O
used	O
to	O
indicate	O
intake	O
of	O
exogenous	O
fatty	B
acids	I
.	O

serum	O
phospholipid	O
fatty	O
acid	O
composition	O
and	O
habitual	O
intake	O
of	O
marine	O
foods	O
registered	O
by	O
a	O
semi	O
-	O
quantitative	O
food	O
frequency	O
questionnaire	O
..	O
objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

objective	O
:	O
to	O
examine	O
the	O
relation	O
between	O
consumption	O
of	O
fish	O
and	O
fish	O
products	O
registered	O
by	O
a	O
comprehensive	O
food	O
frequency	O
questionnaire	O
and	O
the	O
composition	O
of	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
.	O

in	O
separate	O
analyses	O
of	O
lean	O
and	O
fatty	O
fish	O
,	O
consumption	O
of	O
fatty	O
fish	O
was	O
negatively	O
associated	O
with	O
n-6	O
and	O
positively	O
associated	O
with	O
n-3	O
fatty	B
acids	I
in	O
serum	O
phospholipids	O
,	O
while	O
no	O
significant	O
associations	O
were	O
found	O
for	O
lean	O
fish	O
consumption	O
.	O

association	O
between	O
urinary	O
potassium	B
,	O
urinary	O
sodium	O
,	O
current	O
diet	O
,	O
and	O
bone	O
density	O
in	O
prepubertal	O
children	O
..	O
background	O
:	O
our	O
understanding	O
of	O
the	O
role	O
of	O
nutrients	O
in	O
bone	O
development	O
in	O
children	O
is	O
limited	O
.	O

objective	O
:	O
we	O
examined	O
the	O
associations	O
between	O
urinary	O
potassium	B
,	O
urinary	O
sodium	O
,	O
usual	O
dietary	O
intake	O
,	O
and	O
bone	O
mineral	O
density	O
(	O
bmd	O
)	O
in	O
prepubertal	O
children	O
.	O

results	O
:	O
urinary	O
potassium	B
correlated	O
significantly	O
with	O
bmd	O
at	O
all	O
sites	O
(	O
femoral	O
neck	O
:	O
r	O
=	O
0.20	O
,	O
p	O
<	O
0.001	O
;	O
lumbar	O
spine	O
:	O
r	O
=	O
0.19	O
,	O
p	O
=	O
0.001	O
;	O
total	O
body	O
:	O
r	O
=	O
0.24	O
,	O
p	O
<	O
0.001	O
)	O
.	O

no	O
nutrient	O
or	O
food	O
intake	O
estimate	O
was	O
associated	O
with	O
bmd	O
,	O
although	O
urinary	O
potassium	B
correlated	O
significantly	O
with	O
potassium	B
intake	O
(	O
r	O
=	O
0.14	O
,	O
p	O
=	O
0.016	O
)	O
and	O
fruit	O
and	O
vegetable	O
intake	O
(	O
r	O
=	O
0.12	O
,	O
p	O
=	O
0.033	O
)	O
.	O

conclusions	O
:	O
urinary	O
potassium	B
was	O
associated	O
with	O
both	O
dietary	O
intake	O
and	O
bmd	O
independent	O
of	O
lean	O
body	O
mass	O
in	O
these	O
well	O
-	O
nourished	O
,	O
calcium	O
-	O
replete	O
young	O
children	O
.	O

nevertheless	O
,	O
this	O
association	O
is	O
likely	O
to	O
represent	O
dietary	O
intake	O
of	O
potassium	B
and	O
suggests	O
that	O
measurement	O
of	O
urinary	O
potassium	B
is	O
superior	O
to	O
food	O
-	O
frequency	O
questionnaires	O
for	O
assessing	O
potassium	B
intake	O
in	O
this	O
age	O
group	O
.	O

serum	O
beta	B
-	I
carotene	I
and	O
vitamin	B
c	I
as	O
biomarkers	O
of	O
vegetable	O
and	O
fruit	O
intakes	O
in	O
a	O
community	O
-	O
based	O
sample	O
of	O
french	O
adults	O
..	O
relatively	O
high	O
intakes	O
of	O
vegetables	O
and	O
fruit	O
and	O
relatively	O
low	O
intakes	O
of	O
fat	O
are	O
associated	O
with	O
lower	O
rates	O
of	O
heart	O
disease	O
and	O
many	O
types	O
of	O
cancer	O
.	O

this	O
study	O
examined	O
two	O
biomarkers	O
,	O
serum	O
concentrations	O
of	O
beta	B
-	I
carotene	I
and	O
vitamin	B
c	I
,	O
as	O
a	O
function	O
of	O
anthropometric	O
,	O
dietary	O
,	O
and	O
lifestyle	O
factors	O
in	O
a	O
community	O
-	O
based	O
sample	O
of	O
french	O
adults	O
.	O

serum	O
beta	B
-	I
carotene	I
was	O
quantified	O
by	O
hplc	O
and	O
vitamin	B
c	I
was	O
measured	O
by	O
using	O
an	O
automated	O
method	O
.	O

serum	O
beta	B
-	I
carotene	I
and	O
vitamin	B
c	I
concentrations	O
were	O
positively	O
associated	O
with	O
vegetable	O
and	O
fruit	O
intakes	O
and	O
were	O
negatively	O
linked	O
to	O
the	O
consumption	O
of	O
energy	B
,	O
alcohol	O
,	O
and	O
fat	O
.	O

multiple	O
-	O
regression	O
analyses	O
showed	O
that	O
serum	O
beta	B
-	I
carotene	I
concentration	O
was	O
predicted	O
by	O
fruit	O
and	O
vegetable	O
intakes	O
but	O
was	O
inversely	O
associated	O
with	O
body	O
mass	O
,	O
energy	B
and	O
alcohol	O
intakes	O
,	O
and	O
tobacco	O
use	O
.	O

serum	O
vitamin	B
c	I
concentration	O
was	O
positively	O
associated	O
with	O
fruit	O
consumption	O
but	O
was	O
negatively	O
associated	O
with	O
age	O
,	O
body	O
mass	O
,	O
and	O
tobacco	O
use	O
.	O

serum	O
beta	B
-	I
carotene	I
and	O
vitamin	B
c	I
concentrations	O
are	O
useful	O
biomarkers	O
of	O
vegetable	O
and	O
fruit	O
consumption	O
in	O
the	O
french	O
diet	O
.	O

we	O
suggest	O
that	O
discriminant	O
validity	O
,	O
or	O
the	O
ability	O
to	O
distinguish	O
among	O
exposures	O
to	O
different	O
nutrients	O
,	O
is	O
also	O
important	O
.	O
using	O
baseline	O
data	O
from	O
a	O
large	O
clinical	O
trial	O
,	O
we	O
tested	O
the	O
discriminant	O
validity	O
of	O
indexes	O
of	O
intake	O
of	O
vitamin	B
e	I
,	O
alpha	B
-	I
carotene	I
,	O
and	O
beta	B
-	I
carotene	I
.	O

our	O
results	O
suggest	O
that	O
the	O
vitamin	B
e	I
index	O
possesses	O
neither	O
convergent	O
not	O
discriminant	O
validity	O
,	O
the	O
alpha	B
-	I
carotene	I
index	O
adequate	O
convergent	O
and	O
discriminant	O
validity	O
,	O
and	O
the	O
beta	B
-	I
carotene	I
index	O
adequate	O
convergent	O
but	O
no	O
discriminant	O
validity	O
.	O

relationships	O
between	O
dietary	O
intakes	O
and	O
fasting	O
plasma	O
concentrations	O
of	O
fat	O
-	O
soluble	O
vitamins	O
in	O
humans	O
..	O
dietary	O
intakes	O
of	O
retinol	B
equivalents	O
,	O
alpha	B
-	I
tocopherol	I
equivalents	O
,	O
vitamin	B
d	I
and	O
phylloquinone	B
were	O
estimated	O
from	O
three	O
sets	O
of	O
4	O
-	O
d	O
weighed	O
diet	O
records	O
and	O
compared	O
to	O
three	O
corresponding	O
fasting	O
plasma	O
concentrations	O
of	O
retinol	B
,	O
25	O
-	O
hydroxyvitamin	O
d	O
,	O
alpha	B
-	I
tocopherol	I
,	O
and	O
phylloquinone	B
measured	O
in	O
34	O
healthy	O
adults	O
over	O
20	O
wk	O
.	O

phylloquinone	B
was	O
the	O
only	O
fat	O
-	O
soluble	O
vitamin	O
with	O
a	O
significant	O
correlation	O
between	O
dietary	O
intake	O
and	O
fasting	O
plasma	O
concentration	O
(	O
r	O
=	O
0.51	O
,	O
p	O
=	O
0.004	O
)	O
.	O

this	O
correlation	O
improved	O
with	O
an	O
increase	O
in	O
both	O
the	O
number	O
of	O
independent	O
diet	O
records	O
and	O
independent	O
plasma	O
measures	O
.	O
of	O
the	O
dietary	O
intake	O
measures	O
,	O
all	O
the	O
fat	O
-	O
soluble	O
vitamins	O
had	O
greater	O
within	O
than	O
between	O
subject	O
variance	O
,	O
with	O
the	O
highest	O
measured	O
for	O
phylloquinone	B
(	O
6.86:1	O
)	O
.	O

of	O
the	O
plasma	O
measures	O
,	O
only	O
phylloquinone	B
had	O
a	O
within	O
-	O
to	O
-	O
between	O
subject	O
variance	O
ratio	O
greater	O
than	O
one	O
(	O
5.36:1	O
)	O
.	O

relative	O
validity	O
of	O
the	O
dh	O
and	O
the	O
24	O
-	O
hour	O
diet	O
recalls	O
was	O
assessed	O
by	O
comparing	O
nutrient	O
intake	O
derived	O
from	O
both	O
methods	O
with	O
the	O
urinary	O
excretion	O
of	O
nitrogen	B
(	O
n	O
)	O
and	O
plasma	O
levels	O
of	O
carotenes	O
,	O
vitamin	O
e	O
and	O
vitamin	O
c.	O
methods	O
:	O
the	O
urinary	O
excretion	O
of	O
n	O
was	O
estimated	O
from	O
four	O
24	O
-	O
hour	O
urine	O
collections	O
of	O
64	O
subjects	O
(	O
30	O
males	O
and	O
34	O
females	O
)	O
,	O
and	O
plasma	O
levels	O
of	O
carotenes	O
and	O
vitamins	O
c	O
and	O
e	O
from	O
one	O
fasting	O
blood	O
collection	O
in	O
72	O
subjects	O
(	O
32	O
men	O
and	O
40	O
women	O
)	O
.	O

the	O
crude	O
pearson	O
correlation	O
coefficient	O
between	O
plasma	O
level	O
of	O
vitamin	B
c	I
and	O
dietary	O
intake	O
according	O
to	O
the	O
dh	O
was	O
0.46	O
and	O
according	O
to	O
the	O
24	O
-	O
hour	O
diet	O
recall	O
was	O
0.49	O
.	O

for	O
beta	B
-	I
carotene	I
it	O
was	O
0.33	O
and	O
0.42	O
and	O
for	O
total	O
carotenoids	B
it	O
was	O
0.27	O
and	O
0.28	O
.	O

for	O
vitamin	O
e	O
,	O
after	O
adjusting	O
for	O
cholesterol	B
levels	O
and	O
energy	O
intake	O
,	O
it	O
was	O
0.33	O
and	O
0.36	O
.	O

to	O
assess	O
the	O
relative	O
validity	O
,	O
12	O
monthly	O
24	O
-	O
hour	O
recalls	O
served	O
as	O
reference	O
method	O
,	O
together	O
with	O
four	O
determinations	O
of	O
24	O
-	O
hour	O
urinary	O
nitrogen	B
excretion	O
,	O
predicted	O
basal	O
metabolic	O
rate	O
,	O
and	O
serum	O
beta	B
-	I
carotene	I
and	O
alpha	B
-	I
tocopherol	I
levels	O
.	O

results	O
:	O
protein	O
and	O
among	O
women	O
,	O
energy	B
intake	O
were	O
underestimated	O
by	O
the	O
questionnaire	O
compared	O
to	O
urinary	O
nitrogen	B
excretion	O
and	O
the	O
basal	O
metabolic	O
rate	O
,	O
respectively	O
.	O

correlation	O
coefficients	O
between	O
0.2	O
and	O
0.5	O
were	O
observed	O
for	O
beta	B
-	I
carotene	I
and	O
vitamin	B
c	I
for	O
men	O
and	O
for	O
beta	B
-	I
carotene	I
and	O
vitamin	B
e	I
for	O
women	O
.	O

associations	O
with	O
serum	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
-0.16	O
for	O
men	O
;	O
0.13	O
for	O
women	O
)	O
and	O
alpha	B
-	I
tocopherol	I
(	O
0.23	O
and	O
0.15	O
,	O
respectively	O
)	O
were	O
much	O
poorer	O
than	O
those	O
obtained	O
with	O
24	O
-	O
hour	O
recalls	O
.	O

correlations	O
between	O
protein	O
intake	O
and	O
24	O
-	O
hour	O
urinary	O
nitrogen	B
excretion	O
were	O
0.47	O
and	O
0.53	O
,	O
respectively	O
.	O

conclusions	O
:	O
the	O
ffq	O
seems	O
adequate	O
for	O
ranking	O
subjects	O
according	O
to	O
intake	O
of	O
energy	B
,	O
macronutrients	O
,	O
dietary	O
fibre	O
and	O
retinol	O
,	O
but	O
it	O
does	O
not	O
yield	O
such	O
good	O
results	O
for	O
beta	B
-	I
carotene	I
,	O
vitamin	B
c	I
for	O
men	O
,	O
vitamin	B
e	I
for	O
women	O
.	O

correlation	O
coefficients	O
between	O
the	O
energy	O
-	O
adjusted	O
nutrients	O
measured	O
by	O
repeated	O
24	O
-	O
hour	O
recalls	O
and	O
the	O
semi	O
-	O
quantitative	O
ffq	O
ranged	O
from	O
0.25	O
for	O
beta	B
-	I
carotene	I
and	O
polyunsaturated	O
fats	O
to	O
>	O
0.50	O
for	O
saturated	O
fats	O
,	O
cis	O
-	O
linoleic	O
acid	O
,	O
calcium	O
and	O
phosphorus	O
(	O
average	O
:	O
0.46	O
for	O
men	O
and	O
0.39	O
for	O
women	O
)	O
.	O

dietary	O
intakes	O
from	O
the	O
ffq	O
were	O
significantly	O
correlated	O
to	O
plasma	O
levels	O
of	O
vitamin	O
c	O
,	O
but	O
not	O
beta	B
-	I
carotene	I
or	O
cholesterol	O
.	O

dietary	O
protein	O
intake	O
assessed	O
by	O
both	O
ffq	O
was	O
correlated	O
(	O
0.36	O
,	O
0.30	O
)	O
with	O
average	O
urinary	O
nitrogen	B
excretion	O
levels	O
from	O
three	O
24	O
-	O
hour	O
urine	O
samples	O
.	O

a	O
single	O
laboratory	O
analyzed	O
plasma	O
samples	O
for	O
beta	B
-	I
carotene	I
,	O
alpha	O
-	O
carotene	O
,	O
lutein	O
,	O
and	O
lycopene	O
.	O

data	O
base	O
were	O
significantly	O
higher	O
for	O
beta	B
-	I
carotene	I
and	O
lycopene	O
;	O
however	O
,	O
correlations	O
between	O
intakes	O
and	O
plasma	O
values	O
were	O
significantly	O
different	O
only	O
for	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.44	O
for	O
mangels	O
versus	O
0.32	O
for	O
block	O
,	O
p	O
=	O
0.015	O
)	O
.	O

three	O
24	O
h	O
urine	O
samples	O
were	O
collected	O
on	O
3	O
different	O
days	O
over	O
the	O
week	O
of	O
food	O
recording	O
for	O
the	O
analysis	O
of	O
urea	O
-	O
n	O
,	O
p	O
and	O
k.	O
on	O
the	O
4th	O
day	O
of	O
food	O
recording	O
,	O
blood	O
was	O
collected	O
for	O
determination	O
of	O
alpha	O
-	O
tocopherol	O
,	O
beta	B
-	I
carotene	I
and	O
ascorbic	O
acid	O
.	O

blood	O
ascorbic	O
acid	O
and	O
beta	B
-	I
carotene	I
concentrations	O
correlated	O
with	O
dietary	O
intake	O
when	O
determined	O
from	O
7dr	O
(	O
both	O
r	O
0.44	O
)	O
,	O
but	O
not	O
when	O
determined	O
from	O
ffq	O
.	O

erythrocyte	O
levels	O
compared	O
with	O
reported	O
dietary	O
intake	O
of	O
marine	O
n-3	O
fatty	B
acids	I
in	O
pregnant	O
women	O
..	O

it	O
is	O
well	O
established	O
that	O
marine	O
n-3	O
fatty	B
acids	I
measured	O
in	O
erythrocyte	O
phospholipids	O
of	O
non	O
-	O
pregnant	O
subjects	O
reflect	O
the	O
subjects	O
'	O
intake	O
of	O
these	O
fatty	B
acids	I
.	O

in	O
135	O
pregnant	O
women	O
in	O
the	O
30th	O
week	O
of	O
gestation	O
we	O
compared	O
intake	O
of	O
marine	O
n-3	O
fatty	B
acids	I
and	O
energy	O
,	O
estimated	O
by	O
a	O
combined	O
dietary	O
self	O
-	O
administered	O
questionnaire	O
and	O
interview	O
,	O
with	O
fatty	B
acids	I
measured	O
in	O
erythrocyte	O
phospholipids	O
.	O

daily	O
intake	O
(	O
g	O
/	O
d	O
)	O
and	O
nutrient	O
density	O
of	O
marine	O
n-3	O
fatty	B
acids	I
(	O
mg	O
/	O
mj	O
)	O
correlated	O
with	O
the	O
n-3	O
fatty	O
acid	O
:	O
arachidonic	O
acid	O
ratio	O
(	O
fa	O
-	O
ratio	O
)	O
with	O
correlation	O
coefficients	O
of	O
0.48	O
and	O
0.54	O
respectively	O
.	O

conclusions	O
from	O
the	O
study	O
were	O
(	O
1	O
)	O
levels	O
of	O
erythrocyte	O
fatty	B
acids	I
in	O
pregnant	O
women	O
may	O
be	O
employed	O
as	O
a	O
qualitative	O
method	O
to	O
rank	O
subjects	O
according	O
to	O
intake	O
of	O
marine	O
n-3	O
fatty	B
acids	I
;	O
(	O
2	O
)	O
with	O
respect	O
to	O
the	O
power	O
to	O
explain	O
fa	O
-	O
ratio	O
variability	O
,	O
three	O
simple	O
marine	O
food	O
frequency	O
questions	O
were	O
comparable	O
with	O
intake	O
of	O
marine	O
n-3	O
fatty	B
acids	I
assessed	O
by	O
an	O
elaborate	O
semiquantitative	O
dietary	O
method	O
involving	O
an	O
interview	O
.	O

omega-3	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
of	O
obese	O
patients	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
reflect	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
and	O
docosahexaenoic	O
acid	O
..	O

we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
..	O
we	O
examined	O
the	O
relationship	O
between	O
long	O
-	O
term	O
dietary	O
intake	O
of	O
eicosapentaenoic	O
acid	O
(	O
epa	O
)	O
and	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
and	O
the	O
relative	O
content	O
of	O
these	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
triglycerides	O
from	O
53	O
obese	O
dutch	O
subjects--19	O
men	O
and	O
34	O
women	O
--	O
with	O
non	O
-	O
insulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
niddm	O
)	O
.	O

correlation	O
coefficients	O
(	O
spearman	O
)	O
between	O
the	O
dietary	O
intake	O
of	O
epa	O
(	O
%	O
of	O
total	O
fat	O
)	O
and	O
epa	O
in	O
adipose	O
tissue	O
(	O
%	O
of	O
total	O
fatty	B
acids	I
)	O
were	O
0.76	O
for	O
men	O
and	O
0.57	O
for	O
women	O
.	O

we	O
conclude	O
that	O
the	O
analysis	O
of	O
fatty	B
acids	I
in	O
one	O
adipose	O
tissue	O
biopsy	O
provides	O
information	O
on	O
long	O
-	O
term	O
epa	O
and	O
dha	O
intakes	O
in	O
obese	O
subjects	O
with	O
niddm	O
,	O
and	O
can	O
replace	O
otherwise	O
necessarily	O
frequent	O
diet	O
analyses	O
over	O
a	O
long	O
period	O
.	O

plasma	O
carotenoids	B
as	O
biomarkers	O
of	O
vegetable	O
and	O
fruit	O
intake	O
..	O
higher	O
intakes	O
of	O
vegetables	O
and	O
fruits	O
are	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
certain	O
human	O
cancers	O
.	O

plasma	O
carotenoids	B
(	O
alpha	B
-	I
carotene	I
,	O
beta	B
-	I
carotene	I
,	O
lutein	O
,	O
beta	O
-	O
cryptoxanthin	O
,	O
and	O
lycopene	B
)	O
were	O
measured	O
in	O
50	O
male	O
and	O
49	O
female	O
participants	O
,	O
aged	O
18	O
-	O
37	O
years	O
,	O
with	O
a	O
wide	O
range	O
of	O
habitual	O
vegetable	O
and	O
fruit	O
intakes	O
.	O

the	O
sum	O
of	O
the	O
plasma	O
carotenoids	B
(	O
excluding	O
lycopene	B
)	O
was	O
highly	O
correlated	O
with	O
intake	O
of	O
total	O
vegetables	O
and	O
fruits	O
(	O
r	O
=	O
0.59	O
)	O
.	O

of	O
the	O
individual	O
plasma	O
carotenoids	B
,	O
plasma	O
alpha	B
-	I
carotene	I
had	O
the	O
highest	O
correlation	O
with	O
intakes	O
of	O
both	O
total	O
vegetables	O
(	O
r	O
=	O
0.50	O
)	O
and	O
total	O
fruits	O
(	O
r	O
=	O
0.58	O
)	O
.	O

intakes	O
of	O
foods	O
with	O
high	O
carotenoid	O
contents	O
were	O
correlated	O
with	O
their	O
corresponding	O
plasma	O
concentrations	O
as	O
follows	O
:	O
high	O
beta	B
-	I
carotene	I
foods	O
(	O
r	O
=	O
0.41	O
)	O
;	O
high	O
lutein	O
foods	O
(	O
r	O
=	O
0.46	O
)	O
;	O
and	O
high	O
lycopene	B
foods	O
(	O
r	O
=	O
0.11	O
)	O
.	O

multiple	O
regression	O
analyses	O
showed	O
that	O
intake	O
of	O
total	O
vegetables	O
and	O
fruits	O
was	O
the	O
most	O
significant	O
determinant	O
of	O
each	O
plasma	O
carotenoid	O
except	O
lycopene	B
.	O

the	O
utility	O
of	O
combining	O
the	O
plasma	O
carotenoids	B
as	O
biomarkers	O
of	O
vegetable	O
and	O
fruit	O
intake	O
was	O
assessed	O
by	O
a	O
stepwise	O
regression	O
of	O
total	O
vegetable	O
and	O
fruit	O
intake	O
on	O
plasma	O
carotenoids	B
.	O

significant	O
determinants	O
of	O
intake	O
of	O
total	O
vegetables	O
and	O
fruits	O
were	O
alpha	B
-	I
carotene	I
,	O
beta	O
-	O
cryptoxanthin	O
,	O
lutein	O
,	O
and	O
energy	B
intake	O
(	O
r2	O
=	O
0.53).(abstract	O
truncated	O
at	O
250	O
words	O
)	O

the	O
correlation	O
between	O
the	O
intake	O
of	O
lutein	O
,	O
lycopene	B
and	O
beta	B
-	I
carotene	I
from	O
vegetables	O
and	O
fruits	O
,	O
and	O
blood	O
plasma	O
concentrations	O
in	O
a	O
group	O
of	O
women	O
aged	O
50	O
-	O
65	O
years	O
in	O
the	O
uk	O
..	O
the	O
correlations	O
between	O
the	O
mean	O
of	O
4	O
d	O
weighed	O
intakes	O
of	O
lutein	O
,	O
lycopene	B
and	O
beta	B
-	I
carotene	I
and	O
mean	O
plasma	O
concentrations	O
during	O
each	O
of	O
the	O
four	O
seasons	O
were	O
lutein	O
r	O
0.64	O
,	O
lycopene	B
r	O
0.47	O
and	O
beta	B
-	I
carotene	I
r	O
0.45	O
.	O

there	O
was	O
a	O
significantly	O
higher	O
intake	O
of	O
lutein	O
during	O
the	O
spring	O
compared	O
with	O
summer	O
and	O
autumn	O
,	O
lycopene	B
intake	O
was	O
significantly	O
higher	O
during	O
the	O
summer	O
and	O
autumn	O
and	O
there	O
were	O
no	O
significant	O
seasonal	O
differences	O
in	O
beta	B
-	I
carotene	I
intake	O
.	O

bmi	O
was	O
inversely	O
correlated	O
with	O
plasma	O
beta	B
-	I
carotene	I
(	O
r-0.41	O
)	O
.	O

relationship	O
between	O
dietary	O
intake	O
and	O
plasma	O
concentrations	O
of	O
carotenoids	B
in	O
premenopausal	O
women	O
:	O
application	O
of	O
the	O
usda	O
-	O
nci	O
carotenoid	O
food	O
-	O
composition	O
database	O
..	O
the	O
diet	O
-	O
plasma	O
relationships	O
for	O
carotenoids	B
were	O
examined	O
in	O
a	O
group	O
of	O
98	O
nonsmoking	O
premenopausal	O
women	O
who	O
participated	O
in	O
the	O
cross	O
-	O
sectional	O
phase	O
of	O
the	O
national	O
cancer	O
institute	O
(	O
nci)-us	O
department	O
of	O
agriculture	O
(	O
usda	O
)	O
diet	O
study	O
on	O
alcohol	O
-	O
hormone	O
metabolism	O
,	O
1988	O
-	O
90	O
.	O

with	O
use	O
of	O
the	O
newly	O
developed	O
usda	O
-	O
nci	O
carotenoid	O
food	O
-	O
composition	O
database	O
,	O
the	O
mean	O
daily	O
intakes	O
of	O
carotenoids	B
were	O
significantly	O
higher	O
when	O
estimated	O
from	O
the	O
food	O
-	O
frequency	O
questionnaire	O
(	O
ffq	O
)	O
than	O
from	O
the	O
7	O
-	O
d	O
diet	O
records	O
.	O

lycopene	B
(	O
mean	O
=	O
0.58	O
mmol	O
/	O
l	O
)	O
,	O
lutein	O
plus	O
zeaxanthin	O
(	O
mean	O
=	O
0.46	O
mmol	O
/	O
l	O
)	O
,	O
and	O
beta	B
-	I
carotene	I
(	O
mean	O
=	O
0.34	O
mmol	O
/	O
l	O
)	O
were	O
the	O
major	O
plasma	O
carotenoids	B
.	O

after	O
adjustment	O
for	O
body	O
mass	O
index	O
,	O
energy	O
and	O
alcohol	O
intakes	O
,	O
and	O
total	O
plasma	O
cholesterol	O
concentration	O
,	O
the	O
following	O
significant	O
correlation	O
(	O
p	O
<	O
0.05	O
)	O
were	O
observed	O
between	O
the	O
diet	O
record	O
and	O
the	O
ffq	O
-	O
estimated	O
carotenoid	O
intakes	O
and	O
their	O
respective	O
plasma	O
concentrations	O
:	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.58	O
vs	O
0.49	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.51	O
vs	O
0.49	O
)	O
,	O
beta	B
-	I
cryptoxanthin	I
(	O
r	O
=	O
0.49	O
vs	O
0.36	O
)	O
,	O
lutein	O
plus	O
zeaxanthin	O
(	O
r	O
=	O
0.31	O
vs	O
0.37	O
)	O
,	O
lycopene	B
(	O
r	O
=	O
0.50	O
vs	O
0.26	O
)	O
,	O
and	O
total	O
carotenoids	B
(	O
r	O
=	O
0.57	O
vs	O
0.49	O
)	O
.	O

contributions	O
of	O
vitamin	B
d	I
intake	O
and	O
seasonal	O
sunlight	O
exposure	O
to	O
plasma	O
25	O
-	O
hydroxyvitamin	O
d	O
concentration	O
in	O
elderly	O
women	O
..	O
we	O
investigated	O
the	O
contributions	O
(	O
1.00	O
-	O
8.03	O
micrograms	O
/	O
d	O
,	O
or	O
40	O
-	O
321	O
iu	O
/	O
d	O
)	O
of	O
vitamin	B
d	I
intake	O
and	O
seasonal	O
sunlight	O
exposure	O
to	O
plasma	O
25(oh)d	O
in	O
59	O
healthy	O
women	O
aged	O
70	O
-	O
97	O
y	O
with	O
a	O
mean	O
total	O
vitamin	B
d	I
intake	O
of	O
8.58	O
micrograms	O
/	O
d	O
(	O
343	O
iu	O
/	O
d	O
)	O
.	O

in	O
the	O
summer	O
and	O
winter	O
,	O
each	O
subject	O
had	O
a	O
fasting	O
blood	O
measurement	O
and	O
assessments	O
of	O
vitamin	B
d	I
intake	O
and	O
sunlight	O
exposure	O
.	O

vitamin	B
d	I
intake	O
was	O
significantly	O
correlated	O
with	O
plasma	O
25(oh)d	O
in	O
the	O
summer	O
(	O
r	O
=	O
0.52	O
,	O
p	O
<	O
0.01	O
)	O
and	O
winter	O
(	O
r	O
=	O
0.63	O
,	O
p	O
<	O
0.01	O
)	O
.	O

the	O
influence	O
of	O
sunlight	O
exposure	O
measured	O
in	O
the	O
summer	O
on	O
the	O
25(oh)d	O
concentration	O
was	O
dependent	O
on	O
the	O
vitamin	B
d	I
intake	O
.	O

in	O
subjects	O
with	O
lower	O
vitamin	B
d	I
intakes	O
(	O
1.00	O
-	O
8.03	O
micrograms	O
/	O
d	O
,	O
or	O
40	O
-	O
321	O
iu	O
/	O
d	O
)	O
,	O
the	O
wintertime	O
25(oh)d	O
concentrations	O
of	O
those	O
with	O
low	O
and	O
high	O
sunlight	O
exposure	O
were	O
comparable	O
.	O

in	O
subjects	O
with	O
higher	O
vitamin	B
d	I
intakes	O
(	O
11.15	O
-	O
28.68	O
micrograms	O
/	O
d	O
,	O
or	O
446	O
-	O
1147	O
iu	O
/	O
d	O
)	O
,	O
however	O
,	O
the	O
wintertime	O
25(oh)d	O
concentrations	O
of	O
those	O
with	O
high	O
sunlight	O
exposure	O
were	O
lower	O
than	O
those	O
with	O
lower	O
exposure	O
[	O
63.8	O
+	O
/-	O
3.9	O
and	O
80.6	O
+	O
/-	O
6.7	O
nmol	O
/	O
l	O
,	O
respectively	O
,	O
p	O
=	O
0.066	O
;	O
p	O
(	O
intake	O
by	O
exposure	O
interaction	O
)	O
<	O
0.05	O
]	O
.	O

this	O
suggests	O
that	O
the	O
contribution	O
of	O
vitamin	B
d	I
intake	O
to	O
plasma	O
25(oh)d	O
concentration	O
may	O
be	O
influenced	O
by	O
sunlight	O
exposure	O
..	O
we	O
investigated	O
the	O
contributions	O
(	O
1.00	O
-	O
8.03	O
micrograms	O
/	O
d	O
,	O
or	O
40	O
-	O
321	O
iu	O
/	O
d	O
)	O
of	O
vitamin	B
d	I
intake	O
and	O
seasonal	O
sunlight	O
exposure	O
to	O
plasma	O
25(oh)d	O
in	O
59	O
healthy	O
women	O
aged	O
70	O
-	O
97	O
y	O
with	O
a	O
mean	O
total	O
vitamin	B
d	I
intake	O
of	O
8.58	O
micrograms	O
/	O
d	O
(	O
343	O
iu	O
/	O
d	O
)	O
.	O

in	O
the	O
summer	O
and	O
winter	O
,	O
each	O
subject	O
had	O
a	O
fasting	O
blood	O
measurement	O
and	O
assessments	O
of	O
vitamin	B
d	I
intake	O
and	O
sunlight	O
exposure	O
.	O

vitamin	B
d	I
intake	O
was	O
significantly	O
correlated	O
with	O
plasma	O
25(oh)d	O
in	O
the	O
summer	O
(	O
r	O
=	O
0.52	O
,	O
p	O
<	O
0.01	O
)	O
and	O
winter	O
(	O
r	O
=	O
0.63	O
,	O
p	O
<	O
0.01	O
)	O
.	O

the	O
influence	O
of	O
sunlight	O
exposure	O
measured	O
in	O
the	O
summer	O
on	O
the	O
25(oh)d	O
concentration	O
was	O
dependent	O
on	O
the	O
vitamin	B
d	I
intake	O
.	O

in	O
subjects	O
with	O
lower	O
vitamin	B
d	I
intakes	O
(	O
1.00	O
-	O
8.03	O
micrograms	O
/	O
d	O
,	O
or	O
40	O
-	O
321	O
iu	O
/	O
d	O
)	O
,	O
the	O
wintertime	O
25(oh)d	O
concentrations	O
of	O
those	O
with	O
low	O
and	O
high	O
sunlight	O
exposure	O
were	O
comparable	O
.	O

in	O
subjects	O
with	O
higher	O
vitamin	B
d	I
intakes	O
(	O
11.15	O
-	O
28.68	O
micrograms	O
/	O
d	O
,	O
or	O
446	O
-	O
1147	O
iu	O
/	O
d	O
)	O
,	O
however	O
,	O
the	O
wintertime	O
25(oh)d	O
concentrations	O
of	O
those	O
with	O
high	O
sunlight	O
exposure	O
were	O
lower	O
than	O
those	O
with	O
lower	O
exposure	O
[	O
63.8	O
+	O
/-	O
3.9	O
and	O
80.6	O
+	O
/-	O
6.7	O
nmol	O
/	O
l	O
,	O
respectively	O
,	O
p	O
=	O
0.066	O
;	O
p	O
(	O
intake	O
by	O
exposure	O
interaction	O
)	O
<	O
0.05	O
]	O
.	O

this	O
suggests	O
that	O
the	O
contribution	O
of	O
vitamin	B
d	I
intake	O
to	O
plasma	O
25(oh)d	O
concentration	O
may	O
be	O
influenced	O
by	O
sunlight	O
exposure	O
.	O

after	O
adjustment	O
for	O
energy	O
intake	O
,	O
percentage	O
of	O
energy	O
from	O
alcohol	O
,	O
and	O
plasma	O
lipid	O
concentrations	O
,	O
significant	O
diet	O
-	O
plasma	O
correlations	O
for	O
the	O
ffq	O
and	O
the	O
food	O
diaries	O
(	O
fd	O
)	O
included	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.29	O
and	O
0.43	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.36	O
ffq	O
only	O
)	O
,	O
beta	B
-	I
cryptoxanthin	I
(	O
r	O
=	O
0.46	O
and	O
0.44	O
)	O
,	O
lutein	O
(	O
r	O
=	O
0.44	O
fd	O
only	O
)	O
,	O
and	O
lycopene	B
(	O
r	O
=	O
0.53	O
fd	O
only	O
)	O
.	O

dietary	O
carotenoid	O
intakes	O
were	O
associated	O
with	O
plasma	O
carotenoid	O
concentrations	O
for	O
all	O
the	O
carotenoids	B
except	O
for	O
beta	B
-	I
carotene	I
when	O
food	O
diaries	O
were	O
used	O
whereas	O
the	O
diet	O
-	O
plasma	O
correlation	O
for	O
the	O
provitamin	O
a	O
carotenoids	B
were	O
consistently	O
significant	O
when	O
the	O
ffq	O
was	O
used	O
..	O
a	O
newly	O
available	O
carotenoid	O
food	O
-	O
composition	O
database	O
providing	O
specific	O
carotenoid	O
values	O
for	O
>	O
2300	O
foods	O
was	O
linked	O
to	O
dietary	O
data	O
on	O
57	O
male	O
nonsmokers	O
to	O
examine	O
the	O
association	O
between	O
dietary	O
carotenoid	O
intake	O
and	O
plasma	O
carotenoid	O
concentrations	O
over	O
3	O
wk	O
when	O
free	O
-	O
living	O
.	O

after	O
adjustment	O
for	O
energy	O
intake	O
,	O
percentage	O
of	O
energy	O
from	O
alcohol	O
,	O
and	O
plasma	O
lipid	O
concentrations	O
,	O
significant	O
diet	O
-	O
plasma	O
correlations	O
for	O
the	O
ffq	O
and	O
the	O
food	O
diaries	O
(	O
fd	O
)	O
included	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.29	O
and	O
0.43	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.36	O
ffq	O
only	O
)	O
,	O
beta	B
-	I
cryptoxanthin	I
(	O
r	O
=	O
0.46	O
and	O
0.44	O
)	O
,	O
lutein	O
(	O
r	O
=	O
0.44	O
fd	O
only	O
)	O
,	O
and	O
lycopene	B
(	O
r	O
=	O
0.53	O
fd	O
only	O
)	O
.	O

dietary	O
carotenoid	O
intakes	O
were	O
associated	O
with	O
plasma	O
carotenoid	O
concentrations	O
for	O
all	O
the	O
carotenoids	B
except	O
for	O
beta	B
-	I
carotene	I
when	O
food	O
diaries	O
were	O
used	O
whereas	O
the	O
diet	O
-	O
plasma	O
correlation	O
for	O
the	O
provitamin	O
a	O
carotenoids	B
were	O
consistently	O
significant	O
when	O
the	O
ffq	O
was	O
used	O
..	O
a	O
newly	O
available	O
carotenoid	O
food	O
-	O
composition	O
database	O
providing	O
specific	O
carotenoid	O
values	O
for	O
>	O
2300	O
foods	O
was	O
linked	O
to	O
dietary	O
data	O
on	O
57	O
male	O
nonsmokers	O
to	O
examine	O
the	O
association	O
between	O
dietary	O
carotenoid	O
intake	O
and	O
plasma	O
carotenoid	O
concentrations	O
over	O
3	O
wk	O
when	O
free	O
-	O
living	O
.	O

after	O
adjustment	O
for	O
energy	O
intake	O
,	O
percentage	O
of	O
energy	O
from	O
alcohol	O
,	O
and	O
plasma	O
lipid	O
concentrations	O
,	O
significant	O
diet	O
-	O
plasma	O
correlations	O
for	O
the	O
ffq	O
and	O
the	O
food	O
diaries	O
(	O
fd	O
)	O
included	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.29	O
and	O
0.43	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.36	O
ffq	O
only	O
)	O
,	O
beta	B
-	I
cryptoxanthin	I
(	O
r	O
=	O
0.46	O
and	O
0.44	O
)	O
,	O
lutein	O
(	O
r	O
=	O
0.44	O
fd	O
only	O
)	O
,	O
and	O
lycopene	B
(	O
r	O
=	O
0.53	O
fd	O
only	O
)	O
.	O

dietary	O
carotenoid	O
intakes	O
were	O
associated	O
with	O
plasma	O
carotenoid	O
concentrations	O
for	O
all	O
the	O
carotenoids	B
except	O
for	O
beta	B
-	I
carotene	I
when	O
food	O
diaries	O
were	O
used	O
whereas	O
the	O
diet	O
-	O
plasma	O
correlation	O
for	O
the	O
provitamin	O
a	O
carotenoids	B
were	O
consistently	O
significant	O
when	O
the	O
ffq	O
was	O
used	O
..	O
a	O
newly	O
available	O
carotenoid	O
food	O
-	O
composition	O
database	O
providing	O
specific	O
carotenoid	O
values	O
for	O
>	O
2300	O
foods	O
was	O
linked	O
to	O
dietary	O
data	O
on	O
57	O
male	O
nonsmokers	O
to	O
examine	O
the	O
association	O
between	O
dietary	O
carotenoid	O
intake	O
and	O
plasma	O
carotenoid	O
concentrations	O
over	O
3	O
wk	O
when	O
free	O
-	O
living	O
.	O

after	O
adjustment	O
for	O
energy	O
intake	O
,	O
percentage	O
of	O
energy	O
from	O
alcohol	O
,	O
and	O
plasma	O
lipid	O
concentrations	O
,	O
significant	O
diet	O
-	O
plasma	O
correlations	O
for	O
the	O
ffq	O
and	O
the	O
food	O
diaries	O
(	O
fd	O
)	O
included	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.29	O
and	O
0.43	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.36	O
ffq	O
only	O
)	O
,	O
beta	B
-	I
cryptoxanthin	I
(	O
r	O
=	O
0.46	O
and	O
0.44	O
)	O
,	O
lutein	O
(	O
r	O
=	O
0.44	O
fd	O
only	O
)	O
,	O
and	O
lycopene	B
(	O
r	O
=	O
0.53	O
fd	O
only	O
)	O
.	O

dietary	O
carotenoid	O
intakes	O
were	O
associated	O
with	O
plasma	O
carotenoid	O
concentrations	O
for	O
all	O
the	O
carotenoids	B
except	O
for	O
beta	B
-	I
carotene	I
when	O
food	O
diaries	O
were	O
used	O
whereas	O
the	O
diet	O
-	O
plasma	O
correlation	O
for	O
the	O
provitamin	O
a	O
carotenoids	B
were	O
consistently	O
significant	O
when	O
the	O
ffq	O
was	O
used	O
..	O
a	O
newly	O
available	O
carotenoid	O
food	O
-	O
composition	O
database	O
providing	O
specific	O
carotenoid	O
values	O
for	O
>	O
2300	O
foods	O
was	O
linked	O
to	O
dietary	O
data	O
on	O
57	O
male	O
nonsmokers	O
to	O
examine	O
the	O
association	O
between	O
dietary	O
carotenoid	O
intake	O
and	O
plasma	O
carotenoid	O
concentrations	O
over	O
3	O
wk	O
when	O
free	O
-	O
living	O
.	O

after	O
adjustment	O
for	O
energy	O
intake	O
,	O
percentage	O
of	O
energy	O
from	O
alcohol	O
,	O
and	O
plasma	O
lipid	O
concentrations	O
,	O
significant	O
diet	O
-	O
plasma	O
correlations	O
for	O
the	O
ffq	O
and	O
the	O
food	O
diaries	O
(	O
fd	O
)	O
included	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.29	O
and	O
0.43	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.36	O
ffq	O
only	O
)	O
,	O
beta	B
-	I
cryptoxanthin	I
(	O
r	O
=	O
0.46	O
and	O
0.44	O
)	O
,	O
lutein	O
(	O
r	O
=	O
0.44	O
fd	O
only	O
)	O
,	O
and	O
lycopene	B
(	O
r	O
=	O
0.53	O
fd	O
only	O
)	O
.	O

dietary	O
carotenoid	O
intakes	O
were	O
associated	O
with	O
plasma	O
carotenoid	O
concentrations	O
for	O
all	O
the	O
carotenoids	B
except	O
for	O
beta	B
-	I
carotene	I
when	O
food	O
diaries	O
were	O
used	O
whereas	O
the	O
diet	O
-	O
plasma	O
correlation	O
for	O
the	O
provitamin	O
a	O
carotenoids	B
were	O
consistently	O
significant	O
when	O
the	O
ffq	O
was	O
used	O
..	O
a	O
newly	O
available	O
carotenoid	O
food	O
-	O
composition	O
database	O
providing	O
specific	O
carotenoid	O
values	O
for	O
>	O
2300	O
foods	O
was	O
linked	O
to	O
dietary	O
data	O
on	O
57	O
male	O
nonsmokers	O
to	O
examine	O
the	O
association	O
between	O
dietary	O
carotenoid	O
intake	O
and	O
plasma	O
carotenoid	O
concentrations	O
over	O
3	O
wk	O
when	O
free	O
-	O
living	O
.	O

after	O
adjustment	O
for	O
energy	O
intake	O
,	O
percentage	O
of	O
energy	O
from	O
alcohol	O
,	O
and	O
plasma	O
lipid	O
concentrations	O
,	O
significant	O
diet	O
-	O
plasma	O
correlations	O
for	O
the	O
ffq	O
and	O
the	O
food	O
diaries	O
(	O
fd	O
)	O
included	O
alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.29	O
and	O
0.43	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.36	O
ffq	O
only	O
)	O
,	O
beta	B
-	I
cryptoxanthin	I
(	O
r	O
=	O
0.46	O
and	O
0.44	O
)	O
,	O
lutein	O
(	O
r	O
=	O
0.44	O
fd	O
only	O
)	O
,	O
and	O
lycopene	B
(	O
r	O
=	O
0.53	O
fd	O
only	O
)	O
.	O

dietary	O
carotenoid	O
intakes	O
were	O
associated	O
with	O
plasma	O
carotenoid	O
concentrations	O
for	O
all	O
the	O
carotenoids	B
except	O
for	O
beta	B
-	I
carotene	I
when	O
food	O
diaries	O
were	O
used	O
whereas	O
the	O
diet	O
-	O
plasma	O
correlation	O
for	O
the	O
provitamin	O
a	O
carotenoids	B
were	O
consistently	O
significant	O
when	O
the	O
ffq	O
was	O
used	O
.	O

the	O
accuracy	O
of	O
parental	O
reports	O
of	O
their	O
children	O
's	O
intake	O
of	O
fruits	O
and	O
vegetables	O
:	O
validation	O
of	O
a	O
food	O
frequency	O
questionnaire	O
with	O
serum	O
levels	O
of	O
carotenoids	B
and	O
vitamins	O
c	O
,	O
a	O
,	O
and	O
e	O
..	O
it	O
has	O
been	O
recommended	O
that	O
u.s	O
.	O

we	O
then	O
compared	O
these	O
reports	O
by	O
parents	O
of	O
their	O
children	O
's	O
intakes	O
of	O
fruits	O
and	O
vegetables	O
,	O
and	O
the	O
derived	O
estimates	O
of	O
intake	O
of	O
carotenoids	B
and	O
vitamins	O
c	O
,	O
a	O
,	O
and	O
e	O
,	O
with	O
the	O
children	O
's	O
serum	O
levels	O
of	O
carotenoids	B
and	O
vitamins	O
c	O
,	O
a	O
,	O
and	O
e.	O
the	O
dietary	O
reports	O
of	O
intakes	O
of	O
35	O
fruits	O
and	O
vegetables	O
showed	O
spearman	O
rank	O
-	O
order	O
correlations	O
of	O
0.30	O
with	O
serum	O
carotenoids	B
and	O
0.34	O
with	O
serum	O
vitamin	O
c.	O
children	O
in	O
the	O
highest	O
quartile	O
for	O
intake	O
of	O
fruits	O
and	O
vegetables	O
according	O
to	O
their	O
parents	O
'	O
food	O
frequency	O
reports	O
had	O
35	O
%	O
higher	O
carotene	O
levels	O
and	O
31	O
%	O
higher	O
vitamin	B
c	I
levels	O
in	O
their	O
serum	O
than	O
did	O
children	O
in	O
the	O
lowest	O
quartile	O
for	O
intake	O
of	O
fruits	O
and	O
vegetables	O
.	O

adipose	O
tissue	O
fatty	B
acids	I
as	O
biomarkers	O
of	O
dietary	O
exposure	O
in	O
danish	O
men	O
and	O
women	O
..	O
adipose	O
tissue	O
fatty	B
acids	I
,	O
it	O
has	O
been	O
proposed	O
,	O
reflect	O
dietary	O
intake	O
.	O
using	O
data	O
from	O
a	O
validation	O
study	O
preceding	O
a	O
prospective	O
study	O
on	O
diet	O
,	O
cancer	O
,	O
and	O
health	O
in	O
denmark	O
,	O
we	O
were	O
able	O
to	O
compare	O
fatty	O
acid	O
profiles	O
in	O
adipose	O
tissue	O
biopsies	O
from	O
86	O
individuals	O
(	O
23	O
men	O
and	O
63	O
women	O
)	O
aged	O
40	O
-	O
64	O
y	O
and	O
dietary	O
intake	O
of	O
fatty	B
acids	I
(	O
as	O
percentage	O
of	O
total	O
fat	O
)	O
assessed	O
by	O
two	O
7	O
-	O
d	O
weighed	O
-	O
diet	O
records	O
or	O
by	O
a	O
semi	O
-	O
quantitative	O
food	O
frequency	O
questionnaire	O
.	O

correlation	O
coefficients	O
(	O
pearson	O
r	O
)	O
between	O
fatty	O
acid	O
concentrations	O
in	O
adipose	O
tissue	O
biopsies	O
(	O
as	O
percentage	O
of	O
total	O
peak	O
area	O
)	O
and	O
dietary	O
intake	O
of	O
fatty	O
acid	O
(	O
percentage	O
of	O
total	O
fat	O
)	O
,	O
determined	O
from	O
the	O
diet	O
records	O
for	O
men	O
and	O
women	O
,	O
respectively	O
,	O
were	O
as	O
follows	O
:	O
polyunsaturated	O
fatty	B
acids	I
r	O
=	O
0.74	O
and	O
r	O
=	O
0.46	O
;	O
n	O
-	O
3	O
fatty	B
acids	I
of	O
marine	O
origin	O
:	O
eicosapentaenoic	O
acid	O
r	O
=	O
0.15	O
and	O
r	O
=	O
0.61	O
,	O
and	O
docosahexaenoic	O
acid	O
r	O
=	O
0.47	O
and	O
r	O
=	O
0.57	O
.	O

correlation	O
coefficients	O
obtained	O
by	O
using	O
the	O
food	O
frequency	O
questionnaire	O
were	O
slightly	O
lower	O
for	O
most	O
fatty	B
acids	I
.	O

toenail	O
selenium	B
as	O
an	O
indicator	O
of	O
selenium	B
intake	O
among	O
middle	O
-	O
aged	O
men	O
in	O
an	O
area	O
with	O
low	O
soil	O
selenium	B
..	O
toenail	O
selenium	B
concentration	O
has	O
been	O
proposed	O
as	O
a	O
long	O
-	O
term	O
(	O
6	O
-	O
12	O
mo	O
)	O
indicator	O
of	O
human	O
selenium	B
status	O
.	O

this	O
study	O
investigated	O
the	O
association	O
between	O
toenail	O
selenium	B
concentration	O
and	O
selenium	B
intake	O
and	O
other	O
dietary	O
factors	O
among	O
166	O
urban	O
men	O
aged	O
55	O
-	O
69	O
y.	O
the	O
dietary	O
information	O
was	O
collected	O
by	O
food	O
records	O
covering	O
a	O
6	O
-	O
mo	O
period	O
.	O

the	O
mean	O
selenium	B
intake	O
from	O
food	O
was	O
42.5	O
micrograms	O
/	O
d	O
and	O
the	O
dietary	O
intake	O
was	O
equal	O
to	O
that	O
of	O
users	O
and	O
nonusers	O
of	O
selenium	B
supplements	O
.	O

the	O
mean	O
toenail	O
selenium	B
concentration	O
was	O
0.47	O
mg	O
/	O
kg	O
.	O

the	O
mean	O
selenium	B
intake	O
from	O
supplements	O
was	O
29.7	O
micrograms	O
/	O
d	O
among	O
supplement	O
users	O
.	O

in	O
the	O
analysis	O
of	O
covariance	O
the	O
best	O
predictors	O
of	O
toenail	O
selenium	B
concentration	O
were	O
selenium	B
intake	O
from	O
supplements	O
and	O
food	O
,	O
and	O
among	O
supplement	O
users	O
dietary	O
beta	O
-	O
carotene	O
also	O
.	O

determinants	O
of	O
plasma	O
ascorbic	O
acid	O
in	O
a	O
healthy	O
male	O
population	O
..	O
the	O
antioxidant	O
properties	O
of	O
vitamin	B
c	I
may	O
be	O
involved	O
in	O
the	O
prevention	O
of	O
cancer	O
.	O

the	O
correlation	O
between	O
dietary	O
vitamin	B
c	I
intake	O
as	O
estimated	O
by	O
a	O
dietary	O
questionnaire	O
and	O
plasma	O
ascorbic	O
acid	O
(	O
aa	O
)	O
was	O
examined	O
in	O
68	O
nonsmoking	O
male	O
volunteers	O
aged	O
30	O
-	O
59	O
years	O
.	O

the	O
determinants	O
of	O
plasma	O
aa	O
were	O
examined	O
by	O
a	O
multiple	O
regression	O
model	O
containing	O
dietary	O
vitamin	B
c	I
,	O
calories	O
,	O
body	O
weight	O
,	O
and	O
amount	O
of	O
beverages	O
consumed	O
.	O

higher	O
vitamin	B
c	I
intake	O
(	O
p	O
<	O
0.0002	O
)	O
increased	O
plasma	O
aa	O
,	O
while	O
greater	O
body	O
weight	O
(	O
p	O
<	O
0.005	O
)	O
decreased	O
plasma	O
aa	O
.	O

a	O
significant	O
correlation	O
(	O
r	O
=	O
0.43	O
;	O
p	O
<	O
0.0003	O
)	O
between	O
vitamin	B
c	I
intake	O
and	O
plasma	O
aa	O
was	O
observed	O
.	O

vitamin	B
c	I
supplement	O
users	O
had	O
higher	O
plasma	O
aa	O
compared	O
to	O
nonusers	O
.	O

the	O
relationship	O
between	O
plasma	O
aa	O
and	O
vitamin	B
c	I
intake	O
appears	O
to	O
be	O
curvilinear	O
with	O
the	O
non	O
-	O
supplement	O
users	O
at	O
the	O
linear	O
part	O
of	O
the	O
curve	O
and	O
the	O
supplement	O
users	O
at	O
the	O
plateau	O
.	O

plasma	O
aa	O
is	O
an	O
appropriate	O
biomarker	O
,	O
in	O
our	O
subjects	O
,	O
of	O
dietary	O
vitamin	B
c	I
except	O
for	O
people	O
consuming	O
large	O
amounts	O
of	O
this	O
vitamin	O
either	O
in	O
their	O
diet	O
or	O
in	O
supplemental	O
form	O
..	O
the	O
antioxidant	O
properties	O
of	O
vitamin	B
c	I
may	O
be	O
involved	O
in	O
the	O
prevention	O
of	O
cancer	O
.	O

the	O
correlation	O
between	O
dietary	O
vitamin	B
c	I
intake	O
as	O
estimated	O
by	O
a	O
dietary	O
questionnaire	O
and	O
plasma	O
ascorbic	O
acid	O
(	O
aa	O
)	O
was	O
examined	O
in	O
68	O
nonsmoking	O
male	O
volunteers	O
aged	O
30	O
-	O
59	O
years	O
.	O

the	O
determinants	O
of	O
plasma	O
aa	O
were	O
examined	O
by	O
a	O
multiple	O
regression	O
model	O
containing	O
dietary	O
vitamin	B
c	I
,	O
calories	O
,	O
body	O
weight	O
,	O
and	O
amount	O
of	O
beverages	O
consumed	O
.	O

higher	O
vitamin	B
c	I
intake	O
(	O
p	O
<	O
0.0002	O
)	O
increased	O
plasma	O
aa	O
,	O
while	O
greater	O
body	O
weight	O
(	O
p	O
<	O
0.005	O
)	O
decreased	O
plasma	O
aa	O
.	O

a	O
significant	O
correlation	O
(	O
r	O
=	O
0.43	O
;	O
p	O
<	O
0.0003	O
)	O
between	O
vitamin	B
c	I
intake	O
and	O
plasma	O
aa	O
was	O
observed	O
.	O

vitamin	B
c	I
supplement	O
users	O
had	O
higher	O
plasma	O
aa	O
compared	O
to	O
nonusers	O
.	O

the	O
relationship	O
between	O
plasma	O
aa	O
and	O
vitamin	B
c	I
intake	O
appears	O
to	O
be	O
curvilinear	O
with	O
the	O
non	O
-	O
supplement	O
users	O
at	O
the	O
linear	O
part	O
of	O
the	O
curve	O
and	O
the	O
supplement	O
users	O
at	O
the	O
plateau	O
.	O

plasma	O
aa	O
is	O
an	O
appropriate	O
biomarker	O
,	O
in	O
our	O
subjects	O
,	O
of	O
dietary	O
vitamin	B
c	I
except	O
for	O
people	O
consuming	O
large	O
amounts	O
of	O
this	O
vitamin	O
either	O
in	O
their	O
diet	O
or	O
in	O
supplemental	O
form	O
.	O

correlations	O
of	O
vitamin	O
a	O
and	O
e	O
intakes	O
with	O
the	O
plasma	O
concentrations	O
of	O
carotenoids	O
and	O
tocopherols	O
among	O
american	O
men	O
and	O
women	O
..	O
the	O
authors	O
investigated	O
the	O
association	O
of	O
diet	O
and	O
other	O
factors	O
with	O
the	O
plasma	O
concentrations	O
of	O
carotenoids	O
,	O
retinol	B
and	O
tocopherols	O
in	O
a	O
sample	O
of	O
121	O
men	O
and	O
186	O
women	O
participating	O
in	O
two	O
prospective	O
investigations	O
of	O
dietary	O
etiologies	O
of	O
chronic	O
diseases	O
.	O

lycopene	B
(	O
mean	O
concentration	O
,	O
0.82	O
mumol	O
/	O
l	O
in	O
men	O
,	O
0.76	O
mumol	O
/	O
l	O
in	O
women	O
)	O
,	O
beta	B
-	I
carotene	I
(	O
mean	O
0.46	O
mumol	O
/	O
l	O
in	O
men	O
,	O
0.58	O
mumol	O
/	O
l	O
in	O
women	O
)	O
and	O
lutein	B
(	O
mean	O
0.28	O
mumol	O
/	O
l	O
in	O
men	O
,	O
0.27	O
mumol	O
/	O
l	O
in	O
women	O
)	O
were	O
the	O
major	O
circulating	O
carotenoids	O
.	O
among	O
nonsmokers	O
,	O
dietary	O
carotenoid	O
,	O
as	O
typically	O
calculated	O
in	O
epidemiologic	O
studies	O
,	O
was	O
significantly	O
correlated	O
with	O
plasma	O
beta	B
-	I
carotene	I
(	O
r	O
=	O
0.34	O
in	O
men	O
,	O
r	O
=	O
0.30	O
in	O
women	O
)	O
,	O

alpha	B
-	I
carotene	I
(	O
r	O
=	O
0.52	O
in	O
men	O
,	O
r	O
=	O
0.37	O
in	O
women	O
)	O
and	O
lutein	B
(	O
r	O
=	O
0.36	O
in	O
men	O
,	O
r	O
=	O
0.19	O
in	O
women	O
)	O
,	O
but	O
not	O
with	O
plasma	O
zeaxanthin	B
(	O
r	O
=	O
0.11	O
and	O
r	O
=	O
0.02	O
)	O
or	O
lycopene	B
(	O
r	O
=	O
0.13	O
and	O
r	O
=	O
0.01	O
)	O
after	O
adjusting	O
for	O
plasma	O
cholesterol	B
and	O
triglycerides	O
,	O
body	O
mass	O
index	O
and	O
energy	B
intake	O
.	O

total	O
vitamin	O
e	O
intake	O
was	O
positively	O
associated	O
with	O
plasma	O
concentrations	O
of	O
alpha	B
-	I
tocopherol	I
(	O
r	O
=	O
0.51	O
in	O
men	O
,	O
r	O
=	O
0.41	O
in	O
women	O
)	O
and	O
inversely	O
associated	O
with	O
plasma	O
concentrations	O
of	O
gamma	B
-	I
tocopherol	I
(	O
r	O
=	O
-0.51	O
in	O
men	O
r	O
=	O
-0.42	O
in	O
women	O
)	O
,	O
but	O
this	O
was	O
primarily	O
due	O
to	O
use	O
of	O
vitamin	O
e	O
supplements	O
.	O

fatty	O
acid	O
composition	O
of	O
subcutaneous	O
adipose	O
tissue	O
and	O
diet	O
in	O
postmenopausal	O
us	O
women	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
data	O
also	O
provide	O
further	O
support	O
for	O
the	O
validity	O
of	O
the	O
food	O
-	O
frequency	O
questionnaire	O
in	O
the	O
assessment	O
of	O
fat	O
intake	O
..	O
the	O
distributions	O
of	O
fatty	B
acids	I
in	O
subcutaneous	O
-	O
adipose	O
-	O
tissue	O
aspirates	O
and	O
their	O
relation	O
to	O
intake	O
as	O
assessed	O
by	O
a	O
semiquantitative	O
food	O
-	O
frequency	O
questionnaire	O
were	O
investigated	O
in	O
115	O
postmenopausal	O
us	O
women	O
free	O
from	O
cancer	O
.	O

percentages	O
of	O
fatty	B
acids	I
in	O
adipose	O
tissue	O
were	O
significantly	O
correlated	O
with	O
the	O
percentage	O
of	O
total	O
fat	O
intake	O
for	O
polyunsaturated	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.37	O
)	O
,	O
n-3	O
fatty	B
acids	I
of	O
marine	O
origin	O
(	O
spearman	O
correlation	O
=	O
0.48	O
)	O
,	O
and	O
trans	O
fatty	B
acids	I
(	O
spearman	O
correlation	O
=	O
0.51	O
)	O
but	O
not	O
for	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
.	O

these	O
data	O
suggest	O
that	O
intakes	O
of	O
polyunsaturated	O
fatty	B
acids	I
,	O
including	O
n-3	O
fatty	B
acids	I
,	O
and	O
trans	O
fatty	B
acids	I
are	O
reflected	O
in	O
the	O
adipose	O
tissue	O
but	O
that	O
intakes	O
of	O
saturated	O
and	O
monounsaturated	O
fatty	B
acids	I
are	O
not	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

the	O
results	O
showed	O
that	O
total	O
energy	B
intake	O
and	O
the	O
percentage	O
of	O
energy	B
derived	O
from	O
sugar	O
were	O
higher	O
in	O
smokers	O
,	O
and	O
that	O
both	O
dietary	O
and	O
serum	O
values	O
of	O
vitamin	O
c	O
,	O
beta	B
-	I
carotene	I
and	O
vitamin	O
e	O
were	O
lower	O
in	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

after	O
adjustment	O
for	O
serum	O
lipids	O
,	O
energy	B
intake	O
and	O
body	O
mass	O
index	O
,	O
correlation	O
coefficients	O
between	O
dietary	O
and	O
serum	O
vitamins	O
c	O
and	O
e	O
were	O
similar	O
for	O
smokers	O
(	O
r	O
0.555	O
and	O
0.25	O
respectively	O
)	O
and	O
non	O
-	O
smokers	O
(	O
r	O
0.58	O
and	O
0.32	O
respectively	O
)	O
.	O

correlation	O
between	O
dietary	O
and	O
serum	O
carotenes	O
was	O
reduced	O
from	O
0.28	O
in	O
non	O
-	O
smokers	O
to	O
0.09	O
in	O
smokers	O
and	O
correlations	O
for	O
retinol	B
and	O
total	O
vitamin	O
a	O
were	O
weakly	O
significant	O
only	O
for	O
non	O
-	O
smokers	O
.	O

the	O
food	O
-	O
frequency	O
questionnaire	O
assigned	O
greater	O
than	O
70	O
%	O
of	O
subjects	O
correctly	O
into	O
the	O
upper	O
or	O
lower	O
plus	O
adjacent	O
tertiles	O
of	O
serum	O
vitamin	O
values	O
,	O
with	O
the	O
exception	O
of	O
beta	B
-	I
carotene	I
and	O
total	O
vitamin	O
a	O
for	O
smokers	O
.	O

thus	O
,	O
the	O
food	O
-	O
frequency	O
questionnaire	O
appeared	O
to	O
be	O
an	O
adequate	O
tool	O
for	O
assigning	O
individuals	O
into	O
tertiles	O
of	O
serum	O
antioxidant	O
vitamins	O
with	O
the	O
main	O
exception	O
of	O
beta	B
-	I
carotene	I
for	O
smokers	O
.	O

relative	O
and	O
biomarker	O
-	O
based	O
validity	O
of	O
a	O
food	O
-	O
frequency	O
questionnaire	O
estimating	O
intake	O
of	O
fats	B
and	O
cholesterol	O
..	O

the	O
relative	O
validity	O
of	O
a	O
104	O
-	O
item	O
food	O
-	O
frequency	O
method	O
to	O
assess	O
intakes	O
of	O
fats	B
and	O
cholesterol	O
was	O
tested	O
against	O
the	O
dietary	O
history	O
of	O
191	O
men	O
and	O
women	O
.	O

pearson	O
correlation	O
coefficients	O
ranged	O
from	O
0.38	O
for	O
linoleic	O
acid	O
(	O
%	O
of	O
energy	O
)	O
to	O
0.83	O
for	O
energy	O
intake	O
,	O
with	O
0.78	O
and	O
0.75	O
for	O
the	O
intakes	O
of	O
total	O
fat	O
and	O
saturated	O
fatty	B
acids	I
,	O
respectively	O
.	O

mean	O
intakes	O
were	O
overestimated	O
by	O
the	O
food	O
-	O
frequency	O
questionnaire	O
relative	O
to	O
the	O
dietary	O
history	O
by	O
5	O
%	O
for	O
energy	O
and	O
monounsaturated	O
fatty	B
acids	I
(	O
%	O
of	O
energy	O
)	O
and	O
up	O
to	O
30	O
%	O
for	O
linoleic	O
acid	O
intake	O
.	O

dietary	O
intake	O
of	O
aflatoxins	B
and	O
the	O
level	O
of	O
albumin	O
-	O
bound	O
aflatoxin	O
in	O
peripheral	O
blood	O
in	O
the	O
gambia	O
,	O
west	O
africa	O
..	O

the	O
present	O
study	O
was	O
designed	O
to	O
validate	O
the	O
use	O
of	O
aflatoxin	B
-	I
albumin	I
adducts	I
in	O
peripheral	O
blood	O
as	O
a	O
measure	O
of	O
individual	O
exposure	O
to	O
this	O
carcinogen	O
.	O

these	O
studies	O
demonstrate	O
the	O
validity	O
of	O
aflatoxin	B
-	I
albumin	I
adducts	I
as	O
a	O
marker	O
of	O
human	O
exposure	O
to	O
this	O
carcinogen	O
..	O
aflatoxin	O
is	O
implicated	O
as	O
a	O
risk	O
factor	O
for	O
hepatocellular	O
carcinoma	O
in	O
areas	O
of	O
the	O
world	O
with	O
a	O
high	O
incidence	O
of	O
this	O
tumor	O
.	O

the	O
present	O
study	O
was	O
designed	O
to	O
validate	O
the	O
use	O
of	O
aflatoxin	B
-	I
albumin	I
adducts	I
in	O
peripheral	O
blood	O
as	O
a	O
measure	O
of	O
individual	O
exposure	O
to	O
this	O
carcinogen	O
.	O

these	O
studies	O
demonstrate	O
the	O
validity	O
of	O
aflatoxin	B
-	I
albumin	I
adducts	I
as	O
a	O
marker	O
of	O
human	O
exposure	O
to	O
this	O
carcinogen	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
..	O
a	O
study	O
was	O
conducted	O
in	O
12	O
free	O
-	O
living	O
subjects	O
to	O
determine	O
quantitative	O
and	O
qualitative	O
plasma	O
phospholipid	O
(	O
pl	O
)	O
,	O
free	O
fatty	O
acid	O
(	O
ffa	O
)	O
,	O
triglyceride	O
(	O
tg	O
)	O
,	O
and	O
cholesterol	O
ester	O
(	O
ce	O
)	O
fatty	O
acid	O
(	O
fa	O
)	O
variations	O
over	O
time	O
(	O
0.8	O
,	O
and	O
22	O
mo	O
)	O
and	O
to	O
correlate	O
these	O
fas	O
with	O
dietary	O
intake	O
.	O

correlations	O
between	O
diet	O
and	O
fas	O
occurred	O
mostly	O
in	O
men	O
for	O
whom	O
dietary	O
percent	O
fat	O
energy	B
was	O
positively	O
correlated	O
with	O
percent	O
monounsaturated	O
plasma	O
tg	O
fas	O
,	O
and	O
ethanol	B
(	O
g	O
/	O
d	O
)	O
was	O
positively	O
correlated	O
with	O
plasma	O
ce	O
16:1	O
omega	O
7	O
(	O
mumol	O
/	O
l	O
)	O
.	O

factors	O
such	O
as	O
ethanol	B
consumption	O
and	O
sex	O
differences	O
may	O
influence	O
fa	O
metabolism	O
.	O

the	O
correlation	O
between	O
total	O
protein	O
and	O
3	B
-	I
methylhistidine	I
was	O
r	O
=	O
0.42	O
(	O
n	O
=	O
96	O
)	O
.	O

validation	O
of	O
a	O
dietary	O
questionnaire	O
with	O
plasma	O
carotenoid	O
and	O
alpha	B
-	I
tocopherol	I
levels	O
..	O
we	O
assessed	O
the	O
validity	O
of	O
a	O
self	O
-	O
administered	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
by	O
comparing	O
carotene	O
and	O
vitamin	B
e	I
intake	O
scores	O
derived	O
from	O
form	O
with	O
plasma	O
carotenoid	O
and	O
alpha	B
-	I
tocopherol	I
levels	O
among	O
a	O
group	O
of	O
59	O
men	O
and	O
women	O
.	O

the	O
simple	O
correlation	O
between	O
vitamin	B
e	I
intake	O
and	O
plasma	O
alpha	B
-	I
tocopherol	I
was	O
0.12	O
(	O
p	O
=	O
0.19	O
)	O
.	O

as	O
expected	O
on	O
the	O
basis	O
of	O
previous	O
randomized	O
trials	O
,	O
the	O
correlation	O
between	O
preformed	O
vitamin	O
a	O
intake	O
and	O
plasma	O
retinol	B
was	O
weak	O
and	O
not	O
statistically	O
significant	O
.	O

in	O
addition	O
,	O
they	O
illustrate	O
the	O
importance	O
of	O
adjusting	O
blood	O
alpha	B
-	I
tocopherol	I
levels	O
for	O
lipid	O
concentrations	O
when	O
the	O
former	O
are	O
used	O
as	O
surrogates	O
for	O
vitamin	B
e	I
intake	O
.	O

cyp1a1	O
and	O
gstm1	O
polymorphisms	O
affect	O
urinary	O
1	B
-	I
hydroxypyrene	I
levels	O
after	O
pah	O
exposure	O
..	O
certain	O
human	O
biotransformation	O
enzymes	O
have	O
been	O
implicated	O
in	O
the	O
formation	O
and	O
scavenging	O
of	O
the	O
ultimate	O
reactive	O
metabolites	O
,	O
the	O
diolepoxides	O
,	O
from	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
.	O

in	O
the	O
present	O
study	O
,	O
performed	O
on	O
aluminum	O
smelter	O
workers	O
,	O
we	O
have	O
analyzed	O
airborne	O
pah	O
,	O
the	O
pyrene	O
metabolite	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
in	O
urine	O
,	O
and	O
genotypes	O
for	O
biotransformation	O
enzymes	O
involved	O
in	O
pah	O
metabolism	O
.	O

influence	O
of	O
genetic	O
polymorphisms	O
of	O
cyp1a1	O
and	O
gstm1	O
on	O
the	O
urinary	O
levels	O
of	O
1	B
-	I
hydroxypyrene	I
..	O

the	O
aim	O
of	O
the	O
present	O
study	O
is	O
to	O
evaluate	O
the	O
influence	O
of	O
the	O
genetic	O
polymorphism	O
of	O
two	O
enzymes	O
involved	O
in	O
the	O
biotransformation	O
of	O
xenobiotics	O
,	O
cytochrome	O
p450	O
1a1	O
(	O
cyp1a1	O
)	O
and	O
glutathione	O
-	O
s	O
-	O
transferase	O
m1	O
(	O
gstm1	O
)	O
,	O
on	O
the	O
urinary	O
levels	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
oh	O
-	O
p	O
)	O
in	O
workers	O
exposed	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
and	O
in	O
unexposed	O
workers	O
(	O
controls	O
)	O
.	O

simultaneous	O
determination	O
of	O
nicotine	B
and	O
pah	O
metabolites	O
in	O
human	O
hair	O
specimen	O
:	O
a	O
potential	O
methodology	O
to	O
assess	O
tobacco	O
smoke	O
contribution	O
in	O
pah	O
exposure	O
..	O
the	O
present	O
methodology	O
was	O
developed	O
to	O
simultaneously	O
assess	O
chronic	O
exposure	O
to	O
pahs	O
and	O
to	O
tobacco	O
from	O
the	O
analysis	O
of	O
one	O
hair	O
specimen	O
per	O
examined	O
individual	O
.	O

the	O
method	O
is	O
a	O
two	O
step	O
extraction	O
of	O
twelve	O
mono	O
-	O
hydroxy	O
-	O
pahs	O
and	O
of	O
nicotine	B
,	O
and	O
their	O
separate	O
analysis	O
by	O
optimized	O
methods	O
using	O
gas	O
chromatography	O
-	O
negative	O
chemical	O
ionization	O
-	O
mass	O
spectrometry	O
.	O

all	O
the	O
hair	O
samples	O
tested	O
positive	O
for	O
nicotine	B
.	O

the	O
simultaneous	O
detection	O
of	O
nicotine	B
and	O
oh	O
-	O
pahs	O
in	O
hair	O
is	O
possible	O
and	O
provides	O
reliable	O
results	O
.	O

highly	O
significant	O
correlations	O
were	O
found	O
between	O
pah	B
-	I
albumin	I
adducts	I
and	O
aas	O
in	O
plasma	O
(	O
p	O
=	O
0.001	O
)	O
and	O
ggs	O
in	O
hemoglobin	O
(	O
p	O
=	O
0.001	O
)	O
.	O

significant	O
correlations	O
were	O
also	O
observed	O
between	O
urinary	O
8	O
-	O
oxo-7	O
,	O
8	O
-	O
dihydro-2'-deoxyguanosine	O
and	O
aas	O
in	O
plasma	O
(	O
p	O
=	O
0.001	O
)	O
and	O
pah	B
-	I
albumin	I
adducts	I
(	O
p	O
=	O
0.002	O
)	O
.	O

a	O
significant	O
negative	O
correlation	O
was	O
only	O
observed	O
between	O
bulky	O
carcinogen	O
-	O
dna	O
adducts	O
and	O
pah	B
-	I
albumin	I
adducts	I
(	O
p	O
=	O
0.02	O
)	O
and	O
between	O
dna	O
adduct	O
and	O
urinary	O
mutagenic	O
activity	O
(	O
p	O
=	O
0.02	O
)	O
in	O
the	O
gstm1	O
null	O
group	O
,	O
but	O
not	O
in	O
the	O
workers	O
who	O
were	O
homozygotes	O
or	O
heterozygotes	O
for	O
gstm1	O
.	O

highly	O
significant	O
correlations	O
were	O
found	O
between	O
pah	B
-	I
albumin	I
adducts	I
and	O
aas	O
in	O
plasma	O
(	O
p	O
=	O
0.001	O
)	O
and	O
ggs	O
in	O
hemoglobin	O
(	O
p	O
=	O
0.001	O
)	O
.	O

significant	O
correlations	O
were	O
also	O
observed	O
between	O
urinary	O
8	O
-	O
oxo-7	O
,	O
8	O
-	O
dihydro-2'-deoxyguanosine	O
and	O
aas	O
in	O
plasma	O
(	O
p	O
=	O
0.001	O
)	O
and	O
pah	B
-	I
albumin	I
adducts	I
(	O
p	O
=	O
0.002	O
)	O
.	O

a	O
significant	O
negative	O
correlation	O
was	O
only	O
observed	O
between	O
bulky	O
carcinogen	O
-	O
dna	O
adducts	O
and	O
pah	B
-	I
albumin	I
adducts	I
(	O
p	O
=	O
0.02	O
)	O
and	O
between	O
dna	O
adduct	O
and	O
urinary	O
mutagenic	O
activity	O
(	O
p	O
=	O
0.02	O
)	O
in	O
the	O
gstm1	O
null	O
group	O
,	O
but	O
not	O
in	O
the	O
workers	O
who	O
were	O
homozygotes	O
or	O
heterozygotes	O
for	O
gstm1	O
.	O

highly	O
significant	O
correlations	O
were	O
found	O
between	O
pah	B
-	I
albumin	I
adducts	I
and	O
aas	O
in	O
plasma	O
(	O
p	O
=	O
0.001	O
)	O
and	O
ggs	O
in	O
hemoglobin	O
(	O
p	O
=	O
0.001	O
)	O
.	O

significant	O
correlations	O
were	O
also	O
observed	O
between	O
urinary	O
8	O
-	O
oxo-7	O
,	O
8	O
-	O
dihydro-2'-deoxyguanosine	O
and	O
aas	O
in	O
plasma	O
(	O
p	O
=	O
0.001	O
)	O
and	O
pah	B
-	I
albumin	I
adducts	I
(	O
p	O
=	O
0.002	O
)	O
.	O

a	O
significant	O
negative	O
correlation	O
was	O
only	O
observed	O
between	O
bulky	O
carcinogen	O
-	O
dna	O
adducts	O
and	O
pah	B
-	I
albumin	I
adducts	I
(	O
p	O
=	O
0.02	O
)	O
and	O
between	O
dna	O
adduct	O
and	O
urinary	O
mutagenic	O
activity	O
(	O
p	O
=	O
0.02	O
)	O
in	O
the	O
gstm1	O
null	O
group	O
,	O
but	O
not	O
in	O
the	O
workers	O
who	O
were	O
homozygotes	O
or	O
heterozygotes	O
for	O
gstm1	O
.	O

we	O
also	O
measured	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
and	O
2	O
-	O
naphthol	O
,	O
to	O
assess	O
pah	O
exposure	O
,	O
and	O
mda	O
,	O
to	O
assess	O
oxidative	O
stress	O
.	O

the	O
series	O
of	O
biomarkers	O
included	O
pah	O
metabolites	O
in	O
urine	O
,	O
urine	O
mutagenicity	O
,	O
pah	O
-	O
dna	O
adducts	O
in	O
white	O
blood	O
cells	O
determined	O
by	O
32p	O
-	O
postlabeling	O
,	O
pah	B
-	I
albumin	I
adducts	I
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
elisa	O
)	O
,	O
dna	O
damage	O
in	O
lymphocytes	O
detected	O
by	O
comet	O
assay	O
,	O
chromosomal	O
aberrations	O
,	O
sister	O
chromatid	O
exchanges	O
,	O
and	O
glutathione	O
s	O
-	O
transferase	O
m1	O
(	O
gstm1	O
)	O
genotypes	O
.	O

the	O
series	O
of	O
biomarkers	O
included	O
pah	O
metabolites	O
in	O
urine	O
,	O
urine	O
mutagenicity	O
,	O
pah	O
-	O
dna	O
adducts	O
in	O
white	O
blood	O
cells	O
determined	O
by	O
32p	O
-	O
postlabeling	O
,	O
pah	B
-	I
albumin	I
adducts	I
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
elisa	O
)	O
,	O
dna	O
damage	O
in	O
lymphocytes	O
detected	O
by	O
comet	O
assay	O
,	O
chromosomal	O
aberrations	O
,	O
sister	O
chromatid	O
exchanges	O
,	O
and	O
glutathione	O
s	O
-	O
transferase	O
m1	O
(	O
gstm1	O
)	O
genotypes	O
.	O

the	O
measured	O
urinary	O
concentrations	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
pyr	O
)	O
in	O
samples	O
from	O
malaysia	O
,	O
korea	O
,	O
and	O
japan	O
(	O
∼	O
100	O
pg	O
/	O
ml	O
)	O
were	O
similar	O
to	O
those	O
reported	O
for	O
north	O
america	O
and	O
western	O
europe	O
.	O

among	O
the	O
12	O
oh	O
-	O
pah	O
compounds	O
analyzed	O
,	O
hydroxynaphthalene	O
(	O
nap	O
:	O
sum	O
of	O
1	B
-	I
hydroxynaphthalene	I
and	O
2	B
-	I
hydroxynaphthalene	I
)	O
was	O
the	O
dominant	O
compound	O
(	O
accounting	O
for	O
60	O
-	O
90	O
%	O
of	O
total	O
oh	O
-	O
pahs	O
)	O
,	O
followed	O
by	O
hydroxyphenanthrene	O
(	O
phen	O
:	O
sum	O
of	O
2	O
-	O
hydroxyphenanthrene	O
,	O
3	O
-	O
hydroxyphenanthrene	O
,	O
4	O
-	O
hydroxyphenanthrene	O
,	O
and	O
9	B
-	I
hydroxyphenanthrene	I
[	O
3	O
-	O
16	O
%	O
]	O
)	O
,	O
2	B
-	I
hydroxyfluorene	I
(	O
3	O
-	O
20	O
%	O
)	O
,	O
and	O
1	O
-	O
pyr	O
(	O
2	O
-	O
8	O
%	O
)	O
.	O

korea	O
national	O
survey	O
for	O
environmental	O
pollutants	O
in	O
the	O
human	O
body	O
2008	O
:	O
1	O
-	O
hydroxypyrene	O
,	O
2	O
-	O
naphthol	O
,	O
and	O
cotinine	B
in	O
urine	O
of	O
the	O
korean	O
population	O
..	O
the	O
korea	O
national	O
survey	O
for	O
environmental	O
pollutants	O
in	O
the	O
human	O
body	O
conducts	O
representative	O
korean	O
population	O
studies	O
,	O
which	O
were	O
first	O
initiated	O
in	O
2005	O
in	O
korea	O
.	O

the	O
urinary	O
levels	O
of	O
1	O
-	O
hydroxypyrene	O
,	O
2	O
-	O
naphthol	O
,	O
and	O
cotinine	B
were	O
measured	O
for	O
exposure	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
and	O
nicotine	O
.	O

the	O
geometric	O
means	O
of	O
the	O
urinary	O
1	O
-	O
hydroxypyrene	O
,	O
2	O
-	O
naphthol	O
and	O
cotinine	B
concentrations	O
in	O
the	O
korean	O
general	O
population	O
were	O
0.15	O
μg	O
/	O
l	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
):	O
0.13	O
-	O
0.17	O
)	O
,	O
3.84	O
μg	O
/	O
l	O
(	O
95	O
%	O
ci	O
:	O
3.57	O
-	O
4.11	O
)	O
and	O
47.42	O
μg	O
/	O
l	O
(	O
95	O
%	O
ci	O
:	O
40.52	O
-	O
54.32	O
)	O
respectively	O
.	O

when	O
these	O
values	O
were	O
compared	O
with	O
reference	O
ranges	O
for	O
the	O
united	O
states	O
and	O
germany	O
,	O
the	O
levels	O
of	O
1	O
-	O
hydroxypyrene	O
,	O
2	O
-	O
naphthol	O
,	O
and	O
cotinine	B
were	O
very	O
similar	O
for	O
korea	O
and	O
germany	O
,	O
however	O
,	O
these	O
levels	O
were	O
slightly	O
lower	O
in	O
the	O
united	O
states	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
..	O
the	O
german	O
environmental	O
survey	O
(	O
geres	O
)	O
is	O
a	O
cross	O
-	O
sectional	O
probability	O
study	O
to	O
determine	O
the	O
exposure	O
of	O
the	O
general	O
population	O
to	O
environmental	O
contaminants	O
.	O

human	O
biomonitoring	O
comprised	O
the	O
determination	O
of	O
arsenic	O
,	O
cadmium	O
,	O
mercury	O
,	O
metabolites	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
pentachlorophenol	O
(	O
pcp	O
)	O
,	O
other	O
chlorophenols	O
,	O
precious	O
metals	O
(	O
gold	O
,	O
platinum	O
,	O
iridium	O
)	O
,	O
nicotine	O
,	O
and	O
cotinine	B
in	O
urine	O
.	O

levels	O
of	O
1	B
-	I
hydroxypyrene	I
and	O
other	O
monohydroxy	O
polycyclic	O
aromatic	O
hydrocarbons	O
in	O
children	O
:	O
a	O
study	O
based	O
on	O
u.s	O
.	O
reference	O
range	O
values	O
..	O
urine	O
samples	O
collected	O
in	O
1999	O
and	O
2000	O
as	O
part	O
of	O
the	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
(	O
nhanes	O
)	O
were	O
analyzed	O
for	O
14	O
monohydroxy	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
,	O
metabolites	O
of	O
7	O
pah	O
compounds	O
)	O
and	O
for	O
the	O
first	O
time	O
reference	O
range	O
values	O
were	O
calculated	O
for	O
these	O
metabolites	O
in	O
the	O
u.s	O
.	O

more	O
than	O
99	O
%	O
of	O
the	O
urine	O
samples	O
contained	O
a	O
detectable	O
amount	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohpyrene	O
)	O
,	O
a	O
metabolite	O
of	O
pyrene	O
.	O

assessment	O
of	O
ddt	O
,	O
dde	O
,	O
and	O
1	B
-	I
hydroxypyrene	I
levels	O
in	O
blood	O
and	O
urine	O
samples	O
in	O
children	O
from	O
chiapas	O
mexico	O
..	O
purpose	O
:	O
the	O
aim	O
of	O
this	O
study	O
was	O
assess	O
co	O
-	O
exposure	O
to	O
ddt	O
,	O
dde	O
(	O
main	O
ddt	O
metabolite	O
)	O
,	O
and	O
pahs	O
(	O
1	B
-	I
hydroxypyrene	I
)	O
in	O
areas	O
where	O
biomass	O
is	O
used	O
to	O
cook	O
and	O
to	O
heat	O
homes	O
and	O
where	O
ddt	O
was	O
used	O
to	O
combat	O
malaria	O
transmission	O
.	O

analyses	O
of	O
1	B
-	I
hydroxypyrene	I
were	O
performed	O
by	O
hplc	O
using	O
a	O
fluorescence	O
detector	O
.	O

moreover	O
,	O
high	O
levels	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
a	O
pah	O
biomarker	O
)	O
were	O
found	O
in	O
urine	O
samples	O
(	O
range	O
,	O
0.02	O
to	O
4.82	O
 	O
μmol	O
/	O
mol	O
creatinine	O
)	O
.	O

this	O
study	O
aimed	O
to	O
investigate	O
the	O
excretion	O
half	O
-	O
life	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
pyr	O
)	O
,	O
the	O
most	O
used	O
biomarker	O
for	O
pah	O
exposure	O
,	O
and	O
9	O
other	O
oh	O
-	O
pahs	O
following	O
a	O
dietary	O
exposure	O
in	O
9	O
nonsmoking	O
volunteers	O
with	O
no	O
occupational	O
exposure	O
to	O
pahs	O
.	O

the	O
geometric	O
mean	O
for	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
pyr)--the	O
most	O
commonly	O
used	O
biomarker	O
for	O
pah	O
exposure	O
--	O
was	O
49.6	O
ng	O
/	O
l	O
urine	O
,	O
or	O
46.4	O
ng	O
/	O
g	O
creatinine	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
as	O
a	O
biomarker	O
of	O
pah	O
exposure	O
in	O
3	O
-	O
year	O
-	O
old	O
ukrainian	O
children	O
..	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
is	O
a	O
biomarker	O
of	O
polycyclic	O
aromatic	O
hydrocarbon	O
(	O
pah	O
)	O
exposure	O
.	O

environmental	O
exposure	O
of	O
small	O
children	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
..	O
objectives	O
:	O
the	O
aim	O
of	O
the	O
study	O
was	O
to	O
assess	O
the	O
intake	O
(	O
by	O
various	O
routes	O
of	O
exposure	O
)	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
by	O
children	O
living	O
in	O
a	O
czech	O
city	O
,	O
and	O
its	O
effect	O
on	O
excretion	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
in	O
summer	O
and	O
winter	O
periods	O
.	O

biomarkers	O
were	O
:	O
wbc	O
aromatic	O
-	O
dna	O
adducts	O
by	O
(	O
32)p	O
-	O
postlabeling	O
and	O
pah	B
-	I
dna	I
adducts	I
by	O
elisa	O
(	O
as	O
indicators	O
of	O
dna	O
damage	O
from	O
pahs	O
and	O
other	O
aromatics	O
)	O
and	O
plasma	O
cotinine	B
(	O
as	O
an	O
internal	O
dosimeter	O
of	O
cigarette	O
smoke	O
)	O
.	O

a	O
significant	O
correlation	O
between	O
paired	O
newborn	O
/	O
maternal	O
samples	O
was	O
seen	O
for	O
aromatic	O
-	O
dna	O
adduct	O
levels	O
(	O
r	O
=	O
0.3	O
;	O
p	O
<	O
0.001	O
)	O
and	O
plasma	O
cotinine	B
(	O
r	O
=	O
0.8	O
;	O
p	O
<	O
0.001	O
)	O
but	O
not	O
pah	O
-	O
dna	O
adduct	O
levels	O
(	O
r	O
=	O
0.14	O
;	O
p	O
=	O
0.13	O
)	O
.	O

the	O
difference	O
was	O
significant	O
for	O
aromatic	O
-	O
dna	O
adduct	O
levels	O
(	O
16.6	O
+	O
/-	O
12.5	O
versus	O
14.21	O
+	O
/-	O
15.4/10(8	O
)	O
nucleotides	O
;	O
p	O
=	O
0.002	O
)	O
and	O
plasma	O
cotinine	B
(	O
14.2	O
+	O
/-	O
35.5	O
versus	O
8.3	O
+	O
/-	O
24.5	O
ng	O
/	O
ml	O
;	O
p	O
<	O
0.001	O
)	O
but	O
not	O
for	O
pah	O
-	O
dna	O
adduct	O
levels	O
(	O
7.9	O
+	O
/-	O
9.9	O
versus	O
5.9	O
+	O
/-	O
8.2/10(8	O
)	O
nucleotides	O
;	O
p	O
=	O
0.13	O
)	O
.	O

the	O
increase	O
in	O
bpde	B
-	I
dna	I
adduct	I
levels	O
in	O
lmf	O
(	O
ln	O
values	O
)	O
was	O
significantly	O
related	O
to	O
chronic	O
inhalatory	O
and	O
high	O
pah	O
exposure	O
(	O
linear	O
multiple	O
regression	O
analysis	O
,	O
f	O
=	O
6.37	O
,	O
p	O
<	O
0.01	O
;	O
t	O
=	O
4.2	O
,	O
p	O
<	O
0.001	O
)	O
.	O

skin	O
acute	O
(	O
or	O
short	O
-	O
term	O
)	O
and	O
high	O
pah	O
exposure	O
,	O
charcoal	O
-	O
grilled	O
meat	O
consumption	O
and	O
smoking	O
habit	O
did	O
not	O
seem	O
to	O
influence	O
bpde	B
-	I
dna	I
adduct	I
formation	O
in	O
lmf	O
.	O

evaluation	O
of	O
intra-	O
and	O
interindividual	O
variation	O
of	O
urinary	O
1	B
-	I
hydroxypyrene	I
,	O
a	O
biomarker	O
of	O
exposure	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
..	O

intraindividual	O
variation	O
of	O
urinary	O
1	B
-	I
hydroxypyrene	I
concentrations	O
,	O
calculated	O
as	O
a	O
coefficient	O
of	O
variance	O
(	O
cv	O
)	O
,	O
ranged	O
from	O
14	O
to	O
109	O
%	O
whereas	O
inter	O
-	O
individual	O
variation	O
ranged	O
from	O
69	O
to	O
109	O
%	O
.	O

three	O
-	O
way	O
analysis	O
of	O
variance	O
disclosed	O
a	O
significant	O
effect	O
of	O
sex	O
,	O
exposure	O
to	O
environmental	O
tobacco	O
smoke	O
and	O
day	O
of	O
examination	O
on	O
1	B
-	I
hydroxypyrene	I
concentrations	O
not	O
corrected	O
for	O
creatinine	O
.	O

the	O
appropriate	O
sample	O
size	O
for	O
population	O
studies	O
and	O
the	O
minimum	O
number	O
of	O
observations	O
for	O
the	O
individual	O
assessment	O
of	O
environmental	O
exposure	O
to	O
pahs	O
calculated	O
on	O
the	O
basis	O
of	O
inter-	O
and	O
intraindividual	O
variability	O
of	O
1	B
-	I
hydroxypyrene	I
concentrations	O
in	O
urine	O
amounted	O
to	O
164	O
and	O
99	O
,	O
respectively	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
may	O
be	O
considered	O
a	O
good	O
indicator	O
of	O
environmental	O
exposure	O
to	O
pahs	O
at	O
the	O
group	O
level	O
..	O
the	O
study	O
was	O
performed	O
on	O
30	O
,	O
8	O
-	O
year	O
-	O
old	O
children	O
living	O
in	O
an	O
industrial	O
town	O
of	O
the	O
upper	O
silesia	O
region	O
.	O

intraindividual	O
variation	O
of	O
urinary	O
1	B
-	I
hydroxypyrene	I
concentrations	O
,	O
calculated	O
as	O
a	O
coefficient	O
of	O
variance	O
(	O
cv	O
)	O
,	O
ranged	O
from	O
14	O
to	O
109	O
%	O
whereas	O
inter	O
-	O
individual	O
variation	O
ranged	O
from	O
69	O
to	O
109	O
%	O
.	O

three	O
-	O
way	O
analysis	O
of	O
variance	O
disclosed	O
a	O
significant	O
effect	O
of	O
sex	O
,	O
exposure	O
to	O
environmental	O
tobacco	O
smoke	O
and	O
day	O
of	O
examination	O
on	O
1	B
-	I
hydroxypyrene	I
concentrations	O
not	O
corrected	O
for	O
creatinine	O
.	O

the	O
appropriate	O
sample	O
size	O
for	O
population	O
studies	O
and	O
the	O
minimum	O
number	O
of	O
observations	O
for	O
the	O
individual	O
assessment	O
of	O
environmental	O
exposure	O
to	O
pahs	O
calculated	O
on	O
the	O
basis	O
of	O
inter-	O
and	O
intraindividual	O
variability	O
of	O
1	B
-	I
hydroxypyrene	I
concentrations	O
in	O
urine	O
amounted	O
to	O
164	O
and	O
99	O
,	O
respectively	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
may	O
be	O
considered	O
a	O
good	O
indicator	O
of	O
environmental	O
exposure	O
to	O
pahs	O
at	O
the	O
group	O
level	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
levels	O
and	O
some	O
genotoxicity	O
parameters	O
(	O
sister	O
-	O
chromatid	O
exchange	O
,	O
sce	O
;	O
micronucleus	O
,	O
mn	O
)	O
have	O
been	O
compared	O
among	O
engine	O
repair	O
workers	O
(	O
n	O
=	O
61	O
,	O
age	O
:	O
between	O
13	O
and	O
18	O
)	O
and	O
workers	O
not	O
occupationally	O
exposed	O
to	O
pah	O
(	O
n	O
=	O
30	O
,	O
age	O
:	O
between	O
13	O
and	O
19	O
)	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
levels	O
of	O
garbage	O
collectors	O
with	O
low	O
-	O
level	O
exposure	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
..	O
because	O
garbage	O
collectors	O
work	O
in	O
the	O
street	O
,	O
they	O
are	O
exposed	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
in	O
motor	O
vehicle	O
exhaust	O
gas	O
as	O
they	O
work	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
oh	O
-	O
pyrene	O
)	O
began	O
to	O
be	O
used	O
as	O
a	O
biological	O
monitoring	O
index	O
for	O
human	O
exposure	O
to	O
high	O
concentrations	O
of	O
pahs	O
.	O

we	O
determined	O
the	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
hp	O
)	O
concentration	O
and	O
the	O
creatinine	O
-	O
adjusted	O
1	O
-	O
hp	O
concentration	O
in	O
644	O
randomly	O
selected	O
dutch	O
children	O
,	O
aged	O
1	O
-	O
6	O
years	O
and	O
living	O
in	O
five	O
areas	O
with	O
roughly	O
different	O
levels	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
in	O
soil	O
and	O
ambient	O
air	O
.	O

the	O
aim	O
of	O
study	O
was	O
to	O
assess	O
the	O
uptake	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
by	O
children	O
living	O
in	O
a	O
city	O
and	O
its	O
effect	O
on	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
excretion	O
.	O

1-	O
,	O
2-	O
,	O
3-	O
,	O
and	O
4	O
-	O
hydroxyphenanthrenes	O
,	O
and	O
1	B
-	I
hydroxypyrene	I
)	O
.	O

1	B
-	I
hydroxyfluorene	I
exhibited	O
the	O
greatest	O
difference	O
between	O
smokers	O
and	O
nonsmokers	O
,	O
with	O
a	O
5	O
-	O
fold	O
difference	O
in	O
polish	O
subjects	O
and	O
a	O
25	O
-	O
fold	O
difference	O
in	O
us	O
subjects	O
,	O
followed	O
by	O
3-	O
and	O
2	O
-	O
hydroxyfluorenes	O
,	O
2	O
-	O
naphthol	O
,	O
and	O
1	B
-	I
hydroxypyrene	I
.	O

1	B
-	I
hydroxyfluorene	I
had	O
the	O
highest	O
correlation	O
with	O
urine	O
nicotine	O
equivalents	O
(	O
r	O
=	O
0.77	O
)	O
and	O
urine	O
nnal	O
(	O
r	O
=	O
0.64	O
)	O
.	O

while	O
the	O
half	O
-	O
lives	O
of	O
pah	O
metabolites	O
were	O
<	O
10	O
h	O
in	O
smokers	O
,	O
1	B
-	I
hydroxyfluorene	I
had	O
the	O
largest	O
ratio	O
of	O
initial	O
to	O
terminal	O
urine	O
concentration	O
(	O
58.4	O
±	O
38.6	O
,	O
mean	O
±	O
sd	O
)	O
after	O
smoking	O
.	O

receiver	O
operating	O
characteristic	O
(	O
roc	O
)	O
analysis	O
of	O
pahs	O
among	O
polish	O
and	O
us	O
subjects	O
further	O
showed	O
that	O
hydroxyfluorenes	O
are	O
most	O
highly	O
discriminative	O
of	O
smokers	O
from	O
nonsmokers	O
followed	O
by	O
2	O
-	O
naphthol	O
and	O
1	B
-	I
hydroxypyrene	I
.	O

in	O
conclusion	O
,	O
hydroxyfluorenes	O
,	O
particularly	O
1	B
-	I
hydroxyfluorene	I
,	O
and	O
2	O
-	O
naphthol	O
are	O
more	O
selective	O
of	O
tobacco	O
smoke	O
than	O
1	B
-	I
hydroxypyrene	I
and	O
hydroxyphenanthrenes	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
;	O
a	O
biomarker	O
of	O
pah	O
exposure	O
)	O
was	O
determined	O
by	O
reverse	O
-	O
phase	O
-	O
hplc	O
;	O
dna	O
damage	O
by	O
the	O
comet	O
assay	O
(	O
olive	O
tail	O
moment	O
(	O
otm	O
)	O
parameter	O
)	O
;	O
cyp1a1	O
*	O
2c	O
and	O
cyp1b1	O
*	O
3	O
polymorphisms	O
by	O
real	O
time	O
-	O
pcr	O
;	O
and	O
gstm1	O
*	O
0	O
and	O
gstt1	O
*	O
0	O
by	O
multiplex	O
pcr	O
.	O

urinary	O
levels	O
of	O
1	B
-	I
hydroxypyrene	I
in	O
children	O
residing	O
near	O
a	O
coal	O
-	O
fired	O
power	O
plant	O
..	O
background	O
:	O
the	O
effects	O
of	O
emissions	O
from	O
coal	O
-	O
fired	O
power	O
plants	O
on	O
children	O
's	O
exposure	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
are	O
not	O
well	O
understood	O
.	O

objectives	O
:	O
this	O
study	O
aimed	O
to	O
evaluate	O
the	O
sources	O
and	O
the	O
urinary	O
levels	O
of	O
1	B
-	I
hydroxypyrene	I
,	O
a	O
biomarker	O
of	O
exposure	O
to	O
pahs	O
,	O
among	O
children	O
living	O
in	O
proximity	O
to	O
a	O
coal	O
-	O
fired	O
power	O
plant	O
.	O

each	O
child	O
's	O
urinary	O
1	B
-	I
hydroxypyrene	I
concentration	O
was	O
measured	O
by	O
a	O
high	O
-	O
performance	O
liquid	O
chromatography	O
-	O
fluorescence	O
detector	O
method	O
.	O

multiple	O
regression	O
analysis	O
was	O
used	O
to	O
assess	O
factors	O
significantly	O
associated	O
with	O
urinary	O
1	B
-	I
hydroxypyrene	I
levels	O
.	O

children	O
living	O
in	O
high	O
exposure	O
communities	O
had	O
higher	O
mean	O
urinary	O
1	B
-	I
hydroxypyrene	I
concentrations	O
than	O
those	O
in	O
low	O
exposure	O
communities	O
(	O
0.186	O
and	O
0.194	O
vs.	O
0.113	O
and	O
0.122	O
μmol	O
/	O
mol	O
-	O
creatinine	O
,	O
respectively	O
)	O
.	O

the	O
difference	O
in	O
urinary	O
1	B
-	I
hydroxypyrene	I
levels	O
between	O
the	O
high	O
exposure	O
communities	O
and	O
one	O
low	O
exposure	O
community	O
remained	O
significant	O
after	O
adjusting	O
for	O
age	O
,	O
gender	O
,	O
environmental	O
tobacco	O
smoke	O
,	O
dietary	O
exposure	O
,	O
and	O
traffic	O
.	O

conclusions	O
:	O
children	O
living	O
in	O
communities	O
downwind	O
of	O
and	O
in	O
proximity	O
to	O
the	O
coal	O
-	O
fired	O
power	O
plant	O
had	O
significantly	O
increased	O
urinary	O
1	B
-	I
hydroxypyrene	I
levels	O
.	O

the	O
concentrations	O
of	O
8	O
-	O
hydroxy-2'-deoxyguanosine	O
(	O
8	O
-	O
ohdg	O
)	O
,	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
,	O
inorganic	O
arsenic	O
(	O
ias	O
)	O
and	O
monomethylarsonic	O
acid	O
(	O
mma	O
)	O
,	O
and	O
cotinine	B
in	O
spot	O
urine	O
samples	O
,	O
collected	O
from	O
134	O
children	O
(	O
3	O
-	O
6	O
yrs	O
)	O
from	O
a	O
kindergarten	O
in	O
kanagawa	O
,	O
japan	O
,	O
were	O
measured	O
as	O
biomarkers	O
of	O
oxidative	O
stress	O
or	O
exposure	O
to	O
environmental	O
chemicals	O
.	O

the	O
median	O
(	O
min	O
-	O
max	O
)	O
creatinine	O
-	O
corrected	O
concentrations	O
of	O
urinary	O
biomarkers	O
were	O
4.45	O
(	O
1.98	O
-	O
12.3	O
)	O
,	O
0.127	O
(	O
0.04	O
-	O
2.41	O
)	O
,	O
4.78	O
(	O
1.18	O
-	O
12.7	O
)	O
,	O
and	O
0.62	O
(	O
<	O
0.6	O
-	O
19.0	O
)	O
μg	O
/	O
g	O
cre	O
for	O
8	O
-	O
ohdg	O
,	O
1	O
-	O
ohp	O
,	O
ias+mma	O
,	O
and	O
cotinine	B
,	O
respectively	O
.	O

results	O
:	O
we	O
found	O
that	O
increased	O
urinary	O
2	B
-	I
hydroxynaphthalene	I
(	O
2	O
-	O
ohna	O
)	O
levels	O
were	O
associated	O
with	O
increased	O
comet	O
parameters	O
,	O
including	O
the	O
percentage	O
of	O
dna	O
in	O
the	O
tail	O
(	O
tail%	O
)	O

the	O
urinary	O
level	O
of	O
1	B
-	I
hydroxypyrene	I
was	O
associated	O
only	O
with	O
increased	O
tail%	O
(	O
5.32	O
;	O
95	O
%	O
ci	O
,	O
0.47	O
-	O
10.17	O
)	O
.	O

seasonal	O
variations	O
in	O
the	O
levels	O
of	O
pah	B
-	I
dna	I
adducts	I
in	O
young	O
adults	O
living	O
in	O
mexico	O
city	O
..	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
are	O
ubiquitous	O
components	O
of	O
polluted	O
air	O
.	O

the	O
bioactivation	O
of	O
some	O
pahs	O
produces	O
reactive	O
metabolites	O
that	O
bind	O
to	O
dna	O
,	O
and	O
the	O
presence	O
of	O
elevated	O
levels	O
of	O
pah	B
-	I
dna	I
adducts	I
in	O
tissues	O
such	O
as	O
blood	O
lymphocytes	O
represents	O
an	O
elevated	O
risk	O
for	O
the	O
development	O
of	O
cancer	O
.	O

we	O
have	O
compared	O
the	O
levels	O
of	O
pah	B
-	I
dna	I
adducts	I
and	O
the	O
percentage	O
of	O
cells	O
with	O
chromosomal	O
aberrations	O
(	O
cwas	O
)	O
using	O
a	O
matched	O
set	O
of	O
peripheral	O
blood	O
lymphocytes	O
obtained	O
on	O
two	O
separate	O
occasions	O
from	O
young	O
non	O
-	O
smoking	O
inhabitants	O
of	O
the	O
mcma	O
(	O
n	O
=	O
92	O
)	O
during	O
the	O
2006	O
dry	O
season	O
and	O
the	O
following	O
rainy	O
season	O
.	O

pah	B
-	I
dna	I
adducts	I
were	O
analysed	O
using	O
the	O
r7	O
,	O
t8	O
-	O
dihydroxy	O
-	O
t-9	O
,	O
10	O
-	O
oxy-7,8,9,10	O
-	O
tetrahydrobenzo[a]pyrene	O
(	O
bpde)-dna	O
chemiluminescence	O
immunoassay	O
(	O
cia	O
)	O
.	O

the	O
levels	O
of	O
pah	B
-	I
dna	I
adducts	I
were	O
significantly	O
higher	O
(	O
p	O
<	O
0.001	O
)	O
in	O
the	O
dry	O
season	O
(	O
10.66	O
±	O
3.05	O
per	O
10(9	O
)	O
nt	O
,	O
n	O
=	O
92	O
)	O
than	O
during	O
the	O
rainy	O
season	O
(	O
9.50	O
±	O
2.85	O
per	O
10(9	O
)	O
nt	O
,	O
n	O
=	O
92	O
)	O
and	O
correlated	O
with	O
the	O
seasonal	O
levels	O
of	O
particulate	O
matter	O
with	O
a	O
diameter	O
of	O
≤	O
10	O
μm	O
(	O
pm(10	O
)	O
)	O
.	O

urinary	O
levels	O
of	O
2	O
-	O
naphthol	O
and	O
1	B
-	I
hydroxypyrene	I
(	O
biomarkers	O
of	O
exposure	O
to	O
pahs	O
)	O
,	O
and	O
malondialdehyde	O
(	O
mda	O
;	O
a	O
biomarker	O
of	O
oxidative	O
stress	O
)	O
were	O
analyzed	O
in	O
715	O
pregnant	O
women	O
at	O
12	O
-	O
28	O
weeks	O
of	O
gestation	O
.	O

urinary	O
2	O
-	O
naphthol	O
,	O
1	B
-	I
hydroxypyrene	I
and	O
mda	O
levels	O
were	O
analyzed	O
by	O
high	O
-	O
performance	O
liquid	O
chromatography	O
-	O
fluorescence	O
detection	O
.	O

results	O
:	O
the	O
urinary	O
mda	O
level	O
was	O
positively	O
correlated	O
with	O
the	O
2	O
-	O
naphthol	O
level	O
(	O
r=0.255	O
,	O
p<0.001	O
)	O
and	O
1	B
-	I
hydroxypyrene	I
level	O
(	O
r=0.240	O
,	O
p<0.001	O
)	O
.	O

multiple	O
regression	O
analysis	O
after	O
adjustment	O
for	O
covariates	O
revealed	O
that	O
the	O
urinary	O
1	B
-	I
hydroxypyrene	I
level	O
was	O
positively	O
associated	O
with	O
the	O
mda	O
level	O
;	O
these	O
positive	O
associations	O
only	O
existed	O
in	O
pregnant	O
women	O
,	O
with	O
either	O
the	O
fruit	O
and	O
vegetable	O
intake	O
or	O
the	O
vitamin	O
c	O
intake	O
in	O
the	O
first	O
tertile	O
(	O
<	O
390.1	O
 	O
g	O
/	O
day	O
)	O
or	O
in	O
the	O
first	O
and	O
second	O
tertiles	O
(	O
<	O
141.5	O
 	O
mg	O
/	O
day	O
)	O
,	O
respectively	O
.	O

urinary	O
levels	O
of	O
2	O
-	O
naphthol	O
and	O
1	B
-	I
hydroxypyrene	I
(	O
biomarkers	O
of	O
exposure	O
to	O
pahs	O
)	O
,	O
and	O
malondialdehyde	O
(	O
mda	O
;	O
a	O
biomarker	O
of	O
oxidative	O
stress	O
)	O
were	O
analyzed	O
in	O
715	O
pregnant	O
women	O
at	O
12	O
-	O
28	O
weeks	O
of	O
gestation	O
.	O

urinary	O
2	O
-	O
naphthol	O
,	O
1	B
-	I
hydroxypyrene	I
and	O
mda	O
levels	O
were	O
analyzed	O
by	O
high	O
-	O
performance	O
liquid	O
chromatography	O
-	O
fluorescence	O
detection	O
.	O

results	O
:	O
the	O
urinary	O
mda	O
level	O
was	O
positively	O
correlated	O
with	O
the	O
2	O
-	O
naphthol	O
level	O
(	O
r=0.255	O
,	O
p<0.001	O
)	O
and	O
1	B
-	I
hydroxypyrene	I
level	O
(	O
r=0.240	O
,	O
p<0.001	O
)	O
.	O

multiple	O
regression	O
analysis	O
after	O
adjustment	O
for	O
covariates	O
revealed	O
that	O
the	O
urinary	O
1	B
-	I
hydroxypyrene	I
level	O
was	O
positively	O
associated	O
with	O
the	O
mda	O
level	O
;	O
these	O
positive	O
associations	O
only	O
existed	O
in	O
pregnant	O
women	O
,	O
with	O
either	O
the	O
fruit	O
and	O
vegetable	O
intake	O
or	O
the	O
vitamin	O
c	O
intake	O
in	O
the	O
first	O
tertile	O
(	O
<	O
390.1	O
 	O
g	O
/	O
day	O
)	O
or	O
in	O
the	O
first	O
and	O
second	O
tertiles	O
(	O
<	O
141.5	O
 	O
mg	O
/	O
day	O
)	O
,	O
respectively	O
.	O

the	O
influence	O
of	O
metabolic	O
gene	O
polymorphisms	O
on	O
urinary	O
1	B
-	I
hydroxypyrene	I
concentration	O
in	O
thai	O
bus	O
drivers	O
..	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
are	O
associated	O
with	O
an	O
increased	O
cancer	O
risk	O
.	O

exposure	O
of	O
children	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
in	O
mexico	O
:	O
assessment	O
of	O
multiple	O
sources	O
..	O
purpose	O
:	O
biological	O
monitoring	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
has	O
expanded	O
rapidly	O
since	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
was	O
suggested	O
as	O
a	O
biological	O
index	O
for	O
pyrene	O
.	O

individual	O
exposures	O
to	O
pahs	O
were	O
measured	O
as	O
spot	O
urinary	O
concentrations	O
of	O
four	O
pah	O
metabolites	O
,	O
including	O
1	O
-	O
naphthol	O
(	O
1	O
-	O
n	O
)	O
,	O
2	O
-	O
naphthol	O
(	O
2	O
-	O
n	O
)	O
,	O
2	B
-	I
hydroxyfluorene	I
(	O
2	O
-	O
of	O
)	O
and	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
op	O
)	O
,	O
which	O
were	O
adjusted	O
by	O
urinary	O
creatinine	O
(	O
cr	O
)	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
levels	O
in	O
offshore	O
workers	O
..	O
objectives	O
:	O
to	O
compare	O
differences	O
in	O
pre-	O
and	O
post	O
-	O
shift	O
urinary	O
1	B
-	I
hydroxypyrene	I

using	O
lc	O
-	O
ms	O
/	O
ms	O
,	O
four	O
urinary	O
metabolites	O
of	O
pah	O
including	O
1	B
-	I
hydroxynaphthalene	I
(	O
1	O
-	O
n	O
)	O
,	O
2	B
-	I
hydroxynaphthalene	I
(	O
2	O
-	O
n	O
)	O
,	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
p	O
)	O
and	O
2	B
-	I
hydroxyfluorene	I
(	O
2	O
-	O
f	O
)	O
were	O
measured	O
in	O
spot	O
urinary	O
samples	O
,	O
which	O
were	O
adjusted	O
by	O
urinary	O
creatinine	O
(	O
cr	O
)	O
.	O

a	O
limited	O
number	O
of	O
studies	O
have	O
suggested	O
that	O
pahs	O
exposure	O
may	O
be	O
associated	O
with	O
semen	O
quality	O
.	O
to	O
examine	O
the	O
association	O
of	O
four	O
pah	O
metabolites	O
,	O
1	O
-	O
hydroxynapthalene	O
(	O
1	O
-	O
n	O
)	O
,	O
2	O
-	O
hydroxynapthalene	O
(	O
2	O
-	O
n	O
)	O
,	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
and	O
2	B
-	I
hydroxyfluorene	I
(	O
2	O
-	O
ohf	O
)	O
with	O
altered	O
semen	O
quality	O
,	O
542	O
subjects	O
were	O
recruited	O
through	O
the	O
clinic	O
following	O
strict	O
eligibility	O
screening	O
.	O
using	O
lc	O
-	O
ms	O
/	O
ms	O
,	O
individual	O
exposures	O
were	O
measured	O
as	O
spot	O
urinary	O
concentrations	O
of	O
pah	O
metabolites	O
adjusted	O
by	O
creatinine	O
(	O
cr	O
)	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
and	O
pah	O
exposure	O
in	O
4	O
-	O
year	O
-	O
old	O
spanish	O
children	O
..	O
aims	O
:	O
exposure	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
,	O
among	O
the	O
main	O
compounds	O
present	O
in	O
polluted	O
urban	O
air	O
,	O
is	O
of	O
concern	O
for	O
children	O
's	O
health	O
.	O

childhood	O
exposure	O
to	O
pah	O
was	O
assessed	O
by	O
urinary	O
monitoring	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
,	O
a	O
pyrene	O
metabolite	O
,	O
investigating	O
its	O
association	O
with	O
exposure	O
to	O
air	O
pollution	O
and	O
other	O
factors	O
related	O
to	O
pah	O
in	O
air	O
.	O

seasonal	O
and	O
regional	O
contributors	O
of	O
1	B
-	I
hydroxypyrene	I
among	O
children	O
near	O
a	O
steel	O
mill	O
..	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
is	O
a	O
biomarker	O
of	O
exposure	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pah	O
)	O
.	O

urinary	O
1	B
-	I
hydroxypyrene	I
,	O
air	O
pollution	O
exposure	O
and	O
associated	O
life	O
style	O
factors	O
in	O
pregnant	O
women	O
..	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
is	O
a	O
biomarker	O
of	O
exposure	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
.	O

1	B
-	I
hydroxypyrene	I
could	O
be	O
a	O
good	O
marker	O
of	O
exposure	O
to	O
pahs	O
from	O
tobacco	O
and	O
diet	O
,	O
and	O
also	O
a	O
useful	O
marker	O
of	O
short	O
term	O
exposure	O
to	O
air	O
pollution	O
.	O

levels	O
of	O
1	B
-	I
hydroxypyrene	I
,	O
symptoms	O
and	O
immunologic	O
markers	O
in	O
vulcanization	O
workers	O
in	O
the	O
southern	O
sweden	O
rubber	O
industries	O
..	O
objectives	O
:	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
hp	O
)	O
levels	O
in	O
contemporary	O
swedish	O
vulcanization	O
workers	O
and	O
in	O
controls	O
.	O

we	O
evaluated	O
the	O
influence	O
of	O
physicochemical	O
properties	O
of	O
four	O
thms	O
(	O
chloroform	O
,	O
bromodichloromethane	O
,	O
dibromochloromethane	B
,	O
and	O
bromoform	O
)	O
on	O
the	O
internal	O
dose	O
after	O
showering	O
.	O

thm	O
levels	O
were	O
significantly	O
correlated	O
between	O
different	O
matrices	O
(	O
e.g.	O
dibromochloromethane	B
levels	O
)	O
in	O
water	O
and	O
air	O
(	O
r=0.941	O
)	O
;	O
blood	O
and	O
water	O
(	O
r=0.845	O
)	O
;	O
and	O
blood	O
and	O
air	O
(	O
r=0.831	O
)	O
.	O

results	O
:	O
blood	O
σthm	O
[	O
sum	O
of	O
chloroform	O
(	O
tcm	O
)	O
,	O
bromodichloromethane	B
(	O
bdcm	O
)	O
,	O
dibromo	O
-	O
chloromethane	O
(	O
dbcm	O
)	O
,	O
and	O
bromoform	O
(	O
tbm	O
)	O
]	O
concentrations	O
varied	O
by	O
site	O
and	O
season	O
.	O

the	O
results	O
reported	O
show	O
that	O
only	O
chloroform	O
and	O
bromodichloromethane	B
were	O
detected	O
in	O
the	O
urine	O
of	O
those	O
people	O
exposed	O
,	O
which	O
can	O
be	O
used	O
as	O
a	O
specific	O
index	O
of	O
exposure	O
to	O
these	O
compounds	O
.	O

the	O
results	O
reported	O
show	O
that	O
only	O
chloroform	O
and	O
bromodichloromethane	B
were	O
detected	O
in	O
the	O
urine	O
of	O
those	O
people	O
exposed	O
,	O
which	O
can	O
be	O
used	O
as	O
a	O
specific	O
index	O
of	O
exposure	O
to	O
these	O
compounds	O
.	O

decreased	O
birth	O
weight	O
in	O
relation	O
to	O
maternal	O
urinary	O
trichloroacetic	B
acid	I
levels	O
..	O
background	O
:	O
the	O
effect	O
of	O
exposure	O
to	O
disinfection	O
by	O
-	O
products	O
(	O
dbps	O
)	O
during	O
pregnancy	O
on	O
newborn	O
's	O
birth	O
weight	O
has	O
been	O
commonly	O
described	O
in	O
animal	O
studies	O
.	O

validation	O
of	O
urinary	O
trichloroacetic	B
acid	I
as	O
a	O
biomarker	O
of	O
exposure	O
to	O
drinking	O
water	O
disinfection	O
by	O
-	O
products	O
..	O
disinfection	O
by	O
-	O
products	O
(	O
dbps	O
)	O
in	O
drinking	O
water	O
represent	O
a	O
public	O
health	O
issue	O
and	O
a	O
challenge	O
for	O
epidemiology	O
to	O
provide	O
evidence	O
towards	O
the	O
causation	O
of	O
various	O
hypothesized	O
health	O
effects	O
.	O

the	O
objective	O
of	O
this	O
study	O
was	O
to	O
validate	O
urinary	O
trichloroacetic	B
acid	I
(	O
tcaa	O
)	O
excretion	O
as	O
a	O
biomarker	O
of	O
exposure	O
to	O
dbps	O
in	O
an	O
experimental	O
exposure	O
cohort	O
.	O

in	O
addition	O
,	O
the	O
urine	O
levels	O
of	O
4'-oh	B
-	I
phip	I
(	O
2	O
-	O
amino-1	O
-	O
methyl-6-(4'-hydroxy)phenylimidazo[4,5	O
-	O
b]pyridine	O
)	O
and	O
5	B
-	I
oh	I
-	I
phip	I
(	O
2	O
-	O
amino-1	O
-	O
methyl-6-(5	O
-	O
hydroxy)phenylimidazo[4,5	O
-	O
b]pyridine	O
)	O
also	O
showed	O
a	O
narrow	O
variation	O
between	O
the	O
samples	O
.	O

the	O
analysis	O
of	O
urine	O
samples	O
after	O
acid	O
hydrolysis	O
did	O
not	O
give	O
additional	O
information	O
but	O
showed	O
a	O
notable	O
increase	O
in	O
norharman	B
in	O
some	O
cases	O
.	O

in	O
addition	O
,	O
the	O
urine	O
levels	O
of	O
4'-oh	B
-	I
phip	I
(	O
2	O
-	O
amino-1	O
-	O
methyl-6-(4'-hydroxy)phenylimidazo[4,5	O
-	O
b]pyridine	O
)	O
and	O
5	B
-	I
oh	I
-	I
phip	I
(	O
2	O
-	O
amino-1	O
-	O
methyl-6-(5	O
-	O
hydroxy)phenylimidazo[4,5	O
-	O
b]pyridine	O
)	O
also	O
showed	O
a	O
narrow	O
variation	O
between	O
the	O
samples	O
.	O

the	O
analysis	O
of	O
urine	O
samples	O
after	O
acid	O
hydrolysis	O
did	O
not	O
give	O
additional	O
information	O
but	O
showed	O
a	O
notable	O
increase	O
in	O
norharman	B
in	O
some	O
cases	O
.	O

sixteen	O
(	O
18.6	O
%	O
)	O
of	O
86	O
nonsmokers	O
were	O
positive	O
for	O
urinary	O
2	O
-	O
amino-9h	O
-	O
pyrido[2,3	O
-	O
b]indole	O
(	O
aalphac	B
)	O
versus	O
41	O
(	O
48.8	O
%	O
)	O
of	O
84	O
cigarette	O
smokers	O
;	O
the	O
difference	O
was	O
statistically	O
significant	O
(	O
p	O
<	O
0.001	O
)	O
.	O

the	O
number	O
of	O
cigarettes	O
smoked	O
per	O
day	O
was	O
positively	O
and	O
significantly	O
related	O
to	O
urinary	O
levels	O
of	O
aalphac	B
in	O
study	O
subjects	O
(	O
p	O
<	O
0.001	O
)	O
;	O
the	O
mean	O
level	O
among	O
nonsmokers	O
was	O
2.54	O
ng	O
/	O
g	O
creatinine	O
,	O
whereas	O
the	O
means	O
for	O
light	O
(	O
1	O
-	O
19	O
cigarettes	O
per	O
day	O
)	O
and	O
heavy	O
(	O
20	O
+	O
cigarettes	O
per	O
day	O
)	O
smokers	O
were	O
7.50	O
and	O
11.92	O
ng	O
/	O
g	O
creatinine	O
,	O
respectively	O
.	O

our	O
data	O
indicate	O
that	O
aalphac	B
represents	O
a	O
major	O
haa	O
exposure	O
in	O
adult	O
men	O
of	O
shanghai	O
,	O
china	O
,	O
and	O
that	O
tobacco	O
smoke	O
is	O
an	O
important	O
point	O
source	O
of	O
their	O
aalphac	B
exposure	O
.	O

the	O
profile	O
for	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	O
)	O
was	O
dominated	O
by	O
the	O
most	O
chlorinated	O
congener	O
,	O
ocdd	B
(	O
>	O
58	O
%	O
)	O
,	O
while	O
decreasing	O
concentrations	O
with	O
increasing	O
degree	O
of	O
chlorination	O
were	O
seen	O
for	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	O
)	O
;	O
mocdfs	B
(	O
>	O
83	O
%	O
)	O
and	O
dicdfs	B
(	O
>	O
6	O
%	O
)	O
.	O

moreover	O
,	O
mocdfs	B
contributed	O
more	O
than	O
60	O
%	O
of	O
the	O
∑cl(1	O
-	O
8)dd	O
/	O
fs	O
and	O
was	O
highly	O
correlated	O
with	O
∑cl(1	O
-	O
8)dd	O
/	O
fs	O
.	O

fs	O
(	O
r(s)=0.96	O
)	O
,	O
and	O
the	O
combination	O
of	O
2	O
-	O
mocdf	O
and	O
ocdd	B
could	O
explain	O
the	O
95.9	O
%	O
variation	O
in	O
the	O
serum	O
of	O
∑cl(1	O
-	O
8)dd	O
/	O
fs	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

results	O
:	O
a	O
10	O
%	O
increase	O
in	O
the	O
concentrations	O
of	O
2	B
-	I
hydroxyfluorene	I
was	O
significantly	O
negatively	O
associated	O
with	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
-11.2	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.2	O
to	O
-0.02	O
)	O
,	O
forced	O
vital	O
capacity	O
(	O
-11.6	O
ml	O
,	O
95	O
%	O
ci	O
:	O
-22.9	O
to	O
-0.2	O
)	O
,	O
and	O
ph	O
of	O
ebc	O
(	O
-0.035	O
,	O
95	O
%	O
ci	O
:	O
-0.066	O
to	O
-0.005	O
)	O
.	O

the	O
congeners	O
1,2,3,4,6,7,8	O
-	O
heptachlorodibenzodioxin	O
and	O
pcb-114	B
were	O
significantly	O
higher	O
in	O
current	O
firefighters	O
when	O
compared	O
to	O
former	O
or	O
non	O
-	O
firefighters	O
.	O

the	O
congeners	O
1,2,3,4,6,7,8	O
-	O
heptachlorodibenzodioxin	O
and	O
pcb-114	B
were	O
significantly	O
higher	O
in	O
current	O
firefighters	O
when	O
compared	O
to	O
former	O
or	O
non	O
-	O
firefighters	O
.	O

concentrations	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
,	O
polychlorinated	O
dibenzofurans	O
,	O
and	O
polychlorinated	O
biphenyls	O
in	O
blood	O
and	O
breast	O
milk	O
collected	O
from	O
pregnant	O
women	O
in	O
sapporo	O
city	O
,	O
japan	O
..	O
we	O
measured	O
the	O
concentrations	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	B
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
,	O
dioxin	O
-	O
like	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
in	O
paired	O
samples	O
of	O
blood	O
and	O
breast	O
milk	O
collected	O
from	O
67	O
secundiparas	O
in	O
sapporo	O
city	O
,	O
japan	O
,	O
and	O
combined	O
this	O
data	O
with	O
those	O
of	O
the	O
30	O
secundiparas	O
previously	O
measured	O
.	O

the	O
arithmetic	O
mean	O
total	O
toxic	O
equivalents	O
(	O
teq	O
-	O
who	O
)	O
concentrations	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
non	O
-	O
ortho	O
pcbs	B
,	O
and	O
mono	O
-	O
ortho	O
pcbs	B
in	O
blood	O
and	O
breast	O
milk	O
of	O
the	O
97	O
secundiparous	O
subjects	O
were	O
3.0	O
-	O
23	O
(	O
mean	O
:	O
13	O
,	O
median	O
:	O
14	O
)	O
and	O
2.7	O
-	O
20	O
(	O
mean	O
:	O
8.6	O
,	O
median	O
:	O
8.5	O
)	O
pg	O
teq	O
g(-1	O
)	O
lipid	O
,	O
respectively	O
.	O

the	O
partitioning	O
ratios	O
of	O
individual	O
congeners	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
dioxin	O
-	O
like	O
pcbs	B
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
from	O
blood	O
to	O
breast	O
milk	O
in	O
secundiparas	O
were	O
almost	O
the	O
same	O
as	O
those	O
of	O
primiparas	O
that	O
have	O
been	O
recently	O
reported	O
,	O
suggesting	O
that	O
the	O
partitioning	O
ratios	O
of	O
these	O
compounds	O
from	O
maternal	O
blood	O
to	O
breast	O
milk	O
in	O
women	O
is	O
little	O
affected	O
by	O
delivery	O
.	O

we	O
measured	O
the	O
concentrations	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	B
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
,	O
dioxin	O
-	O
like	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
in	O
paired	O
samples	O
of	O
blood	O
and	O
breast	O
milk	O
collected	O
from	O
67	O
secundiparas	O
in	O
sapporo	O
city	O
,	O
japan	O
,	O
and	O
combined	O
this	O
data	O
with	O
those	O
of	O
the	O
30	O
secundiparas	O
previously	O
measured	O
.	O

the	O
arithmetic	O
mean	O
total	O
toxic	O
equivalents	O
(	O
teq	O
-	O
who	O
)	O
concentrations	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
non	O
-	O
ortho	O
pcbs	B
,	O
and	O
mono	O
-	O
ortho	O
pcbs	B
in	O
blood	O
and	O
breast	O
milk	O
of	O
the	O
97	O
secundiparous	O
subjects	O
were	O
3.0	O
-	O
23	O
(	O
mean	O
:	O
13	O
,	O
median	O
:	O
14	O
)	O
and	O
2.7	O
-	O
20	O
(	O
mean	O
:	O
8.6	O
,	O
median	O
:	O
8.5	O
)	O
pg	O
teq	O
g(-1	O
)	O
lipid	O
,	O
respectively	O
.	O

the	O
partitioning	O
ratios	O
of	O
individual	O
congeners	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
dioxin	O
-	O
like	O
pcbs	B
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
from	O
blood	O
to	O
breast	O
milk	O
in	O
secundiparas	O
were	O
almost	O
the	O
same	O
as	O
those	O
of	O
primiparas	O
that	O
have	O
been	O
recently	O
reported	O
,	O
suggesting	O
that	O
the	O
partitioning	O
ratios	O
of	O
these	O
compounds	O
from	O
maternal	O
blood	O
to	O
breast	O
milk	O
in	O
women	O
is	O
little	O
affected	O
by	O
delivery	O
.	O

among	O
17	O
congeners	O
of	O
pcdd	O
/	O
fs	O
,	O
the	O
2,3,7,8	O
-	O
tcdf	O
,	O
1,2,3,7,8	O
-	O
pecdf	O
,	O
2,3,4,7,8	O
-	O
pecdf	O
,	O
1,2,3,4,7,8	O
-	O
hxcdf	O
,	O
1,2,3,6,7,8	O
-	O
hxcdf	O
,	O
and	O
2,3,4,6,7,8	B
-	I
hxcdf	I
congener	O
concentrations	O
in	O
2007	O
increased	O
134	O
%	O
,	O
55	O
%	O
,	O
53	O
%	O
,	O
57	O
%	O
,	O
65	O
%	O
and	O
130	O
%	O
when	O
compared	O
to	O
2002	O
levels	O
,	O
respectively	O
.	O

among	O
17	O
congeners	O
of	O
pcdd	O
/	O
fs	O
,	O
the	O
2,3,7,8	O
-	O
tcdf	O
,	O
1,2,3,7,8	O
-	O
pecdf	O
,	O
2,3,4,7,8	O
-	O
pecdf	O
,	O
1,2,3,4,7,8	O
-	O
hxcdf	O
,	O
1,2,3,6,7,8	O
-	O
hxcdf	O
,	O
and	O
2,3,4,6,7,8	B
-	I
hxcdf	I
congener	O
concentrations	O
in	O
2007	O
increased	O
134	O
%	O
,	O
55	O
%	O
,	O
53	O
%	O
,	O
57	O
%	O
,	O
65	O
%	O
and	O
130	O
%	O
when	O
compared	O
to	O
2002	O
levels	O
,	O
respectively	O
.	O

distribution	O
of	O
pcdd	B
/	I
fs	I
,	O
pcbs	B
,	O
pbdes	B
and	O
organochlorine	O
residues	O
in	O
children	O
's	O
blood	O
from	O
zhejiang	O
,	O
china	O
..	O
concentrations	O
and	O
congener	O
specific	O
profiles	O
of	O
pcdd	B
/	I
fs	I
,	O
pcbs	B
,	O
pbdes	B
and	O
organochlorine	O
residues	O
were	O
measured	O
in	O
22	O
pooled	O
blood	O
samples	O
representing	O
66	O
children	O
from	O
both	O
polluted	O
areas	O
(	O
e	O
-	O
waste	O
recycling	O
region	O
)	O
and	O
case	O
control	O
areas	O
in	O
zhejiang	O
province	O
,	O
china	O
.	O

who	O
-	O
teq-2005	O
for	O
pcbs	B
and	O
pcdd	B
/	I
fs	I
were	O
11.9+/-4.62	O
pg	O
g(-1	O
)	O
lipid	O
and	O
10.3+/-6.39	O
pg	O
g(-1	O
)	O
lipid	O
,	O
respectively	O
.	O

the	O
results	O
showed	O
that	O
pcbs	B
,	O
pbdes	B
and	O
organochlorine	O
residues	O
in	O
the	O
e	O
-	O
waste	O
recycling	O
area	O
were	O
significantly	O
(	O
p<0.001	O
)	O
higher	O
than	O
the	O
case	O
control	O
areas	O
.	O

high	O
levels	O
of	O
pcdd	B
/	I
fs	I
were	O
detected	O
in	O
the	O
case	O
control	O
area	O
(	O
longyou	O
)	O
,	O
where	O
na	O
-	O
pcp	O
had	O
been	O
widely	O
sprayed	O
to	O
prevent	O
snailborne	O
schistosomiasis	O
.	O

the	O
contamination	O
levels	O
and	O
profiles	O
were	O
compared	O
with	O
those	O
documented	O
in	O
previous	O
publications	O
..	O
concentrations	O
and	O
congener	O
specific	O
profiles	O
of	O
pcdd	B
/	I
fs	I
,	O
pcbs	B
,	O
pbdes	B
and	O
organochlorine	O
residues	O
were	O
measured	O
in	O
22	O
pooled	O
blood	O
samples	O
representing	O
66	O
children	O
from	O
both	O
polluted	O
areas	O
(	O
e	O
-	O
waste	O
recycling	O
region	O
)	O
and	O
case	O
control	O
areas	O
in	O
zhejiang	O
province	O
,	O
china	O
.	O

who	O
-	O
teq-2005	O
for	O
pcbs	B
and	O
pcdd	B
/	I
fs	I
were	O
11.9+/-4.62	O
pg	O
g(-1	O
)	O
lipid	O
and	O
10.3+/-6.39	O
pg	O
g(-1	O
)	O
lipid	O
,	O
respectively	O
.	O

the	O
results	O
showed	O
that	O
pcbs	B
,	O
pbdes	B
and	O
organochlorine	O
residues	O
in	O
the	O
e	O
-	O
waste	O
recycling	O
area	O
were	O
significantly	O
(	O
p<0.001	O
)	O
higher	O
than	O
the	O
case	O
control	O
areas	O
.	O

high	O
levels	O
of	O
pcdd	B
/	I
fs	I
were	O
detected	O
in	O
the	O
case	O
control	O
area	O
(	O
longyou	O
)	O
,	O
where	O
na	O
-	O
pcp	O
had	O
been	O
widely	O
sprayed	O
to	O
prevent	O
snailborne	O
schistosomiasis	O
.	O

the	O
contamination	O
levels	O
and	O
profiles	O
were	O
compared	O
with	O
those	O
documented	O
in	O
previous	O
publications	O
..	O
concentrations	O
and	O
congener	O
specific	O
profiles	O
of	O
pcdd	B
/	I
fs	I
,	O
pcbs	B
,	O
pbdes	B
and	O
organochlorine	O
residues	O
were	O
measured	O
in	O
22	O
pooled	O
blood	O
samples	O
representing	O
66	O
children	O
from	O
both	O
polluted	O
areas	O
(	O
e	O
-	O
waste	O
recycling	O
region	O
)	O
and	O
case	O
control	O
areas	O
in	O
zhejiang	O
province	O
,	O
china	O
.	O

who	O
-	O
teq-2005	O
for	O
pcbs	B
and	O
pcdd	B
/	I
fs	I
were	O
11.9+/-4.62	O
pg	O
g(-1	O
)	O
lipid	O
and	O
10.3+/-6.39	O
pg	O
g(-1	O
)	O
lipid	O
,	O
respectively	O
.	O

the	O
results	O
showed	O
that	O
pcbs	B
,	O
pbdes	B
and	O
organochlorine	O
residues	O
in	O
the	O
e	O
-	O
waste	O
recycling	O
area	O
were	O
significantly	O
(	O
p<0.001	O
)	O
higher	O
than	O
the	O
case	O
control	O
areas	O
.	O

high	O
levels	O
of	O
pcdd	B
/	I
fs	I
were	O
detected	O
in	O
the	O
case	O
control	O
area	O
(	O
longyou	O
)	O
,	O
where	O
na	O
-	O
pcp	O
had	O
been	O
widely	O
sprayed	O
to	O
prevent	O
snailborne	O
schistosomiasis	O
.	O

levels	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
and	O
dibenzofurans	O
(	O
pcdd	O
/	O
fs	O
)	O
and	O
trace	O
metals	O
in	O
the	O
blood	O
of	O
nonoccupationally	O
exposed	O
residents	O
living	O
in	O
the	O
vicinity	O
of	O
a	O
municipal	O
solid	O
waste	O
incinerator	O
and	O
electric	O
arc	O
furnace	O
..	O
this	O
study	O
examines	O
levels	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	B
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
,	O
and	O
trace	O
metals	O
in	O
the	O
blood	O
of	O
the	O
nonoccupationally	O
exposed	O
residents	O
living	O
in	O
the	O
vicinity	O
of	O
municipal	O
solid	O
waste	O
incinerators	O
(	O
mswis	O
)	O
and	O
electric	O
arc	O
furnaces	O
(	O
eafs	O
)	O
.	O

we	O
measured	O
the	O
concentrations	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	B
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
,	O
dioxin	O
-	O
like	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
in	O
paired	O
samples	O
of	O
blood	O
and	O
breast	O
milk	O
collected	O
from	O
89	O
primiparous	O
mothers	O
in	O
sapporo	O
city	O
,	O
japan	O
,	O
and	O
studied	O
the	O
relationships	O
of	O
these	O
compounds	O
between	O
blood	O
and	O
breast	O
milk	O
for	O
these	O
women	O
plus	O
30	O
primiparous	O
mothers	O
in	O
whom	O
these	O
data	O
had	O
been	O
previously	O
reported	O
.	O

the	O
present	O
study	O
is	O
one	O
of	O
the	O
few	O
studies	O
in	O
which	O
the	O
concentration	O
distributions	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
dioxin	O
-	O
like	O
pcbs	B
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
have	O
been	O
investigated	O
in	O
blood	O
and	O
breast	O
milk	O
collected	O
from	O
the	O
same	O
mothers	O
.	O

the	O
arithmetic	O
mean	O
teq	O
concentrations	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
non	O
-	O
ortho	O
pcbs	B
,	O
and	O
mono	O
-	O
ortho	O
pcbs	B
in	O
blood	O
and	O
breast	O
milk	O
of	O
these	O
119	O
subjects	O
were	O
8.2	O
,	O
2.9	O
,	O
5.1	O
,	O
and	O
0.4	O
pg	O
teq	O
g(-1)lipid	O
,	O
respectively	O
,	O
and	O
4.8	O
,	O
2.0	O
,	O
4.0	O
,	O
and	O
0.4	O
pg	O
teq	O
g(-1)lipid	O
,	O
respectively	O
,	O
with	O
the	O
total	O
teq	O
concentrations	O
of	O
these	O
dioxin	O
-	O
like	O
compounds	O
being	O
7.0	O
-	O
36	O
(	O
mean	O
:	O
17	O
,	O
median	O
:	O
14	O
)	O
and	O
5.7	O
-	O
41	O
(	O
mean	O
:	O
11	O
,	O
median	O
:	O
10	O
)	O
pg	O
teq	O
g(-1)lipid	O
,	O
respectively	O
.	O

statistically	O
significant	O
correlations	O
were	O
observed	O
between	O
maternal	O
age	O
and	O
the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
or	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
maternal	O
blood	O
,	O
and	O
significant	O
correlations	O
were	O
also	O
observed	O
between	O
maternal	O
age	O
and	O
the	O
total	O
teq	O
concentration	O
of	O
these	O
dioxin	O
-	O
like	O
compounds	O
or	O
the	O
total	O
concentration	O
of	O
56	O
pcb	O
congeners	O
in	O
breast	O
milk	O
.	O

the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
in	O
maternal	O
blood	O
showed	O
a	O
close	O
correlation	O
to	O
that	O
in	O
subjects	O
'	O
breast	O
milk	O
,	O
and	O
there	O
was	O
also	O
good	O
correlation	O
between	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
maternal	O
blood	O
and	O
that	O
in	O
subjects	O
'	O
breast	O
milk	O
.	O

pearson	O
and	O
spearman	O
correlation	O
analyses	O
showed	O
a	O
relationship	O
between	O
the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
and	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
maternal	O
blood	O
,	O
and	O
also	O
showed	O
an	O
association	O
between	O
the	O
total	O
teq	O
concentration	O
of	O
these	O
dioxin	O
-	O
like	O
compounds	O
and	O
the	O
total	O
concentration	O
of	O
56	O
pcb	O
congeners	O
in	O
breast	O
milk	O
.	O

the	O
concentration	O
of	O
hexacb-153	O
in	O
maternal	O
blood	O
showed	O
significant	O
correlations	O
to	O
the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
or	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
in	O
that	O
sample	O
.	O

these	O
findings	O
suggested	O
that	O
hexacb-153	O
may	O
be	O
an	O
indicator	O
of	O
total	O
teq	O
concentrations	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
and	O
total	O
concentrations	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
blood	O
and	O
breast	O
milk	O
of	O
primiparous	O
mothers	O
..	O
we	O
measured	O
the	O
concentrations	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	B
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
,	O
dioxin	O
-	O
like	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
in	O
paired	O
samples	O
of	O
blood	O
and	O
breast	O
milk	O
collected	O
from	O
89	O
primiparous	O
mothers	O
in	O
sapporo	O
city	O
,	O
japan	O
,	O
and	O
studied	O
the	O
relationships	O
of	O
these	O
compounds	O
between	O
blood	O
and	O
breast	O
milk	O
for	O
these	O
women	O
plus	O
30	O
primiparous	O
mothers	O
in	O
whom	O
these	O
data	O
had	O
been	O
previously	O
reported	O
.	O

the	O
present	O
study	O
is	O
one	O
of	O
the	O
few	O
studies	O
in	O
which	O
the	O
concentration	O
distributions	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
dioxin	O
-	O
like	O
pcbs	B
,	O
and	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
have	O
been	O
investigated	O
in	O
blood	O
and	O
breast	O
milk	O
collected	O
from	O
the	O
same	O
mothers	O
.	O

the	O
arithmetic	O
mean	O
teq	O
concentrations	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
non	O
-	O
ortho	O
pcbs	B
,	O
and	O
mono	O
-	O
ortho	O
pcbs	B
in	O
blood	O
and	O
breast	O
milk	O
of	O
these	O
119	O
subjects	O
were	O
8.2	O
,	O
2.9	O
,	O
5.1	O
,	O
and	O
0.4	O
pg	O
teq	O
g(-1)lipid	O
,	O
respectively	O
,	O
and	O
4.8	O
,	O
2.0	O
,	O
4.0	O
,	O
and	O
0.4	O
pg	O
teq	O
g(-1)lipid	O
,	O
respectively	O
,	O
with	O
the	O
total	O
teq	O
concentrations	O
of	O
these	O
dioxin	O
-	O
like	O
compounds	O
being	O
7.0	O
-	O
36	O
(	O
mean	O
:	O
17	O
,	O
median	O
:	O
14	O
)	O
and	O
5.7	O
-	O
41	O
(	O
mean	O
:	O
11	O
,	O
median	O
:	O
10	O
)	O
pg	O
teq	O
g(-1)lipid	O
,	O
respectively	O
.	O

statistically	O
significant	O
correlations	O
were	O
observed	O
between	O
maternal	O
age	O
and	O
the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
or	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
maternal	O
blood	O
,	O
and	O
significant	O
correlations	O
were	O
also	O
observed	O
between	O
maternal	O
age	O
and	O
the	O
total	O
teq	O
concentration	O
of	O
these	O
dioxin	O
-	O
like	O
compounds	O
or	O
the	O
total	O
concentration	O
of	O
56	O
pcb	O
congeners	O
in	O
breast	O
milk	O
.	O

the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
in	O
maternal	O
blood	O
showed	O
a	O
close	O
correlation	O
to	O
that	O
in	O
subjects	O
'	O
breast	O
milk	O
,	O
and	O
there	O
was	O
also	O
good	O
correlation	O
between	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
maternal	O
blood	O
and	O
that	O
in	O
subjects	O
'	O
breast	O
milk	O
.	O

pearson	O
and	O
spearman	O
correlation	O
analyses	O
showed	O
a	O
relationship	O
between	O
the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
and	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
maternal	O
blood	O
,	O
and	O
also	O
showed	O
an	O
association	O
between	O
the	O
total	O
teq	O
concentration	O
of	O
these	O
dioxin	O
-	O
like	O
compounds	O
and	O
the	O
total	O
concentration	O
of	O
56	O
pcb	O
congeners	O
in	O
breast	O
milk	O
.	O

the	O
concentration	O
of	O
hexacb-153	O
in	O
maternal	O
blood	O
showed	O
significant	O
correlations	O
to	O
the	O
total	O
teq	O
concentration	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
or	O
the	O
total	O
concentration	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
in	O
that	O
sample	O
.	O

these	O
findings	O
suggested	O
that	O
hexacb-153	O
may	O
be	O
an	O
indicator	O
of	O
total	O
teq	O
concentrations	O
of	O
pcdds	B
,	O
pcdfs	B
,	O
and	O
dioxin	O
-	O
like	O
pcbs	B
and	O
total	O
concentrations	O
of	O
56	O
non	O
-	O
dioxin	O
-	O
like	O
pcb	O
congeners	O
in	O
blood	O
and	O
breast	O
milk	O
of	O
primiparous	O
mothers	O
.	O

pcdd	O
/	O
f	O
and	O
pcb	O
in	O
human	O
serum	O
of	O
differently	O
exposed	O
population	O
groups	O
of	O
an	O
italian	O
city	O
..	O
a	O
chemical	O
plant	O
located	O
in	O
brescia	O
,	O
an	O
industrial	O
city	O
in	O
north	O
-	O
western	O
italy	O
,	O
produced	O
polychlorobiphenyls	O
(	O
pcbs	B
)	O
during	O
a	O
30	O
-	O
50	O
year	O
period	O
,	O
causing	O
widespread	O
pollution	O
of	O
the	O
surrounding	O
agricultural	O
area	O
.	O

the	O
respective	O
contribution	O
of	O
pcdds	O
,	O
pcdfs	O
,	O
mono	O
-	O
ortho	O
and	O
non	O
-	O
ortho	O
pcbs	B
(	O
dioxin	O
-	O
like	O
pcbs	B
)	O
to	O
(	O
toxicity	O
equivalents	O
)	O
teq	O
of	O
the	O
population	O
groups	O
of	O
this	O
study	O
were	O
also	O
compared	O
to	O
literature	O
data	O
:	O
the	O
two	O
groups	O
with	O
a	O
high	O
contamination	O
level	O
,	O
together	O
with	O
the	O
human	O
milk	O
sample	O
,	O
displayed	O
a	O
higher	O
incidence	O
of	O
mono	O
-	O
ortho	O
pcbs	B
and	O
a	O
lower	O
contribution	O
of	O
pcdd	O
,	O
possibly	O
correlated	O
with	O
the	O
source	O
of	O
contamination	O
..	O
a	O
chemical	O
plant	O
located	O
in	O
brescia	O
,	O
an	O
industrial	O
city	O
in	O
north	O
-	O
western	O
italy	O
,	O
produced	O
polychlorobiphenyls	O
(	O
pcbs	B
)	O
during	O
a	O
30	O
-	O
50	O
year	O
period	O
,	O
causing	O
widespread	O
pollution	O
of	O
the	O
surrounding	O
agricultural	O
area	O
.	O

the	O
respective	O
contribution	O
of	O
pcdds	O
,	O
pcdfs	O
,	O
mono	O
-	O
ortho	O
and	O
non	O
-	O
ortho	O
pcbs	B
(	O
dioxin	O
-	O
like	O
pcbs	B
)	O
to	O
(	O
toxicity	O
equivalents	O
)	O
teq	O
of	O
the	O
population	O
groups	O
of	O
this	O
study	O
were	O
also	O
compared	O
to	O
literature	O
data	O
:	O
the	O
two	O
groups	O
with	O
a	O
high	O
contamination	O
level	O
,	O
together	O
with	O
the	O
human	O
milk	O
sample	O
,	O
displayed	O
a	O
higher	O
incidence	O
of	O
mono	O
-	O
ortho	O
pcbs	B
and	O
a	O
lower	O
contribution	O
of	O
pcdd	O
,	O
possibly	O
correlated	O
with	O
the	O
source	O
of	O
contamination	O
.	O

employees	O
working	O
only	O
in	O
the	O
pentachlorophenol	O
units	O
had	O
mean	O
lipid	O
-	O
adjusted	O
levels	O
for	O
123478	O
-	O
h6cdd	O
of	O
16.1	O
ppt	O
,	O
123678	O
-	O
h6cdd	O
of	O
150.6	O
ppt	O
,	O
123789	O
-	O
h6cdd	O
of	O
20.2	O
ppt	O
,	O
1234678	O
-	O
h7cdd	O
of	O
192.6	O
ppt	O
,	O
and	O
ocdd	B
of	O
2,594.0	O
ppt	O
compared	O
with	O
the	O
worker	O
referent	O
levels	O
for	O
the	O
same	O
congeners	O
of	O
7.5	O
,	O
74.7	O
,	O
8.6	O
,	O
68.7	O
,	O
and	O
509.1	O
ppt	O
,	O
respectively	O
.	O

evaluation	O
of	O
pcdd	B
/	I
fs	I
patterns	O
emitted	O
from	O
incinerator	O
via	O
direct	O
ambient	O
sampling	O
and	O
indirect	O
serum	O
levels	O
assessment	O
of	O
taiwanese	O
..	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
pcdd	B
/	I
fs	I
patterns	O
in	O
ambient	O
air	O
based	O
on	O
data	O
information	O
emitted	O
from	O
incinerator	O
generated	O
from	O
ambient	O
air	O
measurements	O
and	O
those	O
in	O
serum	O
.	O

four	O
circular	O
zones	O
,	O
namely	O
a	O
,	O
b	O
,	O
c	O
,	O
and	O
d	O
,	O
were	O
identified	O
based	O
on	O
simulated	O
ambient	O
annual	O
average	O
pcdd	B
/	I
fs	I
concentrations	O
,	O
from	O
a	O
selected	O
municipal	O
waste	O
incinerator	O
.	O

pcdd	B
/	I
fs	I
profiles	O
were	O
documented	O
both	O
for	O
air	O
and	O
serum	O
samples	O
collected	O
.	O

comparing	O
to	O
the	O
congener	O
patterns	O
from	O
ambient	O
air	O
and	O
serum	O
samples	O
,	O
we	O
found	O
that	O
ocdd	O
,	O
ocdf	O
,	O
1,2,3,4,6,7,8	O
-	O
hpcdd	O
,	O
and	O
1,2,3,4,6,7,8	B
-	I
hpcdf	I
were	O
the	O
predominant	O
groups	O
among	O
17	O
congeners	O
from	O
both	O
the	O
ambient	O
air	O
and	O
serum	O
sample	O
.	O

and	O
,	O
factor	O
analysis	O
showed	O
the	O
distribution	O
patterns	O
of	O
pcdd	B
/	I
fs	I
from	O
ambient	O
air	O
and	O
serum	O
samples	O
are	O
almost	O
identical	O
across	O
different	O
zones	O
,	O
except	O
for	O
congener	O
patterns	O
of	O
serum	O
samples	O
from	O
residents	O
in	O
zone	O
c.	O
in	O
addition	O
,	O
the	O
average	O
pcdd	B
/	I
fs	I
level	O
significantly	O
reduced	O
for	O
about	O
10	O
folds	O
than	O
those	O
of	O
the	O
other	O
three	O
seasons	O
when	O
the	O
incinerator	O
was	O
shut	O
down	O
in	O
one	O
of	O
sampling	O
periods	O
.	O

we	O
might	O
conclude	O
that	O
ambient	O
air	O
exposure	O
was	O
the	O
most	O
important	O
contributor	O
to	O
pcdd	B
/	I
fs	I
levels	O
in	O
ambient	O
air	O
but	O
not	O
the	O
single	O
in	O
serum	O
.	O

profile	O
of	O
pcdd	O
/	O
f	O
levels	O
in	O
serum	O
of	O
general	O
taiwanese	O
between	O
different	O
gender	O
,	O
age	O
and	O
smoking	O
status	O
..	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
and	O
dibenzofurans	O
(	O
pcdd	B
/	I
fs	I
)	O
are	O
persistent	O
organic	O
pollutants	O
that	O
are	O
resistant	O
to	O
environmental	O
and	O
biological	O
degradation	O
and	O
disperse	O
into	O
various	O
environmental	O
compartments	O
throughout	O
the	O
atmosphere	O
,	O
water	O
,	O
soil	O
,	O
sediments	O
,	O
and	O
food	O
.	O

many	O
factors	O
,	O
such	O
as	O
age	O
,	O
sex	O
,	O
lifestyle	O
,	O
and	O
metabolism	O
,	O
can	O
explain	O
the	O
distribution	O
of	O
serum	O
levels	O
after	O
humans	O
exposed	O
to	O
pcdd	B
/	I
fs	I
.	O

the	O
aim	O
of	O
our	O
study	O
was	O
therefore	O
to	O
investigate	O
the	O
pcdd	B
/	I
fs	I
distribution	O
and	O
profile	O
of	O
the	O
general	O
population	O
in	O
northern	O
taiwan	O
.	O

in	O
addition	O
,	O
nonsmokers	O
and	O
passive	O
smokers	O
showed	O
higher	O
levels	O
of	O
pcdd	B
/	I
fs	I
than	O
active	O
smokers	O
.	O

the	O
serum	O
concentrations	O
of	O
2,3,4,7,8	O
-	O
pecdf	O
;	O
1,2,3,7,8	O
-	O
pecdd	O
;	O
and	O
1,2,3,6,7,8	B
-	I
hxcdd	I
in	O
some	O
subjects	O
seemed	O
to	O
increase	O
with	O
their	O
age	O
,	O
which	O
might	O
have	O
been	O
caused	O
by	O
the	O
longer	O
half	O
-	O
lives	O
of	O
these	O
substances	O
.	O

in	O
future	O
studies	O
,	O
more	O
information	O
about	O
food	O
consumption	O
,	O
occupational	O
exposure	O
,	O
open	O
-	O
combustion	O
,	O
and	O
other	O
potential	O
factors	O
needs	O
to	O
be	O
collected	O
to	O
clarify	O
the	O
most	O
important	O
factors	O
affecting	O
the	O
distribution	O
of	O
serum	O
pcdd	B
/	I
fs	I
in	O
the	O
general	O
population	O
in	O
taiwan	O
.	O

assessment	O
of	O
current	O
serum	O
levels	O
of	O
pcdd	O
/	O
fs	O
,	O
dl	O
-	O
pcbs	O
and	O
pbdes	B
in	O
a	O
dutch	O
cohort	O
with	O
known	O
perinatal	O
pcdd	O
/	O
f	O
exposure	O
..	O
as	O
part	O
of	O
a	O
longitudinal	O
cohort	O
study	O
,	O
now	O
in	O
its	O
second	O
decade	O
,	O
we	O
determined	O
pcdds	O
/	O
fs	O
dl	O
-	O
pcbs	O
and	O
pbdes	B
in	O
serum	O
of	O
adolescents	O
with	O
known	O
perinatal	O
pcdd	O
/	O
f	O
exposure	O
.	O
of	O
the	O
original	O
cohort	O
,	O
33	O
adolescents	O
aged	O
14	O
-	O
19	O
years	O
,	O
who	O
had	O
been	O
studied	O
previously	O
during	O
their	O
neonatal	O
(	O
n=60	O
)	O
,	O
toddler	O
and	O
pre	O
-	O
pubertal	O
period	O
(	O
n=41	O
)	O
agreed	O
to	O
participate	O
in	O
the	O
current	O
follow	O
-	O
up	O
.	O
pcdd	O
/	O
f-	O
,	O
dl	O
-	O
pcb-	O
and	O
pbde	O
congeners	O
were	O
measured	O
using	O
gc	O
/	O
ms	O
.	O

pbde	O
levels	O
however	O
are	O
relatively	O
high	O
compared	O
to	O
other	O
european	O
countries	O
,	O
more	O
research	O
on	O
possible	O
health	O
effects	O
of	O
these	O
levels	O
,	O
especially	O
for	O
subjects	O
with	O
outlier	O
concentrations	O
,	O
should	O
be	O
performed	O
..	O
as	O
part	O
of	O
a	O
longitudinal	O
cohort	O
study	O
,	O
now	O
in	O
its	O
second	O
decade	O
,	O
we	O
determined	O
pcdds	O
/	O
fs	O
dl	O
-	O
pcbs	O
and	O
pbdes	B
in	O
serum	O
of	O
adolescents	O
with	O
known	O
perinatal	O
pcdd	O
/	O
f	O
exposure	O
.	O
of	O
the	O
original	O
cohort	O
,	O
33	O
adolescents	O
aged	O
14	O
-	O
19	O
years	O
,	O
who	O
had	O
been	O
studied	O
previously	O
during	O
their	O
neonatal	O
(	O
n=60	O
)	O
,	O
toddler	O
and	O
pre	O
-	O
pubertal	O
period	O
(	O
n=41	O
)	O
agreed	O
to	O
participate	O
in	O
the	O
current	O
follow	O
-	O
up	O
.	O
pcdd	O
/	O
f-	O
,	O
dl	O
-	O
pcb-	O
and	O
pbde	O
congeners	O
were	O
measured	O
using	O
gc	O
/	O
ms	O
.	O

pbde	O
levels	O
however	O
are	O
relatively	O
high	O
compared	O
to	O
other	O
european	O
countries	O
,	O
more	O
research	O
on	O
possible	O
health	O
effects	O
of	O
these	O
levels	O
,	O
especially	O
for	O
subjects	O
with	O
outlier	O
concentrations	O
,	O
should	O
be	O
performed	O
..	O
as	O
part	O
of	O
a	O
longitudinal	O
cohort	O
study	O
,	O
now	O
in	O
its	O
second	O
decade	O
,	O
we	O
determined	O
pcdds	O
/	O
fs	O
dl	O
-	O
pcbs	O
and	O
pbdes	B
in	O
serum	O
of	O
adolescents	O
with	O
known	O
perinatal	O
pcdd	O
/	O
f	O
exposure	O
.	O
of	O
the	O
original	O
cohort	O
,	O
33	O
adolescents	O
aged	O
14	O
-	O
19	O
years	O
,	O
who	O
had	O
been	O
studied	O
previously	O
during	O
their	O
neonatal	O
(	O
n=60	O
)	O
,	O
toddler	O
and	O
pre	O
-	O
pubertal	O
period	O
(	O
n=41	O
)	O
agreed	O
to	O
participate	O
in	O
the	O
current	O
follow	O
-	O
up	O
.	O
pcdd	O
/	O
f-	O
,	O
dl	O
-	O
pcb-	O
and	O
pbde	O
congeners	O
were	O
measured	O
using	O
gc	O
/	O
ms	O
.	O

concentrations	O
of	O
polybrominated	O
diphenyl	O
ethers	O
,	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
and	O
dibenzofurans	O
,	O
and	O
polychlorinated	O
biphenyls	O
in	O
human	O
blood	O
samples	O
from	O
korea	O
..	O
analysis	O
of	O
blood	O
samples	O
is	O
an	O
effective	O
way	O
of	O
evaluating	O
contamination	O
by	O
persistent	O
pollutants	O
such	O
as	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
/	O
furans	O
(	O
pcdd	O
/	O
fs	O
)	O
,	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
human	O
population	O
.	O

concentrations	O
of	O
pbdes	B
,	O
pcdd	O
/	O
fs	O
and	O
pcbs	B
were	O
measured	O
in	O
the	O
blood	O
of	O
laborers	O
(	O
n	O
=	O
13	O
)	O
working	O
full	O
time	O
in	O
two	O
different	O
municipal	O
waste	O
incinerator	O
(	O
mwi	O
)	O
plants	O
and	O
residents	O
from	O
the	O
general	O
population	O
(	O
n	O
=	O
22	O
)	O
living	O
in	O
areas	O
near	O
mwis	O
in	O
korea	O
.	O

the	O
concentrations	O
of	O
pbdes	B
were	O
found	O
to	O
be	O
slightly	O
higher	O
in	O
the	O
blood	O
of	O
incineration	O
workers	O
(	O
8.61	O
-	O
46.05	O
ng	O
/	O
g	O
lipid	O
;	O
mean	O
,	O
19.33	O
ng	O
/	O
g	O
lipid	O
;	O
median	O
,	O
15.94	O
ng	O
/	O
g	O
lipid	O
)	O
in	O
comparison	O
to	O
that	O
of	O
residents	O
from	O
the	O
general	O
population	O
(	O
7.24	O
-	O
28.89	O
ng	O
/	O
g	O
lipid	O
;	O
mean	O
,	O
15.06	O
ng	O
/	O
g	O
lipid	O
;	O
median	O
,	O
14.34	O
ng	O
/	O
g	O
lipid	O
)	O
.	O

in	O
addition	O
,	O
the	O
average	O
total	O
crude	O
concentration	O
of	O
pcdd	O
/	O
fs	O
was	O
7.40	O
ng	O
/	O
g	O
lipids	O
,	O
which	O
was	O
4.1	O
times	O
greater	O
than	O
for	O
pbdes	B
.	O

the	O
presence	O
of	O
the	O
bde	O
183	O
congener	O
was	O
characteristic	O
in	O
the	O
blood	O
of	O
workers	O
from	O
an	O
electronic	O
dismantling	O
facility	O
in	O
mwis	O
..	O
analysis	O
of	O
blood	O
samples	O
is	O
an	O
effective	O
way	O
of	O
evaluating	O
contamination	O
by	O
persistent	O
pollutants	O
such	O
as	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
/	O
furans	O
(	O
pcdd	O
/	O
fs	O
)	O
,	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
human	O
population	O
.	O

concentrations	O
of	O
pbdes	B
,	O
pcdd	O
/	O
fs	O
and	O
pcbs	B
were	O
measured	O
in	O
the	O
blood	O
of	O
laborers	O
(	O
n	O
=	O
13	O
)	O
working	O
full	O
time	O
in	O
two	O
different	O
municipal	O
waste	O
incinerator	O
(	O
mwi	O
)	O
plants	O
and	O
residents	O
from	O
the	O
general	O
population	O
(	O
n	O
=	O
22	O
)	O
living	O
in	O
areas	O
near	O
mwis	O
in	O
korea	O
.	O

the	O
concentrations	O
of	O
pbdes	B
were	O
found	O
to	O
be	O
slightly	O
higher	O
in	O
the	O
blood	O
of	O
incineration	O
workers	O
(	O
8.61	O
-	O
46.05	O
ng	O
/	O
g	O
lipid	O
;	O
mean	O
,	O
19.33	O
ng	O
/	O
g	O
lipid	O
;	O
median	O
,	O
15.94	O
ng	O
/	O
g	O
lipid	O
)	O
in	O
comparison	O
to	O
that	O
of	O
residents	O
from	O
the	O
general	O
population	O
(	O
7.24	O
-	O
28.89	O
ng	O
/	O
g	O
lipid	O
;	O
mean	O
,	O
15.06	O
ng	O
/	O
g	O
lipid	O
;	O
median	O
,	O
14.34	O
ng	O
/	O
g	O
lipid	O
)	O
.	O

in	O
addition	O
,	O
the	O
average	O
total	O
crude	O
concentration	O
of	O
pcdd	O
/	O
fs	O
was	O
7.40	O
ng	O
/	O
g	O
lipids	O
,	O
which	O
was	O
4.1	O
times	O
greater	O
than	O
for	O
pbdes	B
.	O

the	O
presence	O
of	O
the	O
bde	O
183	O
congener	O
was	O
characteristic	O
in	O
the	O
blood	O
of	O
workers	O
from	O
an	O
electronic	O
dismantling	O
facility	O
in	O
mwis	O
..	O
analysis	O
of	O
blood	O
samples	O
is	O
an	O
effective	O
way	O
of	O
evaluating	O
contamination	O
by	O
persistent	O
pollutants	O
such	O
as	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
/	O
furans	O
(	O
pcdd	O
/	O
fs	O
)	O
,	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
human	O
population	O
.	O

concentrations	O
of	O
pbdes	B
,	O
pcdd	O
/	O
fs	O
and	O
pcbs	B
were	O
measured	O
in	O
the	O
blood	O
of	O
laborers	O
(	O
n	O
=	O
13	O
)	O
working	O
full	O
time	O
in	O
two	O
different	O
municipal	O
waste	O
incinerator	O
(	O
mwi	O
)	O
plants	O
and	O
residents	O
from	O
the	O
general	O
population	O
(	O
n	O
=	O
22	O
)	O
living	O
in	O
areas	O
near	O
mwis	O
in	O
korea	O
.	O

the	O
concentrations	O
of	O
pbdes	B
were	O
found	O
to	O
be	O
slightly	O
higher	O
in	O
the	O
blood	O
of	O
incineration	O
workers	O
(	O
8.61	O
-	O
46.05	O
ng	O
/	O
g	O
lipid	O
;	O
mean	O
,	O
19.33	O
ng	O
/	O
g	O
lipid	O
;	O
median	O
,	O
15.94	O
ng	O
/	O
g	O
lipid	O
)	O
in	O
comparison	O
to	O
that	O
of	O
residents	O
from	O
the	O
general	O
population	O
(	O
7.24	O
-	O
28.89	O
ng	O
/	O
g	O
lipid	O
;	O
mean	O
,	O
15.06	O
ng	O
/	O
g	O
lipid	O
;	O
median	O
,	O
14.34	O
ng	O
/	O
g	O
lipid	O
)	O
.	O

in	O
addition	O
,	O
the	O
average	O
total	O
crude	O
concentration	O
of	O
pcdd	O
/	O
fs	O
was	O
7.40	O
ng	O
/	O
g	O
lipids	O
,	O
which	O
was	O
4.1	O
times	O
greater	O
than	O
for	O
pbdes	B
.	O

inverse	O
age	O
-	O
dependent	O
accumulation	O
of	O
decabromodiphenyl	O
ether	O
and	O
other	O
pbdes	B
in	O
serum	O
from	O
a	O
general	O
adult	O
population	O
..	O
polybromodiphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
including	O
the	O
decabromodiphenyl	O
congener	O
(	O
bde-209	B
)	O
,	O
were	O
determined	O
in	O
the	O
serum	O
of	O
731	O
individuals	O
from	O
a	O
general	O
adult	O
population	O
(	O
18	O
-	O
74	O
years	O
)	O
collected	O
in	O
2002	O
in	O
catalonia	O
(	O
north	O
-	O
eastern	O
spain	O
)	O
.	O

the	O
bde-209	B
was	O
the	O
predominant	O
congener	O
(	O
median	O
3.7	O
ng	O
/	O
g	O
lipid	O
)	O
followed	O
by	O
bde-47	B
(	O
2.6	O
ng	O
/	O
g	O
lipid	O
)	O
and	O
bde-99	B
(	O
1.2	O
ng	O
/	O

pbdes	B
in	O
this	O
population	O
(	O
median	O
15.4	O
ng	O
/	O
g	O
lipid	O
)	O
ranked	O
amongst	O
the	O
highest	O
of	O
previously	O
described	O
concentrations	O
in	O
populations	O
in	O
europe	O
,	O
asia	O
,	O
new	O
zealand	O
and	O
australia	O
,	O
yet	O
it	O
was	O
lower	O
than	O
those	O
found	O
in	O
north	O
american	O
reports	O
.	O

however	O
,	O
unlike	O
usual	O
trends	O
of	O
higher	O
accumulation	O
of	O
pops	O
through	O
age	O
,	O
the	O
higher	O
concentrations	O
were	O
found	O
in	O
young	O
individuals	O
(	O
<	O
30	O
years	O
)	O
rather	O
than	O
in	O
adults	O
(	O
≥30	O
years	O
)	O
,	O
with	O
differences	O
of	O
14	O
%	O
,	O
31	O
%	O
and	O
46	O
%	O
in	O
the	O
most	O
abundant	O
congeners	O
(	O
i.e.	O
bde-209	B
,	O
bde-99	B
and	O
bde-47	B
,	O
respectively	O
)	O
.	O

this	O
age	O
-	O
dependent	O
distribution	O
of	O
pbdes	B
(	O
including	O
the	O
case	O
for	O
bde-209	B
,	O
which	O
is	O
shown	O
for	O
the	O
first	O
time	O
in	O
this	O
study	O
)	O
is	O
explained	O
by	O
the	O
higher	O
and	O
widespread	O
use	O
of	O
these	O
compounds	O
since	O
the	O
1980s	O
.	O

socio	O
-	O
economic	O
level	O
was	O
also	O
a	O
determinant	O
of	O
bde-47	B
concentrations	O
,	O
but	O
only	O
relevant	O
for	O
the	O
least	O
affluent	O
class	O
,	O
suggesting	O
that	O
lifestyle	O
and	O
environmental	O
conditions	O
in	O
the	O
dwelling	O
place	O
may	O
also	O
contribute	O
to	O
exposure	O
.	O

seven	O
meo	O
-	O
bdes	O
,	O
fifteen	O
oh	O
-	O
bdes	O
and	O
three	O
bromophenols	B
(	O
brps	O
)	O
were	O
analyzed	O
in	O
blood	O
plasma	O
of	O
116	O
humans	O
that	O
had	O
been	O
collected	O
by	O
the	O
hong	O
kong	O
red	O
cross	O
.	O

3	O
-	O
meo	O
-	O
bde-47	O
,	O
6	B
-	I
oh	I
-	I
bde-47	I
and	O
2	O
,	O
4	O
,	O
5	O
-	O
tbp	O
were	O
the	O
predominant	O
meo	O
-	O
bdes	O
,	O
oh	O
-	O
bdes	O
and	O
brps	O
,	O
respectively	O
.	O

coefficients	O
of	O
determination	O
for	O
some	O
pairs	O
of	O
congeners	O
such	O
as	O
3	B
-	I
oh	I
-	I
bde-100	I
and	O
6	B
-	I
oh	I
-	I
bde-47	I
,	O
6	B
-	I
oh	I
-	I
bde-85	I
and	O
5'-oh	O
-	O
bde-99	O
,	O
and	O
2	O
,	O
4	O
-	O
dbp	O
and	O
6	B
-	I
oh	I
-	I
bde-85	I
,	O
were	O
near	O
1.0	O
,	O
which	O
is	O
consistent	O
with	O
them	O
having	O
common	O
sources	O
.	O

serum	O
pbdes	B
in	O
a	O
north	O
carolina	O
toddler	O
cohort	O
:	O
associations	O
with	O
handwipes	O
,	O
house	O
dust	O
,	O
and	O
socioeconomic	O
variables	O
..	O
background	O
:	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
persistent	O
,	O
bioaccumulative	O
,	O
and	O
endocrine	O
-	O
disrupting	O
chemicals	O
.	O

objectives	O
:	O
we	O
used	O
handwipes	O
to	O
estimate	O
exposure	O
to	O
pbdes	B
in	O
house	O
dust	O
among	O
toddlers	O
and	O
examined	O
sex	O
,	O
age	O
,	O
breast	O
-	O
feeding	O
,	O
race	O
,	O
and	O
parents	O
'	O
education	O
as	O
predictors	O
of	O
serum	O
pbdes	B
.	O

blood	O
,	O
handwipe	O
,	O
and	O
house	O
dust	O
samples	O
were	O
collected	O
and	O
analyzed	O
for	O
pbdes	B
.	O

results	O
:	O
pbdes	B
were	O
detected	O
in	O
all	O
serum	O
samples	O
(	O
geometric	O
mean	O
for	O
σpentabde	O
in	O
serum	O
was	O
43.3	O
ng	O
/	O
g	O
lipid	O
)	O
,	O
98	O
%	O
of	O
the	O
handwipe	O
samples	O
,	O
and	O
100	O
%	O
of	O
the	O
dust	O
samples	O
.	O

conclusions	O
:	O
our	O
study	O
suggests	O
that	O
hand	O
-	O
to	O
-	O
mouth	O
activity	O
may	O
be	O
a	O
significant	O
source	O
of	O
exposure	O
to	O
pbdes	B
.	O

specifically	O
,	O
serum	O
σbde3	O
was	O
inversely	O
associated	O
with	O
socioeconomic	O
status	O
,	O
whereas	O
serum	O
bde-153	B
was	O
positively	O
associated	O
with	O
duration	O
of	O
breast	O
-	O
feeding	O
and	O
mother	O
's	O
education	O
.	O

in	O
addition	O
,	O
as	O
pbdes	B
are	O
being	O
phased	O
out	O
and	O
replaced	O
by	O
other	O
flame	O
retardants	O
,	O
the	O
health	O
consequences	O
of	O
these	O
chemical	O
replacements	O
should	O
be	O
investigated	O
and	O
weighed	O
against	O
their	O
purported	O
fire	O
safety	O
benefits	O
.	O

assessment	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
in	O
serum	O
from	O
the	O
korean	O
general	O
population	O
..	O
in	O
2009	O
and	O
2010	O
,	O
720	O
serum	O
samples	O
were	O
collected	O
from	O
non	O
-	O
occupationally	O
exposed	O
study	O
participants	O
at	O
four	O
korean	O
locations	O
and	O
monitored	O
for	O
the	O
presence	O
of	O
27	O
polybrominated	O
diphenyl	O
ether	O
(	O
pbde	O
)	O
congeners	O
.	O

the	O
most	O
abundant	O
congener	O
detected	O
in	O
serum	O
samples	O
was	O
bde-153	B
,	O
followed	O
by	O
bde-47	B
and	O
bde-99	O
.	O

we	O
also	O
observed	O
a	O
positive	O
increase	O
of	O
bde-153	B
with	O
regard	O
to	O
age	O
.	O

in	O
addition	O
,	O
we	O
estimated	O
the	O
daily	O
exposure	O
to	O
pbdes	B
from	O
previously	O
published	O
reports	O
of	O
pbde	O
concentrations	O
in	O
food	O
and	O
dust	O
,	O
and	O
determined	O
the	O
individual	O
contributions	O
of	O
a	O
variety	O
of	O
sources	O
.	O

while	O
the	O
concentration	O
of	O
the	O
decabrominated	O
diphenyl	O
ether	O
(	O
bde-209	B
)	O
increased	O
,	O
the	O
concentration	O
of	O
other	O
congeners	O
(	O
bde-47	O
,	O
bde-99	O
,	O
bde-100	O
,	O
bde-153	O
,	O
bde-154	O
,	O
bde-183	B
)	O
decreased	O
slightly	O
or	O
remained	O
at	O
the	O
same	O
level	O
.	O

prenatal	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
and	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
may	O
influence	O
birth	O
weight	O
among	O
infants	O
in	O
a	O
swedish	O
cohort	O
with	O
background	O
exposure	O
:	O
a	O
cross	O
-	O
sectional	O
study	O
..	O
background	O
:	O
prenatal	O
exposure	O
to	O
persistent	O
organic	O
pollutants	O
,	O
e.g.	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
and	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
has	O
been	O
suggested	O
to	O
negatively	O
affect	O
birth	O
weight	O
although	O
epidemiological	O
evidence	O
is	O
still	O
inconclusive	O
.	O

we	O
investigated	O
if	O
prenatal	O
exposure	O
to	O
pcbs	B
and	O
pbdes	B
is	O
related	O
to	O
birth	O
weight	O
in	O
a	O
swedish	O
population	O
with	O
background	O
exposure	O
.	O

samples	O
were	O
analysed	O
for	O
di	O
-	O
ortho	O
pcbs	B
(	O
cb-138	O
,	O
153	O
,	O
180	O
)	O
and	O
tetra-	O
to	O
hexa-	O
brominated	O
pbdes	B
(	O
bde-47	O
,	O
99	O
,	O
100	O
,	O
153	O
)	O
.	O

results	O
:	O
in	O
the	O
multivariate	O
model	O
,	O
prenatal	O
exposure	O
to	O
di	O
-	O
ortho	O
pcbs	B
was	O
significantly	O
associated	O
with	O
increased	O
birth	O
weight	O
(	O
β	O
 	O
=	O
 	O
137	O
;	O
p	O
 	O
=	O
 	O
0.02	O
)	O
.	O

maternal	O
pre	O
-	O
pregnancy	O
bmi	O
and	O
weight	O
gain	O
during	O
pregnancy	O
were	O
important	O
confounders	O
of	O
the	O
association	O
between	O
di	O
-	O
ortho	O
pcbs	B
and	O
birth	O
weight	O
.	O

conclusions	O
:	O
our	O
results	O
indicate	O
that	O
prenatal	O
exposure	O
to	O
di	O
-	O
ortho	O
pcbs	B
and	O
pbde(4	O
)	O
may	O
influence	O
birth	O
weight	O
in	O
different	O
directions	O
,	O
i.e.	O
pcb	O
exposure	O
was	O
associated	O
with	O
higher	O
birth	O
weight	O
and	O
pbde	O
exposure	O
with	O
lower	O
birth	O
weight	O
.	O

we	O
speculate	O
that	O
even	O
small	O
pcb-	O
and	O
pbde	O
-	O
induced	O
shifts	O
in	O
the	O
distribution	O
of	O
birth	O
weight	O
may	O
influence	O
future	O
public	O
health	O
in	O
populations	O
with	O
background	O
exposure	O
..	O
background	O
:	O
prenatal	O
exposure	O
to	O
persistent	O
organic	O
pollutants	O
,	O
e.g.	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
and	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
has	O
been	O
suggested	O
to	O
negatively	O
affect	O
birth	O
weight	O
although	O
epidemiological	O
evidence	O
is	O
still	O
inconclusive	O
.	O

we	O
investigated	O
if	O
prenatal	O
exposure	O
to	O
pcbs	B
and	O
pbdes	B
is	O
related	O
to	O
birth	O
weight	O
in	O
a	O
swedish	O
population	O
with	O
background	O
exposure	O
.	O

samples	O
were	O
analysed	O
for	O
di	O
-	O
ortho	O
pcbs	B
(	O
cb-138	O
,	O
153	O
,	O
180	O
)	O
and	O
tetra-	O
to	O
hexa-	O
brominated	O
pbdes	B
(	O
bde-47	O
,	O
99	O
,	O
100	O
,	O
153	O
)	O
.	O

results	O
:	O
in	O
the	O
multivariate	O
model	O
,	O
prenatal	O
exposure	O
to	O
di	O
-	O
ortho	O
pcbs	B
was	O
significantly	O
associated	O
with	O
increased	O
birth	O
weight	O
(	O
β	O
 	O
=	O
 	O
137	O
;	O
p	O
 	O
=	O
 	O
0.02	O
)	O
.	O

maternal	O
pre	O
-	O
pregnancy	O
bmi	O
and	O
weight	O
gain	O
during	O
pregnancy	O
were	O
important	O
confounders	O
of	O
the	O
association	O
between	O
di	O
-	O
ortho	O
pcbs	B
and	O
birth	O
weight	O
.	O

conclusions	O
:	O
our	O
results	O
indicate	O
that	O
prenatal	O
exposure	O
to	O
di	O
-	O
ortho	O
pcbs	B
and	O
pbde(4	O
)	O
may	O
influence	O
birth	O
weight	O
in	O
different	O
directions	O
,	O
i.e.	O
pcb	O
exposure	O
was	O
associated	O
with	O
higher	O
birth	O
weight	O
and	O
pbde	O
exposure	O
with	O
lower	O
birth	O
weight	O
.	O

levels	O
of	O
tetrabromobisphenol	O
a	O
,	O
hexabromocyclododecanes	O
and	O
polybrominated	O
diphenyl	O
ethers	O
in	O
human	O
milk	O
from	O
the	O
general	O
population	O
in	O
beijing	O
,	O
china	O
..	O
three	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
,	O
tetrabromobisphenol	O
a	O
(	O
tbbpa	B
)	O
,	O
hexabromocyclododecane	O
(	O
hbcd	B
)	O
and	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
were	O
measured	O
in	O
103	O
human	O
milk	O
samples	O
collected	O
from	O
beijing	O
in	O
2011	O
.	O

ultra	O
-	O
performance	O
liquid	O
chromatography	O
-	O
mass	O
spectrometry	O
(	O
uplc	O
-	O
ms	O
/	O
ms	O
)	O
analysis	O
indicated	O
that	O
the	O
levels	O
of	O
tbbpa	B
ranged	O
from	O
<	O
lod	O
to	O
12.46	O
ng	O
g(-1	O
)	O
lipid	O
weight	O
(	O
lw	O
)	O
,	O
with	O
a	O
median	O
value	O
of	O
0.10	O
ng	O
g(-1	O
)	O
lw	O
.	O

three	O
hbcd	B
diastereoisomers	O
(	O
α-	O
,	O
β-	O
and	O
γ	O
-	O
hbcd	O
)	O
were	O
also	O
measured	O
using	O
uplc	O
-	O
ms	O
/	O
ms	O
.	O

bde-209	B
dominated	O
the	O
pbde	O
profile	O
in	O
the	O
majority	O
of	O
the	O
human	O
milk	O
samples	O
.	O

the	O
mean	O
estimated	O
daily	O
intakes	O
(	O
edis	O
)	O
of	O
tbbpa	B
,	O
σhbcds	O
and	O
σpbdes	O
by	O
breast	O
-	O
fed	O
infants	O
were	O
2.34	O
,	O
24.89	O
and	O
71.27	O
ng	O
kg(-1	O
)	O

hydroxylated	O
polybrominated	O
diphenyl	O
ethers	O
in	O
paired	O
maternal	O
and	O
cord	O
sera	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
were	O
widely	O
used	O
as	O
flame	O
retardants	O
in	O
the	O
past	O
three	O
decades	O
.	O

it	O
is	O
not	O
clear	O
whether	O
hydroxylated	O
pbdes	B
(	O
oh	B
-	I
pbdes	I
)	O
,	O
with	O
greater	O
hydrophilicity	O
,	O
have	O
different	O
concentrations	O
in	O
maternal	O
and	O
cord	O
serum	O
samples	O
.	O

we	O
analyzed	O
pbdes	B
(	O
bde-28	O
,	O
-47	O
,	O
-99	O
,	O
-100	O
,	O
-153	O
,	O
-154	O
,	O
-209	O
)	O
and	O
oh	B
-	I
pbdes	I
(	O
6	O
-	O
oh	O
-	O
bde-47	O
,	O
5	O
-	O
oh	O
-	O
bde-47	O
,	O
4'-oh	O
-	O
bde-49	O
,	O
5'-oh	B
-	I
bde-99	I
)	O
in	O
20	O
pairs	O
of	O
maternal	O
and	O
cord	O
serum	O
samples	O
collected	O
in	O
cincinnati	O
,	O
oh	O
in	O
2011	O
.	O

the	O
geometric	O
mean	O
concentration	O
of	O
∑oh	O
-	O
bdes	O
(	O
the	O
sum	O
of	O
four	O
oh	B
-	I
pbdes	I
)	O
was	O
49.76	O
pg	O
/	O
ml	O
in	O
cord	O
sera	O
,	O
higher	O
than	O
32.84	O
pg	O
/	O
ml	O
in	O
maternal	O
sera	O
.	O

results	O
:	O
a	O
small	O
,	O
imprecise	O
,	O
yet	O
consistent	O
positive	O
association	O
was	O
apparent	O
between	O
bdes	O
47	O
,	O
99	O
,	O
and	O
100	O
and	O
increased	O
externalizing	O
behaviors	O
,	O
specifically	O
activity	O
/	O
impulsivity	O
behaviors	O
.	O
externalizing	O
domain	O
t	O
-	O
scores	O
ranged	O
from	O
30	O
to	O
87	O
with	O
a	O
mean	O
of	O
47.8	O
.	O
compared	O
with	O
those	O
with	O
bde-47	B
concentrations	O
below	O
the	O
median	O
,	O
adjusted	O
externalizing	O
behavior	O
domain	O
scores	O
were	O
1.6	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
):	O
-1.2	O
,	O
4.4	O
]	O
and	O
2.8	O
(	O
95	O
%	O
ci	O
-0.1	O
,	O
5.7	O
)	O
points	O
higher	O
for	O
children	O
born	O
to	O
women	O
with	O
breast	O
milk	O
concentrations	O
in	O
the	O
3rd	O
and	O
4th	O
quartiles	O
,	O
respectively	O
.	O

polybrominated	O
diphenyl	O
ethers	O
exposure	O
in	O
breast	O
milk	O
in	O
shanghai	O
,	O
china	O
:	O
levels	O
,	O
influencing	O
factors	O
and	O
potential	O
health	O
risk	O
for	O
infants	O
..	O
the	O
use	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
is	O
increasing	O
annually	O
in	O
china	O
.	O

the	O
estimated	O
daily	O
intake	O
of	O
pbdes	B
by	O
infants	O
via	O
breastfeeding	O
was	O
determined	O
for	O
evaluating	O
the	O
potential	O
health	O
risk	O
for	O
infants	O
.	O

the	O
median	O
of	O
estimated	O
daily	O
intake	O
of	O
bde-99	B
(	O
6.67	O
ng	O
/	O
kg	O
/	O
day	O
)	O
by	O
infants	O
via	O
breastfeeding	O
was	O
below	O
the	O
human	O
no	O
adverse	O
effect	O
level	O
(	O
nael	O
)	O
set	O
for	O
bde-99	B
for	O
neurodevelopmental	O
toxicity	O
(	O
18.8	O
ng	O
/	O
kg	O
/	O
day	O
)	O
.	O

however	O
,	O
3	O
(	O
6	O
%	O
)	O
of	O
the	O
samples	O
exceeded	O
the	O
human	O
nael	O
.	O
taking	O
the	O
high	O
detection	O
rate	O
of	O
pbdes	B
in	O
breast	O
milk	O
together	O
with	O
6	O
%	O
of	O
their	O
edi	O
higher	O
than	O
nael	O
in	O
shanghai	O
,	O
more	O
studies	O
on	O
the	O
effects	O
of	O
maternal	O
pbde	O
exposure	O
on	O
fetal	O
growth	O
and	O
child	O
neurodevelopment	O
are	O
warranted	O
.	O

levels	O
and	O
congener	O
profiles	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
in	O
breast	O
milk	O
from	O
shanghai	O
:	O
implication	O
for	O
exposure	O
route	O
of	O
higher	O
brominated	O
bdes	O
..	O
breast	O
milk	O
has	O
been	O
widely	O
used	O
as	O
a	O
bioindicator	O
to	O
assess	O
the	O
extent	O
of	O
human	O
exposure	O
to	O
pbdes	B
via	O
various	O
exposure	O
routes	O
.	O

in	O
this	O
study	O
,	O
48	O
breast	O
milk	O
samples	O
were	O
collected	O
from	O
primiparous	O
women	O
in	O
shanghai	O
city	O
,	O
and	O
14	O
pbdes	B
congeners	O
(	O
bde-28	B
,	O
-47	O
,	O
-99	O
,	O
-100	O
,	O
-153	O
,	O
-154	O
,	O
-183	O
,	O
-196	O
,	O
-197	O
,	O
-203	O
,	O
-206	O
,	O
-207	O
,	O
-208	O
,	O
and	O
-209	O
)	O
were	O
quantified	O
using	O
gas	O
chromatography	O
-	O
electron	O
capture	O
negative	O
ionization	O
-	O
mass	O
spectrometry	O
.	O

the	O
mean	O
concentration	O
of	O
total	O
pbdes	B
was	O
8.6	O
ng	O
/	O
g	O
lipid	O
weight	O
,	O
and	O
ranged	O
from	O
1.8	O
to	O
26.7	O
ng	O
/	O
g	O
lipid	O
weight	O
.	O

the	O
congener	O
profiles	O
in	O
this	O
study	O
exhibited	O
a	O
specific	O
pattern	O
in	O
human	O
milk	O
found	O
worldwide	O
,	O
bde-153	B
and	O
bde-28	B
accounted	O
for	O
a	O
relatively	O
higher	O
proportion	O
of	O
lower	O
brominated	O
bdes	O
(	O
from	O
tri-	O
to	O
hepta	O
-	O
bdes	O
)	O
,	O
whereas	O
higher	O
brominated	O
bdes	O
(	O
from	O
octa-	O
to	O
deca	O
-	O
bdes	O
)	O
contributed	O
more	O
than	O
70	O
%	O
of	O
the	O
total	O
pbdes	B
.	O

the	O
spearman	O
's	O
correlation	O
coefficient	O
among	O
higher	O
brominated	O
bdes	O
showed	O
a	O
positive	O
relationship	O
,	O
and	O
concentration	O
levels	O
of	O
higher	O
brominated	O
bdes	O
were	O
statistically	O
different	O
between	O
office	O
workers	O
and	O
housewives	O
.	O
due	O
to	O
relatively	O
higher	O
proportion	O
of	O
pbdes	B
from	O
octa-	O
to	O
deca	O
-	O
bdes	O
were	O
detected	O
,	O
air	O
inhalation	O
and	O
dust	O
ingestion	O
might	O
be	O
the	O
major	O
exposure	O
routes	O
of	O
higher	O
brominated	O
bdes	O
.	O

cord	O
blood	O
levels	O
of	O
thyroid	O
hormones	O
and	O
igf-1	O
weakly	O
correlate	O
with	O
breast	O
milk	O
levels	O
of	O
pbdes	B
in	O
taiwan	O
..	O
in	O
vivo	O
studies	O
indicate	O
that	O
prenatal	O
or	O
neonatal	O
exposure	O
of	O
rodents	O
to	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
disrupts	O
thyroid	O
hormone	O
balance	O
,	O
but	O
few	O
studies	O
have	O
reported	O
an	O
association	O
of	O
pbdes	B
and	O
insulin	O
-	O
like	O
growth	O
factor	O
1	O
(	O
igf-1	O
)	O
.	O

the	O
goal	O
was	O
to	O
examine	O
whether	O
pbdes	B
exposure	O
affects	O
the	O
levels	O
of	O
thyroid	O
hormones	O
and	O
igf-1	O
in	O
cord	O
blood	O
.	O

after	O
examining	O
multiple	O
stepwise	O
linear	O
regression	O
models	O
with	O
adjustment	O
for	O
maternal	O
age	O
,	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
,	O
parity	O
,	O
gestational	O
age	O
,	O
and	O
region	O
(	O
namely	O
,	O
central	O
and	O
southern	O
taiwan	O
)	O
,	O
we	O
found	O
that	O
log	O
of	O
t4	O
in	O
cord	O
blood	O
was	O
significantly	O
but	O
slightly	O
correlated	O
with	O
higher	O
bde-154	B
(	O
b=0.113	O
,	O
p=0.017	O
)	O
in	O
breast	O
milk	O
.	O

the	O
log	O
of	O
ft4	O
concentration	O
was	O
significantly	O
related	O
to	O
a	O
decrease	O
in	O
the	O
log	O
of	O
bde-99	B
level	O
(	O
b=-0.137	O
,	O
p=0.043	O
)	O
and	O
an	O
increase	O
in	O
the	O
log	O
of	O
bde-154	B
level	O
(	O
b=0.158	O
,	O
p=0.008	O
)	O
.	O

meanwhile	O
,	O
the	O
log	O
of	O
igf-1	O
level	O
was	O
also	O
significantly	O
linked	O
to	O
an	O
increase	O
in	O
the	O
log	O
of	O
bde-196	B
level	O
(	O
b=0.532	O
,	O
p=0.028	O
)	O
and	O
decrease	O
in	O
the	O
log	O
of	O
bde-85	B
level	O
(	O
b=-0.235	O
,	O
p=0.018	O
)	O
.	O

few	O
epidemiological	O
studies	O
report	O
an	O
association	O
between	O
pbdes	B
exposure	O
and	O
igf-1	O
.	O

based	O
on	O
our	O
findings	O
,	O
further	O
in	O
vivo	O
and	O
epidemiological	O
studies	O
are	O
encouraged	O
and	O
needed	O
to	O
explore	O
associations	O
between	O
pbdes	B
exposure	O
and	O
levels	O
of	O
thyroid	O
hormones	O
and	O
igf-1	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

these	O
samples	O
were	O
all	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
for	O
other	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
(	O
sum	O
of	O
41	O
congeners	O
)	O
was	O
7.1	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
0.48	O
to	O
1980	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
most	O
common	O
tri-	O
to	O
heptabrominated	O
congeners	O
were	O
bde-47	B
(	O
30	O
%	O
of	O
total	O
)	O
,	O
bde-99	B
(	O
24	O
%	O
)	O
,	O
bde-183	B
(	O
15	O
%	O
)	O
,	O
bde-153	B
(	O
12	O
%	O
)	O
,	O
bde-28	B
(	O
9.5	O
%	O
)	O
,	O
and	O
bde-100	B
(	O
6.2	O
%	O
)	O
.	O

in	O
particular	O
,	O
bde-209	B
was	O
detected	O
in	O
28	O
samples	O
;	O
the	O
median	O
bde-209	B
concentration	O
in	O
these	O
samples	O
was	O
42	O
ng	O
/	O
g	O
lipid	O
,	O
ranging	O
from	O
nd	O
to	O
1770	O
ng	O
/	O
g	O
lipid	O
.	O

the	O
congener	O
with	O
the	O
highest	O
serum	O
concentration	O
was	O
2,2',4,4'-tetrabromodiphenyl	O
ether	O
(	O
bde-47	B
)	O

[	O
geometric	O
mean	O
20.5	O
ng	O
/	O
g	O
lipid	O
]	O
;	O
followed	O
by	O
2,2',4,4',5,5'-hexabde	O
(	O
bde-153	B
)	O

[	O
5.7	O
ng	O
/	O
g	O
lipid	O
]	O
;	O
2,2',4,4',5	O
-	O
pentabde	O
(	O
bde-99	B
)	O
[	O
5.0	O
ng	O
/	O
g	O
lipid	O
;	O
a	O
value	O
equal	O
to	O
the	O
highest	O
limit	O
of	O
detection	O
for	O
an	O
individual	O
sample	O
]	O
;	O
2,2',4,4',6	O
-	O
pentabde	O
(	O
bde-100	B
)	O
[	O
3.9	O
ng	O
/	O
g	O
lipid	O
]	O
;	O
bb-153	O
[	O
2.3	O
ng	O
/	O
g	O
lipid	O
]	O
;	O
and	O
2,4,4'-tribde	O
(	O
bde-28	B
)	O

for	O
bde-47	B
,	O
we	O
observed	O
no	O
significant	O
difference	O
in	O
the	O
least	O
-	O
squares	O
geometric	O
mean	O
(	O
lsgm	O
)	O
by	O
sex	O
,	O
but	O
with	O
age	O
we	O
found	O
both	O
a	O
linear	O
decrease	O
(	O
p	O
=	O
0.01	O
)	O
and	O
a	O
positive	O
quadratic	O
trend	O
(	O
p	O
=	O
0.01	O
)	O
.	O

mexican	O
americans	O
had	O
the	O
highest	O
lsgm	O
of	O
bde-47	B
(	O
24.5	O
ng	O
/	O
g	O
lipid	O
)	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
non	O
-	O
hispanic	O
whites	O
(	O
19.7	O
ng	O
/	O
g	O
lipid	O
,	O
p	O
=	O
0.01	O
)	O
.	O

adults	O
60	O
years	O
and	O
older	O
were	O
twice	O
as	O
likely	O
as	O
adults	O
20	O
-	O
59	O
years	O
old	O
to	O
have	O
a	O
serum	O
bde-47	B
concentration	O
above	O
the	O
95th	O
percentile	O
(	O
p	O
=	O
0.02	O
)	O
.	O

plasma	O
concentrations	O
of	O
selected	O
organobromine	O
compounds	O
and	O
polychlorinated	O
biphenyls	O
in	O
postmenopausal	O
women	O
of	O
québec	O
,	O
canada	O
..	O
background	O
:	O
brominated	O
flame	O
retardants	O
,	O
especially	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
have	O
been	O
widely	O
used	O
in	O
north	O
america	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
level	O
of	O
exposure	O
of	O
human	O
populations	O
to	O
these	O
compounds	O
.	O

methods	O
:	O
we	O
measured	O
concentrations	O
of	O
four	O
pbdes	B
,	O
one	O
polybrominated	O
biphenyl	O
,	O
and	O
for	O
comparative	O
purposes	O
,	O
41	O
polychlorinated	O
biphenyl	O
(	O
pcb	O
)	O
congeners	O
in	O
plasma	O
samples	O
from	O
110	O
healthy	O
postmenopausal	O
women	O
who	O
were	O
recruited	O
at	O
a	O
mammography	O
clinic	O
in	O
2003	O
-	O
2004	O
.	O

results	O
:	O
pbde-47	O
was	O
the	O
major	O
pbde	O
congener	O
,	O
with	O
a	O
mean	O
(	O
geometric	O
)	O
concentration	O
of	O
8.1	O
ng	O
/	O
g	O
lipids	O
and	O
extreme	O
values	O
reaching	O
1,780	O
ng	O
/	O
g.	O
by	O
comparison	O
,	O
the	O
mean	O
concentration	O
of	O
the	O
major	O
pcb	O
congener	O
(	O
pcb-153	B
)	O
was	O
41.7	O
ng	O
/	O
g	O
and	O
the	O
highest	O
value	O
was	O
177	O
ng	O
/	O
g.	O
pbdes	B
47	O
,	O
99	O
,	O
and	O
100	O
were	O
strongly	O
intercorrelated	O
,	O
but	O
weaker	O
correlations	O
were	O
noted	O
with	O
pbde-153	O
.	O

as	O
the	O
sum	O
of	O
pbdes	B
(	O
summation	O
operatorpbdes	O
)	O
increased	O
,	O
the	O
relative	O
contribution	O
of	O
pbde-47	O
to	O
the	O
summation	O
operatorpbdes	O
increased	O
,	O
whereas	O
that	O
of	O
pbde-153	O
decreased	O
.	O

pbde-153	O
was	O
the	O
only	O
brominated	O
compound	O
correlated	O
to	O
pcb-153	B
.	O

age	O
and	O
body	O
mass	O
index	O
gain	O
since	O
the	O
age	O
of	O
18	O
years	O
were	O
significant	O
predictors	O
of	O
pcb-153	B
plasma	O
levels	O
.	O

concentrations	O
of	O
polybrominated	O
diphenyl	O
ethers	O
in	O
blood	O
serum	O
from	O
new	O
zealand	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
were	O
measured	O
in	O
samples	O
of	O
human	O
blood	O
serum	O
taken	O
from	O
23	O
donors	O
in	O
wellington	O
,	O
new	O
zealand	O
.	O

the	O
most	O
likely	O
source	O
of	O
this	O
contamination	O
is	O
considered	O
to	O
be	O
the	O
release	O
of	O
pbdes	B
from	O
imported	O
consumer	O
goods	O
.	O

this	O
study	O
was	O
conducted	O
to	O
examine	O
pbde	O
exposure	O
in	O
koreans	O
,	O
with	O
a	O
special	O
focus	O
on	O
incinerator	O
workers	O
due	O
to	O
their	O
potential	O
for	O
occupational	O
exposure	O
to	O
pbdes	B
.	O

in	O
all	O
groups	O
tested	O
,	O
bde-47	B
was	O
dominant	O

followed	O
by	O
bde-153	B
(	O
23.6	O
%	O
)	O
and	O
relatively	O
high	O
portions	O
of	O
bde-183	B
(	O
16.5	O
%	O
)	O
were	O
found	O
.	O

overall	O
,	O
our	O
data	O
suggest	O
that	O
the	O
occupational	O
exposure	O
of	O
incinerator	O
workers	O
to	O
pbdes	B
can	O
be	O
considered	O
minor	O
,	O
while	O
other	O
lifestyle	O
factors	O
can	O
have	O
a	O
greater	O
contribution	O
to	O
pbde	O
exposure	O
.	O

associations	O
between	O
polybrominated	O
diphenyl	O
ether	O
(	O
pbde	O
)	O
flame	O
retardants	O
,	O
phenolic	O
metabolites	O
,	O
and	O
thyroid	O
hormones	O
during	O
pregnancy	O
..	O
background	O
:	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
chemical	O
additives	O
used	O
as	O
flame	O
retardants	O
in	O
commercial	O
products	O
.	O

pbdes	B
are	O
bioaccumulative	O
and	O
persistent	O
and	O
have	O
been	O
linked	O
to	O
several	O
adverse	O
health	O
outcomes	O
.	O

objectives	O
:	O
this	O
study	O
leverages	O
an	O
ongoing	O
pregnancy	O
cohort	O
to	O
measure	O
pbdes	B
and	O
pbde	O
metabolites	O
in	O
serum	O
collected	O
from	O
an	O
understudied	O
population	O
of	O
pregnant	O
women	O
late	O
in	O
their	O
third	O
trimester	O
.	O

a	O
secondary	O
objective	O
was	O
to	O
determine	O
whether	O
the	O
pbdes	B
or	O
their	O
metabolites	O
were	O
associated	O
with	O
maternal	O
thyroid	O
hormones	O
.	O

serum	O
was	O
analyzed	O
for	O
a	O
suite	O
of	O
pbdes	B
,	O
three	O
phenolic	O
metabolites	O
(	O
i.e.	O
,	O
containing	O
an	O
-oh	O
moiety	O
)	O
,	O
and	O
five	O
thyroid	O
hormones	O
.	O

results	O
:	O
pbdes	B
were	O
detected	O
in	O
all	O
samples	O
and	O
ranged	O
from	O
3.6	O
to	O
694	O
ng	O
/	O
g	O
lipid	O
.	O

associations	O
between	O
t4	O
and	O
pbdes	B
remained	O
after	O
controlling	O
for	O
smoking	O
status	O
,	O
maternal	O
age	O
,	O
race	O
,	O
gestational	O
age	O
,	O
and	O
parity	O
.	O

conclusions	O
:	O
pbdes	B
and	O
oh	O
-	O
bdes	O
are	O
prevalent	O
in	O
this	O
cohort	O
,	O
and	O
levels	O
are	O
similar	O
to	O
those	O
in	O
the	O
general	O
population	O
.	O

given	O
their	O
long	O
half	O
-	O
lives	O
,	O
pbdes	B
may	O
be	O
affecting	O
thyroid	O
regulation	O
throughout	O
pregnancy	O
.	O

further	O
research	O
is	O
warranted	O
to	O
determine	O
mechanisms	O
through	O
which	O
pbdes	B
affect	O
thyroid	O
hormone	O
levels	O
in	O
developing	O
fetuses	O
and	O
newborn	O
babies	O
.	O

human	O
maternal	O
and	O
umbilical	O
cord	O
blood	O
concentrations	O
of	O
polybrominated	O
diphenyl	O
ethers	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
widely	O
used	O
as	O
flame	O
retardants	O
in	O
commercial	O
products	O
,	O
have	O
become	O
ubiquitous	O
environmental	O
contaminants	O
.	O

although	O
adult	O
human	O
exposure	O
to	O
pbdes	B
is	O
well	O
documented	O
,	O
developmental	O
exposure	O
is	O
less	O
well	O
characterized	O
.	O

we	O
conclude	O
that	O
:	O
the	O
fetus	O
is	O
exposed	O
to	O
pbdes	B
from	O
at	O
least	O
the	O
second	O
trimester	O
of	O
pregnancy	O
onward	O
;	O
pbde	O
congeners	O
are	O
higher	O
in	O
ucs	O
compared	O
to	O
maternal	O
serum	O
samples	O
collected	O
at	O
delivery	O
;	O
and	O
that	O
developmental	O
pbde	O
exposure	O
is	O
potentially	O
associated	O
with	O
lower	O
birth	O
weight	O
.	O

negative	O
associations	O
between	O
pbde	O
levels	O
and	O
thyroid	O
hormones	O
in	O
cord	O
blood	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
causing	O
thyroidal	O
effects	O
have	O
been	O
demonstrated	O
in	O
in	O
vivo	O
and	O
in	O
vitro	O
studies	O
.	O

pbdes	B
with	O
structural	O
similarities	O
to	O
thyroid	O
hormones	O
have	O
increased	O
recently	O
,	O
but	O
the	O
health	O
effects	O
for	O
thyroid	O
hormones	O
have	O
not	O
been	O
well	O
studied	O
.	O

a	O
doubling	O
of	O
bde-154	B
was	O
associated	O
with	O
0.043	O
ng	O
/	O
ml	O
lower	O
triiodothyronine	O
(	O
t3	O
)	O
values	O
(	O
adjusted	O
r=-0.245	O
,	O
p=0.043	O
)	O
.	O

likewise	O
a	O
doubling	O
of	O
bde-153	B
was	O
associated	O
with	O
0.143	O
ng	O
/	O
ml	O
lower	O
free	O
t3	O
(	O
ft3	O
)	O
values	O
and	O
a	O
doubling	O
of	O
bde-183	B
with	O
0.084	O
ng	O
/	O
ml	O
lower	O
ft3	O
values	O
(	O
adjusted	O
r=-0.487	O
,	O
p=0.023	O
)	O
.	O

in	O
contrast	O
,	O
the	O
t4	O
(	O
thyroxine)/t3	O
ratio	O
increased	O
by	O
4.93	O
(	O
adjusted	O
r=0.277	O
,	O
p=0.017	O
)	O
when	O
doubling	O
bde-100	B
exposure	O
.	O

no	O
significant	O
associations	O
with	O
bde-47	B
or	O
any	O
other	O
of	O
the	O
pbdes	B
was	O
found	O
.	O

our	O
findings	O
of	O
an	O
inverse	O
relationship	O
between	O
bde-153	B
,	O
bde-154	B
or	O
bde-184	O
and	O
thyroid	O
hormones	O
confirm	O
the	O
results	O
of	O
animal	O
experiments	O
but	O
are	O
in	O
contrast	O
to	O
most	O
epidemiological	O
studies	O
.	O

high	O
postnatal	O
exposures	O
to	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
via	O
breast	O
milk	O
in	O
california	O
:	O
does	O
bde-209	B
transfer	O
to	O
breast	O
milk	O
?	O
.	O

pbde	O
levels	O
varied	O
100	O
-	O
fold	O
.	O
bde-47	B
was	O
the	O
dominant	O
pbde	O
congener	O
,	O
with	O
levels	O
exceeding	O
the	O
u.s.epa	O
reference	O
dose	O
(	O
rfd	O
)	O
for	O
neurodevelopmental	O
toxicity	O
(	O
100	O
ng	O
/	O
kg	O
/	O
day	O
)	O
in	O
most	O
(	O
60	O
%	O
)	O
breast	O
milk	O
samples	O
.	O

in	O
some	O
samples	O
,	O
bde-209	B
(	O
2/82	O
)	O
and/or	O
bde-153	B
(	O
5/82	O
)	O
were	O
the	O
dominant	O
congeners	O
,	O
suggesting	O
that	O
bde-209	B
can	O
transfer	O
to	O
breast	O
milk	O
and/or	O
break	O
down	O
in	O
the	O
mother	O
and	O
transfer	O
to	O
the	O
nursing	O
infant	O
as	O
the	O
lower	O
-	O
brominated	O
pbdes	B
associated	O
with	O
adverse	O
effects	O
.	O

pbde	O
levels	O
in	O
california	O
breast	O
milk	O
are	O
approaching	O
those	O
of	O
pcbs	B
,	O
and	O
the	O
trend	O
pbdes	B
>	O
pcbs	B
may	O
continue	O
as	O
pbdes	B
migrate	O
from	O
products	O
to	O
the	O
indoor	O
and	O
outdoor	O
environments	O
..	O
breast	O
milk	O
samples	O
collected	O
during	O
2003	O
-	O
2005	O
from	O
82	O
first	O
-	O
time	O
mothers	O
in	O
24	O
communities	O
located	O
throughout	O
california	O
contained	O
levels	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
∑(tri	O
-	O
hexa	O
(	O
8))pbdes	O
;	O
median	O
=	O
53.3	O
ng	O
/	O
g	O
lw	O
,	O
range	O
=	O
9.60	O
-	O
1291	O
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
∑(12)pcbs	O
;	O
median	O
=	O
73.4	O
ng	O
/	O
g	O
lw	O
,	O
range	O
=	O
22.2	O
-	O
433	O
)	O
that	O
are	O
among	O
the	O
highest	O
in	O
the	O
world	O
.	O

pbde	O
levels	O
varied	O
100	O
-	O
fold	O
.	O
bde-47	B
was	O
the	O
dominant	O
pbde	O
congener	O
,	O
with	O
levels	O
exceeding	O
the	O
u.s.epa	O
reference	O
dose	O
(	O
rfd	O
)	O
for	O
neurodevelopmental	O
toxicity	O
(	O
100	O
ng	O
/	O
kg	O
/	O
day	O
)	O
in	O
most	O
(	O
60	O
%	O
)	O
breast	O
milk	O
samples	O
.	O

in	O
some	O
samples	O
,	O
bde-209	B
(	O
2/82	O
)	O
and/or	O
bde-153	B
(	O
5/82	O
)	O
were	O
the	O
dominant	O
congeners	O
,	O
suggesting	O
that	O
bde-209	B
can	O
transfer	O
to	O
breast	O
milk	O
and/or	O
break	O
down	O
in	O
the	O
mother	O
and	O
transfer	O
to	O
the	O
nursing	O
infant	O
as	O
the	O
lower	O
-	O
brominated	O
pbdes	B
associated	O
with	O
adverse	O
effects	O
.	O

pbde	O
levels	O
in	O
california	O
breast	O
milk	O
are	O
approaching	O
those	O
of	O
pcbs	B
,	O
and	O
the	O
trend	O
pbdes	B
>	O
pcbs	B
may	O
continue	O
as	O
pbdes	B
migrate	O
from	O
products	O
to	O
the	O
indoor	O
and	O
outdoor	O
environments	O
.	O

distribution	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
other	O
persistent	O
organic	O
pollutants	O
in	O
human	O
serum	O
from	O
greece	O
..	O
human	O
serum	O
samples	O
(	O
n=61	O
)	O
were	O
collected	O
in	O
attika	O
,	O
greece	O
between	O
june	O
and	O
october	O
2007	O
and	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
hexabromocyclododecane	O
(	O
hbcd	B
)	O
,	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
and	O
organochlorine	O
pesticides	O
(	O
ocps	O
)	O
.	O

hbcd	B
was	O
also	O
detected	O
in	O
70	O
%	O
of	O
the	O
samples	O
.	O

no	O
age	O
dependency	O
was	O
found	O
for	O
pbdes	B
.	O

σ(11)pcb	O
(	O
sum	O
of	O
pcbs	B
74	O
,	O
99	O
,	O
118	O
,	O
138	O
,	O
146	O
,	O
153	O
,	O
156	O
,	O
170	O
,	O
180	O
,	O
183	O
and	O
187	O
,	O
)	O
in	O
all	O
samples	O
(	O
n=61	O
)	O
ranged	O
from	O
36	O
to	O
402	O
ng	O
g(-1	O
)	O
lipid	O
,	O
with	O
a	O
median	O
of	O
110	O
ng	O
g(-1	O
)	O
lipid	O
.	O

this	O
is	O
the	O
first	O
study	O
to	O
report	O
levels	O
of	O
pbdes	B
in	O
a	O
possibly	O
occupationally	O
exposed	O
subset	O
of	O
the	O
greek	O
population	O
.	O

polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
breast	O
milk	O
from	O
the	O
pacific	O
northwest	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
..	O
breast	O
milk	O
samples	O
from	O
40	O
first	O
-	O
time	O
mothers	O
from	O
the	O
pacific	O
northwest	O
of	O
the	O
us	O
and	O
canada	O
were	O
analyzed	O
for	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

total	O
pbdes	B
(	O
summation	O
operator	O
pbdes	B
)	O
,	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
12	O
pbdes	B
congeners	O
analyzed	O
,	O
ranged	O
from	O
6	O
to	O
321	O
ppb	O
(	O
lipid	O
weight	O
)	O
(	O
mean=96	O
ppb	O
;	O
median=50	O
ppb	O
)	O
.	O

summation	O
operator	O
pcbs	B
were	O
calculated	O
by	O
summing	O
values	O
for	O
the	O
82	O
pcb	O
congeners	O
analyzed	O
,	O
and	O
ranged	O
from	O
49	O
to	O
415	O
ppb	O
(	O
lipid	O
weight	O
)	O

approximately	O
30	O
%	O
of	O
the	O
mothers	O
(	O
13/40	O
)	O
have	O
summation	O
operator	O
pbdes	B
>	O
summation	O
operator	O
pcbs	B
in	O
their	O
milk	O
samples	O
,	O
and	O
approximately	O
65	O
%	O
(	O
25/40	O
)	O
have	O
bde	O
47	O
>	O
pcb	O
153	O
in	O
breast	O
milk	O
samples	O
,	O
with	O
bde	O
47	O
averaging	O
3	O
-	O
fold	O
greater	O
levels	O
than	O
pcb	O
153	O
.	O

clearly	O
,	O
the	O
lower	O
brominated	O
pbdes	B
are	O
surpassing	O
pcbs	B
as	O
a	O
major	O
environmental	O
concern	O
in	O
north	O
america	O
,	O
and	O
are	O
likely	O
affecting	O
significant	O
portions	O
of	O
the	O
populations	O
in	O
these	O
regions	O
.	O

pbdes	B
have	O
become	O
a	O
major	O
persistent	O
organic	O
pollutant	O
.	O

however	O
,	O
there	O
are	O
no	O
positive	O
correlations	O
between	O
levels	O
of	O
summation	O
operator	O
pbdes	B
and	O
summation	O
operator	O
pcbs	B
,	O
or	O
between	O
levels	O
of	O
pbde	O
47	O
and	O
pcb	O
153	O
,	O
suggesting	O
there	O
may	O
be	O
some	O
differences	O
in	O
exposure	O
pathways	O
for	O
pbdes	B
and	O
pcbs	B
in	O
humans	O
.	O

partitioning	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
in	O
serum	O
and	O
milk	O
from	O
the	O
same	O
mothers	O
..	O
we	O
and	O
others	O
have	O
previously	O
described	O
partitioning	O
of	O
chemicals	O
,	O
including	O
polychlorinated	O
-	O
p	O
-	O
dioxins	O
,	O
dibenzofurans	O
,	O
and	O
biphenyls	O
in	O
different	O
types	O
of	O
human	O
tissues	O
and	O
fluids	O
,	O
including	O
blood	O
and	O
milk	O
.	O

additionally	O
,	O
we	O
previously	O
reported	O
the	O
blood	O
to	O
milk	O
partitioning	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
in	O
a	O
group	O
of	O
11	O
women	O
.	O

in	O
this	O
study	O
we	O
extend	O
these	O
findings	O
,	O
describing	O
the	O
levels	O
of	O
pbdes	B
detected	O
in	O
the	O
serum	O
and	O
milk	O
of	O
29	O
women	O
from	O
texas	O
.	O

hydroxy	O
-	O
pcbs	O
,	O
pbdes	B
,	O
and	O
hbcdds	O
in	O
serum	O
from	O
an	O
elderly	O
population	O
of	O
swedish	O
fishermen	O
's	O
wives	O
and	O
associations	O
with	O
bone	O
density	O
..	O
lack	O
of	O
human	O
exposure	O
data	O
is	O
frequently	O
reported	O
as	O
a	O
critical	O
gap	O
in	O
risk	O
assessments	O
of	O
environmental	O
pollutants	O
,	O
especially	O
regarding	O
"	O
new	O
"	O
pollutants	O
.	O

the	O
objectives	O
of	O
this	O
study	O
were	O
to	O
assess	O
serum	O
levels	O
of	O
the	O
persistent	O
2,2',4,4',5,5'-hexachlorobiphenyl	O
(	O
cb-153	O
)	O
,	O
hydroxylated	O
polychlorinated	O
biphenyl	O
metabolites	O
(	O
oh	O
-	O
pcbs	O
)	O
,	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
and	O
hexabromocyclodode	O
-	O
canes	O
(	O
hbcdds	O
)	O
in	O
a	O
group	O
of	O
swedish	O
middle	O
-	O
aged	O
and	O
elderly	O
women	O
expected	O
to	O
be	O
relatively	O
highly	O
exposed	O
,	O
and	O
to	O
evaluate	O
the	O
impact	O
of	O
potential	O
determinants	O
(	O
e.g.	O
,	O
fish	O
intake	O
,	O
age	O
)	O
for	O
the	O
inter	O
-	O
individual	O
variation	O
,	O
as	O
well	O
as	O
to	O
investigate	O
the	O
association	O
between	O
these	O
pollutants	O
and	O
bone	O
density	O
.	O

the	O
objectives	O
of	O
this	O
study	O
were	O
to	O
assess	O
serum	O
levels	O
of	O
the	O
persistent	O
2,2',4,4',5,5'-hexachlorobiphenyl	O
(	O
cb-153	O
)	O
,	O
hydroxylated	O
polychlorinated	O
biphenyl	O
metabolites	O
(	O
oh	O
-	O
pcbs	O
)	O
,	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
and	O
hexabromocyclodode	O
-	O
canes	O
(	O
hbcdds	O
)	O
in	O
a	O
group	O
of	O
swedish	O
middle	O
-	O
aged	O
and	O
elderly	O
women	O
expected	O
to	O
be	O
relatively	O
highly	O
exposed	O
,	O
and	O
to	O
evaluate	O
the	O
impact	O
of	O
potential	O
determinants	O
(	O
e.g.	O
,	O
fish	O
intake	O
,	O
age	O
)	O
for	O
the	O
inter	O
-	O
individual	O
variation	O
,	O
as	O
well	O
as	O
to	O
investigate	O
the	O
association	O
between	O
these	O
pollutants	O
and	O
bone	O
density	O
.	O

polybrominated	O
diphenyl	O
ethers	O
in	O
paired	O
samples	O
of	O
maternal	O
and	O
umbilical	O
cord	O
blood	O
plasma	O
and	O
associations	O
with	O
house	O
dust	O
in	O
a	O
danish	O
cohort	O
..	O
brominated	O
flame	O
retardants	O
(	O
bfrs	O
)	O
,	O
in	O
particular	O
the	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
have	O
been	O
used	O
in	O
consumer	O
products	O
for	O
many	O
years	O
to	O
increase	O
fire	O
resistance	O
.	O

the	O
major	O
objectives	O
of	O
this	O
study	O
were	O
to	O
investigate	O
the	O
maternal	O
and	O
fetal	O
exposure	O
to	O
pbdes	B
on	O
the	O
basis	O
of	O
maternal	O
and	O
umbilical	O
cord	O
plasma	O
samples	O
and	O
to	O
study	O
the	O
extent	O
of	O
placental	O
transfer	O
for	O
different	O
pbde	O
congeners	O
.	O

pbdes	B
were	O
detected	O
in	O
all	O
maternal	O
and	O
umbilical	O
cord	O
plasma	O
samples	O
.	O

the	O
positive	O
correlations	O
for	O
pbdes	B
for	O
both	O
maternal	O
and	O
umbilical	O
cord	O
plasma	O
with	O
house	O
dust	O
showed	O
that	O
domestic	O
house	O
dust	O
is	O
a	O
significant	O
source	O
of	O
human	O
exposure	O
to	O
pbdes	B
in	O
denmark	O
including	O
in	O
utero	O
exposure	O
.	O

relationships	O
between	O
polybrominated	O
diphenyl	O
ether	O
concentrations	O
in	O
house	O
dust	O
and	O
serum	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
have	O
been	O
measured	O
in	O
the	O
home	O
environment	O
and	O
in	O
humans	O
,	O
but	O
studies	O
linking	O
environmental	O
levels	O
to	O
body	O
burdens	O
are	O
limited	O
.	O

this	O
study	O
provides	O
evidence	O
that	O
house	O
dust	O
is	O
a	O
primary	O
exposure	O
pathway	O
of	O
pbdes	B
and	O
supports	O
the	O
use	O
of	O
dust	O
pbde	O
concentrations	O
as	O
a	O
marker	O
for	O
exposure	O
to	O
pbde	O
congeners	O
other	O
than	O
bde	O
153	O
.	O

decabromodiphenyl	O
ether	O
(	O
bde-209	B
)	O
was	O
quantitated	O
in	O
13	O
children	O
and	O
9	O
mothers	O
.	O

associations	O
were	O
significant	O
for	O
12	O
-	O
month	O
psychomotor	O
development	O
index	O
(	O
bde-47	B
)	O
,	O
24	O
-	O
month	O
mental	O
development	O
index	O
(	O
mdi	O
)	O
(	O
bde-47	B
,	O
99	O
,	O
and	O
100	O
)	O
,	O
36	O
-	O
month	O
mdi	O
(	O
bde-100	B
)	O
,	O
48	O
-	O
month	O
full	O
-	O
scale	O
and	O
verbal	O
iq	O
(	O
bde-47	B
,	O
99	O
,	O
and	O
100	O
)	O
and	O
performance	O
iq	O
(	O
bde-100	B
)	O
,	O
and	O
72	O
-	O
month	O
performance	O
iq	O
(	O
bde-100	B
)	O
.	O

congener	O
-	O
specific	O
body	O
burden	O
levels	O
and	O
possible	O
determinants	O
of	O
polybrominated	O
diphenyl	O
ethers	O
in	O
the	O
general	O
japanese	O
population	O
..	O
objective	O
:	O
our	O
objective	O
was	O
to	O
investigate	O
congener	O
-	O
specific	O
body	O
burden	O
levels	O
and	O
possible	O
determinants	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
in	O
the	O
japanese	O
human	O
population	O
.	O

methods	O
:	O
we	O
conducted	O
a	O
cross	O
-	O
sectional	O
study	O
on	O
72	O
participants	O
aged	O
15	O
-	O
74	O
years	O
;	O
subjects	O
were	O
not	O
occupationally	O
exposed	O
to	O
pbdes	B
or	O
dioxin	O
-	O
like	O
polychlorinated	O
biphenyls	O
(	O
dl	O
-	O
pcbs	O
)	O
.	O

the	O
median	O
concentration	O
of	O
total	O
pbdes	B
was	O
3.6	O
ng	O
g(-1	O
)	O
lipid	O
.	O

the	O
most	O
abundant	O
congener	O
was	O
bde-209	B
(	O
median	O
concentration	O
,	O
0.90	O
ng	O
g(-1	O
)	O
lipid	O
)	O
,	O
followed	O
by	O
bde-153	O
,	O
bde-207	O
,	O
and	O
bde-47	B
in	O
the	O
given	O
order	O
.	O

in	O
contrast	O
,	O
the	O
main	O
exposure	O
routes	O
to	O
high	O
-	O
brominated	O
pbdes	B
in	O
humans	O
are	O
probably	O
not	O
associated	O
with	O
fish	O
consumption	O
.	O

the	O
mean+/-standard	O
deviation	O
of	O
sigma	O
pbdes	B
in	O
breast	O
milk	O
is	O
3.59+/-1.07	O
ng	O
/	O
g	O
lipid	O
.	O

our	O
current	O
value	O
of	O
sigma	O
pbdes	B
in	O
breast	O
milk	O
is	O
0.7	O
-	O
fold	O
lower	O
compared	O
to	O
the	O
past	O
value	O
in	O
our	O
previous	O
study	O
between	O
2000	O
and	O
2001	O
.	O

higher	O
levels	O
of	O
sigma	O
pbdes	B
might	O
be	O
significantly	O
associated	O
with	O
older	O
maternal	O
age	O
and	O
maternal	O
age	O
of	O
the	O
present	O
study	O
is	O
between	O
22	O
and	O
42	O
years	O
old	O
.	O

levels	O
of	O
sigma	O
pbdes	B
and	O
certain	O
pbdes	B
in	O
breast	O
milk	O
are	O
not	O
correlated	O
with	O
maternal	O
pre	O
-	O
pregnant	O
bmi	O
(	O
body	O
mass	O
index	O
)	O
,	O
parity	O
,	O
and	O
lipid	O
contents	O
of	O
breast	O
milk	O
.	O

the	O
sigma	O
pbdes	B
level	O
in	O
breast	O
milk	O
is	O
lower	O
in	O
more	O
educated	O
women	O
after	O
controlling	O
for	O
age	O
and	O
pre	O
-	O
pregnancy	O
bmi	O
in	O
our	O
subjects	O
.	O

the	O
main	O
factors	O
associated	O
with	O
sigma	O
pbdes	B
in	O
breast	O
milk	O
are	O
age	O
and	O
education	O
level	O
among	O
the	O
binary	O
variables	O
of	O
demographic	O
,	O
socioeconomic	O
,	O
and	O
lifestyle	O
characteristics	O
in	O
this	O
report	O
.	O

the	O
exploratory	O
relationships	O
are	O
found	O
between	O
pbdes	B
in	O
breast	O
milk	O
and	O
age	O
,	O
education	O
level	O
,	O
or	O
occupational	O
exposure	O
due	O
to	O
small	O
sampling	O
size	O
.	O

levels	O
and	O
patterns	O
of	O
polybrominated	O
diphenyl	O
ethers	O
in	O
children	O
's	O
plasma	O
from	O
dalian	O
,	O
china	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
potential	O
persistent	O
organic	O
pollutants	O
which	O
have	O
raised	O
many	O
concerns	O
in	O
recent	O
years	O
.	O

research	O
focusing	O
on	O
children	O
exposure	O
to	O
pbdes	B
is	O
important	O
but	O
insufficient	O
.	O

the	O
levels	O
and	O
patterns	O
of	O
pbdes	B
in	O
children	O
's	O
plasma	O
from	O
dalian	O
,	O
china	O
were	O
studied	O
for	O
the	O
first	O
time	O
.	O

bde-153	B
was	O
the	O
dominant	O
congener	O
,	O
followed	O
by	O
bde-99	O
,	O
47	O
,	O
and	O
183	O
.	O

high	O
abundance	O
of	O
bde-183	B
suggested	O
a	O
higher	O
octa	O
-	O
bde	O
use	O
in	O
china	O
.	O

the	O
levels	O
of	O
pbdes	B
in	O
children	O
's	O
plasma	O
in	O
the	O
present	O
study	O
were	O
9	O
-	O
30	O
times	O
higher	O
than	O
those	O
in	O
non	O
-	O
occupational	O
exposure	O
people	O
from	O
guangzhou	O
,	O
south	O
china	O
and	O
those	O
in	O
human	O
milk	O
of	O
general	O
adults	O
from	O
other	O
cities	O
of	O
china	O
,	O
but	O
were	O
at	O
the	O
moderate	O
levels	O
of	O
those	O
in	O
children	O
around	O
the	O
world	O
.	O

these	O
results	O
indicate	O
that	O
children	O
in	O
dalian	O
are	O
at	O
a	O
high	O
risk	O
of	O
exposure	O
to	O
pbdes	B
.	O

the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
associations	O
between	O
the	O
occurrence	O
of	O
pbdes	B
in	O
breast	O
milk	O
of	O
women	O
and	O
their	O
demographic	O
parameters	O
.	O

thirty	O
two	O
breast	O
milk	O
samples	O
were	O
collected	O
and	O
subsequently	O
30	O
congeners	O
of	O
pbdes	B
were	O
analyzed	O
using	O
a	O
high	O
resolution	O
gas	O
chromatograph	O
with	O
a	O
high	O
resolution	O
mass	O
spectrometer	O
.	O

higher	O
levels	O
of	O
sigmapbdes	O
and	O
higher	O
brominated	O
pbdes	B
,	O
such	O
as	O
nonabdes	O
and	O
decabde	O
,	O
had	O
slightly	O
but	O
not	O
significantly	O
negative	O
correlations	O
with	O
lower	O
pre	O
-	O
pregnant	O
bmi	O
(	O
<	O
or	O
=	O
21	O
kg	O
/	O
m(2	O
)	O
)	O
.	O

pbdes	B
pattern	O
of	O
breast	O
milk	O
may	O
have	O
changed	O
after	O
pentabdes	O
were	O
stopped	O
to	O
use	O
in	O
taiwan	O
.	O

a	O
growing	O
body	O
of	O
literature	O
suggests	O
that	O
pbdes	B
may	O
disrupt	O
thyroid	O
hormone	O
homeostasis	O
.	O

although	O
thyroid	O
hormones	O
play	O
an	O
essential	O
role	O
in	O
brain	O
development	O
,	O
few	O
studies	O
have	O
investigated	O
relations	O
between	O
prenatal	O
exposure	O
to	O
pbdes	B
and	O
neonatal	O
thyroid	O
hormone	O
levels	O
,	O
and	O
none	O
have	O
measured	O
thyroid	O
-	O
stimulating	O
hormone	O
(	O
tsh	O
)	O
levels	O
in	O
neonates	O
.	O

the	O
authors	O
found	O
no	O
conclusive	O
evidence	O
that	O
prenatal	O
exposure	O
to	O
pbdes	B
at	O
levels	O
similar	O
to	O
those	O
of	O
the	O
general	O
us	O
population	O
is	O
related	O
to	O
neonatal	O
tsh	O
.	O

factors	O
associated	O
with	O
serum	O
polybrominated	O
diphenyl	O
ether	O
(	O
pbde	O
)	O
levels	O
among	O
school	O
-	O
age	O
children	O
in	O
the	O
chamacos	O
cohort	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
a	O
class	O
of	O
flame	O
retardants	O
historically	O
used	O
in	O
textiles	O
,	O
furniture	O
,	O
and	O
electronic	O
products	O
.	O

polycyclic	O
aromatic	O
hydrocarbons	O
:	O
determinants	O
of	O
urinary	O
1	B
-	I
hydroxypyrene	I
glucuronide	I
concentration	O
and	O
risk	O
of	O
colorectal	O
cancer	O
in	O
the	O
shanghai	O
women	O
's	O
health	O
study	O
..	O
background	O
:	O
associations	O
between	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
and	O
colorectal	O
cancer	O
have	O
been	O
reported	O
previously	O
but	O
few	O
studies	O
have	O
characterized	O
pah	O
exposure	O
using	O
biological	O
measurements	O
.	O

we	O
evaluated	O
colorectal	O
cancer	O
risk	O
in	O
relation	O
to	O
urinary	O
concentration	O
of	O
1	B
-	I
hydroxypyrene	I
glucuronide	I
(	O
1	O
-	O
ohpg	O
)	O
,	O
a	O
polycyclic	O
aromatic	O
hydrocarbon	O
(	O
pah	O
)	O
metabolite	O
,	O
and	O
assessed	O
determinants	O
of	O
pah	O
exposure	O
among	O
controls	O
in	O
the	O
shanghai	O
women	O
's	O
health	O
study	O
(	O
swhs	O
)	O
.	O

assessment	O
of	O
the	O
levels	O
of	O
persistent	O
organic	O
pollutants	O
and	O
1	B
-	I
hydroxypyrene	I
in	O
blood	O
and	O
urine	O
samples	O
from	O
mexican	O
children	O
living	O
in	O
an	O
endemic	O
malaria	O
area	O
in	O
mexico	O
..	O

the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
exposure	O
levels	O
to	O
persistent	O
organic	O
pollutants	O
and	O
1	B
-	I
hydroxypyrene	I
in	O
children	O
living	O
in	O
an	O
endemic	O
malaria	O
zone	O
in	O
mexico	O
.	O

for	O
total	O
polychlorinated	O
biphenyls	O
the	O
blood	O
levels	O
ranged	O
from	O
2,584.9	O
to	O
14,547.9	O
ng	O
/	O
g	O
lipid	O
.	O
regarding	O
urinary	O
1	B
-	I
hydroxypyrene	I
levels	O
,	O
the	O
mean	O
level	O
was	O
2.9	O
±	O
3.1	O
μmol	O
/	O
mol	O
creatinine	O
.	O

we	O
measured	O
urinary	O
1	B
-	I
hydroxypyrene	I
and	O
2	O
-	O
naphthol	O
as	O
pah	O
metabolites	O
and	O
urinary	O
levels	O
of	O
8	O
-	O
hydroxy-2'-deoxyguanosine	O
and	O
malondialdehyde	O
as	O
oxidative	O
stress	O
biomarkers	O
in	O
327	O
breast	O
cancer	O
cases	O
and	O
654	O
controls	O
in	O
the	O
shanghai	O
women	O
's	O
health	O
study	O
.	O

determinants	O
of	O
urinary	O
1	B
-	I
hydroxypyrene	I
glucuronide	I
in	O
south	O
korean	O
children	O
..	O
objectives	O
:	O
this	O
study	O
was	O
conducted	O
to	O
investigate	O
the	O
dominant	O
sources	O
of	O
the	O
urinary	O
pyrene	O
metabolite	O
,	O
1	B
-	I
hydroxypyrene	I
glucuronide	I
(	O
1	O
-	O
ohpg	O
)	O
,	O
in	O
south	O
korean	O
children	O
.	O

pah	O
metabolite	O
levels	O
ranged	O
from	O
33.9	O
ng	O
/	O
l	O
for	O
9	B
-	I
hydroxyphenanthrene	I
to	O
2,465.4	O
ng	O
/	O
l	O
for	O
2	O
-	O
hydroxynaphthalene	O
.	O

associations	O
for	O
involuntary	O
smoking	O
were	O
stronger	O
and	O
statistically	O
significant	O
for	O
1	O
-	O
hydroxypyrene	O
,	O
2	O
-	O
hydroxyfluorene	O
,	O
3	O
-	O
hydroxyfluorene	O
,	O
9	O
-	O
hydroxyfluorene	O
,	O
1	O
-	O
hydroxyphenanthrene	O
,	O
2	O
-	O
hydroxyphenanthrene	O
,	O
and	O
3	B
-	I
hydroxyphenanthrene	I
compared	O
with	O
other	O
metabolites	O
.	O

the	O
geometric	O
mean	O
levels	O
of	O
cadmium	O
and	O
lead	O
in	O
whole	O
blood	O
amounted	O
to	O
0.36	O
and	O
21.7	O
microg	O
l(-1	O
)	O
,	O
those	O
of	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
serum	O
to	O
68	O
,	O
94	O
and	O
20.9	O
ng	O
g(-1	O
)	O
fat	O
,	O
and	O
those	O
of	O
1	B
-	I
hydroxypyrene	I
and	O
t	O
,	O
t'-muconic	O
acid	O
in	O
urine	O
to	O
88	O
ng	O
g(-1	O
)	O
creatinine	O
and	O
72	O
microg	O
g(-1	O
)	O
creatinine	O
.	O

significant	O
regional	O
differences	O
in	O
internal	O
lead	O
,	O
cadmium	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
exposure	O
were	O
observed	O
in	O
function	O
of	O
area	O
of	O
residence	O
,	O
even	O
after	O
adjustment	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
(	O
and	O
body	O
mass	O
index	O
for	O
the	O
chlorinated	O
compounds	O
)	O
.	O

compared	O
to	O
a	O
reference	O
mean	O
,	O
internal	O
exposure	O
was	O
significantly	O
higher	O
in	O
one	O
or	O
more	O
of	O
the	O
areas	O
:	O
cd	O
and	O
pb	O
in	O
the	O
antwerp	O
agglomeration	O
,	O
cd	O
in	O
the	O
antwerp	O
harbour	O
,	O
pcbs	B
in	O
the	O
ghent	O
agglomeration	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
ghent	O
harbour	O
,	O
cd	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
rural	O
area	O
,	O
dde	O
in	O
olen	O
and	O
in	O
the	O
albert	O
canal	O
areas	O
.	O

the	O
geometric	O
mean	O
levels	O
of	O
cadmium	O
and	O
lead	O
in	O
whole	O
blood	O
amounted	O
to	O
0.36	O
and	O
21.7	O
microg	O
l(-1	O
)	O
,	O
those	O
of	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
serum	O
to	O
68	O
,	O
94	O
and	O
20.9	O
ng	O
g(-1	O
)	O
fat	O
,	O
and	O
those	O
of	O
1	B
-	I
hydroxypyrene	I
and	O
t	O
,	O
t'-muconic	O
acid	O
in	O
urine	O
to	O
88	O
ng	O
g(-1	O
)	O
creatinine	O
and	O
72	O
microg	O
g(-1	O
)	O
creatinine	O
.	O

significant	O
regional	O
differences	O
in	O
internal	O
lead	O
,	O
cadmium	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
exposure	O
were	O
observed	O
in	O
function	O
of	O
area	O
of	O
residence	O
,	O
even	O
after	O
adjustment	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
(	O
and	O
body	O
mass	O
index	O
for	O
the	O
chlorinated	O
compounds	O
)	O
.	O

compared	O
to	O
a	O
reference	O
mean	O
,	O
internal	O
exposure	O
was	O
significantly	O
higher	O
in	O
one	O
or	O
more	O
of	O
the	O
areas	O
:	O
cd	O
and	O
pb	O
in	O
the	O
antwerp	O
agglomeration	O
,	O
cd	O
in	O
the	O
antwerp	O
harbour	O
,	O
pcbs	B
in	O
the	O
ghent	O
agglomeration	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
ghent	O
harbour	O
,	O
cd	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
rural	O
area	O
,	O
dde	O
in	O
olen	O
and	O
in	O
the	O
albert	O
canal	O
areas	O
.	O

the	O
geometric	O
mean	O
levels	O
of	O
cadmium	O
and	O
lead	O
in	O
whole	O
blood	O
amounted	O
to	O
0.36	O
and	O
21.7	O
microg	O
l(-1	O
)	O
,	O
those	O
of	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
serum	O
to	O
68	O
,	O
94	O
and	O
20.9	O
ng	O
g(-1	O
)	O
fat	O
,	O
and	O
those	O
of	O
1	B
-	I
hydroxypyrene	I
and	O
t	O
,	O
t'-muconic	O
acid	O
in	O
urine	O
to	O
88	O
ng	O
g(-1	O
)	O
creatinine	O
and	O
72	O
microg	O
g(-1	O
)	O
creatinine	O
.	O

significant	O
regional	O
differences	O
in	O
internal	O
lead	O
,	O
cadmium	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
exposure	O
were	O
observed	O
in	O
function	O
of	O
area	O
of	O
residence	O
,	O
even	O
after	O
adjustment	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
(	O
and	O
body	O
mass	O
index	O
for	O
the	O
chlorinated	O
compounds	O
)	O
.	O

compared	O
to	O
a	O
reference	O
mean	O
,	O
internal	O
exposure	O
was	O
significantly	O
higher	O
in	O
one	O
or	O
more	O
of	O
the	O
areas	O
:	O
cd	O
and	O
pb	O
in	O
the	O
antwerp	O
agglomeration	O
,	O
cd	O
in	O
the	O
antwerp	O
harbour	O
,	O
pcbs	B
in	O
the	O
ghent	O
agglomeration	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
ghent	O
harbour	O
,	O
cd	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
rural	O
area	O
,	O
dde	O
in	O
olen	O
and	O
in	O
the	O
albert	O
canal	O
areas	O
.	O

the	O
geometric	O
mean	O
levels	O
of	O
cadmium	O
and	O
lead	O
in	O
whole	O
blood	O
amounted	O
to	O
0.36	O
and	O
21.7	O
microg	O
l(-1	O
)	O
,	O
those	O
of	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
serum	O
to	O
68	O
,	O
94	O
and	O
20.9	O
ng	O
g(-1	O
)	O
fat	O
,	O
and	O
those	O
of	O
1	B
-	I
hydroxypyrene	I
and	O
t	O
,	O
t'-muconic	O
acid	O
in	O
urine	O
to	O
88	O
ng	O
g(-1	O
)	O
creatinine	O
and	O
72	O
microg	O
g(-1	O
)	O
creatinine	O
.	O

significant	O
regional	O
differences	O
in	O
internal	O
lead	O
,	O
cadmium	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
exposure	O
were	O
observed	O
in	O
function	O
of	O
area	O
of	O
residence	O
,	O
even	O
after	O
adjustment	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
(	O
and	O
body	O
mass	O
index	O
for	O
the	O
chlorinated	O
compounds	O
)	O
.	O

compared	O
to	O
a	O
reference	O
mean	O
,	O
internal	O
exposure	O
was	O
significantly	O
higher	O
in	O
one	O
or	O
more	O
of	O
the	O
areas	O
:	O
cd	O
and	O
pb	O
in	O
the	O
antwerp	O
agglomeration	O
,	O
cd	O
in	O
the	O
antwerp	O
harbour	O
,	O
pcbs	B
in	O
the	O
ghent	O
agglomeration	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
ghent	O
harbour	O
,	O
cd	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
rural	O
area	O
,	O
dde	O
in	O
olen	O
and	O
in	O
the	O
albert	O
canal	O
areas	O
.	O

the	O
geometric	O
mean	O
levels	O
of	O
cadmium	O
and	O
lead	O
in	O
whole	O
blood	O
amounted	O
to	O
0.36	O
and	O
21.7	O
microg	O
l(-1	O
)	O
,	O
those	O
of	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
serum	O
to	O
68	O
,	O
94	O
and	O
20.9	O
ng	O
g(-1	O
)	O
fat	O
,	O
and	O
those	O
of	O
1	B
-	I
hydroxypyrene	I
and	O
t	O
,	O
t'-muconic	O
acid	O
in	O
urine	O
to	O
88	O
ng	O
g(-1	O
)	O
creatinine	O
and	O
72	O
microg	O
g(-1	O
)	O
creatinine	O
.	O

significant	O
regional	O
differences	O
in	O
internal	O
lead	O
,	O
cadmium	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
exposure	O
were	O
observed	O
in	O
function	O
of	O
area	O
of	O
residence	O
,	O
even	O
after	O
adjustment	O
for	O
age	O
,	O
sex	O
,	O
smoking	O
(	O
and	O
body	O
mass	O
index	O
for	O
the	O
chlorinated	O
compounds	O
)	O
.	O

compared	O
to	O
a	O
reference	O
mean	O
,	O
internal	O
exposure	O
was	O
significantly	O
higher	O
in	O
one	O
or	O
more	O
of	O
the	O
areas	O
:	O
cd	O
and	O
pb	O
in	O
the	O
antwerp	O
agglomeration	O
,	O
cd	O
in	O
the	O
antwerp	O
harbour	O
,	O
pcbs	B
in	O
the	O
ghent	O
agglomeration	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
ghent	O
harbour	O
,	O
cd	O
,	O
pcbs	B
,	O
dde	O
and	O
hcb	O
in	O
the	O
rural	O
area	O
,	O
dde	O
in	O
olen	O
and	O
in	O
the	O
albert	O
canal	O
areas	O
.	O

1	B
-	I
hydroxypyrene	I
concentrations	O
in	O
first	O
morning	O
voids	O
and	O
24	O
-	O
h	O
composite	O
urine	O
:	O
intra-	O
and	O
inter	O
-	O
individual	O
comparisons	O
..	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
has	O
been	O
suggested	O
as	O
an	O
exposure	O
biomarker	O
for	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
.	O

creatinine	O
adjustments	O
did	O
not	O
significantly	O
improve	O
overall	O
correlations	O
between	O
first	O
morning	O
void	O
and	O
24	O
-	O
h	O
measurements	O
,	O
but	O
increased	O
total	O
variances	O
for	O
24	O
-	O
h	O
urines	O
explained	O
by	O
first	O
morning	O
urines	O
in	O
coke	O
workers	O
..	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
has	O
been	O
suggested	O
as	O
an	O
exposure	O
biomarker	O
for	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
.	O

1	B
-	I
hydroxypyrene	I
as	O
a	O
biomarker	O
of	O
pah	O
exposure	O
among	O
subjects	O
living	O
in	O
two	O
separate	O
regions	O
from	O
a	O
steel	O
mill	O
..	O
objective	O
:	O
steel	O
mills	O
are	O
known	O
to	O
be	O
a	O
source	O
of	O
ambient	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
,	O
and	O
increased	O
cancer	O
risk	O
has	O
been	O
reported	O
among	O
neighborhoods	O
previously	O
.	O

in	O
this	O
study	O
,	O
we	O
tried	O
to	O
assess	O
the	O
exposure	O
to	O
pahs	O
among	O
residents	O
nearby	O
to	O
a	O
large	O
steel	O
mill	O
in	O
korea	O
by	O
measuring	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
.	O

higher	O
urinary	O
1	B
-	I
hydroxypyrene	I
concentration	O
is	O
associated	O
with	O
cooking	O
practice	O
in	O
a	O
chinese	O
population	O
..	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
is	O
a	O
biomarker	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
exposure	O
.	O

the	O
concentration	O
of	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
hop	O
)	O
was	O
significantly	O
higher	O
in	O
bangkok	O
schoolchildren	O
.	O

elevated	O
concentrations	O
of	O
1	B
-	I
hydroxypyrene	I
in	O
schoolchildren	O
during	O
winter	O
in	O
christchurch	O
,	O
new	O
zealand	O
..	O
particulate	O
air	O
pollution	O
is	O
significantly	O
elevated	O
during	O
the	O
winter	O
in	O
christchurch	O
,	O
new	O
zealand	O
,	O
largely	O
attributable	O
to	O
use	O
of	O
wood	O
burners	O
for	O
domestic	O
home	O
heating	O
,	O
topography	O
,	O
and	O
meteorological	O
conditions	O
.	O

polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
are	O
a	O
key	O
component	O
of	O
airborne	O
particulate	O
matter	O
(	O
pm	O
)	O
and	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
has	O
previously	O
been	O
used	O
to	O
assess	O
exposure	O
of	O
people	O
to	O
pahs	O
.	O

effect	O
of	O
urban	O
traffic	O
,	O
individual	O
habits	O
,	O
and	O
genetic	O
polymorphisms	O
on	O
background	O
urinary	O
1	B
-	I
hydroxypyrene	I
excretion	O
..	O
purpose	O
:	O
potential	O
sources	O
of	O
exposure	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
and	O
genetic	O
polymorphisms	O
were	O
investigated	O
in	O
relation	O
to	O
their	O
contribution	O
to	O
interindividual	O
variation	O
in	O
baseline	O
levels	O
of	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
excretion	O
in	O
subjects	O
without	O
occupational	O
exposure	O
to	O
pahs	O
.	O

urinary	O
monohydroxylated	O
phenanthrenes	O
and	O
hydroxypyrene	O
--	O
the	O
effects	O
of	O
smoking	O
habits	O
and	O
changes	O
induced	O
by	O
smoking	O
on	O
monooxygenase	O
-	O
mediated	O
metabolism	O
..	O
objectives	O
:	O
internal	O
polycyclic	O
aromatic	O
hydrocarbon	O
(	O
pah	O
)	O
exposure	O
is	O
usually	O
studied	O
by	O
determining	O
1	B
-	I
hydroxypyrene	I
in	O
urine	O
.	O

in	O
many	O
studies	O
,	O
increased	O
urinary	O
levels	O
of	O
1	B
-	I
hydroxypyrene	I
have	O
been	O
found	O
in	O
smokers	O
compared	O
with	O
non	O
-	O
smokers	O
.	O

therefore	O
,	O
in	O
our	O
study	O
,	O
urine	O
specimens	O
from	O
smokers	O
and	O
non	O
-	O
smokers	O
were	O
tested	O
for	O
four	O
monohydroxylated	O
phenanthrenes	O
in	O
addition	O
to	O
1	B
-	I
hydroxypyrene	I
.	O

subjects	O
and	O
methods	O
:	O
spot	O
urine	O
samples	O
from	O
288	O
non	O
-	O
smokers	O
and	O
100	O
smokers	O
were	O
analysed	O
for	O
1-	O
,	O
2-	O
,	O
3-	O
and	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
by	O
a	O
very	O
sensitive	O
high	O
performance	O
liquid	O
chromatography	O
(	O
hplc	O
)	O
method	O
with	O
fluorescence	O
detection	O
.	O

results	O
:	O
highly	O
significant	O
differences	O
and	O
dose	O
-	O
response	O
relationships	O
with	O
regard	O
to	O
cigarettes	O
smoked	O
per	O
day	O
were	O
found	O
for	O
2-	O
,	O
3-	O
and	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
,	O
but	O
not	O
for	O
1	O
-	O
hydroxyphenanthrene	O
.	O

when	O
the	O
ratio	O
of	O
the	O
sum	O
of	O
hydroxyphenanthrenes	O
to	O
1	B
-	I
hydroxypyrene	I
,	O
and	O
the	O
ratio	O
of	O
1-	O
and	O
2-/3-	O
and	O
4	B
-	I
hydroxyphenanthrene	I
were	O
taken	O
into	O
consideration	O
,	O
significant	O
negative	O
dose	O
-	O
response	O
relationships	O
to	O
the	O
numbers	O
of	O
cigarettes	O
smoked	O
per	O
day	O
,	O
were	O
found	O
.	O

conclusion	O
:	O
1	B
-	I
hydroxypyrene	I
as	O
well	O
as	O
2-	O
,	O
3-	O
and	O
4	O
-	O
monohydroxylated	O
phenanthrenes	O
in	O
urine	O
may	O
be	O
used	O
as	O
parameters	O
to	O
detect	O
pah	O
exposure	O
from	O
cigarette	O
smoking	O
.	O

urinary	O
hydroxy	O
-	O
metabolites	O
of	O
naphthalene	O
,	O
phenanthrene	O
and	O
pyrene	O
as	O
markers	O
of	O
exposure	O
to	O
diesel	O
exhaust	O
..	O
objective	O
:	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
exposure	O
of	O
bus	O
-	O
garage	O
and	O
waste	O
-	O
collection	O
workers	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
derived	O
from	O
diesel	O
exhaust	O
by	O
the	O
measurement	O
of	O
levels	O
of	O
seven	O
urinary	O
pah	O
metabolites	O
:	O
2	O
-	O
naphthol	O
,	O
1	O
-	O
hydroxyphenanthrene	O
,	O
2	O
-	O
hydroxyphenanthrene	O
,	O
3	O
-	O
hydroxyphenanthrene	O
,	O
1	O
+	O
9	O
-	O
hydroxyphenanthrene	O
,	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
.	O

the	O
mean	O
level	O
of	O
the	O
hydroxyphenanthrenes	B
in	O
the	O
samples	O
of	O
exposed	O
workers	O
was	O
between	O
0.40	O
and	O
0.70	O
micromol	O
/	O
mol	O
creatinine	O
and	O
in	O
the	O
control	O
samples	O
0.40	O
-	O
0.60	O
micromol	O
/	O
mol	O
creatinine	O
.	O

the	O
concentration	O
of	O
1	B
-	I
hydroxypyrene	I
was	O
higher	O
among	O
exposed	O
workers	O
in	O
both	O
pre	O
-	O
shift	O
and	O
post	O
-	O
shift	O
samples	O
(	O
mean	O
0.10	O
-	O
0.15	O
micromol	O
/	O
mol	O
creatinine	O
)	O
than	O
in	O
control	O
group	O
(	O
mean	O
0.05	O
-	O
0.06	O
micromol	O
/	O
mol	O
creatinine	O
)	O
in	O
winter	O
(	O
p=0.002	O
,	O
df=78	O
)	O
and	O
in	O
summer	O
(	O
p<0.001	O
,	O
df=68	O
)	O
.	O

objective	O
:	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
exposure	O
of	O
bus	O
-	O
garage	O
and	O
waste	O
-	O
collection	O
workers	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
derived	O
from	O
diesel	O
exhaust	O
by	O
the	O
measurement	O
of	O
levels	O
of	O
seven	O
urinary	O
pah	O
metabolites	O
:	O
2	O
-	O
naphthol	O
,	O
1	O
-	O
hydroxyphenanthrene	O
,	O
2	O
-	O
hydroxyphenanthrene	O
,	O
3	O
-	O
hydroxyphenanthrene	O
,	O
1	O
+	O
9	O
-	O
hydroxyphenanthrene	O
,	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
.	O

the	O
mean	O
level	O
of	O
the	O
hydroxyphenanthrenes	B
in	O
the	O
samples	O
of	O
exposed	O
workers	O
was	O
between	O
0.40	O
and	O
0.70	O
micromol	O
/	O
mol	O
creatinine	O
and	O
in	O
the	O
control	O
samples	O
0.40	O
-	O
0.60	O
micromol	O
/	O
mol	O
creatinine	O
.	O

the	O
concentration	O
of	O
1	B
-	I
hydroxypyrene	I
was	O
higher	O
among	O
exposed	O
workers	O
in	O
both	O
pre	O
-	O
shift	O
and	O
post	O
-	O
shift	O
samples	O
(	O
mean	O
0.10	O
-	O
0.15	O
micromol	O
/	O
mol	O
creatinine	O
)	O
than	O
in	O
control	O
group	O
(	O
mean	O
0.05	O
-	O
0.06	O
micromol	O
/	O
mol	O
creatinine	O
)	O
in	O
winter	O
(	O
p=0.002	O
,	O
df=78	O
)	O
and	O
in	O
summer	O
(	O
p<0.001	O
,	O
df=68	O
)	O
.	O

objective	O
:	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
exposure	O
of	O
bus	O
-	O
garage	O
and	O
waste	O
-	O
collection	O
workers	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
derived	O
from	O
diesel	O
exhaust	O
by	O
the	O
measurement	O
of	O
levels	O
of	O
seven	O
urinary	O
pah	O
metabolites	O
:	O
2	O
-	O
naphthol	O
,	O
1	O
-	O
hydroxyphenanthrene	O
,	O
2	O
-	O
hydroxyphenanthrene	O
,	O
3	O
-	O
hydroxyphenanthrene	O
,	O
1	O
+	O
9	O
-	O
hydroxyphenanthrene	O
,	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
.	O

the	O
mean	O
level	O
of	O
the	O
hydroxyphenanthrenes	B
in	O
the	O
samples	O
of	O
exposed	O
workers	O
was	O
between	O
0.40	O
and	O
0.70	O
micromol	O
/	O
mol	O
creatinine	O
and	O
in	O
the	O
control	O
samples	O
0.40	O
-	O
0.60	O
micromol	O
/	O
mol	O
creatinine	O
.	O

the	O
concentration	O
of	O
1	B
-	I
hydroxypyrene	I
was	O
higher	O
among	O
exposed	O
workers	O
in	O
both	O
pre	O
-	O
shift	O
and	O
post	O
-	O
shift	O
samples	O
(	O
mean	O
0.10	O
-	O
0.15	O
micromol	O
/	O
mol	O
creatinine	O
)	O
than	O
in	O
control	O
group	O
(	O
mean	O
0.05	O
-	O
0.06	O
micromol	O
/	O
mol	O
creatinine	O
)	O
in	O
winter	O
(	O
p=0.002	O
,	O
df=78	O
)	O
and	O
in	O
summer	O
(	O
p<0.001	O
,	O
df=68	O
)	O
.	O

objective	O
:	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
exposure	O
of	O
bus	O
-	O
garage	O
and	O
waste	O
-	O
collection	O
workers	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
derived	O
from	O
diesel	O
exhaust	O
by	O
the	O
measurement	O
of	O
levels	O
of	O
seven	O
urinary	O
pah	O
metabolites	O
:	O
2	O
-	O
naphthol	O
,	O
1	O
-	O
hydroxyphenanthrene	O
,	O
2	O
-	O
hydroxyphenanthrene	O
,	O
3	O
-	O
hydroxyphenanthrene	O
,	O
1	O
+	O
9	O
-	O
hydroxyphenanthrene	O
,	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
.	O

the	O
mean	O
level	O
of	O
the	O
hydroxyphenanthrenes	B
in	O
the	O
samples	O
of	O
exposed	O
workers	O
was	O
between	O
0.40	O
and	O
0.70	O
micromol	O
/	O
mol	O
creatinine	O
and	O
in	O
the	O
control	O
samples	O
0.40	O
-	O
0.60	O
micromol	O
/	O
mol	O
creatinine	O
.	O

the	O
concentration	O
of	O
1	B
-	I
hydroxypyrene	I
was	O
higher	O
among	O
exposed	O
workers	O
in	O
both	O
pre	O
-	O
shift	O
and	O
post	O
-	O
shift	O
samples	O
(	O
mean	O
0.10	O
-	O
0.15	O
micromol	O
/	O
mol	O
creatinine	O
)	O
than	O
in	O
control	O
group	O
(	O
mean	O
0.05	O
-	O
0.06	O
micromol	O
/	O
mol	O
creatinine	O
)	O
in	O
winter	O
(	O
p=0.002	O
,	O
df=78	O
)	O
and	O
in	O
summer	O
(	O
p<0.001	O
,	O
df=68	O
)	O
.	O

objective	O
:	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
exposure	O
of	O
bus	O
-	O
garage	O
and	O
waste	O
-	O
collection	O
workers	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
derived	O
from	O
diesel	O
exhaust	O
by	O
the	O
measurement	O
of	O
levels	O
of	O
seven	O
urinary	O
pah	O
metabolites	O
:	O
2	O
-	O
naphthol	O
,	O
1	O
-	O
hydroxyphenanthrene	O
,	O
2	O
-	O
hydroxyphenanthrene	O
,	O
3	O
-	O
hydroxyphenanthrene	O
,	O
1	O
+	O
9	O
-	O
hydroxyphenanthrene	O
,	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
.	O

the	O
mean	O
level	O
of	O
the	O
hydroxyphenanthrenes	B
in	O
the	O
samples	O
of	O
exposed	O
workers	O
was	O
between	O
0.40	O
and	O
0.70	O
micromol	O
/	O
mol	O
creatinine	O
and	O
in	O
the	O
control	O
samples	O
0.40	O
-	O
0.60	O
micromol	O
/	O
mol	O
creatinine	O
.	O

the	O
concentration	O
of	O
1	B
-	I
hydroxypyrene	I
was	O
higher	O
among	O
exposed	O
workers	O
in	O
both	O
pre	O
-	O
shift	O
and	O
post	O
-	O
shift	O
samples	O
(	O
mean	O
0.10	O
-	O
0.15	O
micromol	O
/	O
mol	O
creatinine	O
)	O
than	O
in	O
control	O
group	O
(	O
mean	O
0.05	O
-	O
0.06	O
micromol	O
/	O
mol	O
creatinine	O
)	O
in	O
winter	O
(	O
p=0.002	O
,	O
df=78	O
)	O
and	O
in	O
summer	O
(	O
p<0.001	O
,	O
df=68	O
)	O
.	O

objective	O
:	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
exposure	O
of	O
bus	O
-	O
garage	O
and	O
waste	O
-	O
collection	O
workers	O
to	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
derived	O
from	O
diesel	O
exhaust	O
by	O
the	O
measurement	O
of	O
levels	O
of	O
seven	O
urinary	O
pah	O
metabolites	O
:	O
2	O
-	O
naphthol	O
,	O
1	O
-	O
hydroxyphenanthrene	O
,	O
2	O
-	O
hydroxyphenanthrene	O
,	O
3	O
-	O
hydroxyphenanthrene	O
,	O
1	O
+	O
9	O
-	O
hydroxyphenanthrene	O
,	O
4	B
-	I
hydroxyphenanthrene	I
and	O
1	B
-	I
hydroxypyrene	I
.	O

the	O
mean	O
level	O
of	O
the	O
hydroxyphenanthrenes	B
in	O
the	O
samples	O
of	O
exposed	O
workers	O
was	O
between	O
0.40	O
and	O
0.70	O
micromol	O
/	O
mol	O
creatinine	O
and	O
in	O
the	O
control	O
samples	O
0.40	O
-	O
0.60	O
micromol	O
/	O
mol	O
creatinine	O
.	O

the	O
concentration	O
of	O
1	B
-	I
hydroxypyrene	I
was	O
higher	O
among	O
exposed	O
workers	O
in	O
both	O
pre	O
-	O
shift	O
and	O
post	O
-	O
shift	O
samples	O
(	O
mean	O
0.10	O
-	O
0.15	O
micromol	O
/	O
mol	O
creatinine	O
)	O
than	O
in	O
control	O
group	O
(	O
mean	O
0.05	O
-	O
0.06	O
micromol	O
/	O
mol	O
creatinine	O
)	O
in	O
winter	O
(	O
p=0.002	O
,	O
df=78	O
)	O
and	O
in	O
summer	O
(	O
p<0.001	O
,	O
df=68	O
)	O
.	O

3	B
-	I
hydroxybenzo[a]pyrene	I
in	O
the	O
urine	O
of	O
smokers	O
and	O
non	O
-	O
smokers	O
..	O

1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohpy	O
)	O
and	O
3	B
-	I
hydroxybenzo[a]pyrene	I
(	O
3	O
-	O
ohbap	O
)	O
were	O
then	O
determined	O
by	O
automated	O
column	O
-	O
switching	O
high	O
-	O
performance	O
liquid	O
chromatography	O
.	O

1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohpy	O
)	O
and	O
3	B
-	I
hydroxybenzo[a]pyrene	I
(	O
3	O
-	O
ohbap	O
)	O
were	O
then	O
determined	O
by	O
automated	O
column	O
-	O
switching	O
high	O
-	O
performance	O
liquid	O
chromatography	O
.	O

effects	O
of	O
genetic	O
polymorphisms	O
in	O
metabolic	O
enzymes	O
on	O
the	O
relationships	O
between	O
8	O
-	O
hydroxydeoxyguanosine	O
levels	O
in	O
human	O
leukocytes	O
and	O
urinary	O
1	B
-	I
hydroxypyrene	I
and	O
2	O
-	O
naphthol	O
concentrations	O
..	O

the	O
8	O
-	O
hydroxydeoxyguanosine	O
(	O
8	O
-	O
ohdg	O
)	O
level	O
in	O
leukocytes	O
,	O
and	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
and	O
2	O
-	O
naphthol	O
concentrations	O
,	O
were	O
measured	O
by	O
high	O
-	O
performance	O
liquid	O
chromatography	O
.	O

the	O
mean	O
values	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
in	O
automobile	O
emission	O
inspection	O
and	O
waste	O
incineration	O
workers	O
were	O
0.27+/-0.19	O
and	O
0.57+/-0.46	O
micromol	O
/	O
mol	O
creatinine	O
,	O
respectively	O
,	O
and	O
the	O
mean	O
values	O
of	O
2	O
-	O
naphthol	O
in	O
automobile	O
emission	O
inspectors	O
and	O
waste	O
incineration	O
workers	O
were	O
4.80+/-4.01	O
and	O
8.30+/-4.79	O
mol	O
/	O
mol	O
creatinine	O
,	O
respectively	O
.	O

significant	O
difference	O
in	O
urinary	O
metabolites	O
,	O
1	B
-	I
hydroxypyrene	I
and	O
2	O
-	O
naphthol	O
was	O
found	O
between	O
smokers	O
and	O
non	O
-	O
smokers	O
in	O
exposed	O
groups	O
and	O
it	O
may	O
be	O
due	O
to	O
the	O
amounts	O
of	O
smoking	O
cigarettes	O
.	O
in	O
t	O
-	O
lymphocytes	O
,	O
dna	O
damage	O
in	O
control	O
subjects	O
,	O
emission	O
inspection	O
workers	O
and	O
incineration	O
workers	O
were	O
1.42+/-0.22	O
,	O
1.41+/-0.22	O
and	O
1.76+/-0.27	O
,	O
respectively	O
.	O

sources	O
of	O
polycyclic	O
aromatic	O
hydrocarbon	O
exposure	O
in	O
non	O
-	O
occupationally	O
exposed	O
koreans	O
..	O
urinary	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
ohp	O
)	O
,	O
an	O
exposure	O
biomarker	O
for	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
pahs	O
)	O
,	O
was	O
used	O
to	O
identify	O
potential	O
sources	O
of	O
pah	O
exposure	O
for	O
660	O
koreans	O
who	O
were	O
not	O
occupationally	O
exposed	O
to	O
pahs	O
(	O
65	O
%	O
male	O
;	O
35	O
%	O
female	O
;	O
mean	O
age	O
,	O
36.5	O
+	O
/-	O
11.1	O
years	O
)	O
.	O

environmental	O
pollutant	O
assessments	O
included	O
nitrogen	O
dioxide	O
as	O
a	O
marker	O
of	O
traffic	O
-	O
related	O
air	O
pollution	O
,	O
trihalomethanes	O
as	O
a	O
marker	O
of	O
tap	O
water	O
disinfection	O
by	O
-	O
products	O
,	O
organochlorine	O
biomarkers	O
measured	O
in	O
maternal	O
serum	O
during	O
pregnancy	O
(	O
polychlorinated	O
biphenyls	O
(	O
pcb	O
)	O
,	O
dichlorodiphenyl	O
dichloroethylene	O
(	O
p	B
,	I
p'-dde	I
)	O
,	O
hexachlorobenzene	O
and	O
β	O
-	O
hexachlorocyclohexane	O
)	O
and	O
mercury	O
concentrations	O
measured	O
in	O
cord	O
blood	O
.	O

p	B
,	I
p'-dde	I
and	O
β	O
-	O
hexachlorocyclohexane	O
were	O
not	O
related	O
to	O
social	O
class	O
.	O

environmental	O
pollutant	O
assessments	O
included	O
nitrogen	O
dioxide	O
as	O
a	O
marker	O
of	O
traffic	O
-	O
related	O
air	O
pollution	O
,	O
trihalomethanes	O
as	O
a	O
marker	O
of	O
tap	O
water	O
disinfection	O
by	O
-	O
products	O
,	O
organochlorine	O
biomarkers	O
measured	O
in	O
maternal	O
serum	O
during	O
pregnancy	O
(	O
polychlorinated	O
biphenyls	O
(	O
pcb	O
)	O
,	O
dichlorodiphenyl	O
dichloroethylene	O
(	O
p	B
,	I
p'-dde	I
)	O
,	O
hexachlorobenzene	O
and	O
β	O
-	O
hexachlorocyclohexane	O
)	O
and	O
mercury	O
concentrations	O
measured	O
in	O
cord	O
blood	O
.	O

p	B
,	I
p'-dde	I
and	O
β	O
-	O
hexachlorocyclohexane	O
were	O
not	O
related	O
to	O
social	O
class	O
.	O

environmental	O
pollutant	O
assessments	O
included	O
nitrogen	O
dioxide	O
as	O
a	O
marker	O
of	O
traffic	O
-	O
related	O
air	O
pollution	O
,	O
trihalomethanes	O
as	O
a	O
marker	O
of	O
tap	O
water	O
disinfection	O
by	O
-	O
products	O
,	O
organochlorine	O
biomarkers	O
measured	O
in	O
maternal	O
serum	O
during	O
pregnancy	O
(	O
polychlorinated	O
biphenyls	O
(	O
pcb	O
)	O
,	O
dichlorodiphenyl	O
dichloroethylene	O
(	O
p	B
,	I
p'-dde	I
)	O
,	O
hexachlorobenzene	O
and	O
β	O
-	O
hexachlorocyclohexane	O
)	O
and	O
mercury	O
concentrations	O
measured	O
in	O
cord	O
blood	O
.	O

p	B
,	I
p'-dde	I
and	O
β	O
-	O
hexachlorocyclohexane	O
were	O
not	O
related	O
to	O
social	O
class	O
.	O

environmental	O
pollutant	O
assessments	O
included	O
nitrogen	O
dioxide	O
as	O
a	O
marker	O
of	O
traffic	O
-	O
related	O
air	O
pollution	O
,	O
trihalomethanes	O
as	O
a	O
marker	O
of	O
tap	O
water	O
disinfection	O
by	O
-	O
products	O
,	O
organochlorine	O
biomarkers	O
measured	O
in	O
maternal	O
serum	O
during	O
pregnancy	O
(	O
polychlorinated	O
biphenyls	O
(	O
pcb	O
)	O
,	O
dichlorodiphenyl	O
dichloroethylene	O
(	O
p	B
,	I
p'-dde	I
)	O
,	O
hexachlorobenzene	O
and	O
β	O
-	O
hexachlorocyclohexane	O
)	O
and	O
mercury	O
concentrations	O
measured	O
in	O
cord	O
blood	O
.	O

p	B
,	I
p'-dde	I
and	O
β	O
-	O
hexachlorocyclohexane	O
were	O
not	O
related	O
to	O
social	O
class	O
.	O

results	O
:	O
dust	O
analysis	O
showed	O
that	O
dominant	O
constituents	O
were	O
octachlorodibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
ocdd	B
)	O
and	O
1,2,3,4,6,7,8	O
-	O
heptachlorodibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
hpcdd	O
)	O
among	O
the	O
pcdds	O
,	O
and	O
1,2,3,4,6,7,8	O
-	O
heptachlorodibenzofuran	O
(	O
hpcdf	O
)	O
and	O
octachlorodibenzofuran	O
(	O
ocdf	B
)	O
among	O
the	O
pcdfs	O
.	O

however	O
,	O
the	O
teq	O
of	O
pcdfs	O
was	O
significantly	O
higher	O
among	O
the	O
incinerator	O
workers	O
in	O
areas	O
i	O
and	O
ii	O
,	O
and	O
the	O
1,2,3,4,6,7,8	B
-	I
hpcdf	I
concentration	O
was	O
also	O
significantly	O
higher	O
for	O
all	O
three	O
areas	O
.	O

the	O
multiple	O
regression	O
analysis	O
also	O
suggested	O
that	O
significant	O
factors	O
affecting	O
the	O
concentrations	O
in	O
serum	O
samples	O
were	O
area	O
for	O
hxcdd	O
,	O
age	O
for	O
tcdd	O
,	O
pecdd	O
,	O
pecdf	O
,	O
teq	O
of	O
pcdds	O
,	O
teq	O
of	O
pcdfs	O
,	O
and	O
teq	O
of	O
summed	O
pcdds	O
and	O
pcdfs	O
,	O
and	O
bmi	O
for	O
hxcdd	O
,	O
hpcdd	O
,	O
and	O
ocdd	B
.	O

partitioning	O
of	O
dioxins	O
,	O
dibenzofurans	O
,	O
and	O
coplanar	O
pcbs	B
in	O
blood	O
,	O
milk	O
,	O
adipose	O
tissue	O
,	O
placenta	O
and	O
cord	O
blood	O
from	O
five	O
american	O
women	O
..	O
partitioning	O
of	O
dioxins	O
,	O
dibenzofurans	O
and	O
the	O
dioxin	O
-	O
like	O
coplanar	O
pcbs	B
was	O
determined	O
by	O
congener	O
-	O
specific	O
high	O
resolution	O
gc	O
-	O
ms	O
analysis	O
of	O
compounds	O
in	O
6	O
tissue	O
samples	O
each	O
from	O
5	O
women	O
.	O

mean	O
measured	O
levels	O
of	O
total	O
pcdds	O
,	O
pcdfs	B
and	O
coplanar	O
pcbs	B
were	O
352	O
pg	O
/	O
g	O
for	O
adipose	O
tissue	O
,	O
526	O
pg	O
/	O
g	O
for	O
predelivery	O
blood	O
,	O
182	O
pg	O
/	O
g	O
for	O
placenta	O
,	O
165	O
pg	O
/	O
g	O
for	O
cord	O
blood	O
,	O
352	O
pg	O
/	O
g	O
for	O
postpartum	O
blood	O
and	O
220	O
pg	O
/	O
g	O
for	O
milk	O
.	O

mean	O
total	O
teq	O
levels	O
were	O
11.6	O
pg	O
/	O
g	O
teq	O
for	O
adipose	O
tissue	O
,	O
12.1	O
pg	O
/	O
g	O
teq	O
for	O
predelivery	O
blood	O
,	O
10.5	O
pg	O
/	O
g	O
teq	O
for	O
placenta	O
,	O
5.8	O
pg	O
/	O
g	O
teq	O
for	O
cord	O
blood	O
,	O
10.0	O
pg	O
/	O
g	O
teq	O
for	O
postpartum	O
blood	O
and	O
10.2	O
pg	O
/	O
g	O
teq	O
for	O
milk	O
..	O
partitioning	O
of	O
dioxins	O
,	O
dibenzofurans	O
and	O
the	O
dioxin	O
-	O
like	O
coplanar	O
pcbs	B
was	O
determined	O
by	O
congener	O
-	O
specific	O
high	O
resolution	O
gc	O
-	O
ms	O
analysis	O
of	O
compounds	O
in	O
6	O
tissue	O
samples	O
each	O
from	O
5	O
women	O
.	O

mean	O
measured	O
levels	O
of	O
total	O
pcdds	O
,	O
pcdfs	B
and	O
coplanar	O
pcbs	B
were	O
352	O
pg	O
/	O
g	O
for	O
adipose	O
tissue	O
,	O
526	O
pg	O
/	O
g	O
for	O
predelivery	O
blood	O
,	O
182	O
pg	O
/	O
g	O
for	O
placenta	O
,	O
165	O
pg	O
/	O
g	O
for	O
cord	O
blood	O
,	O
352	O
pg	O
/	O
g	O
for	O
postpartum	O
blood	O
and	O
220	O
pg	O
/	O
g	O
for	O
milk	O
.	O

in	O
order	O
to	O
evaluate	O
the	O
pcdd	O
/	O
f	O
background	O
exposure	O
levels	O
of	O
the	O
german	O
population	O
,	O
blood	O
samples	O
collected	O
from	O
95	O
subjects	O
(	O
age	O
12	O
-	O
82	O
years	O
)	O
living	O
in	O
a	O
rural	O
area	O
of	O
north	O
-	O
west	O
germany	O
were	O
analysed	O
for	O
pcdd	O
/	O
f.	O
the	O
median	O
2,3,7,8	B
-	I
tcdd	I
toxicity	O
equivalents	O
(	O
te	O
)	O
were	O
40.8	O
pg	O
i	O
-	O
te	O
/	O
g	O
blood	O
fat	O
and	O
the	O
95th	O
percentile	O
was	O
82.1	O
pg	O
i	O
-	O
te	O
/	O
g	O
blood	O
fat	O
.	O

results	O
:	O
dust	O
analysis	O
showed	O
the	O
greatest	O
amount	O
of	O
octachlorodibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
ocdd	B
)	O
,	O
followed	O
by	O
1,2,3,4,6,7,8	O
-	O
heptachlorodibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
hpcdd	O
)	O
,	O
1,2,3,4,6,7,8	O
-	O
heptachlorodibenzofuran	O
(	O
hpcdf	O
)	O
,	O
and	O
octachlorodibenzofuran	O
(	O
ocdf	B
)	O
.	O

however	O
,	O
the	O
serum	O
1,2,3,4,6,7,8	B
-	I
hpcdf	I
concentration	O
was	O
significantly	O
higher	O
in	O
the	O
incinerator	O
workers	O
than	O
in	O
the	O
controls	O
for	O
all	O
the	O
three	O
areas	O
.	O

when	O
the	O
exposure	O
index	O
to	O
1,2,3,4,6,7,8	B
-	I
hpcdf	I
is	O
defined	O
as	O
the	O
product	O
of	O
the	O
concentration	O
of	O
1,2,3,4,6,7,8	B
-	I
hpcdf	I
in	O
the	O
deposited	O
dust	O
and	O
duration	O
of	O
employment	O
,	O
the	O
concentration	O
of	O
1,2,3,4,6,7,8	B
-	I
hpcdf	I
in	O
serum	O
increased	O
as	O
the	O
exposure	O
index	O
increased	O
.	O

multivariate	O
analysis	O
suggested	O
that	O
the	O
serum	O
concentration	O
of	O
hpcdf	O
increased	O
with	O
duration	O
of	O
employment	O
at	O
the	O
incineration	O
plants	O
and	O
ocdf	B
increased	O
with	O
employment	O
of	O
>	O
or	O
=	O
21	O
years	O
.	O

conclusion	O
:	O
the	O
serum	O
teqs	O
of	O
pcdds	O
and	O
pcdfs	O
was	O
not	O
significantly	O
higher	O
among	O
the	O
incinerator	O
workers	O
,	O
but	O
the	O
serum	O
concentration	O
of	O
1,2,3,4,6,7,8	B
-	I
hpcdf	I
was	O
.	O

changes	O
in	O
serum	O
concentrations	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
hydroxylated	O
pcb	O
metabolites	O
and	O
pentachlorophenol	O
during	O
pregnancy	O
..	O

we	O
studied	O
pregnancy	O
-	O
related	O
changes	O
in	O
serum	O
concentrations	O
of	O
five	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
,	O
cb	O
118	O
,	O
cb	O
138	O
,	O
cb	O
153	O
,	O
cb	O
156	O
,	O
cb	O
180	O
)	O
,	O
three	O
hydroxylated	O
pcb	O
metabolites	O
(	O
4	O
-	O
oh	O
-	O
cb107	O
,	O
4	O
-	O
oh	O
-	O
cb146	O
,	O
4	O
-	O
oh	O
-	O
cb187	O
)	O
,	O
and	O
pentachlorophenol	O
(	O
pcp	O
)	O
.	O

nevertheless	O
,	O
strong	O
positive	O
intra	O
-	O
individual	O
correlations	O
(	O
spearman	O
's	O
r=0.61	O
-	O
0.99	O
)	O
were	O
seen	O
for	O
pcbs	B
during	O
the	O
whole	O
study	O
period	O
.	O

background	O
levels	O
of	O
polychlorinated	O
biphenyls	O
in	O
the	O
population	O
of	O
the	O
canary	O
islands	O
(	O
spain	O
)	O
..	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
are	O
persistent	O
and	O
toxic	O
compounds	O
that	O
have	O
been	O
detected	O
in	O
human	O
serum	O
or	O
tissues	O
worldwide	O
.	O

serum	O
levels	O
of	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
increased	O
with	O
age	O
,	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
,	O
urban	O
habitat	O
,	O
and	O
smoking	O
.	O

the	O
median	O
concentration	O
of	O
the	O
sum	O
of	O
pcbs	B
considered	O
as	O
markers	O
of	O
environmental	O
contamination	O
by	O
these	O
chemicals	O
(	O
m	O
-	O
pcbs	O
)	O
was	O
46.4	O
ng	O
/	O
g	O
lipid	O
.	O

levels	O
of	O
the	O
sum	O
of	O
dioxin	O
-	O
like	O
pcbs	B
(	O
dl	O
-	O
pcbs	O
)	O
were	O
48.5	O
ng	O
/	O
g	O
lipid	O
in	O
the	O
95th	O
percentile	O
,	O
and	O
were	O
also	O
positively	O
associated	O
with	O
age	O
.	O

nevertheless	O
,	O
as	O
these	O
compounds	O
may	O
induce	O
adverse	O
health	O
effects	O
even	O
at	O
very	O
low	O
doses	O
,	O
our	O
findings	O
should	O
be	O
considered	O
by	O
local	O
public	O
health	O
authorities	O
in	O
order	O
to	O
establish	O
measures	O
for	O
diminishing	O
the	O
exposure	O
of	O
the	O
population	O
of	O
these	O
islands	O
to	O
pcbs	B
.	O

a	O
cohort	O
study	O
of	O
developmental	O
polychlorinated	O
biphenyl	O
(	O
pcb	O
)	O
exposure	O
in	O
relation	O
to	O
post	O
-	O
vaccination	O
antibody	O
response	O
at	O
6	O
-	O
months	O
of	O
age	O
..	O
background	O
:	O
extensive	O
experimental	O
data	O
in	O
animals	O
indicate	O
that	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
during	O
pregnancy	O
leads	O
to	O
changes	O
in	O
offspring	O
immune	O
function	O
during	O
the	O
postnatal	O
period	O
.	O

caffeine	O
n3	O
-	O
demethylation	O
(	O
cyp1a2	O
)	O
in	O
a	O
population	O
with	O
an	O
increased	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
..	O
objective	O
:	O
to	O
investigate	O
the	O
cyp1a2	O
phenotype	O
distribution	O
in	O
a	O
population	O
with	O
an	O
increased	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
that	O
would	O
likely	O
induce	O
an	O
increased	O
activity	O
of	O
this	O
enzyme	O
.	O
further	O
,	O
to	O
investigate	O
the	O
effect	O
of	O
sex	O
,	O
smoking	O
,	O
and	O
oral	O
contraceptive	O
use	O
on	O
the	O
cyp1a2	O
activity	O
.	O

assessment	O
of	O
reference	O
values	O
for	O
polychlorinated	O
biphenyl	O
concentration	O
in	O
human	O
blood	O
..	O
a	O
chemical	O
factory	O
which	O
produced	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
operated	O
in	O
brescia	O
,	O
north	O
italy	O
,	O
(	O
about	O
200000	O
inhabitants	O
)	O
from	O
the	O
1930s	O
to	O
the	O
1980s	O
.	O

high	O
levels	O
of	O
pcbs	B
were	O
recently	O
found	O
in	O
soil	O
,	O
food	O
and	O
people	O
living	O
in	O
an	O
area	O
close	O
to	O
the	O
factory	O
.	O

biomonitoring	O
of	O
persistent	O
organochlorine	O
pesticides	O
,	O
pcdd	O
/	O
pcdfs	O
and	O
dioxin	O
-	O
like	O
pcbs	B
in	O
blood	O
of	O
children	O
from	O
south	O
west	O
germany	O
(	O
baden	O
-	O
wuerttemberg	O
)	O
from	O
1993	O
to	O
2003	O
..	O
in	O
the	O
context	O
of	O
a	O
monitoring	O
program	O
,	O
persistent	O
organic	O
pollutants	O
(	O
pops	O
)	O
were	O
quantified	O
in	O
the	O
blood	O
of	O
10	O
year	O
old	O
children	O
at	O
four	O
different	O
demographic	O
regions	O
in	O
baden	O
-	O
wuerttemberg	O
,	O
a	O
highly	O
industrialised	O
federal	O
state	O
in	O
south	O
west	O
germany	O
.	O

pcdd	O
/	O
pcdfs	O
and	O
some	O
relevant	O
coplanar	O
pcbs	B
were	O
determined	O
in	O
pooled	O
samples	O
from	O
children	O
in	O
seven	O
cycles	O
from	O
1993	O
to	O
2003	O
.	O

breast	O
feeding	O
was	O
associated	O
with	O
about	O
30	O
%	O
higher	O
median	O
concentrations	O
of	O
dde	O
,	O
hcb	O
,	O
pcbs	B
and	O
a	O
30	O
%	O
increase	O
for	O
mean	O
pcdd	O
/	O
pcdf	O
concentrations	O
.	O

concerning	O
demographic	O
differences	O
,	O
significant	O
lower	O
concentrations	O
of	O
hcb	O
,	O
pcbs	B
and	O
pcdd	O
/	O
pcdfs	O
could	O
be	O
seen	O
in	O
children	O
from	O
mannheim	O
compared	O
to	O
the	O
region	O
of	O
aulendorf	O
.	O

about	O
10	O
-	O
20	O
%	O
higher	O
concentrations	O
were	O
found	O
in	O
boys	O
compared	O
to	O
girls	O
for	O
hcb	O
,	O
indicator	O
pcbs	B
and	O
pcdd	O
/	O
pcdfs	O
.	O

the	O
pattern	O
of	O
non	O
-	O
ortho	O
and	O
mono	O
-	O
ortho	O
pcbs	B
in	O
the	O
blood	O
of	O
children	O
was	O
similar	O
to	O
the	O
pattern	O
reported	O
for	O
mother	O
's	O
milk	O
,	O
and	O
pcb	O
126	O
and	O
pcb	O
156	O
contributed	O
about	O
70	O
%	O
to	O
the	O
toxicity	O
of	O
dioxin	O
-	O
like	O
pcbs	B
and	O
about	O
one	O
-	O
third	O
to	O
total	O
teq	O
including	O
pcdd	O
/	O
pcdfs	O
..	O
in	O
the	O
context	O
of	O
a	O
monitoring	O
program	O
,	O
persistent	O
organic	O
pollutants	O
(	O
pops	O
)	O
were	O
quantified	O
in	O
the	O
blood	O
of	O
10	O
year	O
old	O
children	O
at	O
four	O
different	O
demographic	O
regions	O
in	O
baden	O
-	O
wuerttemberg	O
,	O
a	O
highly	O
industrialised	O
federal	O
state	O
in	O
south	O
west	O
germany	O
.	O

pcdd	O
/	O
pcdfs	O
and	O
some	O
relevant	O
coplanar	O
pcbs	B
were	O
determined	O
in	O
pooled	O
samples	O
from	O
children	O
in	O
seven	O
cycles	O
from	O
1993	O
to	O
2003	O
.	O

breast	O
feeding	O
was	O
associated	O
with	O
about	O
30	O
%	O
higher	O
median	O
concentrations	O
of	O
dde	O
,	O
hcb	O
,	O
pcbs	B
and	O
a	O
30	O
%	O
increase	O
for	O
mean	O
pcdd	O
/	O
pcdf	O
concentrations	O
.	O

concerning	O
demographic	O
differences	O
,	O
significant	O
lower	O
concentrations	O
of	O
hcb	O
,	O
pcbs	B
and	O
pcdd	O
/	O
pcdfs	O
could	O
be	O
seen	O
in	O
children	O
from	O
mannheim	O
compared	O
to	O
the	O
region	O
of	O
aulendorf	O
.	O

about	O
10	O
-	O
20	O
%	O
higher	O
concentrations	O
were	O
found	O
in	O
boys	O
compared	O
to	O
girls	O
for	O
hcb	O
,	O
indicator	O
pcbs	B
and	O
pcdd	O
/	O
pcdfs	O
.	O

the	O
pattern	O
of	O
non	O
-	O
ortho	O
and	O
mono	O
-	O
ortho	O
pcbs	B
in	O
the	O
blood	O
of	O
children	O
was	O
similar	O
to	O
the	O
pattern	O
reported	O
for	O
mother	O
's	O
milk	O
,	O
and	O
pcb	O
126	O
and	O
pcb	O
156	O
contributed	O
about	O
70	O
%	O
to	O
the	O
toxicity	O
of	O
dioxin	O
-	O
like	O
pcbs	B
and	O
about	O
one	O
-	O
third	O
to	O
total	O
teq	O
including	O
pcdd	O
/	O
pcdfs	O
.	O

blood	O
pressure	O
in	O
relation	O
to	O
concentrations	O
of	O
pcb	O
congeners	O
and	O
chlorinated	O
pesticides	O
..	O
background	O
:	O
residents	O
of	O
anniston	O
,	O
alabama	O
,	O
live	O
near	O
a	O
monsanto	O
plant	O
that	O
manufactured	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
from	O
1929	O
to	O
1971	O
and	O
are	O
relatively	O
heavily	O
exposed	O
.	O

objectives	O
:	O
the	O
goal	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
relationship	O
,	O
if	O
any	O
,	O
between	O
blood	O
pressure	O
and	O
levels	O
of	O
total	O
serum	O
pcbs	B
,	O
several	O
pcb	O
groups	O
with	O
common	O
actions	O
or	O
structure	O
,	O
35	O
individual	O
pcb	O
congeners	O
,	O
and	O
nine	O
chlorinated	O
pesticides	O
.	O

conclusions	O
:	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
,	O
serum	O
concentrations	O
of	O
pcbs	B
,	O
especially	O
those	O
congeners	O
with	O
multiple	O
ortho	O
chlorines	O
,	O
were	O
strongly	O
associated	O
with	O
both	O
systolic	O
and	O
diastolic	O
blood	O
pressure	O
.	O

associations	O
between	O
prenatal	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
and	O
neonatal	O
thyroid	O
-	O
stimulating	O
hormone	O
levels	O
in	O
a	O
mexican	O
-	O
american	O
population	O
,	O
salinas	O
valley	O
,	O
california	O
..	O
background	O
:	O
studies	O
have	O
reported	O
that	O
prenatal	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
may	O
alter	O
neurodevelopment	O
in	O
both	O
humans	O
and	O
animals	O
.	O

because	O
thyroid	O
hormones	O
(	O
th	O
)	O
are	O
essential	O
for	O
normal	O
neurologic	O
development	O
,	O
it	O
has	O
been	O
suggested	O
that	O
the	O
deleterious	O
neurodevelopmental	O
effect	O
of	O
pcbs	B
may	O
occur	O
through	O
th	O
disruption	O
.	O

pcbs	B
may	O
in	O
turn	O
affect	O
th	O
levels	O
by	O
inducing	O
the	O
microsomal	O
enzyme	O
uridinediphosphate	O
glucuronosyltransferase	O
(	O
udp	O
-	O
gt	O
)	O
,	O
which	O
is	O
involved	O
in	O
th	O
elimination	O
.	O

in	O
individual	O
congener	O
analyses	O
,	O
pcbs	B
99	O
,	O
138	O
,	O
153	O
,	O
180	O
,	O
183	O
,	O
187	O
,	O
194	O
,	O
and	O
199	O
were	O
positively	O
associated	O
with	O
neonatal	O
tsh	O
levels	O
after	O
adjustment	O
for	O
covariates	O
.	O

pcbs	B
194	O
and	O
199	O
remained	O
significant	O
after	O
adjustment	O
for	O
multiple	O
hypothesis	O
testing	O
.	O

findings	O
also	O
suggest	O
that	O
pcbs	B
affect	O
th	O
homeostasis	O
even	O
at	O
the	O
low	O
background	O
level	O
of	O
exposure	O
found	O
in	O
the	O
chama	O
-	O
cos	O
(	O
center	O
for	O
the	O
health	O
assessment	O
of	O
mothers	O
and	O
children	O
of	O
salinas	O
)	O
population	O
.	O

analysis	O
of	O
hydroxylated	O
metabolites	O
of	O
pcbs	B
(	O
oh	B
-	I
pcbs	I
)	O
and	O
other	O
chlorinated	O
phenolic	O
compounds	O
in	O
whole	O
blood	O
from	O
canadian	O
inuit	O
..	O
in	O
this	O
study	O
,	O
we	O
identified	O
the	O
main	O
hydroxylated	O
polychlorinated	O
biphenyls	O
(	O
oh	B
-	I
pcbs	I
)	O
and	O
other	O
chlorinated	O
phenolic	O
compounds	O
and	O
we	O
determined	O
their	O
relative	O
concentrations	O
in	O
whole	O
blood	O
from	O
13	O
male	O
and	O
17	O
female	O
inuit	O
from	O
northern	O
quebec	O
,	O
canada	O
,	O
and	O
from	O
a	O
pooled	O
whole	O
blood	O
sample	O
from	O
southern	O
quebec	O
.	O

we	O
also	O
determined	O
concentrations	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

geometric	O
mean	O
concentrations	O
of	O
total	O
oh	B
-	I
pcbs	I
were	O
1.73	O
and	O
1.01	O
ng	O
/	O
g	O
whole	O
blood	O
for	O
inuit	O
men	O
and	O
women	O
,	O
respectively	O
,	O
and	O
0.161	O
ng	O
/	O
g	O
whole	O
blood	O
for	O
the	O
southern	O
population	O
pool	O
.	O

there	O
are	O
limited	O
data	O
available	O
for	O
comparison	O
,	O
but	O
the	O
levels	O
of	O
oh	B
-	I
pcbs	I
in	O
inuit	O
are	O
higher	O
than	O
those	O
previously	O
reported	O
in	O
the	O
literature	O
for	O
other	O
populations	O
.	O

there	O
was	O
a	O
significant	O
correlation	O
(	O
p	O
<	O
0.005	O
)	O
between	O
oh	B
-	I
pcbs	I
and	O
pcbs	B
(	O
r	O
=	O
0.84	O
)	O
and	O
both	O
correlated	O
significantly	O
(	O
p	O
<	O
0.005	O
)	O
with	O
age	O
(	O
r	O
=	O
0.68	O
and	O
0.78	O
,	O
respectively	O
)	O
.	O

the	O
ratio	O
of	O
oh	B
-	I
pcbs	I
to	O
pcbs	B
was	O
lower	O
in	O
inuit	O
(	O
0.11	O
)	O
than	O
in	O
the	O
southern	O
quebec	O
pool	O
(	O
0.33	O
)	O
.	O

there	O
was	O
considerable	O
variability	O
in	O
the	O
congener	O
pattern	O
of	O
the	O
identified	O
oh	B
-	I
pcbs	I
.	O

the	O
main	O
metabolite	O
,	O
4	O
-	O
oh	O
-	O
cb109	O
(	O
4	O
-	O
oh-2,3,3',4	O
'	O
,	O
5	O
-	O
pentachlorobiphenyl	O
)	O
,	O
constituted	O
12	O
-	O
62	O
%	O
of	O
the	O
total	O
oh	B
-	I
pcbs	I
in	O
the	O
samples	O
.	O

the	O
possible	O
role	O
of	O
oh	B
-	I
pcbs	I
in	O
mediating	O
pcb	O
-	O
induced	O
adverse	O
effects	O
needs	O
to	O
be	O
investigated	O
further	O
.	O

the	O
objectives	O
of	O
this	O
study	O
were	O
to	O
determine	O
concentrations	O
of	O
three	O
selected	O
organochlorine	O
pesticides	O
(	O
p	O
,	O
p'-ddt	O
,	O
p	B
,	I
p'-dde	I
,	O
hcb	O
)	O
and	O
three	O
specific	O
pcb	O
congeners	O
(	O
pcb	O
138	O
,	O
153	O
,	O
180	O
)	O
in	O
adipose	O
tissue	O
and	O
serum	O
samples	O
from	O
an	O
urban	O
adult	O
population	O
(	O
n=112	O
)	O
in	O
the	O
city	O
of	O
santa	O
cruz	O
de	O
la	O
sierra	O
,	O
bolivia	O
,	O
and	O
to	O
investigate	O
their	O
relationships	O
within	O
and	O
between	O
the	O
two	O
matrices	O
and	O
with	O
selected	O
socio	O
-	O
demographic	O
characteristics	O
.	O

the	O
percentages	O
of	O
samples	O
positive	O
for	O
these	O
compounds	O
ranged	O
from	O
40	O
%	O
for	O
pcb	O
180	O
to	O
100	O
%	O
for	O
p	B
,	I
p'-dde	I
in	O
adipose	O
tissue	O
,	O
and	O
from	O
21	O
%	O
for	O
hcb	O
to	O
93	O
%	O
for	O
p	B
,	I
p'-dde	I
in	O
serum	O
.	O

we	O
found	O
positive	O
and	O
statistically	O
significant	O
correlations	O
between	O
adipose	O
tissue	O
and	O
serum	O
concentrations	O
only	O
in	O
p	B
,	I
p'-dde	I
and	O
hcb	O
.	O

correlations	O
of	O
fish	O
intake	O
and	O
plasma	O
docosahexaenoic	O
acid	O
levels	O
with	O
each	O
congener	O
of	O
pcdds	B
/	O
pcdfs	B
/	O
dioxin	O
-	O
like	O
pcbs	B
in	O
blood	O
from	O
the	O
japanese	O
population	O
..	O
purpose	O
:	O
the	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
factors	O
associated	O
with	O
blood	O
levels	O
of	O
each	O
congener	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	B
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
,	O
and	O
dioxin	O
-	O
like	O
polychlorinated	O
biphenyls	O
(	O
dl	O
-	O
pcbs	O
)	O
in	O
the	O
japanese	O
population	O
.	O

after	O
adjustment	O
for	O
age	O
,	O
sex	O
,	O
body	O
mass	O
index	O
,	O
smoking	O
habit	O
,	O
and	O
consumption	O
of	O
other	O
food	O
groups	O
,	O
six	O
pcdds	B
/	O
pcdfs	B
with	O
4	O
-	O
6	O
substituted	O
chlorine	O
atoms	O
and	O
10	O
dl	O
-	O
pcbs	O
,	O
but	O
not	O
heptacdd	O
/	O
f	O
or	O
octacdd	O
,	O
showed	O
significant	O
positive	O
correlations	O
with	O
the	O
frequency	O
of	O
intake	O
of	O
fish	O
and	O
shellfish	O
.	O

furthermore	O
,	O
significant	O
positive	O
relationships	O
were	O
also	O
found	O
between	O
plasma	O
levels	O
of	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
,	O
a	O
biomarker	O
of	O
fish	O
intake	O
,	O
and	O
10	O
pcdds	B
/	O
pcdfs	B
with	O
4	O
-	O
6	O
chlorine	O
atoms	O
and	O
10	O
dl	O
-	O
pcbs	O
.	O

the	O
partial	O
correlation	O
coefficients	O
with	O
plasma	O
dha	O
were	O
significantly	O
higher	O
for	O
dl	O
-	O
pcbs	O
than	O
for	O
pcdds	B
/	O
pcdfs	B
,	O
and	O
partial	O
correlation	O
coefficients	O
for	O
pcdds	B
/	O
pcdfs	B
significantly	O
decreased	O
with	O
increasing	O
number	O
of	O
chlorine	O
atoms	O
(	O
spearman	O
r	O
 	O
=	O
 	O
-0.80	O
,	O
p	O
 	O
=	O
 	O
0.001	O
)	O
.	O

conclusions	O
:	O
blood	O
levels	O
of	O
pcdds	B
/	O
pcdfs	B
with	O
4	O
-	O
6	O
chlorine	O
atoms	O
and	O
dl	O
-	O
pcbs	O
were	O
positively	O
associated	O
with	O
fish	O
intake	O
in	O
the	O
japanese	O
population	O
.	O

these	O
results	O
may	O
be	O
explained	O
by	O
the	O
higher	O
degree	O
of	O
bioaccumulation	O
of	O
these	O
congeners	O
in	O
fish	O
and	O
shellfish	O
in	O
the	O
ecosystem	O
,	O
and	O
the	O
high	O
consumption	O
of	O
fish	O
among	O
the	O
japanese	O
population	O
..	O
purpose	O
:	O
the	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
factors	O
associated	O
with	O
blood	O
levels	O
of	O
each	O
congener	O
of	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	B
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
,	O
and	O
dioxin	O
-	O
like	O
polychlorinated	O
biphenyls	O
(	O
dl	O
-	O
pcbs	O
)	O
in	O
the	O
japanese	O
population	O
.	O

after	O
adjustment	O
for	O
age	O
,	O
sex	O
,	O
body	O
mass	O
index	O
,	O
smoking	O
habit	O
,	O
and	O
consumption	O
of	O
other	O
food	O
groups	O
,	O
six	O
pcdds	B
/	O
pcdfs	B
with	O
4	O
-	O
6	O
substituted	O
chlorine	O
atoms	O
and	O
10	O
dl	O
-	O
pcbs	O
,	O
but	O
not	O
heptacdd	O
/	O
f	O
or	O
octacdd	O
,	O
showed	O
significant	O
positive	O
correlations	O
with	O
the	O
frequency	O
of	O
intake	O
of	O
fish	O
and	O
shellfish	O
.	O

furthermore	O
,	O
significant	O
positive	O
relationships	O
were	O
also	O
found	O
between	O
plasma	O
levels	O
of	O
docosahexaenoic	O
acid	O
(	O
dha	O
)	O
,	O
a	O
biomarker	O
of	O
fish	O
intake	O
,	O
and	O
10	O
pcdds	B
/	O
pcdfs	B
with	O
4	O
-	O
6	O
chlorine	O
atoms	O
and	O
10	O
dl	O
-	O
pcbs	O
.	O

the	O
partial	O
correlation	O
coefficients	O
with	O
plasma	O
dha	O
were	O
significantly	O
higher	O
for	O
dl	O
-	O
pcbs	O
than	O
for	O
pcdds	B
/	O
pcdfs	B
,	O
and	O
partial	O
correlation	O
coefficients	O
for	O
pcdds	B
/	O
pcdfs	B
significantly	O
decreased	O
with	O
increasing	O
number	O
of	O
chlorine	O
atoms	O
(	O
spearman	O
r	O
 	O
=	O
 	O
-0.80	O
,	O
p	O
 	O
=	O
 	O
0.001	O
)	O
.	O

conclusions	O
:	O
blood	O
levels	O
of	O
pcdds	B
/	O
pcdfs	B
with	O
4	O
-	O
6	O
chlorine	O
atoms	O
and	O
dl	O
-	O
pcbs	O
were	O
positively	O
associated	O
with	O
fish	O
intake	O
in	O
the	O
japanese	O
population	O
.	O

determinants	O
of	O
serum	O
concentrations	O
of	O
1,1	O
-	O
dichloro-2,2	O
-	O
bis(p	O
-	O
chlorophenyl)ethylene	O
and	O
polychlorinated	O
biphenyls	O
among	O
french	O
women	O
in	O
the	O
cecile	O
study	O
..	O
background	O
:	O
dichlorodiphenyltrichloroethane	O
(	O
ddt	O
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
are	O
persistent	O
organochlorine	O
compounds	O
bioaccumulating	O
in	O
human	O
tissues	O
.	O

objectives	O
:	O
to	O
assess	O
the	O
current	O
serum	O
concentrations	O
of	O
1,1	O
-	O
dichloro-2,2	O
-	O
bis(p	O
-	O
chlorophenyl)ethylene	O
(	O
p	B
,	I
p'-dde	I
)	O
,	O
the	O
main	O
ddt	O
breakdown	O
product	O
,	O
and	O
of	O
pcbs	B
in	O
women	O
from	O
two	O
french	O
administrative	O
areas	O
(	O
ille	O
-	O
et	O
-	O
vilaine	O
and	O
côte	O
d'or	O
)	O
.	O

methods	O
:	O
we	O
measured	O
serum	O
p	B
,	I
p'-dde	I
and	O
pcb	O
levels	O
in	O
1055	O
general	O
population	O
women	O
who	O
were	O
recruited	O
in	O
2005	O
-	O
2007	O
to	O
serve	O
as	O
controls	O
in	O
a	O
case	O
-	O
control	O
study	O
on	O
breast	O
cancer	O
.	O

results	O
:	O
median	O
concentrations	O
of	O
p	B
,	I
p'-dde	I
and	O
total	O
pcbs	B
were	O
85	O
and	O
240ng	O
/	O
g	O
lipid	O
,	O
respectively	O
.	O

based	O
on	O
multivariate	O
analyses	O
,	O
the	O
main	O
predictors	O
of	O
high	O
p	B
,	I
p'-dde	I
levels	O
included	O
age	O
and	O
frequent	O
consumption	O
of	O
saltwater	O
fish	O
in	O
women	O
below	O
50	O
years	O
,	O
and	O
high	O
bmi	O
in	O
older	O
women	O
.	O

the	O
most	O
important	O
predictors	O
of	O
serum	O
p	B
,	I
p'-dde	I
and	O
pcb	O
concentrations	O
among	O
french	O
women	O
include	O
age	O
,	O
body	O
mass	O
index	O
,	O
dietary	O
habits	O
,	O
and	O
place	O
of	O
residence	O
.	O

in	O
utero	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
and	O
reduced	O
neonatal	O
physiological	O
development	O
from	O
guiyu	O
,	O
china	O
..	O
primitive	O
electronic	O
-	O
waste	O
recycling	O
resulted	O
in	O
serious	O
pollution	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
the	O
environment	O
of	O
guiyu	O
,	O
china	O
.	O

we	O
aimed	O
to	O
assess	O
body	O
burdens	O
of	O
pcbs	B
and	O
potential	O
health	O
risks	O
for	O
neonates	O
.	O

pcbs	B
in	O
ucb	O
were	O
determined	O
by	O
gas	O
chromatography	O
coupled	O
with	O
mass	O
spectrometry	O
.	O

neonates	O
from	O
guiyu	O
are	O
exposed	O
to	O
high	O
levels	O
of	O
pcbs	B
;	O
prenatal	O
exposure	O
to	O
pcbs	B
appears	O
to	O
influence	O
neonatal	O
health	O
,	O
but	O
still	O
needs	O
further	O
confirmation	O
.	O

distribution	O
of	O
pcbs	B
,	O
their	O
hydroxylated	O
metabolites	O
,	O
and	O
other	O
phenolic	O
contaminants	O
in	O
human	O
serum	O
from	O
two	O
european	O
countries	O
..	O
human	O
exposure	O
to	O
mixtures	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
may	O
result	O
in	O
the	O
formation	O
of	O
different	O
profiles	O
of	O
hydroxylated	O
pcbs	B
(	O
ho	O
-	O
pcbs	O
)	O
,	O
as	O
a	O
consequence	O
of	O
different	O
exposures	O
or	O
dissimilar	O
metabolism	O
of	O
parent	O
compounds	O
.	O

therefore	O
,	O
we	O
investigated	O
the	O
levels	O
and	O
profiles	O
of	O
pcbs	B
and	O
ho	O
-	O
pcbs	O
in	O
human	O
serum	O
samples	O
collected	O
from	O
two	O
european	O
countries	O
with	O
different	O
degrees	O
of	O
pollution	O
.	O

there	O
was	O
no	O
significant	O
difference	O
between	O
the	O
levels	O
of	O
sum	O
pcbs	B
measured	O
in	O
each	O
set	O
of	O
samples	O
,	O
with	O
a	O
median	O
concentration	O
of	O
3100	O
pg	O
/	O
ml	O
for	O
romanian	O
samples	O
(	O
n	O
=	O
53	O
)	O
and	O
3380	O
pg	O
/	O
ml	O
for	O
belgian	O
samples	O
(	O
n	O
=	O
22	O
)	O
.	O

exposure	O
to	O
hydroxylated	O
polychlorinated	O
biphenyls	O
(	O
oh	B
-	I
pcbs	I
)	O
in	O
the	O
prenatal	O
period	O
and	O
subsequent	O
neurodevelopment	O
in	O
eastern	O
slovakia	O
..	O
background	O
:	O
hydroxylated	O
polychlorinated	O
biphenyls	O
(	O
oh	B
-	I
pcbs	I
)	O
,	O
unlike	O
pcbs	O
,	O
are	O
in	O
general	O
readily	O
excreted	O
yet	O
are	O
still	O
detected	O
in	O
humans	O
and	O
animals	O
.	O

active	O
transport	O
of	O
oh	B
-	I
pcbs	I
across	O
the	O
placenta	O
and	O
hydroxylation	O
of	O
pcbs	O
by	O
the	O
fetus	O
suggest	O
the	O
potential	O
for	O
greater	O
impact	O
on	O
the	O
fetus	O
compared	O
with	O
the	O
parent	O
pcb	O
compounds	O
,	O
but	O
little	O
is	O
known	O
about	O
their	O
health	O
effects	O
,	O
particularly	O
in	O
humans	O
.	O

we	O
conducted	O
a	O
congener	O
-	O
specific	O
analysis	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
blood	O
collected	O
from	O
242	O
yusho	O
patients	O
(	O
mean	O
:	O
65.5	O
years	O
,	O
median	O
:	O
67.0	O
years	O
)	O
and	O
74	O
yusho	O
-	O
suspected	O
persons	O
(	O
mean	O
:	O
54.7	O
years	O
,	O
median	O
:	O
55.0	O
years	O
)	O
in	O
2004	O
,	O
and	O
compared	O
each	O
congener	O
concentrations	O
of	O
pcbs	B
among	O
the	O
groups	O
of	O
yusho	O
patients	O
,	O
yusho	O
-	O
suspected	O
persons	O
,	O
and	O
normal	O
controls	O
(	O
mean	O
:	O
68.1	O
years	O
,	O
median	O
:	O
67.0	O
years	O
)	O
with	O
the	O
concentrations	O
previously	O
reported	O
.	O

among	O
the	O
209	O
pcb	O
congeners	O
,	O
8	O
congeners	O
of	O
mono	O
-	O
ortho	O
pcbs	B
and	O
56	O
congeners	O
of	O
non	O
-	O
dioxin	O
-	O
like	O
pcbs	B
were	O
identified	O
in	O
the	O
blood	O
of	O
yusho	O
patients	O
and	O
yusho	O
-	O
suspected	O
persons	O
.	O

the	O
relative	O
contribution	O
ratios	O
of	O
the	O
concentrations	O
of	O
the	O
tricbs	O
,	O
tetracbs	O
,	O
and	O
pentacbs	B
to	O
the	O
total	O
concentrations	O
of	O
64	O
pcb	O
congeners	O
in	O
the	O
blood	O
of	O
yusho	O
patients	O
were	O
slightly	O
lower	O
than	O
those	O
of	O
yusho	O
-	O
suspected	O
persons	O
and	O
normal	O
controls	O
,	O
and	O
the	O
ratios	O
of	O
nonacbs	B
and	O
decacb-209	O
concentrations	O
were	O
nearly	O
the	O
same	O
among	O
the	O
yusho	O
patients	O
,	O
yusho	O
-	O
suspected	O
persons	O
,	O
and	O
normal	O
controls	O
.	O

however	O
,	O
the	O
ratios	O
of	O
the	O
concentrations	O
of	O
hexacbs	O
,	O
heptacbs	O
,	O
and	O
octacbs	B
to	O
the	O
total	O
concentrations	O
of	O
64	O
pcb	O
congeners	O
in	O
the	O
blood	O
of	O
yusho	O
patients	O
tended	O
to	O
be	O
slightly	O
higher	O
compared	O
to	O
those	O
of	O
the	O
yusho	O
-	O
suspected	O
persons	O
and	O
normal	O
controls	O
.	O

these	O
four	O
congeners	O
may	O
be	O
considered	O
the	O
most	O
important	O
congeners	O
for	O
evaluating	O
the	O
pcbs	B
toxicity	O
of	O
yusho	O
patients	O
.	O

distribution	O
of	O
organochlorine	B
pesticides	I
(	I
ocps	I
)	I
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
human	O
serum	O
from	O
urban	O
areas	O
in	O
korea	O
..	O
concentrations	O
of	O
organochlorine	B
pesticides	I
(	I
ocps	I
)	I
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
were	O
determined	O
in	O
serum	O
samples	O
from	O
residents	O
of	O
a	O
korean	O
urban	O
area	O
(	O
seoul	O
)	O
.	O

p	O
,	O
p'-dde	O
,	O
beta	B
-	I
hch	I
,	O
p	O
,	O
p'-ddt	O
,	O
hcb	O
,	O
and	O
trans	B
-	I
nonachlor	I
were	O
the	O
dominant	O
ocps	O
in	O
most	O
samples	O
.	O

the	O
dominant	O
pcbs	B
were	O
pcb153	O
,	O
138	O
,	O
180	O
,	O
187	O
,	O
and	O
pcb118	O
,	O
which	O
contributed	O
60	O
%	O
to	O
total	O
pcbs	B
.	O

the	O
median	O
concentrations	O
of	O
total	O
ocps	O
and	O
total	O
pcbs	B
were	O
315	O
ng	O
g(-1	O
)	O
lipid	O
and	O
104	O
ng	O
g(-1	O
)	O
lipid	O
,	O
respectively	O
.	O

in	O
females	O
,	O
the	O
serum	O
concentrations	O
of	O
all	O
determined	O
organochlorine	O
compounds	O
except	O
beta	B
-	I
hch	I
were	O
positively	O
correlated	O
with	O
age	O
,	O
and	O
higher	O
concentrations	O
of	O
organochlorine	O
pollutants	O
were	O
found	O
in	O
males	O
than	O
in	O
females	O
.	O

compared	O
to	O
our	O
previous	O
studies	O
,	O
pcb	O
concentrations	O
in	O
serum	O
from	O
urban	O
areas	O
have	O
substantially	O
decreased	O
during	O
the	O
last	O
decade	O
leading	O
to	O
the	O
observation	O
that	O
the	O
strict	O
regulation	O
of	O
pcbs	B
was	O
helpful	O
in	O
controlling	O
the	O
concentration	O
of	O
pcbs	B
in	O
the	O
environment	O
.	O

extensive	O
monitoring	O
programs	O
are	O
required	O
for	O
evaluating	O
the	O
concentrations	O
of	O
ocps	O
and	O
pcbs	B
in	O
serum	O
samples	O
of	O
the	O
general	O
population	O
as	O
an	O
indicator	O
of	O
possible	O
adverse	O
health	O
effects	O
.	O

distribution	O
of	O
polychlorinated	O
biphenyls	O
and	O
organochlorine	O
pesticides	O
in	O
human	O
breast	O
milk	O
from	O
various	O
locations	O
in	O
tunisia	O
:	O
levels	O
of	O
contamination	O
,	O
influencing	O
factors	O
,	O
and	O
infant	O
risk	O
assessment	O
..	O
the	O
concentrations	O
of	O
dichlorodiphenytrichloroethane	O
and	O
its	O
metabolites	O
(	O
ddts	O
)	O
,	O
hexachlorobenzene	O
(	O
hcb	O
)	O
,	O
hexachlorocyclohexane	O
isomers	O
(	O
hchs	O
)	O
,	O
dieldrin	O
,	O
and	O
20	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
were	O
determined	O
in	O
237	O
human	O
breast	O
milk	O
samples	O
collected	O
from	O
12	O
locations	O
in	O
tunisia	O
.	O

the	O
predominant	O
ocs	O
in	O
human	O
breast	O
milk	O
were	O
pcbs	B
,	O
p	O
,	O
p'-dde	O
,	O
p	O
,	O
p'-ddt	O
,	O
hchs	O
,	O
and	O
hcb	O
.	O

with	O
regard	O
to	O
pcbs	B
,	O
we	O
observed	O
the	O
predominance	O
of	O
mid	O
-	O
chlorinated	O
congeners	O
due	O
to	O
the	O
presence	O
of	O
pcbs	B
with	O
high	O
k(ow	O
)	O
such	O
as	O
pcb	O
153	O
,	O
138	O
,	O
and	O
180	O
.	O

the	O
comparison	O
of	O
daily	O
intakes	O
of	O
pcbs	B
,	O
ddts	O
,	O
hchs	O
,	O
and	O
hcb	O
to	O
infants	O
through	O
human	O
breast	O
milk	O
with	O
guidelines	O
proposed	O
by	O
who	O
and	O
health	O
canada	O
shows	O
that	O
some	O
individuals	O
accumulated	O
ocs	O
in	O
breast	O
milk	O
close	O
to	O
or	O
higher	O
than	O
these	O
guidelines	O
.	O

effects	O
of	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
and	O
organochlorine	O
pesticides	O
on	O
thyroid	O
function	O
during	O
pregnancy	O
..	O
in	O
this	O
study	O
,	O
the	O
authors	O
'	O
objective	O
was	O
to	O
determine	O
whether	O
serum	O
concentrations	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
hexachlorobenzene	O
,	O
p	O
,	O
p'-dichlorodiphenyl	O
trichloroethane	O
(	O
ddt	O
)	O
,	O
o	O
,	O
p'-ddt	O
,	O
and	O
p	O
,	O
p'-dichlorodiphenyl	O
dichloroethylene	O
(	O
dde	O
)	O
are	O
associated	O
with	O
thyroid	O
function	O
during	O
pregnancy	O
.	O

pcbs	B
44	O
,	O
52	O
,	O
and	O
183	O
remained	O
significant	O
after	O
the	O
exclusion	O
of	O
two	O
outliers	O
.	O

results	O
suggest	O
that	O
exposure	O
to	O
pcbs	B
and/or	O
hexachlorobenzene	O
at	O
background	O
levels	O
may	O
affect	O
thyroid	O
function	O
during	O
pregnancy	O
.	O

determination	O
of	O
dioxins	O
and	O
polychlorinated	O
biphenyls	O
in	O
breast	O
milk	O
,	O
maternal	O
blood	O
and	O
cord	O
blood	O
from	O
residents	O
of	O
tohoku	O
,	O
japan	O
..	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxins	O
(	O
pcdds	O
)	O
,	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	O
)	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
are	O
bioaccumulative	O
chemicals	O
that	O
are	O
considered	O
to	O
be	O
toxic	O
contaminants	O
based	O
on	O
several	O
epidemiological	O
studies	O
.	O

to	O
elucidate	O
exposure	O
levels	O
of	O
these	O
chemicals	O
in	O
the	O
present	O
study	O
,	O
concentrations	O
of	O
pcdd	O
/	O
dfs	O
,	O
dioxin	O
-	O
like	O
pcbs	B
(	O
dl	O
-	O
pcbs	O
)	O
and	O
pcbs	B
in	O
breast	O
milk	O
,	O
maternal	O
blood	O
and	O
cord	O
blood	O
obtained	O
from	O
the	O
same	O
participants	O
registered	O
in	O
a	O
birth	O
cohort	O
study	O
in	O
tohoku	O
,	O
japan	O
,	O
were	O
measured	O
.	O

the	O
toxicity	O
equivalence	O
quantity	O
concentrations	O
(	O
1998	O
who	O
-	O
tef	O
)	O
and	O
pcbs	B
in	O
breast	O
milk	O
,	O
maternal	O
blood	O
and	O
cord	O
blood	O
on	O
the	O
whole	O
and	O
on	O
a	O
lipid	O
basis	O
were	O
in	O
the	O
order	O
of	O
breast	O
milk	O
>	O
maternal	O
blood	O
>	O
cord	O
blood	O
.	O
pearson	O
's	O
correlation	O
coefficients	O
of	O
teqs	O
and	O
total	O
pcbs	B
among	O
the	O
three	O
specimens	O
were	O
high	O
,	O
with	O
the	O
correlation	O
coefficient	O
of	O
teq	O
between	O
breast	O
milk	O
and	O
maternal	O
blood	O
being	O
the	O
highest	O
(	O
r=0.94	O
,	O
p<0.001	O
)	O
.	O

pearson	O
's	O
correlation	O
coefficient	O
between	O
the	O
teq	O
and	O
pcbs	B
in	O
each	O
specimen	O
was	O
also	O
high	O
(	O
r=0.82	O
-	O
0.95	O
,	O
p<0.001	O
)	O
.	O

teq	O
concentrations	O
and	O
pcbs	B
were	O
negatively	O
associated	O
with	O
parity	O
(	O
p<0.05	O
)	O
,	O
and	O
maternal	O
age	O
was	O
positively	O
associated	O
with	O
pcbs	B
(	O
p<0.05	O
)	O
.	O

these	O
results	O
suggest	O
that	O
parity	O
is	O
an	O
important	O
factor	O
affecting	O
the	O
concentrations	O
of	O
dioxins	O
and	O
pcbs	B
in	O
these	O
specimens	O
.	O

multivariate	O
models	O
showed	O
that	O
many	O
factors	O
independently	O
predicted	O
exposure	O
to	O
bde-47	O
,	O
bde-100	O
,	O
and	O
bde-153	B
and	O
cb-118	O
,	O
cb-138/158	O
,	O
cb-153	O
,	O
and	O
cb-180	O
.	O

multivariate	O
models	O
showed	O
that	O
many	O
factors	O
independently	O
predicted	O
exposure	O
to	O
bde-47	O
,	O
bde-100	O
,	O
and	O
bde-153	B
and	O
cb-118	O
,	O
cb-138/158	O
,	O
cb-153	O
,	O
and	O
cb-180	O
.	O

the	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
all	O
congeners	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
in	O
human	O
serum	O
samples	O
.	O

the	O
mean	O
concentrations	O
of	O
total	O
pcbs	B
and	O
dioxin	O
-	O
like	O
pcbs	B
were	O
242.77ng	O
/	O
g	O
lipid	O
(	O
median	O
:	O
180.17ng	O
/	O
g	O
lipid	O
)	O
and	O
18.57ng	O
/	O
g	O
lipid	O
(	O
median	O
:	O
15.34ng	O
/	O
g	O
lipid	O
)	O
,	O
respectively	O
.	O

penta-	O
,	O
hexa-	O
,	O
and	O
heptachlorinated	O
biphenyls	O
contributed	O
more	O
than	O
80	O
%	O
of	O
the	O
total	O
pcbs	B
detected	O
in	O
human	O
serum	O
.	O

congener	O
-	O
specific	O
analysis	O
indicated	O
that	O
pcb153	O
,	O
pcb138	O
,	O
pcb180	O
,	O
pcb187	O
,	O
and	O
pcb118	O
contributed	O
57.3	O
%	O
of	O
the	O
total	O
pcbs	B
detected	O
in	O
human	O
serum	O
samples	O
.	O
a	O
statistical	O
analysis	O
was	O
performed	O
to	O
determine	O
whether	O
there	O
were	O
significant	O
correlations	O
between	O
pcb	O
concentrations	O
and	O
specific	O
variables	O
such	O
as	O
age	O
,	O
gender	O
,	O
smoking	O
habits	O
,	O
occupation	O
,	O
and	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
.	O

in	O
addition	O
,	O
we	O
found	O
that	O
total	O
pcbs	B
and	O
dioxin	O
-	O
like	O
pcbs	B
highly	O
correlated	O
with	O
pcb153	O
(	O
correlation	O
coefficient	O
r=0.93	O
,	O
p<0.01	O
)	O
and	O
pcb118	O
(	O
correlation	O
coefficient	O
r=0.98	O
,	O
p<0.01	O
)	O
,	O
respectively	O
.	O

thus	O
these	O
two	O
congeners	O
could	O
be	O
satisfactory	O
indicators	O
for	O
total	O
pcbs	B
and	O
dioxin	O
-	O
like	O
pcbs	B
in	O
human	O
serum	O
.	O

the	O
results	O
indicated	O
that	O
serum	O
pcb	O
concentrations	O
were	O
positively	O
associated	O
with	O
cumulative	O
lifetime	O
exposures	O
to	O
pcbs	B
from	O
local	O
fish	O
consumption	O
and	O
occupation	O
.	O

however	O
,	O
participants	O
who	O
lived	O
in	O
the	O
last	O
10	O
years	O
at	O
raquette	O
point	O
,	O
which	O
is	O
the	O
area	O
of	O
the	O
reserve	O
closest	O
to	O
the	O
hazardous	O
waste	O
sites	O
and	O
the	O
only	O
location	O
where	O
elevated	O
levels	O
of	O
pcbs	B
were	O
found	O
in	O
outdoor	O
air	O
,	O
did	O
not	O
have	O
higher	O
serum	O
pcb	O
concentrations	O
than	O
participants	O
who	O
lived	O
elsewhere	O
at	O
akwesasne	O
.	O

regarding	O
pattern	O
matching	O
,	O
mohawk	O
men	O
with	O
the	O
greatest	O
cumulative	O
lifetime	O
exposure	O
to	O
pcbs	B
from	O
local	O
fish	O
consumption	O
had	O
a	O
serum	O
pcb	O
congener	O
pattern	O
that	O
more	O
closely	O
resembled	O
that	O
in	O
fish	O
caught	O
off	O
-	O
shore	O
from	O
one	O
of	O
the	O
hazardous	O
waste	O
sites	O
than	O
did	O
men	O
who	O
ate	O
less	O
local	O
fish	O
.	O

similarly	O
,	O
mohawk	O
men	O
who	O
were	O
occupationally	O
exposed	O
to	O
pcbs	B
were	O
more	O
likely	O
than	O
those	O
without	O
occupational	O
exposure	O
to	O
have	O
a	O
serum	O
pcb	O
congener	O
pattern	O
that	O
was	O
similar	O
to	O
that	O
of	O
aroclor	O
1248	O
,	O
the	O
commercial	O
pcb	O
mixture	O
used	O
locally	O
.	O

high	O
serum	O
pcbs	B
are	O
associated	O
with	O
elevation	O
of	O
serum	O
lipids	O
and	O
cardiovascular	O
disease	O
in	O
a	O
native	O
american	O
population	O
..	O

we	O
have	O
investigated	O
the	O
relationships	O
among	O
the	O
concentration	O
of	O
total	O
serum	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
various	O
pcb	O
congener	O
groupings	O
,	O
and	O
three	O
pesticides	O
to	O
total	O
serum	O
lipids	O
in	O
humans	O
with	O
and	O
without	O
self	O
-	O
reported	O
cardiovascular	O
disease	O
.	O

structural	O
equation	O
modeling	O
,	O
following	O
the	O
definition	O
of	O
latent	O
variables	O
by	O
means	O
of	O
confirmatory	O
factor	O
analysis	O
,	O
was	O
used	O
to	O
analyze	O
the	O
relationships	O
between	O
serum	O
lipids	O
with	O
pcbs	B
and	O
heart	O
disease	O
.	O

there	O
were	O
significant	O
associations	O
among	O
pcbs	B
,	O
lipids	O
,	O
age	O
,	O
and	O
body	O
mass	O
index	O
(	O
bmi	O
)	O
,	O
a	O
fact	O
which	O
justified	O
the	O
application	O
of	O
the	O
structural	O
equation	O
model	O
.	O

the	O
results	O
of	O
this	O
study	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
age	O
is	O
considered	O
as	O
both	O
an	O
exogenous	O
explanatory	O
variable	O
and	O
a	O
biological	O
driving	O
mechanism	O
for	O
the	O
acquisition	O
of	O
pcbs	B
.	O

moreover	O
,	O
the	O
results	O
of	O
this	O
study	O
are	O
consistent	O
with	O
the	O
conclusion	O
that	O
pcbs	B
,	O
acting	O
through	O
p450	O
enzymes	O
,	O
are	O
directly	O
responsible	O
for	O
increased	O
synthesis	O
of	O
cholesterol	O
and	O
triglycerides	O
,	O
substances	O
known	O
to	O
be	O
major	O
risk	O
factors	O
for	O
cardiovascular	O
disease	O
.	O

maternal	O
serum	O
was	O
dominated	O
by	O
2,2',4,4'-tetrabromodiphenyl	O
ether	O
(	O
bde-47	B
)	O
,	O
while	O
2,2',4,4',5,5'-hexabromodiphenyl	O
ether	O
(	O
bde-153	B
)	O
prevailed	O
in	O
the	O
children	O
's	O
serum	O
seven	O
years	O
later	O
.	O

we	O
have	O
previously	O
reported	O
the	O
results	O
for	O
concentrations	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
,	O
p	O
,	O
p'-dichlorodiphenyl	O
-	O
dichloroethylene	O
(	O
pp'-dde	O
)	O
,	O
hexachlorobenzene	O
(	O
hcb	O
)	O
and	O
chlordanes	O
in	O
58	O
cases	O
with	O
testicular	O
cancer	O
,	O
61	O
age	O
-	O
matched	O
controls	O
and	O
44	O
case	O
mothers	O
and	O
45	O
control	O
mothers	O
.	O

in	O
that	O
report	O
,	O
significant	O
increase	O
of	O
odds	O
ratio	O
(	O
or	O
)	O
was	O
found	O
for	O
sum	O
of	O
pcbs	B
,	O
hcb	O
,	O
trans-	O
and	O
cis	O
-	O
nonachlordane	O
in	O
case	O
mothers	O
.	O

these	O
data	O
have	O
now	O
been	O
further	O
analysed	O
for	O
37	O
congeners	O
of	O
pcbs	B
.	O

a	O
priori	O
decided	O
grouping	O
of	O
pcbs	B
yielded	O
for	O
oestrogenic	O
pcbs	B
or	O
=	O
2.4	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
=	O
0.95	O
-	O
6.0	O
,	O
enzyme	O
-	O
inducing	O
pcbsor	O
=	O
2.6	O
,	O
95	O
%	O
ci	O
=	O
1.03	O
-	O
6.5	O
and	O
toxic	O
equivalents	O
(	O
teq	O
)	O
yielded	O
or	O
=	O
3.3	O
,	O
95	O
%	O
ci	O
=	O
1.3	O
-	O
8.4	O
.	O

fetal	O
exposure	O
to	O
pcbs	B
and	O
their	O
hydroxylated	O
metabolites	O
in	O
a	O
dutch	O
cohort	O
..	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
are	O
still	O
the	O
most	O
abundant	O
pollutants	O
in	O
wildlife	O
and	O
humans	O
.	O

hydroxylated	O
pcb	O
metabolites	O
(	O
oh	B
-	I
pcbs	I
)	O
are	O
known	O
to	O
be	O
formed	O
in	O
humans	O
and	O
wildlife	O
.	O

the	O
aim	O
of	O
this	O
study	O
is	O
to	O
measure	O
the	O
levels	O
of	O
pcbs	B
and	O
oh	B
-	I
pcbs	I
in	O
maternal	O
and	O
cord	O
blood	O
samples	O
in	O
a	O
population	O
with	O
background	O
levels	O
of	O
pcbs	B
.	O

the	O
cord	O
versus	O
maternal	O
blood	O
calculated	O
ratio	O
was	O
1.28	O
+	O
/-	O
0.56	O
for	O
pcbs	B
and	O
2.11	O
+	O
/-	O

1.33	O
for	O
oh	B
-	I
pcbs	I
,	O
expressed	O
per	O
gram	O
of	O
lipid	O
.	O

when	O
expressed	O
per	O
gram	O
fresh	O
weight	O
,	O
the	O
ratios	O
are	O
0.32	O
+	O
/-	O
0.15	O
and	O
0.53	O
+	O
/-	O
0.23	O
for	O
pcbs	B
and	O
oh	B
-	I
pcbs	I
,	O
respectively	O
.	O

a	O
significant	O
correlation	O
between	O
the	O
respective	O
maternal	O
and	O
cord	O
levels	O
for	O
both	O
pcbs	B
and	O
oh	B
-	I
pcbs	I
was	O
found	O
.	O

our	O
results	O
indicate	O
that	O
oh	B
-	I
pcbs	I
and	O
pcbs	B
are	O
transferred	O
across	O
the	O
placenta	O
to	O
the	O
fetus	O
in	O
concentrations	O
resulting	O
in	O
levels	O
of	O
approximately	O
50	O
and	O
30	O
%	O
,	O
respectively	O
,	O
of	O
those	O
in	O
maternal	O
plasma	O
.	O

human	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
in	O
a	O
residential	O
community	O
..	O
blood	O
serum	O
concentrations	O
of	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
were	O
measured	O
in	O
members	O
of	O
a	O
residential	O
community	O
who	O
lived	O
near	O
a	O
chemical	O
plant	O
that	O
formerly	O
manufactured	O
pcbs	B
.	O

congener	O
-	O
specific	O
analyses	O
indicated	O
that	O
pcb	O
congeners	O
153	O
,	O
138/158	O
,	O
180	O
,	O
118	O
,	O
and	O
187	O
contributed	O
60	O
-	O
67	O
%	O
of	O
the	O
total	O
pcbs	B
detected	O
in	O
blood	O
from	O
adults	O
and	O
children	O
.	O

past	O
exposures	O
to	O
pcbs	B
may	O
be	O
a	O
significant	O
contributor	O
to	O
the	O
elevated	O
pcb	O
concentrations	O
detected	O
in	O
some	O
adult	O
members	O
of	O
the	O
community	O
.	O

effects	O
of	O
prenatal	O
exposure	O
to	O
polychlorinated	O
biphenyls	O
and	O
dioxins	O
on	O
mental	O
and	O
motor	O
development	O
in	O
japanese	O
children	O
at	O
6	O
months	O
of	O
age	O
..	O
several	O
studies	O
have	O
shown	O
that	O
prenatal	O
and/or	O
postnatal	O
background	O
-	O
level	O
exposure	O
to	O
environmental	O
chemicals	O
,	O
such	O
as	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
and	O
dioxins	O
,	O
induces	O
adverse	O
effects	O
on	O
the	O
neurodevelopment	O
of	O
children	O
.	O

however	O
,	O
other	O
studies	O
have	O
not	O
detected	O
any	O
harmful	O
influences	O
on	O
neurodevelopment	O
.	O
furthermore	O
,	O
except	O
in	O
western	O
countries	O
,	O
no	O
developmental	O
tests	O
have	O
been	O
carried	O
out	O
in	O
relation	O
to	O
detailed	O
assessment	O
of	O
exposure	O
to	O
pcbs	B
and	O
dioxins	O
.	O

in	O
this	O
study	O
(	O
the	O
hokkaido	O
study	O
on	O
environment	O
and	O
children	O
's	O
health	O
)	O
,	O
the	O
effect	O
of	O
prenatal	O
exposure	O
to	O
background	O
levels	O
of	O
pcbs	B
and	O
dioxins	O
on	O
infant	O
neurodevelopment	O
in	O
japan	O
/	O
sapporo	O
was	O
elucidated	O
.	O

the	O
associations	O
between	O
the	O
total	O
or	O
individual	O
isomer	O
level	O
of	O
pcbs	B
and	O
dioxins	O
in	O
134	O
japanese	O
pregnant	O
women	O
's	O
peripheral	O
blood	O
and	O
the	O
mental	O
or	O
motor	O
development	O
of	O
their	O
6	O
-	O
month	O
-	O
old	O
infants	O
were	O
evaluated	O
using	O
the	O
second	O
edition	O
of	O
the	O
bayley	O
scales	O
of	O
infant	O
development	O
.	O

however	O
,	O
the	O
levels	O
of	O
one	O
polychlorinated	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
pcdd	O
)	O
isomer	O
,	O
total	O
pcdds	O
,	O
and	O
total	O
pcdds	O
/	O
polychlorinated	O
dibenzofurans	O
(	O
pcdfs	B
)	O
were	O
significantly	O
negatively	O
associated	O
with	O
mdi	O
,	O
and	O
the	O
levels	O
of	O
two	O
pcdd	O
isomers	O
and	O
three	O
pcdf	O
isomers	O
were	O
significantly	O
negatively	O
associated	O
with	O
the	O
pdi	O
.	O

in	O
utero	O
exposure	O
to	O
background	O
levels	O
of	O
polychlorinated	O
biphenyls	O
and	O
cognitive	O
functioning	O
among	O
school	O
-	O
age	O
children	O
..	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
are	O
ubiquitous	O
environmental	O
contaminants	O
.	O

in	O
utero	O
exposure	O
to	O
background	O
levels	O
of	O
pcbs	B
has	O
been	O
associated	O
with	O
intellectual	O
impairment	O
among	O
children	O
in	O
most	O
,	O
but	O
not	O
all	O
,	O
studies	O
.	O

third	O
trimester	O
serum	O
was	O
analyzed	O
for	O
pcbs	B
in	O
1997	O
-	O
1999	O
for	O
732	O
women	O
selected	O
at	O
random	O
and	O
for	O
an	O
additional	O
162	O
women	O
whose	O
children	O
had	O
either	O
a	O
low	O
or	O
a	O
high	O
iq	O
score	O
.	O

in	O
these	O
data	O
,	O
in	O
utero	O
exposure	O
to	O
background	O
levels	O
of	O
pcbs	B
was	O
not	O
associated	O
with	O
lower	O
iq	O
at	O
age	O
7	O
years	O
.	O

congener	O
-	O
specific	O
analysis	O
identified	O
the	O
predominant	O
pcb	O
congeners	O
as	O
#	O
153	O
(	O
22.2	O
%	O
)	O
,	O
#	O
180	O
(	O
11.6	O
%	O
)	O
,	O
#	O
138	O
(	O
8.4	O
%	O
)	O
,	O
#	O
182/187	O
(	O
6.6	O
%	O
)	O
,	O
#	O
118	O
(	O
5.6	O
%	O
)	O
,	O
#	O
163/164	O
(	O
5.0	O
%	O
)	O
,	O
#	O
99	O
(	O
3.9	O
%	O
)	O
,	O
#	O
74	O
(	O
3.6	O
%	O
)	O
,	O
#	O
146	O
(	O
3.3	O
%	O
)	O
,	O
#	O
170	O
(	O
3.0	O
%	O
)	O
and	O
#	O
156	O
(	O
2.2	O
%	O
)	O
,	O
representing	O
75.6	O
%	O
of	O
all	O
pcbs	B
detected	O
in	O
the	O
human	O
blood	O
samples	O
.	O

congener	O
-	O
specific	O
analysis	O
of	O
209	O
pcb	O
congeners	O
is	O
especially	O
useful	O
in	O
evaluating	O
human	O
exposure	O
to	O
pcbs	B
.	O

environmental	O
exposure	O
to	O
pcbs	B
and	O
cancer	O
incidence	O
in	O
eastern	O
slovakia	O
..	O
in	O
a	O
population	O
-	O
based	O
cross	O
-	O
sectional	O
study	O
,	O
we	O
compared	O
serum	O
levels	O
of	O
15	O
polychlorinated	O
biphenyl	O
(	O
pcb	O
)	O
congeners	O
and	O
three	O
organochlorine	O
pesticides	O
in	O
residents	O
of	O
two	O
districts	O
in	O
eastern	O
slovakia	O
,	O
one	O
with	O
extensive	O
environmental	O
contamination	O
from	O
a	O
former	O
pcb	O
production	O
site	O
(	O
michalovce	O
)	O
and	O
the	O
other	O
matched	O
on	O
geography	O
but	O
with	O
low	O
(	O
background	O
)	O
levels	O
(	O
svidnik	O
)	O
.	O

distribution	O
of	O
pcbs	B
and	O
organochlorine	O
pesticides	O
in	O
umbilical	O
cord	O
and	O
maternal	O
serum	O
..	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
and	O
organochlorine	O
pesticides	O
,	O
such	O
as	O
hexachlorobenzene	O
(	O
hcb	O
)	O
and	O
1,1,1	O
-	O
trichloro-2,2	O
-	O
bis(4	O
-	O
chlorophenyl)ethylene	O
(	O
p	B
,	I
p'-dde	I
)	O
are	O
compounds	O
widespread	O
in	O
the	O
environment	O
,	O
highly	O
lipophilic	O
,	O
and	O
accumulate	O
in	O
biological	O
systems	O
.	O

this	O
study	O
reports	O
the	O
levels	O
of	O
selected	O
pcb	O
congeners	O
,	O
p	B
,	I
p'-dde	I
and	O
hcb	O
in	O
maternal	O
blood	O
and	O
cord	O
blood	O
samples	O
collected	O
at	O
delivery	O
between	O
november	O
and	O
december	O
1999	O
from	O
44	O
women	O
living	O
in	O
the	O
urban	O
area	O
of	O
antwerp	O
,	O
belgium	O
.	O

results	O
show	O
that	O
all	O
newborns	O
contained	O
detectable	O
levels	O
of	O
pcbs	B
,	O
p	B
,	I
p'-dde	I
and	O
hcb	O
.	O

the	O
median	O
concentration	O
of	O
pcbs	B
was	O
450	O
pg	O
/	O
ml	O
and	O
ranged	O
between	O
120	O
and	O
1580	O
pg	O
/	O
ml	O
,	O
while	O
the	O
median	O
concentrations	O
of	O
hcb	O
and	O
p	B
,	I
p'-dde	I
were	O
70	O
and	O
490	O
pg	O
/	O
ml	O
,	O
respectively	O
.	O

concentrations	O
of	O
pcbs	B
and	O
p	B
,	I
p'-dde	I
in	O
cord	O
blood	O
(	O
ng	O
/	O
ml	O
)	O
were	O
positively	O
associated	O
with	O
concentrations	O
in	O
maternal	O
blood	O
(	O
ng	O
/	O
ml	O
)	O
(	O
coefficients=0.74	O
and	O
0.92	O
,	O
p<0.05	O
)	O
.	O

exposure	O
patterns	O
of	O
uv	O
filters	O
,	O
fragrances	O
,	O
parabens	O
,	O
phthalates	O
,	O
organochlor	O
pesticides	O
,	O
pbdes	O
,	O
and	O
pcbs	B
in	O
human	O
milk	O
:	O
correlation	O
of	O
uv	O
filters	O
with	O
use	O
of	O
cosmetics	O
..	O
in	O
order	O
to	O
assess	O
potential	O
risks	O
of	O
exposure	O
to	O
environmental	O
chemicals	O
,	O
more	O
information	O
on	O
concomitant	O
exposure	O
to	O
different	O
chemicals	O
is	O
needed	O
.	O

we	O
present	O
data	O
on	O
chemicals	O
in	O
human	O
milk	O
of	O
a	O
cohort	O
study	O
(	O
2004	O
,	O
2005	O
,	O
2006	O
)	O
of	O
54	O
mother	O
/	O
child	O
pairs	O
,	O
where	O
for	O
the	O
first	O
time	O
,	O
cosmetic	O
uv	O
filters	O
,	O
synthetic	O
musks	O
,	O
parabens	O
and	O
phthalate	O
metabolites	O
were	O
analyzed	O
in	O
the	O
same	O
sample	O
along	O
with	O
persistent	O
organochlor	O
pollutants	O
(	O
pops	O
)	O
,	O
i.e.	O
,	O
organochlor	O
pesticides	O
and	O
metabolites	O
,	O
polybrominated	O
diphenylethers	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

concentrations	O
of	O
pcbs	B
and	O
organochlor	O
pesticides	O
were	O
within	O
ranges	O
seen	O
in	O
western	O
and	O
southern	O
european	O
countries	O
.	O

we	O
present	O
data	O
on	O
chemicals	O
in	O
human	O
milk	O
of	O
a	O
cohort	O
study	O
(	O
2004	O
,	O
2005	O
,	O
2006	O
)	O
of	O
54	O
mother	O
/	O
child	O
pairs	O
,	O
where	O
for	O
the	O
first	O
time	O
,	O
cosmetic	O
uv	O
filters	O
,	O
synthetic	O
musks	O
,	O
parabens	O
and	O
phthalate	O
metabolites	O
were	O
analyzed	O
in	O
the	O
same	O
sample	O
along	O
with	O
persistent	O
organochlor	O
pollutants	O
(	O
pops	O
)	O
,	O
i.e.	O
,	O
organochlor	O
pesticides	O
and	O
metabolites	O
,	O
polybrominated	O
diphenylethers	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

concentrations	O
of	O
pcbs	B
and	O
organochlor	O
pesticides	O
were	O
within	O
ranges	O
seen	O
in	O
western	O
and	O
southern	O
european	O
countries	O
.	O

we	O
present	O
data	O
on	O
chemicals	O
in	O
human	O
milk	O
of	O
a	O
cohort	O
study	O
(	O
2004	O
,	O
2005	O
,	O
2006	O
)	O
of	O
54	O
mother	O
/	O
child	O
pairs	O
,	O
where	O
for	O
the	O
first	O
time	O
,	O
cosmetic	O
uv	O
filters	O
,	O
synthetic	O
musks	O
,	O
parabens	O
and	O
phthalate	O
metabolites	O
were	O
analyzed	O
in	O
the	O
same	O
sample	O
along	O
with	O
persistent	O
organochlor	O
pollutants	O
(	O
pops	O
)	O
,	O
i.e.	O
,	O
organochlor	O
pesticides	O
and	O
metabolites	O
,	O
polybrominated	O
diphenylethers	O
and	O
polychlorinated	O
biphenyls	O
(	O
pcbs	B
)	O
.	O

concentrations	O
of	O
pcbs	B
and	O
organochlor	O
pesticides	O
were	O
within	O
ranges	O
seen	O
in	O
western	O
and	O
southern	O
european	O
countries	O
.	O

bde-100	B
was	O
associated	O
with	O
increased	O
odds	O
of	O
low	O
cord	O
tt4	O
,	O
bde-153	B
with	O
increased	O
odds	O
of	O
low	O
cord	O
tt4	O
and	O
ft4	O
,	O
and	O
no	O
compounds	O
were	O
associated	O
with	O
increased	O
odds	O
of	O
high	O
tsh	O
.	O
for	O
infants	O
born	O
by	O
spontaneous	O
,	O
vaginal	O
,	O
unassisted	O
deliveries	O
,	O
pcbs	O
were	O
associated	O
with	O
lower	O
cord	O
tt4	O
and	O
ft4	O
and	O
lower	O
tt4	O
measured	O
in	O
neonatal	O
blood	O
spots	O
.	O

bde-100	B
was	O
associated	O
with	O
increased	O
odds	O
of	O
low	O
cord	O
tt4	O
,	O
bde-153	B
with	O
increased	O
odds	O
of	O
low	O
cord	O
tt4	O
and	O
ft4	O
,	O
and	O
no	O
compounds	O
were	O
associated	O
with	O
increased	O
odds	O
of	O
high	O
tsh	O
.	O
for	O
infants	O
born	O
by	O
spontaneous	O
,	O
vaginal	O
,	O
unassisted	O
deliveries	O
,	O
pcbs	O
were	O
associated	O
with	O
lower	O
cord	O
tt4	O
and	O
ft4	O
and	O
lower	O
tt4	O
measured	O
in	O
neonatal	O
blood	O
spots	O
.	O

serum	O
levels	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
in	O
foam	O
recyclers	O
and	O
carpet	O
installers	O
working	O
in	O
the	O
united	O
states	O
..	O
increased	O
exposure	O
to	O
the	O
flame	O
retardants	O
known	O
as	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
may	O
be	O
expected	O
to	O
occur	O
during	O
the	O
recycling	O
of	O
polyurethane	O
foam	O
containing	O
these	O
chemicals	O
.	O
to	O
date	O
,	O
no	O
studies	O
in	O
the	O
united	O
states	O
have	O
investigated	O
occupational	O
exposure	O
to	O
these	O
flame	O
retardants	O
during	O
recycling	O
processes	O
.	O

in	O
addition	O
,	O
levels	O
in	O
workers	O
were	O
also	O
compared	O
to	O
the	O
recently	O
published	O
national	O
health	O
and	O
nutrition	O
examination	O
survey	O
(	O
nhanes	O
)	O
data	O
set	O
on	O
pbdes	B
in	O
the	O
general	O
u.s	O
.	O

these	O
data	O
suggest	O
individuals	O
recycling	O
foam	O
-	O
containing	O
products	O
,	O
and/	O
or	O
using	O
products	O
manufactured	O
from	O
recycled	O
foam	O
(	O
i.e.	O
,	O
carpet	O
padding	O
)	O
,	O
have	O
higher	O
body	O
burdens	O
of	O
pbdes	B
,	O
and	O
thus	O
may	O
be	O
at	O
higher	O
risk	O
from	O
adverse	O
health	O
effects	O
associated	O
with	O
brominated	O
flame	O
retardant	O
exposure	O
.	O

distribution	O
of	O
polybrominated	O
diphenyl	O
ethers	O
in	O
human	O
umbilical	O
cord	O
serum	O
,	O
paternal	O
serum	O
,	O
maternal	O
serum	O
,	O
placentas	O
,	O
and	O
breast	O
milk	O
from	O
madrid	O
population	O
,	O
spain	O
..	O
median	O
concentration	O
of	O
total	O
pbdes	B
in	O
maternal	O
serum	O
,	O
paternal	O
serum	O
,	O
umbilical	O
cord	O
serum	O
,	O
and	O
breast	O
milk	O
samples	O
were	O
12	O
,	O
12	O
,	O
17	O
,	O
and	O
6.1	O
ng	O
/	O
g	O
lipid	O
weight	O
(	O
lw	O
)	O
in	O
vallecas	O
and	O
9.7	O
,	O
12	O
,	O
15	O
,	O
and	O
5.5	O
ng	O
/	O
g	O
lw	O
in	O
getafe	O
.	O

the	O
results	O
show	O
that	O
pbdes	B
,	O
like	O
other	O
pops	O
,	O
can	O
cross	O
the	O
placenta	O
barrier	O
,	O
although	O
the	O
speed	O
of	O
the	O
process	O
seems	O
to	O
differ	O
for	O
each	O
pbde	O
congeners	O
.	O

the	O
presence	O
of	O
pbdes	B
in	O
cord	O
blood	O
and	O
placenta	O
samples	O
indicates	O
that	O
there	O
is	O
prenatal	O
exposure	O
of	O
pbdes	B
,	O
which	O
could	O
continue	O
after	O
birth	O
via	O
breast	O
milk	O
.	O

few	O
studies	O
have	O
measured	O
pbdes	B
in	O
immigrant	O
populations	O
.	O

consistent	O
with	O
other	O
studies	O
,	O
2,2',4,4'-tetrabromodiphenyl	O
ether	O
(	O
bde-47	B
)	O
was	O
found	O
at	O
the	O
highest	O
concentration	O
(	O
median	O
=	O
11	O
ng	O
/	O
g	O
lipid	O
;	O
range	O
,	O
2.5	O
-	O
205	O
)	O
followed	O
by	O
2,2',4,4',5	O
-	O
pentabromobiphenyl	O
(	O
bde-99	B
)	O
(	O
median	O
=	O
2.9	O
ng	O
/	O
g	O
lipid	O
;	O
range	O
,	O
0.5	O
-	O
54	O
)	O
,	O
2,2',4,4',5	O
-	O
pentabde	O
(	O
bde-100	B
)	O
(	O
median	O
=	O
1.8	O
ng	O
/	O
g	O
lipid	O
;	O
range	O
,	O
0.6	O
-	O
44	O
)	O
,	O
and	O
2,2',4,4',5,5'-hexabde	O
(	O
bde-153	B
)	O
(	O
median	O
=	O
1.5	O
ng	O
/	O
g	O
lipid	O
;	O
range	O
,	O
0.4	O
-	O
35	O
)	O
.	O

levels	O
of	O
pcb-153	B
(	O
median=	O
4.4	O
ng	O
/	O
g	O
lipid	O
;	O
range	O
,	O
<	O
2	O
-	O
75	O
)	O
were	O
lower	O
than	O
u.s	O
.	O

conclusions	O
:	O
the	O
overall	O
levels	O
of	O
pbdes	B
found	O
were	O
lower	O
than	O
levels	O
observed	O
in	O
other	O
u.s	O
.	O

pbdes	B
have	O
been	O
associated	O
with	O
adverse	O
developmental	O
effects	O
in	O
animals	O
.	O

polybrominated	O
diphenyl	O
ethers	O
in	O
south	O
china	O
maternal	O
and	O
fetal	O
blood	O
and	O
breast	O
milk	O
..	O
twenty	O
-	O
one	O
-	O
paired	O
human	O
fetal	O
and	O
maternal	O
serum	O
and	O
27	O
breast	O
milk	O
samples	O
at	O
south	O
china	O
were	O
analyzed	O
for	O
concentrations	O
of	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
.	O

this	O
is	O
the	O
first	O
report	O
to	O
present	O
the	O
residue	O
levels	O
of	O
pbdes	B
in	O
human	O
samples	O
of	O
china	O
.	O

the	O
concentrations	O
of	O
total	O
pbdes	B
ranged	O
from	O
1.5	O
to	O
17	O
ng	O
/	O
g	O
in	O
the	O
samples	O
and	O
were	O
within	O
the	O
range	O
reported	O
in	O
european	O
samples	O
for	O
a	O
similar	O
population	O
,	O
but	O
lower	O
than	O
human	O
tissue	O
levels	O
in	O
north	O
america	O
.	O

bde-47	B
and	O
-153	O
were	O
the	O
dominant	O
pbde	O
congeners	O
in	O
all	O
samples	O
and	O
accounted	O
for	O
60	O
%	O
of	O
the	O
total	O
pbdes	B
.	O

further	O
research	O
is	O
needed	O
to	O
determine	O
the	O
exposure	O
route	O
of	O
pbdes	B
and	O
their	O
health	O
effects	O
.	O

distribution	O
of	O
polychlorinated	O
biphenyls	O
,	O
organochlorine	O
pesticides	O
and	O
polybrominated	O
diphenyl	O
ethers	O
in	O
human	O
umbilical	O
cord	O
serum	O
,	O
maternal	O
serum	O
and	O
milk	O
from	O
wielkopolska	O
region	O
,	O
poland	O
..	O
the	O
levels	O
of	O
organochlorinated	O
pesticides	O
(	O
ocps	O
):	O
p	B
,	I
p'-ddt	I
and	O
its	O
metabolites	O
,	O
hexachlorobenzene	O
(	O
hcb	O
)	O
,	O
hexachlorocyclohexane	O
isomers	O
(	O
hchs	O
)	O
,	O
chlordanes	O
and	O
their	O
metabolites	O
,	O
and	O
18	O
polychlorinated	O
biphenyl	O
(	O
pcb	O
)	O
congeners	O
were	O
measured	O
in	O
maternal	O
serum	O
,	O
umbilical	O
cord	O
serum	O
and	O
human	O
milk	O
collected	O
from	O
22	O
mothers	O
living	O
in	O
the	O
wielkopolska	O
region	O
,	O
poland	O
.	O

p	B
,	I
p'-ddt	I
and	O
its	O
major	O
metabolite	O
,	O
p	B
,	I
p'-dde	I
,	O
together	O
with	O
hcb	O
,	O
were	O
found	O
in	O
all	O
milk	O
and	O
serum	O
samples	O
.	O

median	O
concentrations	O
of	O
p	B
,	I
p'-dde	I
in	O
maternal	O
serum	O
,	O
umbilical	O
cord	O
serum	O
and	O
milk	O
were	O
343	O
,	O
329	O
and	O
634ng	O
/	O
g	O
lipid	O
weight	O
(	O
lw	O
)	O
.	O

the	O
median	O
concentrations	O
of	O
sum	O
pcbs	B
in	O
maternal	O
serum	O
,	O
umbilical	O
cord	O
serum	O
and	O
milk	O
were	O
79	O
,	O
60	O
and	O
133	O
ng	O
/	O
g	O
lw	O
,	O
respectively	O
.	O

a	O
good	O
correlation	O
(	O
spearman	O
r(s)>0.75	O
,	O
p<0.001	O
)	O
was	O
found	O
for	O
major	O
pcbs	B
,	O
p	B
,	I
p'-ddt	I
and	O
p	B
,	I
p'-dde	I
,	O
between	O
maternal	O
and	O
umbilical	O
cord	O
serum	O
,	O
while	O
the	O
correlation	O
was	O
weaker	O
between	O
milk	O
and	O
serum	O
.	O

the	O
levels	O
of	O
organochlorinated	O
pesticides	O
(	O
ocps	O
):	O
p	B
,	I
p'-ddt	I
and	O
its	O
metabolites	O
,	O
hexachlorobenzene	O
(	O
hcb	O
)	O
,	O
hexachlorocyclohexane	O
isomers	O
(	O
hchs	O
)	O
,	O
chlordanes	O
and	O
their	O
metabolites	O
,	O
and	O
18	O
polychlorinated	O
biphenyl	O
(	O
pcb	O
)	O
congeners	O
were	O
measured	O
in	O
maternal	O
serum	O
,	O
umbilical	O
cord	O
serum	O
and	O
human	O
milk	O
collected	O
from	O
22	O
mothers	O
living	O
in	O
the	O
wielkopolska	O
region	O
,	O
poland	O
.	O

p	B
,	I
p'-ddt	I
and	O
its	O
major	O
metabolite	O
,	O
p	B
,	I
p'-dde	I
,	O
together	O
with	O
hcb	O
,	O
were	O
found	O
in	O
all	O
milk	O
and	O
serum	O
samples	O
.	O

median	O
concentrations	O
of	O
p	B
,	I
p'-dde	I
in	O
maternal	O
serum	O
,	O
umbilical	O
cord	O
serum	O
and	O
milk	O
were	O
343	O
,	O
329	O
and	O
634ng	O
/	O
g	O
lipid	O
weight	O
(	O
lw	O
)	O
.	O

the	O
median	O
concentrations	O
of	O
sum	O
pcbs	B
in	O
maternal	O
serum	O
,	O
umbilical	O
cord	O
serum	O
and	O
milk	O
were	O
79	O
,	O
60	O
and	O
133	O
ng	O
/	O
g	O
lw	O
,	O
respectively	O
.	O

a	O
good	O
correlation	O
(	O
spearman	O
r(s)>0.75	O
,	O
p<0.001	O
)	O
was	O
found	O
for	O
major	O
pcbs	B
,	O
p	B
,	I
p'-ddt	I
and	O
p	B
,	I
p'-dde	I
,	O
between	O
maternal	O
and	O
umbilical	O
cord	O
serum	O
,	O
while	O
the	O
correlation	O
was	O
weaker	O
between	O
milk	O
and	O
serum	O
.	O

comparisons	O
of	O
polybrominated	O
diphenyl	O
ethers	O
levels	O
in	O
paired	O
south	O
korean	O
cord	O
blood	O
,	O
maternal	O
blood	O
,	O
and	O
breast	O
milk	O
samples	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
,	O
commonly	O
used	O
flame	O
retardants	O
,	O
have	O
been	O
reported	O
as	O
potential	O
endocrine	O
disruptor	O
and	O
neurodevelopmental	O
toxicants	O
,	O
thus	O
giving	O
rise	O
to	O
the	O
public	O
health	O
concern	O
.	O

the	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
relationship	O
between	O
umbilical	O
cord	O
blood	O
,	O
maternal	O
blood	O
,	O
and	O
breast	O
milk	O
concentrations	O
of	O
pbdes	B
in	O
south	O
korean	O
.	O

we	O
also	O
measured	O
thyroid	O
hormones	O
levels	O
in	O
maternal	O
and	O
cord	O
blood	O
to	O
assess	O
the	O
association	O
between	O
pbdes	B
exposure	O
and	O
thyroid	O
hormone	O
levels	O
.	O

however	O
,	O
there	O
was	O
no	O
correlation	O
between	O
serum	O
thyroxin	O
(	O
t4	O
)	O
and	O
total	O
pbdes	B
concentrations	O
.	O

the	O
total	O
pbdes	B
concentrations	O
in	O
the	O
umbilical	O
cord	O
blood	O
,	O
maternal	O
blood	O
,	O
and	O
breast	O
milk	O
were	O
10.7±5.1	O
ng	O
g(-1	O
)	O
lipid	O
,	O
7.7±4.2	O
ng	O
g(-1	O
)	O
lipid	O
,	O
and	O
3.0±1.8	O
ng	O
g(-1	O
)	O
lipid	O
,	O
respectively	O
.	O

bde-47	B
(	O
45	O
-	O
73	O
%	O
of	O
total	O
pbdes	B
)	O
was	O
observed	O
to	O
be	O
present	O
dominantly	O
in	O
all	O
samples	O
,	O
followed	O
by	O
bde-153	O
.	O

the	O
measurement	O
of	O
pbdes	B
concentrations	O
in	O
maternal	O
blood	O
or	O
breast	O
milk	O
may	O
help	O
to	O
determine	O
the	O
concentration	O
of	O
pbdes	B
in	O
infant	O
.	O

concentrations	O
and	O
speciation	O
of	O
polybrominated	O
diphenyl	O
ethers	O
in	O
human	O
amniotic	O
fluid	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
persistent	O
organic	O
chemicals	O
used	O
as	O
flame	O
retardants	O
in	O
textiles	O
,	O
plastics	O
,	O
and	O
consumer	O
products	O
.	O

although	O
pbde	O
accumulation	O
in	O
humans	O
has	O
been	O
noted	O
since	O
the	O
1970s	O
,	O
few	O
studies	O
have	O
investigated	O
pbdes	B
within	O
the	O
gestational	O
compartment	O
,	O
and	O
none	O
to	O
date	O
has	O
identified	O
levels	O
in	O
amniotic	O
fluid	O
.	O

bde-47	B
and	O
bde-99	B
were	O
identified	O
in	O
all	O
samples	O
.	O

based	O
on	O
median	O
concentrations	O
,	O
the	O
dominant	O
congeners	O
were	O
bde-208	O
,	O
209	O
,	O
203	O
,	O
206	O
,	O
207	O
,	O
and	O
47	O
representing	O
23	O
,	O
16	O
,	O
12	O
,	O
10	O
,	O
9	O
and	O
6	O
%	O
,	O
respectively	O
,	O
of	O
the	O
total	O
detected	O
pbdes	B
.	O

the	O
study	O
aimed	O
to	O
examine	O
the	O
impact	O
of	O
prenatal	O
exposure	O
to	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
on	O
infant	O
neurodevelopment	O
.	O
pbdes	B
levels	O
in	O
36	O
cord	O
blood	O
samples	O
were	O
analyzed	O
with	O
a	O
high	O
-	O
resolution	O
-	O
gas	O
-	O
chromatograph	O
/	O
high	O
-	O
resolution	O
-	O
mass	O
-	O
spectrometer	O
and	O
infant	O
neurodevelopment	O
was	O
assessed	O
using	O
the	O
bayley	O
scales	O
of	O
infant	O
and	O
toddler	O
development	O
,	O
third	O
edition	O
.	O

as	O
compared	O
to	O
the	O
lower	O
pbdes	B
group	O
(	O
σ(11)pbdes	O
 	O
<	O
 	O
4.63	O
 	O
ng	O
/	O
g	O
lipid	O
)	O
,	O
the	O
higher	O
pbdes	B
group	O
(	O
σ(11)pbdes	O
 	O
>	O
 	O
4.63	O
 	O
ng	O
/	O
g	O
lipid	O
)	O
had	O
a	O
significantly	O
higher	O
actual	O
odds	O
ratio	O
(	O
or	O
 	O

=	O
 	O
1.13	O
,	O
p	O
 	O
<	O
 	O
0.05	O
)	O
of	O
the	O
cognition	O
score	O
as	O
well	O
as	O
a	O
lower	O
odds	O
ratio	O
(	O
or	O
 	O
=	O
 	O
0.904	O
,	O
p	O
 	O
<	O
 	O
0.01	O
)	O
of	O
the	O
adaptive	O
behavior	O
score	O
,	O
suggesting	O
that	O
prenatal	O
pbdes	B
exposure	O
may	O
potentially	O
affect	O
infant	O
neurodevelopment	O
.	O

polybrominated	O
diphenyl	O
ethers	O
and	O
synthetic	O
musks	O
in	O
umbilical	O
cord	O
serum	O
,	O
maternal	O
serum	O
,	O
and	O
breast	O
milk	O
from	O
seoul	O
,	O
south	O
korea	O
..	O
fetal	O
and	O
maternal	O
exposure	O
levels	O
of	O
two	O
emerging	O
pollutants	O
,	O
polybrominated	O
diephenyl	O
ethers	O
(	O
pbdes	B
)	O
and	O
synthetic	O
musks	O
,	O
were	O
measured	O
in	O
korean	O
general	O
population	O
to	O
assess	O
prenatal	O
and	O
postnatal	O
exposures	O
in	O
infants	O
.	O

in	O
comparison	O
to	O
data	O
from	O
other	O
countries	O
and	O
previous	O
data	O
from	O
korea	O
,	O
relatively	O
higher	O
and	O
gradually	O
increasing	O
concentrations	O
for	O
pbdes	B
were	O
found	O
in	O
korean	O
breast	O
milk	O
(	O
<	O
loq	O
to	O
590	O
ng	O
g(-1	O
)	O
lipid	O
wt	O
;	O
median=90	O
ng	O
g(-1	O
)	O
)	O
.	O

differences	O
in	O
pbdes	B
and	O
musk	O
concentrations	O
were	O
found	O
among	O
age	O
groups	O
and	O
parity	O
levels	O
.	O

pbdes	B
concentrations	O
in	O
breast	O
milk	O
were	O
lower	O
in	O
the	O
younger	O
mothers	O
and/or	O
the	O
mothers	O
with	O
multiple	O
parities	O
,	O
while	O
these	O
trends	O
were	O
not	O
found	O
for	O
musks	O
.	O
compared	O
with	O
pbdes	B
,	O
concentrations	O
of	O
musks	O
were	O
significantly	O
lower	O
in	O
breast	O
milk	O
than	O
in	O
serum	O
and	O
a	O
little	O
correlation	O
in	O
concentrations	O
among	O
the	O
three	O
human	O
biological	O
matrices	O
were	O
observed	O
.	O

the	O
differences	O
in	O
the	O
profiles	O
of	O
musks	O
relative	O
to	O
pbdes	B
were	O
due	O
to	O
different	O
clearance	O
rates	O
between	O
these	O
two	O
compounds	O
.	O

the	O
average	O
hazard	O
quotients	O
(	O
hqs	O
)	O
for	O
daily	O
intake	O
of	O
pbdes	B
by	O
infants	O
via	O
lactation	O
were	O
0.62	O
,	O
0.42	O
,	O
and	O
0.19	O
for	O
bde-47	O
,	O
bde-99	O
,	O
and	O
bde-153	O
,	O
respectively	O
.	O

household	O
exposures	O
to	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
in	O
a	O
wisconsin	O
cohort	O
..	O
background	O
:	O
human	O
exposure	O
to	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
is	O
virtually	O
universal	O
in	O
the	O
united	O
states	O
.	O

conclusions	O
:	O
this	O
study	O
demonstrates	O
the	O
usefulness	O
of	O
the	O
portable	O
xrf	O
analyzer	O
in	O
identifying	O
household	O
items	O
that	O
may	O
contribute	O
to	O
human	O
exposure	O
to	O
pbdes	B
.	O

bde-209	B
was	O
the	O
predominant	O
congener	O
,	O
with	O
the	O
mean	O
concentrations	O
of	O
403	O
ng	O
/	O
g	O
lipid	O
in	O
serum	O
and	O
45.6	O
ng	O
/	O
g	O
lipid	O
in	O
breast	O
milk	O
,	O
respectively	O
.	O

bde-209	B
averagely	O
accounted	O
for	O
65.8	O
%	O
and	O
54.2	O
%	O
of	O
the	O
total	O
pbdes	O
,	O
respectively	O
.	O

polybrominated	O
diphenyl	O
ethers	O
(	O
pbde	O
)	O
in	O
serum	O
:	O
findings	O
from	O
a	O
us	O
cohort	O
of	O
consumers	O
of	O
sport	O
-	O
caught	O
fish	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
have	O
been	O
used	O
as	O
flame	O
retardants	O
in	O
foams	O
,	O
fabrics	O
and	O
plastics	O
,	O
and	O
are	O
common	O
contaminants	O
of	O
household	O
air	O
and	O
dust	O
and	O
bioaccumulate	O
in	O
wildlife	O
,	O
and	O
are	O
detectable	O
in	O
human	O
tissues	O
and	O
in	O
fish	O
and	O
animal	O
food	O
products	O
.	O

pbdes	B
are	O
present	O
in	O
the	O
same	O
sport	O
fish	O
but	O
prior	O
to	O
our	O
study	O
the	O
contribution	O
to	O
human	O
pbde	O
body	O
burdens	O
from	O
great	O
lakes	O
sport	O
fish	O
consumption	O
had	O
not	O
been	O
investigated	O
.	O

conclusions	O
:	O
our	O
analysis	O
suggests	O
that	O
2	O
or	O
3	O
blood	O
measurements	O
are	O
enough	O
to	O
limit	O
attenuation	O
of	O
regression	O
coefficients	O
within	O
20	O
%	O
of	O
the	O
true	O
value	O
for	O
most	O
carotenoids	B
and	O
tocopherols	O
.	O

we	O
measured	O
the	O
urinary	O
concentrations	O
of	O
five	O
phenols	O
and	O
three	O
parabens	O
:	O
2,4	O
-	O
dichlorophenol	O
(	O
24	O
-	O
dcp	O
)	O
,	O
2,5	O
-	O
dichlorophenol	O
(	O
25	O
-	O
dcp	O
)	O
,	O
benzophenone-3	O
(	O
bp-3	O
)	O
,	O
bisphenol	B
a	I
(	I
bpa	I
)	I
,	O
triclosan	O
(	O
tcs	O
)	O
,	O
butyl	O
paraben	O
(	O
b	O
-	O
pb	O
)	O
,	O
methyl	O
paraben	O
(	O
m	O
-	O
pb	O
)	O
,	O
and	O
propyl	O
paraben	O
(	O
p	O
-	O
pb	O
)	O
.	O

exceptions	O
were	O
ascorbic	B
acid	I
and	O
malondialdehyde	O
,	O
for	O
which	O
a	O
single	O
measure	O
resulted	O
in	O
little	O
attenuation	O
.	O

measurement	O
variability	O
of	O
plasma	O
beta	B
-	I
sitosterol	I
and	O
campesterol	B
,	O
two	O
new	O
biomarkers	O
for	O
cancer	O
prevention	O
..	O
phytosterols	O
are	O
plant	O
sterols	O
that	O
are	O
structurally	O
similar	O
to	O
cholesterol	O
and	O
are	O
characterized	O
by	O
anti	O
-	O
carcinogenic	O
and	O
anti	O
-	O
atherogenic	O
properties	O
.	O

beta	B
-	I
sitosterol	I
and	O
campesterol	B
are	O
the	O
predominant	O
phytosterols	O
in	O
blood	O
.	O

the	O
present	O
study	O
aimed	O
to	O
analyse	O
the	O
reproducibility	O
and	O
overtime	O
reliability	O
of	O
plasma	O
beta	B
-	I
sitosterol	I
and	O
campesterol	B
measurements	O
.	O

the	O
intraclass	O
correlation	O
coefficients	O
(	O
iccs	O
)	O
of	O
the	O
assay	O
for	O
plasma	O
beta	B
-	I
sitosterol	I
and	O
campesterol	B
were	O
0.88	O
and	O
0.94	O
(	O
95	O
%	O
confidence	O
intervals	O
low	O
bounds	O
(	O
95	O
%	O
ci(low	O
)	O
)	O
were	O
0.66	O
and	O
0.82	O
)	O
,	O
respectively	O
.	O

to	O
study	O
the	O
reliability	O
of	O
beta	B
-	I
sitosterol	I
and	O
campesterol	B
measurement	O
over	O
time	O
,	O
seven	O
premenopausal	O
women	O
were	O
recruited	O
.	O

the	O
overtime	O
iccs	O
of	O
plasma	O
beta	B
-	I
sitosterol	I
and	O
campesterol	B
were	O
0.91	O
(	O
95	O
%	O
ci(low	O
)	O
0.49	O
)	O
and	O
0.58	O
(	O
95	O
%	O
ci(low	O
)	O
0.31	O
)	O
,	O
respectively	O
.	O

the	O
high	O
reproducibility	O
and	O
good	O
overtime	O
reliability	O
of	O
plasma	O
beta	B
-	I
sitosterol	I
and	O
campesterol	B
measurements	O
indicate	O
that	O
they	O
may	O
be	O
suitable	O
for	O
potential	O
clinical	O
and	O
population	O
-	O
based	O
studies	O
on	O
cancer	O
prevention	O
.	O

reliability	O
of	O
fasting	O
plasma	O
alkylresorcinol	O
concentrations	O
measured	O
4	O
months	O
apart	O
..	O
background	O
/	O
objectives	O
:	O
alkylresorcinols	B
(	O
ars	O
)	O
have	O
been	O
suggested	O
as	O
specific	O
dietary	O
biomarkers	O
of	O
whole	O
-	O
grain	O
intake	O
.	O

results	O
:	O
for	O
the	O
20	O
individual	O
fatty	B
acids	I
measured	O
,	O
the	O
reliability	O
coefficients	O
were	O
less	O
than	O
0.50	O
for	O
four	O
,	O
between	O
0.50	O
and	O
0.70	O
for	O
nine	O
,	O
and	O
greater	O
than	O
0.70	O
for	O
seven	O
.	O

among	O
the	O
major	O
fatty	B
acids	I
,	O
arachidonic	O
and	O
alpha	O
-	O
linolenic	O
acids	O
had	O
high	O
reliability	O
coefficients	O
(	O
0.71	O
and	O
0	O
.	O

the	O
reliability	O
coefficients	O
for	O
total	O
monounsaturated	O
fats	O
,	O
omega-6	O
and	O
omega-3	O
fatty	B
acids	I
were	O
moderately	O
high	O
(	O
0.66	O
,	O
0.53	O
and	O
0.66	O
,	O
respectively	O
)	O
,	O
whereas	O
the	O
coefficients	O
for	O
total	O
saturated	O
fats	O
and	O
total	O
polyunsaturated	O
fats	O
were	O
low	O
(	O
0.31	O
and	O
0.43	O
,	O
respectively	O
)	O
.	O

conclusions	O
:	O
these	O
results	O
indicate	O
that	O
the	O
fatty	O
acid	O
composition	O
of	O
serum	O
phospholipids	O
can	O
be	O
a	O
useful	O
tool	O
in	O
epidemiologic	O
studies	O
,	O
although	O
for	O
most	O
fatty	B
acids	I
a	O
single	O
determination	O
is	O
associated	O
with	O
some	O
error	O
in	O
measurement	O
that	O
should	O
be	O
taken	O
into	O
account	O
at	O
the	O
design	O
and	O
analysis	O
stages	O
.	O

storage	O
for	O
up	O
to	O
12	O
y	O
at	O
-80	O
degrees	O
c	O
preserved	O
polyunsaturated	O
fatty	B
acids	I
from	O
oxidation	O
very	O
well	O
.	O

we	O
compared	O
mean	O
plasma	O
levels	O
at	O
baseline	O
,	O
year	O
1	O
,	O
and	O
year	O
4	O
of	O
the	O
study	O
for	O
alpha	O
-	O
carotene	O
,	O
beta	O
-	O
carotene	O
,	O
lycopene	B
,	O
lutein	O
,	O
and	O
beta	O
-	O
cryptoxanthin	O
.	O

variation	O
did	O
not	O
exceed	O
8	O
%	O
for	O
lycopene	B
,	O
lutein	O
,	O
and	O
beta	O
-	O
cryptoxanthin	O
,	O
15	O
%	O
for	O
alpha	O
-	O
carotene	O
,	O
and	O
18	O
%	O
for	O
beta	O
-	O
carotene	O
.	O

spearman	O
correlations	O
for	O
individual	O
carotenoids	B
over	O
time	O
varied	O
between	O
0.50	O
and	O
0.80	O
,	O
with	O
lycopene	B
having	O
the	O
lowest	O
correlation	O
.	O

intraclass	O
correlations	O
ranged	O
from	O
0.47	O
to	O
0.66	O
for	O
carotenoids	B
.	O

conclusion	O
:	O
intraclass	O
correlations	O
for	O
plasma	O
carotenoids	B
over	O
a	O
period	O
of	O
several	O
years	O
are	O
acceptable	O
for	O
epidemiologic	O
studies	O
.	O

iccs	O
were	O
good	O
to	O
excellent	O
for	O
plasma	O
carotenoids	B
(	O
0.73	O
-	O
0.88	O
)	O
,	O
vitamin	O
d	O
analytes	O
(	O
0.56	O
-	O
0.72	O
)	O
,	O
bioactive	O
somatolactogens	O
(	O
0.62	O
)	O
,	O
soluble	O
leptin	O
receptor	O
(	O
0.82	O
)	O
,	O
resistin	O
(	O
0.74	O
)	O
,	O
and	O
postmenopausal	O
melatonin	O
(	O
0.63	O
)	O
.	O

reproducibility	O
was	O
lower	O
for	O
some	O
of	O
the	O
plasma	O
fatty	B
acids	I
(	O
0.38	O
-	O
0.72	O
)	O
,	O
matrix	O
metalloproteinases	O
(	O
0.07	O
-	O
0.91	O
)	O
,	O
and	O
premenopausal	O
melatonin	O
(	O
0.44	O
)	O
.	O

the	O
iccs	O
for	O
plasma	O
and	O
urinary	O
phytoestrogens	O
were	O
poor	O
(	O
<	O
or	O
=	O
0.09	O
)	O
except	O
for	O
enterolactone	B
(	O
plasma	O
,	O
0.44	O
;	O
urinary	O
,	O
0.52	O
)	O
.	O

we	O
detected	O
four	O
phthalate	O
monoesters	O
in	O
all	O
subjects	O
,	O
with	O
median	O
levels	O
of	O
31	O
ng	O
/	O
ml	O
for	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
53	O
ng	O
/	O
ml	O
for	O
monobutyl	O
phthalate	O
(	O
mbp	O
)	O
,	O
211	O
ng	O
/	O
ml	O
for	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
and	O
7.3	O
ng	O
/	O
ml	O
for	O
monoethylhexyl	O
phthalate	O
(	O
mehp	O
)	O
.	O

we	O
detected	O
four	O
phthalate	O
monoesters	O
in	O
all	O
subjects	O
,	O
with	O
median	O
levels	O
of	O
31	O
ng	O
/	O
ml	O
for	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
53	O
ng	O
/	O
ml	O
for	O
monobutyl	O
phthalate	O
(	O
mbp	O
)	O
,	O
211	O
ng	O
/	O
ml	O
for	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
and	O
7.3	O
ng	O
/	O
ml	O
for	O
monoethylhexyl	O
phthalate	O
(	O
mehp	O
)	O
.	O

short	O
-	O
term	O
variations	O
in	O
enterolactone	B
in	O
serum	O
,	O
24	O
-	O
hour	O
urine	O
,	O
and	O
spot	O
urine	O
and	O
relationship	O
with	O
enterolactone	B
concentrations	O
.	O

temporal	O
reproducibility	O
of	O
taurine	B
measurements	O
in	O
frozen	O
serum	O
of	O
healthy	O
postmenopausal	O
women	O
..	O
animal	O
studies	O
and	O
small	O
clinical	O
trials	O
have	O
shown	O
that	O
taurine	B
(	O
2	O
-	O
aminoethanesulphonic	O
acid	O
)	O
,	O
a	O
sulphur	O
-	O
containing	O
molecule	O
mainly	O
obtained	O
from	O
the	O
diet	O
in	O
human	O
subjects	O
,	O
has	O
a	O
variety	O
of	O
biological	O
actions	O
that	O
are	O
related	O
to	O
atherosclerosis	O
and	O
cardiovascular	O
functions	O
.	O

however	O
,	O
epidemiological	O
studies	O
of	O
taurine	B
and	O
chd	O
risk	O
are	O
lacking	O
.	O

we	O
evaluated	O
whether	O
a	O
single	O
measurement	O
of	O
serum	O
taurine	B
could	O
serve	O
as	O
an	O
estimate	O
for	O
long	O
-	O
term	O
serum	O
levels	O
.	O

serum	O
taurine	B
was	O
measured	O
using	O
hplc	O
in	O
three	O
annual	O
samples	O
from	O
thirty	O
postmenopausal	O
women	O
selected	O
from	O
the	O
new	O
york	O
university	O
women	O
's	O
health	O
study	O
.	O

overall	O
,	O
serum	O
taurine	B
values	O
ranged	O
from	O
62.8	O
to	O
245.3	O
nmol	O
/	O
ml	O
,	O
with	O
a	O
mean	O
of	O
140	O
nmol	O
/	O
ml	O
.	O

the	O
intraclass	O
correlation	O
coefficient	O
of	O
a	O
single	O
measurement	O
of	O
serum	O
taurine	B
was	O
0.48	O
(	O
95	O
%	O
ci	O
0.26	O
,	O
0.68	O
)	O
,	O
which	O
can	O
be	O
improved	O
to	O
0.65	O
by	O
using	O
the	O
mean	O
of	O
two	O
annual	O
measurements	O
.	O

these	O
results	O
indicate	O
that	O
the	O
mean	O
of	O
two	O
or	O
more	O
annual	O
measurements	O
of	O
serum	O
taurine	B
is	O
a	O
sufficiently	O
reliable	O
measure	O
of	O
long	O
-	O
term	O
serum	O
levels	O
that	O
can	O
be	O
used	O
in	O
epidemiological	O
studies	O
.	O

objective	O
:	O
to	O
evaluate	O
intraindividual	O
temporal	O
variability	O
in	O
19	O
individual	O
urinary	O
biomarkers	O
(	O
eight	O
phthalate	O
metabolites	O
from	O
six	O
phthalate	O
diesters	O
,	O
six	O
phytoestrogens	O
(	O
two	O
lignans	O
and	O
four	O
isoflavones	B
)	O
and	O
five	O
phenols	O
)	O
among	O
new	O
york	O
city	O
children	O
.	O

objective	O
:	O
to	O
evaluate	O
intraindividual	O
temporal	O
variability	O
in	O
19	O
individual	O
urinary	O
biomarkers	O
(	O
eight	O
phthalate	O
metabolites	O
from	O
six	O
phthalate	O
diesters	O
,	O
six	O
phytoestrogens	O
(	O
two	O
lignans	O
and	O
four	O
isoflavones	B
)	O
and	O
five	O
phenols	O
)	O
among	O
new	O
york	O
city	O
children	O
.	O

the	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
temporal	O
variability	O
in	O
repeated	O
measurements	O
of	O
urinary	O
excretion	O
of	O
bisphenol	B
a	I
(	I
bpa	I
)	I
and	O
seven	O
other	O
phenols	O
.	O

these	O
90	O
samples	O
were	O
analyzed	O
for	O
urinary	O
metabolites	O
of	O
chlorpyrifos	O
(	O
3,5,6	O
-	O
trichloro-2	O
-	O
pyridinol	O
(	O
tcpy	B
)	O
)	O
and	O
carbaryl	O
(	O
1	O
-	O
naphthol	O
(	O
1n	O
)	O
)	O
.	O

tcpy	B
had	O
low	O
reliability	O
with	O
an	O
intraclass	O
correlation	O
coefficient	O
between	O
0.15	O
and	O
0.21	O
,	O
while	O
1n	O
was	O
moderately	O
reliable	O
with	O
an	O
intraclass	O
correlation	O
coefficient	O
between	O
0.55	O
and	O
0.61	O
.	O

when	O
the	O
10	O
men	O
were	O
divided	O
into	O
tertiles	O
based	O
on	O
3	O
-	O
month	O
geometric	O
mean	O
tcpy	B
and	O
1n	O
levels	O
,	O
a	O
single	O
urine	O
sample	O
performed	O
adequately	O
in	O
classifying	O
a	O
subject	O
into	O
the	O
highest	O
or	O
lowest	O
exposure	O
tertiles	O
.	O

sensitivity	O
and	O
specificity	O
ranged	O
from	O
0.44	O
to	O
0.84	O
for	O
tcpy	B
and	O
from	O
0.56	O
to	O
0.89	O
for	O
1n	O
.	O

in	O
mixed	O
-	O
effects	O
models	O
,	O
tcpy	B
was	O
significantly	O
associated	O
with	O
season	O
as	O
well	O
as	O
with	O
consuming	O
grapes	O
and	O
cheese	O
,	O
while	O
1n	O
levels	O
were	O
associated	O
with	O
consuming	O
strawberries	O
.	O

urinary	O
3,5,6	O
-	O
trichloro-2	O
-	O
pyridinol	O
(	O
tcpy	B
)	O
in	O
pregnant	O
women	O
from	O
mexico	O
city	O
:	O
distribution	O
,	O
temporal	O
variability	O
,	O
and	O
relationship	O
with	O
child	O
attention	O
and	O
hyperactivity	O
..	O
attention	O
deficit	O
hyperactivity	O
disorder	O
(	O
adhd	O
)	O
is	O
the	O
most	O
commonly	O
diagnosed	O
and	O
studied	O
cognitive	O
and	O
behavioral	O
disorder	O
in	O
school	O
-	O
age	O
children	O
.	O

the	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
relationship	O
between	O
in	O
utero	O
exposure	O
to	O
chlorpyrifos	O
,	O
chlorpyrifos	O
-	O
methyl	O
,	O
and/or	O
3,5,6	O
-	O
trichloro-2	O
-	O
pyridinol	O
(	O
tcpy	B
)	O
and	O
adhd	O
in	O
school	O
-	O
age	O
mexican	O
children	O
using	O
tcpy	B
as	O
a	O
biomarker	O
of	O
exposure	O
.	O

the	O
temporal	O
reliability	O
of	O
repeated	O
maternal	O
urinary	O
tcpy	B
concentrations	O
across	O
trimesters	O
was	O
also	O
explored	O
(	O
n=21	O
)	O
.	O

to	O
explore	O
associations	O
with	O
adhd	O
-	O
related	O
outcomes	O
in	O
children	O
,	O
third	O
trimester	O
urinary	O
tcpy	B
concentrations	O
in	O
were	O
measured	O
in	O
187	O
mother	O
-	O
child	O
pairs	O
from	O
a	O
prospective	O
birth	O
cohort	O
.	O

the	O
icc	O
was	O
0.41	O
for	O
uncorrected	O
tcpy	B
,	O
and	O
ranged	O
from	O
0.29	O
to	O
0.32	O
for	O
specific	O
gravity	O
-	O
corrected	O
tcpy	B
.	O

we	O
did	O
not	O
observe	O
any	O
statistically	O
significant	O
associations	O
between	O
tertiles	O
of	O
maternal	O
tcpy	B
concentrations	O
and	O
adhd	O
-	O
related	O
outcomes	O
in	O
children	O
.	O

however	O
,	O
compared	O
to	O
the	O
lowest	O
tertile	O
we	O
found	O
suggestive	O
evidence	O
for	O
increased	O
adhd	O
index	O
in	O
the	O
highest	O
tcpy	B
tertile	O
in	O
boys	O
(	O
β=5.55	O
points	O
;	O
95	O
%	O
ci	O
(	O
-0.19	O
,	O
11.3	O
)	O
;	O
p=0.06	O
)	O
and	O
increased	O
attention	O
problems	O
for	O
the	O
middle	O
tertile	O
in	O
girls	O
(	O
β=5.81	O
points	O
;	O
95	O
%	O
ci	O
(	O
-0.75	O
,	O
12.4	O
)	O
;	O
p=0.08	O
)	O
.	O

methods	O
:	O
nine	O
repeated	O
urine	O
samples	O
were	O
collected	O
from	O
7	O
men	O
over	O
the	O
course	O
of	O
3	O
months	O
and	O
analyzed	O
for	O
bis(1,3	O
-	O
dichloro-2	O
-	O
propyl	O
)	O
phosphate	O
(	O
bdcpp	B
)	O
and	O
diphenyl	O
phosphate	O
(	O
dpp	B
)	O
,	O
metabolites	O
of	O
the	O
opfrs	O
tris(1,3	O
-	O
dichloro-2	O
-	O
propyl	O
)	O
phosphate	O
(	O
tdcpp	O
)	O
and	O
triphenyl	O
phosphate	O
(	O
tpp	O
)	O
,	O
respectively	O
.	O

results	O
:	O
bdcpp	B
was	O
detected	O
in	O
91	O
%	O
of	O
urine	O
samples	O
,	O
and	O
dpp	B
in	O
96	O
%	O
.	O

urinary	O
bdcpp	B
showed	O
moderate	O
-	O
to	O
-	O
strong	O
temporal	O
reliability	O
(	O
icc	O
range	O
,	O
0.55	O
-	O
0.72	O
)	O
.	O

iccs	O
for	O
dpp	B
were	O
lower	O
,	O
but	O
moderately	O
reliable	O
(	O
range	O
,	O
0.35	O
-	O
0.51	O
)	O
.	O

there	O
was	O
a	O
weak	O
[	O
spearman	O
r	O
(	O
r(s	O
)	O
)	O
=	O
0.31	O
]	O
but	O
significant	O
(	O
p	O
=	O
0.03	O
)	O
correlation	O
between	O
urinary	O
bdcpp	B
and	O
tdcpp	O
concentrations	O
in	O
house	O
dust	O
that	O
strengthened	O
when	O
nondetects	O
(	O
r(s	O
)	O
=	O
0.47	O
)	O
were	O
excluded	O
.	O

there	O
was	O
no	O
correlation	O
between	O
uncorrected	O
dpp	B
and	O
tpp	O
measured	O
in	O
house	O
dust	O
(	O
r(s	O
)	O
<	O
0.1	O
)	O
.	O

urinary	O
concentrations	O
of	O
bdcpp	B
and	O
dpp	B
were	O
moderately	O
to	O
highly	O
reliable	O
within	O
individuals	O
over	O
3	O
months	O
.	O

variability	O
and	O
predictors	O
of	O
urinary	O
bisphenol	O
a	O
concentrations	O
during	O
pregnancy	O
..	O
background	O
:	O
prenatal	O
bisphenol	B
a	I
(	I
bpa	I
)	I
exposure	O
may	O
be	O
associated	O
with	O
developmental	O
toxicity	O
,	O
but	O
few	O
studies	O
have	O
examined	O
the	O
variability	O
and	O
predictors	O
of	O
urinary	O
bpa	O
concentrations	O
during	O
pregnancy	O
.	O

within	O
-	O
day	O
variability	O
contributed	O
on	O
average	O
84	O
%	O
,	O
and	O
between	O
-	O
day	O
variability	O
accounted	O
for	O
16	O
%	O
of	O
the	O
total	O
variance	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
pyr	O
)	O
.	O

within	O
-	O
day	O
variability	O
contributed	O
on	O
average	O
84	O
%	O
,	O
and	O
between	O
-	O
day	O
variability	O
accounted	O
for	O
16	O
%	O
of	O
the	O
total	O
variance	O
of	O
1	B
-	I
hydroxypyrene	I
(	O
1	O
-	O
pyr	O
)	O
.	O

variability	O
of	O
urinary	O
phthalate	O
metabolite	O
and	O
bisphenol	O
a	O
concentrations	O
before	O
and	O
during	O
pregnancy	O
..	O
background	O
:	O
gestational	O
phthalate	O
and	O
bisphenol	B
a	I
(	I
bpa	I
)	I
exposure	O
may	O
increase	O
the	O
risk	O
of	O
adverse	O
maternal	O
/	O
child	O
health	O
outcomes	O
,	O
but	O
there	O
are	O
few	O
data	O
on	O
the	O
variability	O
of	O
urinary	O
biomarkers	O
before	O
and	O
during	O
pregnancy	O
.	O

we	O
measured	O
urinary	O
concentrations	O
of	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	O
-	O
n	O
-	O
butyl	O
phthalate	O
(	O
mbp	O
)	O
,	O
mono	O
-	O
iso	O
-	O
butyl	O
phthalate	O
,	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
four	O
metabolites	O
of	O
di-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
dehp	O
)	O
,	O
and	O
bpa	O
.	O
after	O
adjusting	O
for	O
specific	O
gravity	O
,	O
we	O
characterized	O
biomarker	O
variability	O
using	O
intraclass	O
correlation	O
coefficients	O
(	O
iccs	O
)	O
and	O
conducted	O
several	O
surrogate	O
category	O
analyses	O
to	O
determine	O
whether	O
a	O
single	O
spot	O
urine	O
sample	O
could	O
adequately	O
classify	O
average	O
gestational	O
exposure	O
.	O

the	O
present	O
results	O
may	O
be	O
related	O
to	O
unique	O
features	O
of	O
the	O
women	O
studied	O
,	O
and	O
replication	O
in	O
other	O
pregnancy	O
cohorts	O
is	O
recommended	O
..	O
background	O
:	O
gestational	O
phthalate	O
and	O
bisphenol	B
a	I
(	I
bpa	I
)	I
exposure	O
may	O
increase	O
the	O
risk	O
of	O
adverse	O
maternal	O
/	O
child	O
health	O
outcomes	O
,	O
but	O
there	O
are	O
few	O
data	O
on	O
the	O
variability	O
of	O
urinary	O
biomarkers	O
before	O
and	O
during	O
pregnancy	O
.	O

we	O
measured	O
urinary	O
concentrations	O
of	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	O
-	O
n	O
-	O
butyl	O
phthalate	O
(	O
mbp	O
)	O
,	O
mono	O
-	O
iso	O
-	O
butyl	O
phthalate	O
,	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
four	O
metabolites	O
of	O
di-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
dehp	O
)	O
,	O
and	O
bpa	O
.	O
after	O
adjusting	O
for	O
specific	O
gravity	O
,	O
we	O
characterized	O
biomarker	O
variability	O
using	O
intraclass	O
correlation	O
coefficients	O
(	O
iccs	O
)	O
and	O
conducted	O
several	O
surrogate	O
category	O
analyses	O
to	O
determine	O
whether	O
a	O
single	O
spot	O
urine	O
sample	O
could	O
adequately	O
classify	O
average	O
gestational	O
exposure	O
.	O

objectives	O
:	O
we	O
examined	O
inter-	O
and	O
intraperson	O
and	O
inter-	O
and	O
intraday	O
variability	O
in	O
the	O
concentrations	O
of	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
the	O
major	O
metabolite	O
of	O
diethyl	O
phthalate	O
,	O
commonly	O
used	O
in	O
personal	O
care	O
products	O
,	O
and	O
mono(2	O
-	O
ethyl-5	O
-	O
hydroxyhexyl	O
)	O
phthalate	O
(	O
mehhp	O
)	O
,	O
a	O
metabolite	O
of	O
di(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
dehp	O
)	O
,	O
a	O
polyvinyl	O
chloride	O
plasticizer	O
of	O
which	O
diet	O
is	O
the	O
principal	O
exposure	O
source	O
,	O
among	O
eight	O
adults	O
who	O
collected	O
all	O
urine	O
voids	O
(	O
average	O
,	O
7.6	O
samples	O
/	O
person	O
/	O
day	O
)	O
for	O
1	O
week	O
.	O

objectives	O
:	O
we	O
examined	O
inter-	O
and	O
intraperson	O
and	O
inter-	O
and	O
intraday	O
variability	O
in	O
the	O
concentrations	O
of	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
the	O
major	O
metabolite	O
of	O
diethyl	O
phthalate	O
,	O
commonly	O
used	O
in	O
personal	O
care	O
products	O
,	O
and	O
mono(2	O
-	O
ethyl-5	O
-	O
hydroxyhexyl	O
)	O
phthalate	O
(	O
mehhp	O
)	O
,	O
a	O
metabolite	O
of	O
di(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
dehp	O
)	O
,	O
a	O
polyvinyl	O
chloride	O
plasticizer	O
of	O
which	O
diet	O
is	O
the	O
principal	O
exposure	O
source	O
,	O
among	O
eight	O
adults	O
who	O
collected	O
all	O
urine	O
voids	O
(	O
average	O
,	O
7.6	O
samples	O
/	O
person	O
/	O
day	O
)	O
for	O
1	O
week	O
.	O

variation	O
in	O
fasting	O
and	O
non	O
-	O
fasting	O
serum	O
enterolactone	B
concentrations	O
in	O
women	O
of	O
the	O
malmö	O
diet	O
and	O
cancer	O
cohort	O
..	O
objectives	O
:	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
variation	O
of	O
enterolactone	B
from	O
fasting	O
and	O
non	O
-	O
fasting	O
blood	O
of	O
middle	O
-	O
aged	O
healthy	O
women	O
eating	O
a	O
normal	O
diet	O
to	O
determine	O
the	O
usefulness	O
of	O
a	O
single	O
sample	O
in	O
epidemiological	O
studies	O
.	O

enterolactone	B
concentrations	O
were	O
analyzed	O
by	O
time	O
-	O
resolved	O
fluoroimmunoassay	O
.	O

conclusions	O
:	O
although	O
the	O
estimated	O
icc	O
for	O
blood	O
samples	O
was	O
moderate	O
,	O
it	O
indicates	O
that	O
enterolactone	B
levels	O
of	O
both	O
fasting	O
and	O
non	O
-	O
fasting	O
blood	O
samples	O
should	O
be	O
useful	O
in	O
future	O
projects	O
within	O
the	O
malmö	O
diet	O
and	O
cancer	O
cohort	O
.	O

within	O
-	O
person	O
reproducibility	O
of	O
urinary	O
bisphenol	O
a	O
and	O
phthalate	B
metabolites	I
over	O
a	O
1	O
to	O
3	O
 	O
year	O
period	O
among	O
women	O
in	O
the	O
nurses	O
'	O
health	O
studies	O
:	O
a	O
prospective	O
cohort	O
study	O
..	O
background	O
:	O
associations	O
of	O
bisphenol	O
a	O
and	O
phthalates	O
with	O
chronic	O
disease	O
health	O
outcomes	O
are	O
increasingly	O
being	O
investigated	O
in	O
epidemiologic	O
studies	O
.	O

therefore	O
,	O
we	O
assessed	O
within	O
-	O
person	O
reproducibility	O
of	O
bisphenol	O
a	O
,	O
eight	O
phthalate	B
metabolites	I
,	O
and	O
phthalic	O
acid	O
in	O
spot	O
urine	O
samples	O
over	O
1	O
to	O
3	O
 	O
years	O
among	O
women	O
enrolled	O
in	O
two	O
large	O
cohort	O
studies	O
.	O

methods	O
:	O
women	O
in	O
the	O
nurses	O
'	O
health	O
study	O
and	O
nurses	O
'	O
health	O
study	O
ii	O
provided	O
two	O
spot	O
urine	O
samples	O
,	O
1	O
to	O
3	O
 	O
years	O
apart	O
(	O
n	O
 	O
=	O
 	O
80	O
women	O
for	O
analyses	O
of	O
bisphenol	O
a	O
;	O
n	O
 	O
=	O
 	O
40	O
women	O
for	O
analyses	O
of	O
phthalate	B
metabolites	I
;	O
n	O
 	O
=	O
 	O
34	O
women	O
for	O
analyses	O
of	O
phthalic	O
acid	O
)	O
.	O

to	O
measure	O
within	O
-	O
person	O
reproducibility	O
,	O
we	O
calculated	O
spearman	O
rank	O
correlation	O
coefficients	O
and	O
intraclass	O
correlation	O
coefficients	O
for	O
creatinine	O
-	O
adjusted	O
concentrations	O
of	O
bisphenol	O
a	O
,	O
phthalate	B
metabolites	I
,	O
and	O
phthalic	O
acid	O
.	O

seven	O
of	O
the	O
eight	O
phthalate	B
metabolites	I
and	O
phthalic	O
acid	O
demonstrated	O
moderate	O
within	O
-	O
person	O
stability	O
over	O
time	O
(	O
spearman	O
correlation	O
or	O
intraclass	O
correlation	O
coefficient	O
 	O
=	O
 	O
0.39	O
-	O
0.55	O
)	O
.	O

the	O
majority	O
of	O
urinary	O
phthalate	B
metabolites	I
and	O
phthalic	O
acid	O
appeared	O
moderately	O
reproducible	O
within	O
women	O
over	O
time	O
,	O
suggesting	O
single	O
measurements	O
may	O
be	O
useful	O
in	O
epidemiologic	O
studies	O
,	O
although	O
observed	O
relative	O
risks	O
can	O
be	O
substantially	O
attenuated	O
.	O

reliability	O
of	O
serum	O
measurements	O
of	O
lignans	O
and	O
isoflavonoid	O
phytoestrogens	O
over	O
a	O
two	O
-	O
year	O
period	O
..	O
we	O
examined	O
the	O
distribution	O
and	O
long	O
-	O
term	O
reliability	O
of	O
serum	O
measurements	O
of	O
the	O
two	O
main	O
human	O
lignans	O
,	O
enterolactone	B
and	O
enterodiol	B
,	O
and	O
the	O
isoflavonoid	O
phytoestrogens	O
daidzein	O
,	O
genistein	O
,	O
equol	O
,	O
and	O
o	B
-	I
desmethylangolensin	I
in	O
the	O
new	O
york	O
university	O
women	O
's	O
health	O
study	O
,	O
a	O
prospective	O
cohort	O
study	O
of	O
sex	O
hormones	O
and	O
breast	O
cancer	O
.	O

the	O
median	O
levels	O
of	O
enterodiol	B
and	O
enterolactone	B
were	O
1.52	O
nmol	O
/	O
liter	O
and	O
20.2	O
nmol	O
/	O
liter	O
,	O
respectively	O
,	O
and	O
were	O
comparable	O
with	O
the	O
levels	O
observed	O
in	O
omnivorous	O
finnish	O
women	O
living	O
in	O
the	O
helsinki	O
area	O
.	O

a	O
substantial	O
number	O
of	O
women	O
,	O
though	O
,	O
had	O
fairly	O
high	O
levels	O
:	O
for	O
instance	O
,	O
15	O
%	O
of	O
the	O
assays	O
showed	O
levels	O
of	O
enterolactone	B
greater	O
than	O
the	O
mean	O
level	O
observed	O
in	O
vegetarian	O
finnish	O
women	O
,	O
i.e.	O
,	O
89.1	O
nmol	O
/	O
liter	O
(	O
h.	O
adlercreutz	O
et	O

the	O
reliability	O
coefficient	O
of	O
a	O
single	O
measurement	O
of	O
enterolactone	B
was	O
moderately	O
high	O
(	O
0.55	O
)	O
,	O
suggesting	O
that	O
serum	O
measurements	O
of	O
this	O
compound	O
could	O
be	O
a	O
useful	O
tool	O
in	O
prospective	O
epidemiological	O
studies	O
with	O
access	O
to	O
repeated	O
blood	O
or	O
serum	O
specimens	O
.	O

for	O
instance	O
,	O
the	O
reliability	O
coefficient	O
of	O
the	O
average	O
of	O
three	O
measurements	O
of	O
enterolactone	B
would	O
be	O
0.79	O
,	O
a	O
level	O
considered	O
acceptable	O
in	O
light	O
of	O
the	O
other	O
sources	O
of	O
error	O
that	O
are	O
present	O
in	O
epidemiological	O
studies	O
(	O
w.	O
willett	O
,	O
stat	O
.	O

temporal	O
variability	O
in	O
urinary	O
levels	O
of	O
drinking	O
water	O
disinfection	O
byproducts	O
dichloroacetic	B
acid	I
and	O
trichloroacetic	B
acid	I
among	O
men	O
..	O
urinary	O
haloacetic	O
acids	O

(	O
haas	O
)	O
,	O
such	O
as	O
dichloroacetic	B
acid	I
(	O
dcaa	O
)	O
and	O
trichloroacetic	B
acid	I
(	O
tcaa	O
)	O
,	O
have	O
been	O
suggested	O
as	O
potential	O
biomarkers	O
of	O
exposure	O
to	O
drinking	O
water	O
disinfection	O
byproducts	O
(	O
dbps	O
)	O
.	O

urinary	O
haloacetic	O
acids	O
(	O
haas	O
)	O
,	O
such	O
as	O
dichloroacetic	B
acid	I
(	O
dcaa	O
)	O
and	O
trichloroacetic	B
acid	I
(	O
tcaa	O
)	O
,	O
have	O
been	O
suggested	O
as	O
potential	O
biomarkers	O
of	O
exposure	O
to	O
drinking	O
water	O
disinfection	O
byproducts	O
(	O
dbps	O
)	O
.	O

temporal	O
variability	O
of	O
polybrominated	O
diphenyl	O
ether	O
(	O
pbde	O
)	O
serum	O
concentrations	O
over	O
one	O
year	O
..	O
polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
flame	O
retardant	O
chemicals	O
used	O
in	O
consumer	O
products	O
.	O

polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
flame	O
retardant	O
chemicals	O
used	O
in	O
consumer	O
products	O
.	O

polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
flame	O
retardant	O
chemicals	O
used	O
in	O
consumer	O
products	O
.	O

polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
flame	O
retardant	O
chemicals	O
used	O
in	O
consumer	O
products	O
.	O

polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
flame	O
retardant	O
chemicals	O
used	O
in	O
consumer	O
products	O
.	O

polybrominated	O
diphenyl	O
ethers	O
(	O
pbdes	B
)	O
are	O
flame	O
retardant	O
chemicals	O
used	O
in	O
consumer	O
products	O
.	O

long	O
-	O
term	O
reproducibility	O
of	O
plasma	O
alkylresorcinols	B
as	O
biomarkers	O
of	O
whole	O
-	O
grain	O
wheat	O
and	O
rye	O
intake	O
within	O
northern	O
sweden	O
health	O
and	O
disease	O
study	O
cohort	O
..	O
background	O
/	O
objectives	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
have	O
been	O
suggested	O
as	O
specific	O
biomarkers	O
of	O
whole	O
-	O
grain	O
(	O
wg	O
)	O
and	O
bran	O
intake	O
from	O
wheat	O
and	O
rye	O
.	O
before	O
using	O
plasma	O
ar	O
as	O
biomarkers	O
in	O
prospective	O
cohort	O
studies	O
,	O
the	O
long	O
-	O
term	O
reproducibility	O
needs	O
to	O
be	O
determined	O
in	O
order	O
to	O
judge	O
how	O
well	O
a	O
single	O
plasma	O
sample	O
reflects	O
the	O
long	O
-	O
term	O
concentration	O
.	O

together	O
with	O
previous	O
data	O
showing	O
high	O
validity	O
of	O
plasma	O
ar	O
as	O
biomarkers	O
of	O
wheat	O
and	O
rye	O
in	O
different	O
populations	O
,	O
the	O
current	O
finding	O
suggest	O
that	O
this	O
biomarker	O
is	O
stable	O
over	O
a	O
long	O
-	O
time	O
period	O
and	O
is	O
therefore	O
probably	O
useful	O
for	O
assessment	O
of	O
long	O
-	O
term	O
wg	O
intake	O
in	O
populations	O
with	O
a	O
wide	O
intake	O
range	O
and	O
a	O
frequent	O
intake	O
..	O
background	O
/	O
objectives	O
:	O
alkylresorcinols	B
(	O
ar	O
)	O
have	O
been	O
suggested	O
as	O
specific	O
biomarkers	O
of	O
whole	O
-	O
grain	O
(	O
wg	O
)	O
and	O
bran	O
intake	O
from	O
wheat	O
and	O
rye	O
.	O
before	O
using	O
plasma	O
ar	O
as	O
biomarkers	O
in	O
prospective	O
cohort	O
studies	O
,	O
the	O
long	O
-	O
term	O
reproducibility	O
needs	O
to	O
be	O
determined	O
in	O
order	O
to	O
judge	O
how	O
well	O
a	O
single	O
plasma	O
sample	O
reflects	O
the	O
long	O
-	O
term	O
concentration	O
.	O

validation	O
of	O
trichloroacetic	B
acid	I
exposure	O
via	O
drinking	O
water	O
during	O
pregnancy	O
using	O
a	O
urinary	O
tcaa	O
biomarker	O
..	O
disinfection	O
by	O
-	O
product	O
(	O
dbp	O
)	O
exposure	O
during	O
pregnancy	O
may	O
be	O
related	O
to	O
reduced	O
fetal	O
growth	O
,	O
but	O
the	O
evidence	O
is	O
inconclusive	O
and	O
improved	O
dbp	O
exposure	O
assessment	O
is	O
required	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

the	O
reliability	O
of	O
plasma	O
carotenoids	O
,	O
retinol	O
,	O
vitamin	O
c	O
,	O
and	O
tocopherols	O
,	O
and	O
of	O
serum	O
folate	O
,	O
homocysteine	B
,	O
and	O
vitamins	O
b6	O
and	O
b12	O
was	O
estimated	O
using	O
an	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
.	O

serum	O
homocysteine	B
and	O
vitamin	B
b12	I
were	O
highly	O
reliable	O
biomarkers	O
,	O
with	O
iccs	O
of	O
0.91	O
and	O
0.75	O
,	O
respectively	O
.	O

those	O
showing	O
more	O
than	O
20	O
%	O
of	O
between	O
-	O
subject	O
coefficients	O
of	O
variances	O
in	O
both	O
male	O
and	O
female	O
were	O
blood	O
vitamin	O
b(6	O
)	O
,	O
vitamin	O
b(12	O
)	O
and	O
folate	O
levels	O
,	O
and	O
urinary	O
vitamin	O
b(1	O
)	O
,	O
vitamin	O
b(2	O
)	O
,	O
vitamin	O
b(12	O
)	O
,	O
nicotinamide	B
metabolites	O
,	O
pantothenic	O
acid	O
,	O
biotin	B
and	O
vitamin	O
c.	O
these	O
results	O
showed	O
that	O
oral	O
administration	O
of	O
constant	O
of	O
water	O
-	O
soluble	O
vitamins	O
generally	O
decreased	O
intra	O
-	O
individual	O
variation	O
,	O
while	O
individual	O
differences	O
in	O
urinary	O
vitamin	O
excretion	O
were	O
observed	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

additionally	O
,	O
the	O
mass	O
fractions	O
of	O
dep	O
,	O
dnbp	O
,	O
dibp	O
and	O
bbzp	O
in	O
dust	O
collected	O
from	O
the	O
children	O
's	O
bedrooms	O
and	O
daycare	O
centers	O
significantly	O
correlated	O
with	O
the	O
concentrations	O
of	O
these	O
phthalates	O
'	O
metabolites	O
(	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
respectively	O
)	O
in	O
the	O
children	O
's	O
urine	O
.	O

the	O
sum	O
of	O
the	O
three	O
dehp	B
metabolites	I
in	O
children	O
's	O
and	O
in	O
adults	O
'	O
urine	O
was	O
90.0	O
and	O
59.1	O
micrograms	O
/	O
l	O
respectively	O
(	O
median	O
values	O
;	O
p	O
=	O
0.074	O
)	O
.	O

total	O
creatinine	O
adjusted	O
dehp	B
metabolites	I
in	O
urine	O
were	O
significantly	O
higher	O
in	O
children	O
than	O
in	O
adults	O
(	O
median	O
values	O
:	O
98.8	O
vs.	O
50.9	O
micrograms	O
/	O
g	O
creatinine	O
;	O
p	O
<	O
0.0001	O
)	O
.	O

the	O
sum	O
of	O
the	O
three	O
dehp	B
metabolites	I
in	O
children	O
's	O
and	O
in	O
adults	O
'	O
urine	O
was	O
90.0	O
and	O
59.1	O
micrograms	O
/	O
l	O
respectively	O
(	O
median	O
values	O
;	O
p	O
=	O
0.074	O
)	O
.	O

total	O
creatinine	O
adjusted	O
dehp	B
metabolites	I
in	O
urine	O
were	O
significantly	O
higher	O
in	O
children	O
than	O
in	O
adults	O
(	O
median	O
values	O
:	O
98.8	O
vs.	O
50.9	O
micrograms	O
/	O
g	O
creatinine	O
;	O
p	O
<	O
0.0001	O
)	O
.	O

the	O
sum	O
of	O
the	O
three	O
dehp	B
metabolites	I
in	O
children	O
's	O
and	O
in	O
adults	O
'	O
urine	O
was	O
90.0	O
and	O
59.1	O
micrograms	O
/	O
l	O
respectively	O
(	O
median	O
values	O
;	O
p	O
=	O
0.074	O
)	O
.	O

total	O
creatinine	O
adjusted	O
dehp	B
metabolites	I
in	O
urine	O
were	O
significantly	O
higher	O
in	O
children	O
than	O
in	O
adults	O
(	O
median	O
values	O
:	O
98.8	O
vs.	O
50.9	O
micrograms	O
/	O
g	O
creatinine	O
;	O
p	O
<	O
0.0001	O
)	O
.	O

the	O
sum	O
of	O
the	O
three	O
dehp	B
metabolites	I
in	O
children	O
's	O
and	O
in	O
adults	O
'	O
urine	O
was	O
90.0	O
and	O
59.1	O
micrograms	O
/	O
l	O
respectively	O
(	O
median	O
values	O
;	O
p	O
=	O
0.074	O
)	O
.	O

total	O
creatinine	O
adjusted	O
dehp	B
metabolites	I
in	O
urine	O
were	O
significantly	O
higher	O
in	O
children	O
than	O
in	O
adults	O
(	O
median	O
values	O
:	O
98.8	O
vs.	O
50.9	O
micrograms	O
/	O
g	O
creatinine	O
;	O
p	O
<	O
0.0001	O
)	O
.	O

circulating	O
levels	O
of	O
bisphenol	B
a	I
(	I
bpa	I
)	I
and	O
phthalates	O
in	O
an	O
elderly	O
population	O
in	O
sweden	O
,	O
based	O
on	O
the	O
prospective	O
investigation	O
of	O
the	O
vasculature	O
in	O
uppsala	O
seniors	O
(	O
pivus	O
)	O
..	O

the	O
plastic	O
manufacture	O
compounds	O
,	O
bisphenol	B
a	I
(	I
bpa	I
)	I
and	O
phthalates	O
,	O
are	O
ubiquitous	O
and	O
have	O
therefore	O
been	O
detected	O
in	O
virtually	O
all	O
types	O
of	O
analyzed	O
human	O
samples	O
.	O

bpa	O
and	O
four	O
out	O
of	O
ten	O
phthalate	O
metabolites	O
,	O
namely	O
,	O
monoisobutyl	O
phthalate	O
(	O
mibp	O
)	O
,	O
monomethyl	B
phthalate	I
(	I
mmp	I
)	I
,	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
mehp	O
)	O
,	O
were	O
detectable	O
in	O
almost	O
all	O
subjects	O
.	O
of	O
the	O
remaining	O
phthalate	O
metabolites	O
,	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
mono-(2	O
-	O
ethyl-5	O
-	O
hydroxyhexyl	O
)	O

a	O
48	O
-	O
h	O
personal	O
air	O
sample	O
was	O
collected	O
and	O
analyzed	O
for	O
dep	O
and	O
dnbp	O
;	O
a	O
maternal	O
spot	O
urine	O
sample	O
was	O
collected	O
and	O
analyzed	O
for	O
their	O
monoester	O
metabolites	O
,	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
and	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
,	O
respectively	O
.	O

levels	O
of	O
metabolites	O
of	O
organophosphate	O
pesticides	O
,	O
phthalates	O
,	O
and	O
bisphenol	O
a	O
in	O
pooled	O
urine	O
specimens	O
from	O
pregnant	O
women	O
participating	O
in	O
the	O
norwegian	O
mother	O
and	O
child	O
cohort	O
study	O
(	O
moba	O
)	O
..	O
concerns	O
about	O
reproductive	O
and	O
developmental	O
health	O
risks	O
of	O
exposure	O
to	O
organophosphate	O
(	O
op	O
)	O
pesticides	O
,	O
phthalates	O
,	O
and	O
bisphenol	B
a	I
(	I
bpa	I
)	I
among	O
the	O
general	O
population	O
are	O
increasing	O
.	O

the	O
diethyl	O
phthalate	O
metabolite	O
mono	O
-	O
ethyl	O
phthalate	O
(	O
mep	O
)	O
was	O
the	O
dominant	O
phthalate	O
metabolite	O
in	O
all	O
three	O
studies	O
,	O
with	O
the	O
mean	O
concentrations	O
of	O
greater	O
than	O
300	O
microg	O
/	O
l.	O
the	O
moba	O
and	O
generation	O
r	O
women	O
had	O
higher	O
mean	O
concentrations	O
of	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
and	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
than	O
the	O
nhanes	O
women	O
.	O

results	O
:	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
was	O
detected	O
at	O
the	O
highest	O
concentration	O
in	O
urine	O
of	O
egyptian	O
girls	O
(	O
median	O
:	O
43.2	O
ng	O
/	O
ml	O
in	O
rural	O
,	O
98.8	O
ng	O
/	O
ml	O
in	O
urban	O
)	O
.	O

storage	O
of	O
food	O
in	O
plastic	O
containers	O
was	O
a	O
statistically	O
significant	O
predictor	O
of	O
urinary	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
concentrations	O
when	O
comparing	O
covariate	O
adjusted	O
means	O
.	O

conclusions	O
:	O
urinary	O
concentrations	O
of	O
dep	O
and	O
dehp	B
metabolites	I
in	O
pregnant	O
women	O
showed	O
lower	O
reproducibility	O
than	O
metabolites	O
for	O
di	O
-	O
n	O
-	O
butyl	O
phthalate	O
and	O
bbzp	O
.	O

if	O
we	O
analyzed	O
all	O
399	O
available	O
samples	O
independent	O
of	O
classification	O
,	O
the	O
highest	O
median	O
values	O
of	O
primary	O
metabolites	O
in	O
this	O
study	O
were	O
found	O
for	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
:	I
49.6	O
microg	O
/	O
l	O
)	O
,	O
followed	O
by	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
:	I
44.9	O
microg	O
/	O
l	O
)	O
,	O
mono	O
-	O
benzyl	O
phthalate	O
(	O
mbzp	O
:	O
7.2	O
microg	O
/	O
l	O
)	O
,	O
and	O
mono-2	O
-	O
ethylhexyl	O
phthalate	O
(	O
mehp	O
:	O
4.9	O
microg	O
/	O
l	O
)	O
.	O

we	O
found	O
detectable	O
levels	O
of	O
metabolites	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
monobutyl	O
phthalate	O
(	O
mbp	O
)	O
,	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
and	O
mono-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
mehp	O
)	O
in	O
>	O
75	O
%	O
of	O
the	O
samples	O
,	O
suggesting	O
widespread	O
exposure	O
in	O
the	O
united	O
states	O
to	O
diethyl	O
phthalate	O
,	O
dibutyl	O
phthalate	O
or	O
diisobutylphthalate	O
,	O
benzylbutyl	O
phthalate	O
,	O
and	O
di-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
,	O
respectively	O
.	O

the	O
highest	O
median	O
concentrations	O
for	O
individual	O
analytes	O
in	O
each	O
family	O
were	O
for	O
enterolactone	B
(	O
298	O
microg	O
/	O
l	O
)	O
,	O
monoethylphthalate	O
(	O
mep	O
;	O
83.2	O
microg	O
/	O
l	O
)	O
,	O
and	O
benzophenone-3	O
(	O
bp3	O
;	O
14.7	O
microg	O
/	O
l	O
)	O
.	O

few	O
or	O
no	O
data	O
have	O
been	O
reported	O
previously	O
for	O
four	O
metabolites	O
:	O
mono(2	O
-	O
ethyl-5	O
-	O
carboxypentyl	O
)	O
phthalate	O
,	O
tridosan	O
,	O
bisphenol	B
a	I
(	I
bpa	I
)	I
,	O
and	O
bp3	O
;	O
these	O
were	O
detected	O
in	O
67	O
-	O
100	O
%	O
of	O
samples	O
with	O
medians	O
of	O
1.8	O
-	O
53.2	O
microg	O
/	O

l.	O
after	O
multivariate	O
adjustment	O
,	O
two	O
analytes	O
,	O
enterolactone	B
and	O
bpa	O
,	O
were	O
higher	O
among	O
girls	O
with	O
body	O
mass	O
index	O
<	O
85th	O
reference	O
percentile	O
than	O
those	O
at	O
or	O
above	O
the	O
85th	O
percentile	O
.	O

monomethyl	B
phthalate	I
(	I
mmp	I
)	I
,	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono	O
(	O
2	O
-	O
isobutyl	O
phthalate	O
)	O
(	O
mibp	O
)	O
,	O
mono	O
-	O
n	O
-	O
butyl	O
phthalate	O
(	O
mbp	O
)	O
,	O
and	O
metabolites	O
of	O
di-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
dehp	O
)	O
were	O
the	O
dominant	O
compounds	O
,	O
collectively	O
accounting	O
for	O
>	O
95	O
%	O
of	O
the	O
total	O
concentrations	O
in	O
the	O
samples	O
from	O
the	O
seven	O
countries	O
.	O

bisphenol	B
a	I
(	I
bpa	I
)	I
is	O
an	O
industrial	O
chemical	O
used	O
primarily	O
in	O
polycarbonate	O
plastic	O
and	O
epoxy	O
resins	O
.	O

results	O
:	O
nine	O
metabolites	O
were	O
detected	O
in	O
at	O
least	O
95	O
%	O
of	O
the	O
samples	O
:	O
mono(2	O
-	O
ethyl-5	O
-	O
carboxypentyl	O
)	O
phthalate	O
,	O
mono(2	O
-	O
ethyl-5	O
-	O
hydroxyhexyl	O
)	O
phthalate	O
,	O
mono(2	O
-	O
ethyl-5	O
-	O
oxohexyl	O
)	O
phthalate	O
,	O
mono(3	O
-	O
carboxypropyl	O
)	O
phthalate	O
,	O
mono(n	O
-	O
butyl	O
)	O
phthalate	O
,	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
,	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
mono(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
and	O
monoisobutyl	O
phthalate	O
.	O

results	O
:	O
three	O
metabolites	O
of	O
di(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
,	O
mono-2	O
-	O
ethyl-5	O
-	O
carboxypentyl	O
phthalate	O
,	O
mono-2	O
-	O
ethyl-5	O
-	O
hydroxyhexyl	O
phthalate	O
,	O
and	O
mono-2	O
-	O
ethyl-5	O
-	O
oxohexyl	O
phthalate	O
;	O
two	O
metabolites	O
of	O
dibutyl	O
phthalates	O
,	O
mono	O
-	O
isobutyl	O
phthalate	O
and	O
mono	O
-	O
n	O
-	O
butyl	O
phthalate	O
;	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
the	O
main	O
metabolite	O
of	O
diethyl	O
phthalate	O
;	O
and	O
two	O
phenols	O
,	O
methyl	O
paraben	O
(	O
m	O
-	O
pb	O
)	O
and	O
2,5	O
-	O
dichlorophenol	O
were	O
detected	O
in	O
the	O
urine	O
samples	O
of	O
all	O
women	O
.	O

the	O
median	O
concentrations	O
of	O
monoethyl	B
phthalate	I
(	I
mep	I
)	I
,	O
monobenzyl	B
phthalate	I
(	I
mbzp	I
)	I
and	O
the	O
sums	O
of	O
the	O
two	O
monobutyl	O
phthalate	O
isoforms	O
(	O
∑mbp(i+n	O
)	O
)	O
,	O
metabolites	O
of	O
di-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
∑dehpm	O
)	O
and	O
of	O
di	O
-	O
iso	O
-	O
nonyl	O
phthalate	O
(	O
∑dinpm	O
)	O
were	O
29	O
,	O
17	O
,	O
111	O
,	O
107	O
and	O
31	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O

urinary	O
metabolite	O
concentrations	O
of	O
organophosphorous	O
pesticides	O
,	O
bisphenol	O
a	O
,	O
and	O
phthalates	O
among	O
pregnant	O
women	O
in	O
rotterdam	O
,	O
the	O
netherlands	O
:	O
the	O
generation	O
r	O
study	O
..	O
concern	O
about	O
potential	O
health	O
impacts	O
of	O
low	O
-	O
level	O
exposures	O
to	O
organophosphorus	O
(	O
op	O
)	O
pesticides	O
,	O
bisphenol	B
a	I
(	I
bpa	I
)	I
,	O
and	O
phthalates	O
among	O
the	O
general	O
population	O
is	O
increasing	O
.	O

the	O
median	O
concentration	O
of	O
mono	O
-	O
ethyl	O
phthalate	O
(	O
mep	O
)	O
was	O
222.0	O
microg	O
/	O
g	O
cr	O
;	O
the	O
median	O
concentrations	O
of	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
and	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
were	O
above	O
50	O
microg	O
/	O
g	O
cr	O
.	O

determinants	O
of	O
urinary	O
bisphenol	O
a	O
concentrations	O
in	O
mexican	O
/	O
mexican	O
--	O
american	O
pregnant	O
women	O
..	O
prenatal	O
exposure	O
to	O
bisphenol	B
a	I
(	I
bpa	I
)	I
may	O
be	O
associated	O
with	O
adverse	O
health	O
effects	O
in	O
the	O
developing	O
fetus	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
predictors	O
of	O
bpa	O
exposure	O
during	O
pregnancy	O
.	O

overall	O
,	O
15	O
phthalates	O
,	O
including	O
di-2	O
-	O
ethylhexyl	O
phthalate	O
(	O
dehp	O
)	O
,	O
di	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
dnbp	I
)	I
,	O
di	B
-	I
isobutyl	I
phthalate	I
(	I
dibp	I
)	I
,	O
di	O
-	O
isononyl	O
phthalate	O
(	O
dinp	O
)	O
,	O
three	O
primary	O
metabolites	O
of	O
dehp	O
[	O
mono-(2	O
-	O
ethylhexyl	O
)	O
phthalate	O
(	O
mehp	O
)	O
,	O
mono	B
-	I
isobutyl	I
phthalate	I
(	I
mibp	I
)	I
,	O
and	O
mono	B
-	I
n	I
-	I
butyl	I
phthalate	I
(	I
mnbp	I
)	I
]	O
,	O
and	O
two	O
secondary	O
metabolites	O
of	O
dehp	O
were	O
analyzed	O
in	O
78	O
breast	O
milk	O
samples	O
.	O

